cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
LUAD	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.3	3.9	0.000112	Crohn's disease	
LUAD	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.46	7.8	3.77E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs10005733	chr4:292001	ZNF718	chr4:53272-156488:+	0.33	5.17	3.42E-7	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs10006789	chr4:1330333	CRIPAK	chr4:1385340-1389782:+	0.22	4.66	4.14E-6	Systolic blood pressure	
LUAD	cis	1	rs10007789	chr4:165890377	C4orf39	chr4:165878100-165880273:+	0.3	5.87	8.13E-9	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs10007789	chr4:165890377	TRIM61	chr4:165875600-165898818:-	0.2	4.07	5.57E-5	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.36	-7.19	2.42E-12	Longevity	
LUAD	cis	1	rs1001373	chr1:171684506	VAMP4	chr1:171669298-171711214:-	0.24	3.87	0.000125	Hippocampal atrophy	
LUAD	cis	1	rs10017445	chr4:68423787	STAP1	chr4:68424446-68473053:+	-0.18	-3.79	0.00017	Parkinson's disease	
LUAD	cis	1	rs10023907	chr4:88772535	SPP1	chr4:88896802-88904562:+	-0.19	-3.82	0.000152	Bone mineral density;Bone mineral density (paediatric, total body less head)	
LUAD	cis	1	rs1002675	chr3:38445226	XYLB	chr3:38388251-38456467:+	0.21	3.82	0.000148	Electrocardiographic conduction measures	
LUAD	cis	1	rs1002676	chr3:38444932	XYLB	chr3:38388251-38456467:+	-0.2	-3.67	0.000271	Electrocardiographic conduction measures	
LUAD	cis	1	rs10027325	chr4:282608	ZNF718	chr4:53272-156488:+	0.25	3.74	0.000203	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs1002978	chr3:112499796	CCDC80	chr3:112323411-112359977:-	-0.12	-3.75	0.000201	Prostate cancer (gene x gene interaction)	
LUAD	cis	1	rs1002979	chr3:112497880	CCDC80	chr3:112323411-112359977:-	-0.12	-3.83	0.000143	Prostate cancer (gene x gene interaction)	
LUAD	cis	1	rs10030019	chr4:106998448	TBCK	chr4:106967233-107237861:-	0.25	4.78	2.37E-6	Airflow obstruction	
LUAD	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.36	-8.2	2.12E-15	Eye color traits	
LUAD	cis	1	rs1003719	chr21:38491095	TTC3	chr21:38445571-38575406:+	0.19	4.15	3.95E-5	Eye color traits	
LUAD	cis	1	rs10041072	chr5:150259642	LOC134466	chr5:150310000-150326146:-	0.28	3.7	0.000236	Crohn's disease	
LUAD	cis	1	rs1004467	chr10:104594507	SFXN2	chr10:104474298-104498946:+	-0.32	-3.67	0.000272	Hypertension;Systolic blood pressure;Diastolic blood pressure	
LUAD	cis	1	rs10048683	chr2:26320519	GPR113	chr2:26531041-26569685:-	-0.22	-3.74	0.000204	Gut microbiome composition (summer)	
LUAD	cis	1	rs10050159	chr4:106765915	INTS12	chr4:106603787-106629881:-	-0.49	-5.5	6.12E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs10050333	chr4:106765813	INTS12	chr4:106603787-106629881:-	-0.49	-5.5	6.12E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.79	14.06	5.77E-38	Type 2 diabetes	
LUAD	cis	1	rs10061105	chr5:150255185	LOC134466	chr5:150310000-150326146:-	0.3	3.82	0.000151	Crohn's disease	
LUAD	cis	1	rs1006396	chr22:30017000	NIPSNAP1	chr22:29950800-29977144:-	0.25	4.25	2.53E-5	Lipid traits	
LUAD	cis	1	rs10077411	chr5:156015151	SGCD	chr5:155135063-156194796:+	0.17	4.16	3.71E-5	Airway responsiveness in chronic obstructive pulmonary disease	
LUAD	cis	1	rs10077734	chr5:156009720	SGCD	chr5:155135063-156194796:+	0.15	3.95	8.89E-5	Airway responsiveness in chronic obstructive pulmonary disease	
LUAD	cis	1	rs10078	chr5:438102	C5orf55	chr5:441645-443258:-	0.23	4.17	3.68E-5	Fat distribution (HIV)	
LUAD	cis	1	rs10080429	chr6:109738106	AKD1	chr6:109814059-110012415:-	-0.22	-4.21	3.04E-5	Height	
LUAD	cis	1	rs10080429	chr6:109738106	SMPD2	chr6:109761931-109765121:+	0.23	4.6	5.48E-6	Height	
LUAD	cis	1	rs10082278	chr1:202495120	PPP1R12B	chr1:202317836-202557697:+	0.22	4.93	1.14E-6	Sex ratio	
LUAD	cis	1	rs10088439	chr8:8576699	CLDN23	chr8:8559666-8561616:+	-0.32	-5.48	6.84E-8	Obesity-related traits	
LUAD	cis	1	rs10090581	chr8:92070160	LRRC69	chr8:92114847-92231464:+	-0.22	-3.84	0.000141	Migraine - clinic-based	
LUAD	cis	1	rs1009242	chr9:131916832	CRAT	chr9:131857075-131873070:-	0.33	6.33	5.58E-10	Blood metabolite ratios	
LUAD	cis	1	rs1009242	chr9:131916832	PPP2R4	chr9:131873244-131911223:+	0.19	3.69	0.000251	Blood metabolite ratios	
LUAD	cis	1	rs10095630	chr8:92071264	LRRC69	chr8:92114847-92231464:+	-0.22	-3.84	0.000138	Migraine - clinic-based	
LUAD	cis	1	rs10095733	chr8:8574646	CLDN23	chr8:8559666-8561616:+	-0.32	-5.51	5.69E-8	Obesity-related traits	
LUAD	cis	1	rs10098234	chr8:8576692	CLDN23	chr8:8559666-8561616:+	-0.32	-5.5	6.09E-8	Obesity-related traits	
LUAD	cis	1	rs10103769	chr8:8573036	CLDN23	chr8:8559666-8561616:+	-0.33	-5.6	3.5E-8	Obesity-related traits	
LUAD	cis	1	rs10110267	chr8:92073814	LRRC69	chr8:92114847-92231464:+	-0.22	-3.77	0.000181	Migraine - clinic-based	
LUAD	cis	1	rs10110591	chr8:8576608	CLDN23	chr8:8559666-8561616:+	0.31	5.48	6.8E-8	Obesity-related traits	
LUAD	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.34	-6.7	5.92E-11	Rheumatoid arthritis	
LUAD	cis	1	rs10120103	chr9:102695468	STX17	chr9:102668915-102736817:+	-0.17	-3.68	0.000263	Alopecia areata	
LUAD	cis	1	rs10121601	chr9:102687445	STX17	chr9:102668915-102736817:+	-0.18	-3.79	0.000169	Alopecia areata	
LUAD	cis	1	rs10123261	chr9:102695442	STX17	chr9:102668915-102736817:+	-0.18	-3.83	0.000147	Alopecia areata	
LUAD	cis	1	rs10127539	chr1:110620117	ALX3	chr1:110602998-110613322:-	-0.2	-3.99	7.54E-5	Blood metabolite levels	
LUAD	cis	1	rs10128711	chr11:18632984	SPTY2D1	chr11:18627949-18656020:-	-0.22	-4.89	1.37E-6	Cholesterol, total	
LUAD	cis	1	rs10136440	chr14:104397367	TDRD9	chr14:104394817-104519002:+	-0.26	-3.99	7.76E-5	Bipolar disorder	
LUAD	cis	1	rs10136948	chr14:75511075	MLH3	chr14:75480467-75518235:-	0.24	4.7	3.39E-6	Height	
LUAD	cis	1	rs10138183	chr14:75615227	MLH3	chr14:75480467-75518235:-	0.26	5	7.95E-7	Height	
LUAD	cis	1	rs10140433	chr14:74659989	C14orf45	chr14:74486059-74549566:+	-0.19	-4.23	2.85E-5	Common traits (Other)	
LUAD	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.46	-10.3	1.25E-22	Common traits (Other)	
LUAD	cis	1	rs10140433	chr14:74659989	ZNF410	chr14:74318674-74398803:+	-0.19	-3.83	0.000147	Common traits (Other)	
LUAD	cis	1	rs10140851	chr14:75512612	MLH3	chr14:75480467-75518235:-	0.23	4.28	2.27E-5	Height	
LUAD	cis	1	rs10142626	chr14:75555636	MLH3	chr14:75480467-75518235:-	0.24	4.58	5.89E-6	Height	
LUAD	cis	1	rs10142865	chr14:75555624	MLH3	chr14:75480467-75518235:-	0.24	4.58	5.89E-6	Height	
LUAD	cis	1	rs10143132	chr14:75525850	MLH3	chr14:75480467-75518235:-	0.22	4.1	4.91E-5	Height	
LUAD	cis	1	rs10144220	chr14:74647904	C14orf45	chr14:74486059-74549566:+	-0.18	-3.96	8.59E-5	Common traits (Other)	
LUAD	cis	1	rs10144220	chr14:74647904	COQ6	chr14:74416643-74429811:+	-0.19	-3.81	0.000154	Common traits (Other)	
LUAD	cis	1	rs10144220	chr14:74647904	DLST	chr14:75348594-75370450:+	-0.21	-3.73	0.000217	Common traits (Other)	
LUAD	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.48	-10.72	3.26E-24	Common traits (Other)	
LUAD	cis	1	rs10144220	chr14:74647904	ZNF410	chr14:74318674-74398803:+	-0.21	-4.22	2.88E-5	Common traits (Other)	
LUAD	cis	1	rs10146482	chr14:75574087	MLH3	chr14:75480467-75518235:-	0.25	4.88	1.44E-6	Height	
LUAD	cis	1	rs10149651	chr14:104394440	TDRD9	chr14:104394817-104519002:+	-0.26	-3.93	9.79E-5	Bipolar disorder	
LUAD	cis	1	rs10149880	chr14:75633008	MLH3	chr14:75480467-75518235:-	-0.26	-4.9	1.28E-6	Height	
LUAD	cis	1	rs10150201	chr14:74649157	C14orf45	chr14:74486059-74549566:+	-0.18	-4.03	6.52E-5	Common traits (Other)	
LUAD	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.46	-10.2	2.82E-22	Common traits (Other)	
LUAD	cis	1	rs10150201	chr14:74649157	ZNF410	chr14:74318674-74398803:+	-0.18	-3.74	0.000209	Common traits (Other)	
LUAD	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.89	-18.17	9.83E-57	Homocysteine levels	
LUAD	cis	1	rs10157597	chr1:45990278	MUTYH	chr1:45794915-45806142:-	0.21	4.41	1.28E-5	Homocysteine levels	
LUAD	cis	1	rs10158100	chr1:202394199	PPP1R12B	chr1:202317836-202557697:+	0.21	4.66	4.07E-6	Sex ratio	
LUAD	cis	1	rs10158107	chr1:202394315	PPP1R12B	chr1:202317836-202557697:+	0.23	5.03	6.95E-7	Sex ratio	
LUAD	cis	1	rs10159280	chr1:202394287	PPP1R12B	chr1:202317836-202557697:+	0.21	4.65	4.24E-6	Sex ratio	
LUAD	cis	1	rs10169714	chr2:73808773	ALMS1	chr2:73612886-73837046:+	0.18	4.35	1.66E-5	Metabolite levels	
LUAD	cis	1	rs10169714	chr2:73808773	ALMS1P	chr2:73872046-73912692:+	0.4	7.5	3.03E-13	Metabolite levels	
LUAD	cis	1	rs10169714	chr2:73808773	FBXO41	chr2:73481800-73498043:-	0.2	3.77	0.00018	Metabolite levels	
LUAD	cis	1	rs1017302	chr12:9367402	LOC642846	chr12:9436253-9466684:+	0.19	4.35	1.65E-5	Non-alcoholic fatty liver disease histology (AST)	
LUAD	cis	1	rs10173081	chr2:102957348	IL1RL1	chr2:102927962-102968497:+	0.34	4.91	1.25E-6	Asthma	
LUAD	cis	1	rs1017698	chr2:219170525	DIRC3	chr2:218148748-218621316:-	-0.17	-3.7	0.000239	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs10177970	chr2:37512968	CEBPZ	chr2:37428778-37458740:-	0.18	3.79	0.000169	Chronic lymphocytic leukemia	
LUAD	cis	1	rs10178409	chr2:73855507	ALMS1	chr2:73612886-73837046:+	0.18	4.18	3.52E-5	Urinary metabolites	
LUAD	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.38	7.12	3.9E-12	Urinary metabolites	
LUAD	cis	1	rs10178409	chr2:73855507	FBXO41	chr2:73481800-73498043:-	0.21	3.83	0.000143	Urinary metabolites	
LUAD	cis	1	rs10178975	chr2:37514564	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.87	0.000125	Chronic lymphocytic leukemia	
LUAD	cis	1	rs10178982	chr2:202227640	ALS2CR12	chr2:202153148-202222101:-	-0.14	-3.76	0.000191	Basal cell carcinoma	
LUAD	cis	1	rs10178982	chr2:202227640	CASP8	chr2:202098166-202152434:+	0.24	5.25	2.25E-7	Basal cell carcinoma	
LUAD	cis	1	rs10179134	chr2:73637519	ALMS1	chr2:73612886-73837046:+	0.19	4.44	1.13E-5	Metabolite levels	
LUAD	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.39	7.47	3.7E-13	Metabolite levels	
LUAD	cis	1	rs10179134	chr2:73637519	FBXO41	chr2:73481800-73498043:-	0.2	3.68	0.00026	Metabolite levels	
LUAD	cis	1	rs10179458	chr2:102934974	IL1RL1	chr2:102927962-102968497:+	0.34	4.94	1.07E-6	Asthma	
LUAD	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.63	11.98	3.63E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs10187192	chr2:73713500	ALMS1	chr2:73612886-73837046:+	0.19	4.5	8.5E-6	Metabolite levels	
LUAD	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.38	7.14	3.49E-12	Metabolite levels	
LUAD	cis	1	rs10187416	chr2:73713741	ALMS1	chr2:73612886-73837046:+	0.2	4.83	1.79E-6	Metabolite levels	
LUAD	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.36	6.86	2.05E-11	Metabolite levels	
LUAD	cis	1	rs10189154	chr2:102937544	IL1RL1	chr2:102927962-102968497:+	0.34	5	8.2E-7	Asthma	
LUAD	cis	1	rs10189526	chr2:102937883	IL1RL1	chr2:102927962-102968497:+	0.34	5	8.2E-7	Asthma	
LUAD	cis	1	rs10190219	chr2:73658331	ALMS1	chr2:73612886-73837046:+	0.18	4.33	1.83E-5	Metabolite levels	
LUAD	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.39	7.39	6.32E-13	Metabolite levels	
LUAD	cis	1	rs1019217	chr11:22842622	SVIP	chr11:22843600-22851382:-	0.21	4.23	2.83E-5	Dialysis-related mortality	
LUAD	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.64	-14.14	2.58E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs10193383	chr2:219157692	DIRC3	chr2:218148748-218621316:-	0.18	3.93	9.91E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs10206064	chr2:219157959	DIRC3	chr2:218148748-218621316:-	0.18	3.93	9.91E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs10206231	chr2:202229225	CASP8	chr2:202098166-202152434:+	0.25	5.53	5.12E-8	Basal cell carcinoma	
LUAD	cis	1	rs10207220	chr2:73785046	ALMS1	chr2:73612886-73837046:+	0.18	4.28	2.21E-5	Metabolite levels	
LUAD	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.4	7.58	1.74E-13	Metabolite levels	
LUAD	cis	1	rs10208155	chr2:61115039	C2orf74	chr2:61372243-61391964:+	0.36	5.65	2.77E-8	Inflammatory skin disease	
LUAD	cis	1	rs10209620	chr2:61173941	C2orf74	chr2:61372243-61391964:+	0.34	5.46	7.53E-8	Inflammatory skin disease	
LUAD	cis	1	rs10210544	chr2:173314339	CDCA7	chr2:174219561-174233718:+	-0.28	-3.76	0.000193	Diabetic kidney disease	
LUAD	cis	1	rs10216533	chr8:143763690	PSCA	chr8:143761875-143764142:+	0.3	7.9	1.85E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs10217337	chr9:102710396	STX17	chr9:102668915-102736817:+	-0.18	-3.88	0.000117	Alopecia areata	
LUAD	cis	1	rs10217366	chr9:102710555	STX17	chr9:102668915-102736817:+	-0.18	-3.88	0.000117	Alopecia areata	
LUAD	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.88	8.49	2.5E-16	Coronary heart disease	
LUAD	cis	1	rs10228845	chr7:21583617	DNAH11	chr7:21582833-21941455:+	-0.41	-9.03	4.04E-18	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
LUAD	cis	1	rs10229224	chr7:21583921	DNAH11	chr7:21582833-21941455:+	-0.4	-8.85	1.66E-17	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
LUAD	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.63	10.3	1.18E-22	Paget's disease	
LUAD	cis	1	rs10234309	chr7:135311167	SLC13A4	chr7:135365993-135412933:-	-0.57	-8.46	3.13E-16	Paget's disease	
LUAD	cis	1	rs10242018	chr7:110929652	IMMP2L	chr7:110303110-111202538:-	0.21	3.92	0.000102	Schizophrenia	
LUAD	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.34	7.56	1.96E-13	Longevity;Endometriosis	
LUAD	cis	1	rs1028390	chr6:55935791	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.29	4.43	1.19E-5	Atopic dermatitis	
LUAD	cis	1	rs1029406	chr11:2309580	C11orf21	chr11:2317507-2323143:-	-0.32	-5.98	4.27E-9	Obesity-related traits	
LUAD	cis	1	rs1029407	chr11:2309582	C11orf21	chr11:2317507-2323143:-	-0.32	-5.98	4.27E-9	Obesity-related traits	
LUAD	cis	1	rs1029408	chr11:2309855	C11orf21	chr11:2317507-2323143:-	-0.32	-5.98	4.36E-9	Obesity-related traits	
LUAD	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.47	-8.32	9.13E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs1034219	chr1:93022678	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs1035142	chr2:202153078	ALS2CR12	chr2:202153148-202222101:-	-0.18	-4.9	1.32E-6	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs1035142	chr2:202153078	CASP8	chr2:202098166-202152434:+	0.21	4.57	6.19E-6	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs1037036	chr17:18764077	FBXW10	chr17:18647326-18682661:+	-0.19	-3.79	0.00017	Educational attainment (years of education)	
LUAD	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.45	-8.06	6.03E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs1039438	chr5:156476770	TIMD4	chr5:156346293-156390266:-	-0.25	-4.57	6.06E-6	Hypertriglyceridemia	
LUAD	cis	1	rs1039664	chr7:65449716	CRCP	chr7:65579805-65619551:+	-0.32	-3.78	0.000174	Diabetic kidney disease	
LUAD	cis	1	rs1039665	chr2:228717392	WDR69	chr2:228736327-228789026:+	0.27	5.72	1.88E-8	Blood pressure	
LUAD	cis	1	rs10404486	chr19:53284135	ZNF600	chr19:53268750-53290034:-	0.27	4.81	1.98E-6	Phospholipid levels (plasma)	
LUAD	cis	1	rs10405457	chr19:44296582	ZNF155	chr19:44488355-44502477:+	-0.24	-4.31	1.93E-5	Breast cancer	
LUAD	cis	1	rs1040726	chr20:3264267	ITPA	chr20:3190056-3204504:+	-0.25	-4.45	1.07E-5	IFN-related cytopenia	
LUAD	cis	1	rs1040727	chr20:3264292	ITPA	chr20:3190056-3204504:+	-0.26	-4.59	5.56E-6	IFN-related cytopenia	
LUAD	cis	1	rs10412219	chr19:33413246	SLC7A9	chr19:33321421-33360683:-	-0.24	-5.14	3.98E-7	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
LUAD	cis	1	rs10416218	chr19:33599127	GPATCH1	chr19:33571786-33621318:+	0.21	3.81	0.000154	Bone properties (heel)	
LUAD	cis	1	rs10416218	chr19:33599127	RHPN2	chr19:33469499-33555824:-	-0.22	-4.57	6.14E-6	Bone properties (heel)	
LUAD	cis	1	rs1041748	chr22:24700854	POM121L9P	chr22:24647589-24661490:+	-0.28	-5.86	8.7E-9	Gut microbiome composition (summer)	
LUAD	cis	1	rs10421887	chr19:44294849	ZNF155	chr19:44488355-44502477:+	0.23	4.2	3.15E-5	Breast cancer	
LUAD	cis	1	rs10421887	chr19:44294849	ZNF404	chr19:44376516-44384288:-	0.19	3.83	0.000144	Breast cancer	
LUAD	cis	1	rs10423531	chr19:33600140	GPATCH1	chr19:33571786-33621318:+	0.22	4.08	5.25E-5	Bone properties (heel)	
LUAD	cis	1	rs10423531	chr19:33600140	RHPN2	chr19:33469499-33555824:-	-0.21	-4.2	3.15E-5	Bone properties (heel)	
LUAD	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.63	-12.33	1.36E-30	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.47	8.32	9.11E-16	Multiple sclerosis	
LUAD	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.23	-4.83	1.84E-6	Multiple sclerosis	
LUAD	cis	1	rs1043515	chr17:36922196	PIP4K2B	chr17:36921945-36956158:-	0.23	4.74	2.85E-6	Height	
LUAD	cis	1	rs1043515	chr17:36922196	PSMB3	chr17:36909002-36920477:+	0.16	4.75	2.73E-6	Height	
LUAD	cis	1	rs1043674	chr14:75549370	MLH3	chr14:75480467-75518235:-	0.24	4.57	6.25E-6	Height	
LUAD	cis	1	rs10439608	chr20:30258814	FRG1B	chr20:29611879-29653908:+	0.22	3.87	0.000123	Subcortical brain region volumes	
LUAD	cis	1	rs10443172	chr1:85485768	MCOLN2	chr1:85391267-85462796:-	0.18	4.3	2.1E-5	Serum sulfate level	
LUAD	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.45	-8.03	7.17E-15	Esophageal cancer (squamous cell)	
LUAD	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.91	-18.56	1.28E-58	Homocysteine levels	
LUAD	cis	1	rs1044717	chr1:45976587	MUTYH	chr1:45794915-45806142:-	0.23	4.71	3.23E-6	Homocysteine levels	
LUAD	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.63	-11.71	4.51E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs1045531	chr8:143763547	PSCA	chr8:143761875-143764142:+	0.3	7.94	1.36E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.68	-12.07	1.46E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.67	-12.16	6.83E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.64	-11.77	2.41E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs1045547	chr8:143763757	PSCA	chr8:143761875-143764142:+	0.3	7.9	1.8E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs1045574	chr8:143763958	LYNX1	chr8:143845758-143859640:-	-0.17	-3.69	0.000252	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs1045574	chr8:143763958	PSCA	chr8:143761875-143764142:+	0.31	8.09	4.83E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs1045605	chr8:143764101	PSCA	chr8:143761875-143764142:+	0.3	7.93	1.51E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs10456622	chr6:49396453	CENPQ	chr6:49431096-49460820:+	-0.25	-6.41	3.41E-10	Folate pathway vitamin levels	
LUAD	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.36	7.58	1.69E-13	Folate pathway vitamin levels	
LUAD	cis	1	rs1046073	chr20:25281333	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.8	14.16	2.07E-38	Type 2 diabetes	
LUAD	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.31	3.76	0.000191	Crohn's disease	
LUAD	cis	1	rs10465591	chr1:202308344	PPP1R12B	chr1:202317836-202557697:+	0.22	4.77	2.47E-6	Sex ratio	
LUAD	cis	1	rs10465756	chr1:93029698	EVI5	chr1:92974255-93257961:-	-0.26	-4.14	4.08E-5	Cholesterol, total	
LUAD	cis	1	rs10468183	chr15:100512047	C15orf51	chr15:100330361-100347132:-	0.2	3.8	0.000164	Urate levels in lean individuals	
LUAD	cis	1	rs1046875	chr17:80685426	FN3K	chr17:80693452-80709073:+	0.2	4.18	3.51E-5	Glycated hemoglobin levels	
LUAD	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.33	5.58	4.03E-8	Glycated hemoglobin levels	
LUAD	cis	1	rs1046896	chr17:80685533	FN3K	chr17:80693452-80709073:+	0.22	4.7	3.36E-6	Glycated hemoglobin levels	
LUAD	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.35	6.02	3.38E-9	Glycated hemoglobin levels	
LUAD	cis	1	rs1046917	chr17:80685655	FN3K	chr17:80693452-80709073:+	0.2	4.15	4.0E-5	Glycated hemoglobin levels	
LUAD	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.33	5.54	5.0E-8	Glycated hemoglobin levels	
LUAD	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.3	-7.54	2.27E-13	Longevity	
LUAD	cis	1	rs1047418	chr14:75605792	EIF2B2	chr14:75469612-75476292:+	0.22	4.18	3.42E-5	Height	
LUAD	cis	1	rs1047418	chr14:75605792	MLH3	chr14:75480467-75518235:-	0.28	5.32	1.58E-7	Height	
LUAD	cis	1	rs10483863	chr14:75322327	C14orf45	chr14:74486059-74549566:+	-0.19	-4.44	1.11E-5	Caffeine consumption	
LUAD	cis	1	rs10485381	chr6:97413827	GPR63	chr6:97245889-97285353:-	-0.26	-4.15	4.0E-5	Body mass index	
LUAD	cis	1	rs10489249	chr1:171714521	VAMP4	chr1:171669298-171711214:-	0.24	3.87	0.000125	Hippocampal atrophy	
LUAD	cis	1	rs10491280	chr5:132196383	UQCRQ	chr5:132202319-132204536:+	0.15	3.79	0.000167	Apolipoprotein A-IV levels	
LUAD	cis	1	rs10492096	chr12:6580582	TAPBPL	chr12:6561177-6575601:+	-0.22	-3.86	0.000127	Hip geometry	
LUAD	cis	1	rs10494304	chr1:156285764	CCT3	chr1:156278752-156308195:-	0.18	4.43	1.15E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs10494833	chr1:202467427	PPP1R12B	chr1:202317836-202557697:+	0.23	5.12	4.45E-7	Sex ratio	
LUAD	cis	1	rs10494874	chr1:205754688	PM20D1	chr1:205797154-205819245:-	-0.35	-6.36	4.56E-10	Prostate-specific antigen levels	
LUAD	cis	1	rs10495285	chr1:229804995	SPHAR	chr1:229440129-229441248:+	0.17	3.85	0.000135	Response to cytadine analogues (cytosine arabinoside)	
LUAD	cis	1	rs10496193	chr2:73773503	ALMS1	chr2:73612886-73837046:+	0.19	4.75	2.73E-6	Metabolite levels	
LUAD	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.35	6.75	4.08E-11	Metabolite levels	
LUAD	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.65	11.75	2.86E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.77	7.71	6.92E-14	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs10503715	chr8:21850687	FGF17	chr8:21900428-21906317:+	-0.16	-3.87	0.000125	Mean corpuscular volume	
LUAD	cis	1	rs10509744	chr10:102271579	SEC31B	chr10:102246403-102289636:-	-0.21	-6.72	4.94E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10510452	chr3:16625048	GALNTL2	chr3:15935569-16271252:+	-0.17	-3.82	0.000153	Testicular germ cell tumor	
LUAD	cis	1	rs10510761	chr3:52965255	TMEM110	chr3:52867139-52931547:-	-0.4	-4.52	7.72E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs10516525	chr4:106668025	INTS12	chr4:106603787-106629881:-	-0.64	-6.37	4.26E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs10516526	chr4:106688904	INTS12	chr4:106603787-106629881:-	-0.64	-6.68	6.5E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs10516527	chr4:106734346	INTS12	chr4:106603787-106629881:-	-0.62	-6.61	1.01E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs10517825	chr4:165893486	C4orf39	chr4:165878100-165880273:+	-0.31	-6.05	2.85E-9	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs10517825	chr4:165893486	TRIM61	chr4:165875600-165898818:-	-0.22	-4.31	1.98E-5	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs10518693	chr15:40700022	DISP2	chr15:40650434-40663256:+	0.32	5.37	1.2E-7	Blood metabolite levels;Blood metabolite ratios	
LUAD	cis	1	rs1051921	chr7:73007943	MLXIPL	chr7:73007524-73038870:-	0.29	4.25	2.57E-5	Triglycerides	
LUAD	cis	1	rs1052676	chr1:171673054	VAMP4	chr1:171669298-171711214:-	0.24	3.92	0.000101	Hippocampal atrophy	
LUAD	cis	1	rs1053414	chr9:36211827	GLIPR2	chr9:36136742-36163902:+	-0.21	-3.92	0.0001	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs1054399	chr10:102312565	SEC31B	chr10:102246403-102289636:-	-0.21	-6.85	2.3E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs1065301	chr10:126616038	UROS	chr10:127477148-127511837:-	0.28	3.82	0.000153	Height	
LUAD	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.26	4.68	3.72E-6	Pancreatic cancer	
LUAD	cis	1	rs10734765	chr12:9369385	LOC642846	chr12:9436253-9466684:+	0.19	4.35	1.65E-5	Non-alcoholic fatty liver disease histology (AST)	
LUAD	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.78	15.92	2.84E-46	Homocysteine levels	
LUAD	cis	1	rs10737909	chr1:15548636	FHAD1	chr1:15573768-15726776:+	0.13	3.79	0.000172	Migraine	
LUAD	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.29	-5	7.84E-7	Hematology traits	
LUAD	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.3	-5.86	8.52E-9	Pancreatic cancer	
LUAD	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.28	5.39	1.11E-7	Pancreatic cancer	
LUAD	cis	1	rs1074407	chr22:38156183	TRIOBP	chr22:38082344-38172562:+	0.19	4.12	4.49E-5	Optic cup area;Vertical cup-disc ratio	
LUAD	cis	1	rs10744482	chr12:131298195	STX2	chr12:131274149-131323811:-	0.19	4.1	4.76E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.46	8.09	4.59E-15	Multiple sclerosis	
LUAD	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.24	-5	8.16E-7	Multiple sclerosis	
LUAD	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.01E-12	Body mass index	
LUAD	cis	1	rs10749860	chr1:46328210	MUTYH	chr1:45794915-45806142:-	0.18	4.31	1.99E-5	Body mass index	
LUAD	cis	1	rs10750422	chr11:129692580	ZBTB44	chr11:130096576-130184607:-	0.28	4.07	5.57E-5	Obesity-related traits	
LUAD	cis	1	rs10752615	chr1:156248609	CCT3	chr1:156278752-156308195:-	-0.16	-3.92	0.000101	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs10753918	chr1:202503061	PPP1R12B	chr1:202317836-202557697:+	0.22	4.85	1.68E-6	Sex ratio	
LUAD	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.29	5.47	7.27E-8	Height	
LUAD	cis	1	rs10755146	chr3:190985158	UTS2D	chr3:190984945-191048325:-	-0.3	-6.29	6.98E-10	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.28	-4.91	1.25E-6	Hematology traits	
LUAD	cis	1	rs10760021	chr9:100697648	C9orf156	chr9:100666772-100684852:-	-0.19	-3.73	0.00021	Quantitative traits	
LUAD	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.36	-7.22	1.94E-12	Rheumatoid arthritis	
LUAD	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.33	-6.54	1.51E-10	Rheumatoid arthritis	
LUAD	cis	1	rs10760589	chr9:131906293	CRAT	chr9:131857075-131873070:-	0.33	6.22	1.08E-9	Blood metabolite ratios	
LUAD	cis	1	rs10760700	chr9:102681811	STX17	chr9:102668915-102736817:+	-0.17	-3.68	0.000264	Alopecia areata	
LUAD	cis	1	rs10760704	chr9:102708564	STX17	chr9:102668915-102736817:+	-0.18	-3.85	0.000135	Alopecia areata	
LUAD	cis	1	rs10760706	chr9:102723692	STX17	chr9:102668915-102736817:+	-0.18	-3.89	0.000113	Alopecia areata	
LUAD	cis	1	rs10761723	chr10:64955581	NRBF2	chr10:64893007-64914785:+	-0.22	-4.76	2.59E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs10761727	chr10:64995493	NRBF2	chr10:64893007-64914785:+	-0.21	-4.68	3.72E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs10761742	chr10:65085048	NRBF2	chr10:64893007-64914785:+	-0.21	-4.71	3.31E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs10762582	chr10:75968316	ADK	chr10:75910965-76469059:+	0.23	3.68	0.000258	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10766969	chr11:22849952	SVIP	chr11:22843600-22851382:-	-0.25	-4.92	1.2E-6	Dialysis-related mortality	
LUAD	cis	1	rs10767971	chr11:32895664	CCDC73	chr11:32623627-32816187:-	0.22	4.16	3.73E-5	Parkinson's disease (age of onset)	
LUAD	cis	1	rs10767972	chr11:32896419	CCDC73	chr11:32623627-32816187:-	0.22	4.16	3.73E-5	Parkinson's disease (age of onset)	
LUAD	cis	1	rs10771431	chr12:9380859	LOC642846	chr12:9436253-9466684:+	0.17	5.13	4.22E-7	Breast size	
LUAD	cis	1	rs10773819	chr12:131279022	STX2	chr12:131274149-131323811:-	0.18	3.95	9.06E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs10773822	chr12:131289107	STX2	chr12:131274149-131323811:-	0.19	4.22	2.97E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs1077514	chr1:23766233	PNRC2	chr1:24286301-24289947:+	0.23	3.75	0.000196	Cholesterol, total	
LUAD	cis	1	rs10778213	chr12:103495151	NUP37	chr12:102467975-102513869:-	0.15	3.99	7.67E-5	C-reactive protein	
LUAD	cis	1	rs1077889	chr20:25267893	FAM182A	chr20:26035250-26067552:+	-0.18	-3.76	0.000192	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs10782922	chr1:92974595	EVI5	chr1:92974255-93257961:-	-0.27	-4.32	1.89E-5	Cholesterol, total	
LUAD	cis	1	rs10783594	chr12:54067135	ATP5G2	chr12:54058945-54070512:-	0.28	6.01	3.63E-9	Height	
LUAD	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.47	8.32	9.11E-16	Multiple sclerosis	
LUAD	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.23	-4.83	1.84E-6	Multiple sclerosis	
LUAD	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.47	8.32	9.11E-16	Multiple sclerosis	
LUAD	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.23	-4.83	1.84E-6	Multiple sclerosis	
LUAD	cis	1	rs10786596	chr10:102282126	SEC31B	chr10:102246403-102289636:-	-0.2	-6.3	6.84E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10786597	chr10:102291287	SEC31B	chr10:102246403-102289636:-	-0.2	-6.44	2.85E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10786598	chr10:102291579	SEC31B	chr10:102246403-102289636:-	-0.2	-6.44	2.85E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.29	1.23E-12	Body mass index	
LUAD	cis	1	rs10789475	chr1:46304177	MUTYH	chr1:45794915-45806142:-	0.18	4.21	2.99E-5	Body mass index	
LUAD	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.14	3.44E-12	Body mass index	
LUAD	cis	1	rs10789481	chr1:46383583	MUTYH	chr1:45794915-45806142:-	0.19	4.42	1.19E-5	Body mass index	
LUAD	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.79E-12	Body mass index	
LUAD	cis	1	rs10789487	chr1:46420221	MUTYH	chr1:45794915-45806142:-	0.17	4.01	6.9E-5	Body mass index	
LUAD	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.2	-4	7.31E-5	Height	
LUAD	cis	1	rs10797432	chr1:2501338	MMEL1	chr1:2522081-2564481:-	-0.29	-5.73	1.75E-8	Ulcerative colitis	
LUAD	cis	1	rs10800830	chr1:202323296	PPP1R12B	chr1:202317836-202557697:+	0.21	4.68	3.79E-6	Sex ratio	
LUAD	cis	1	rs10800831	chr1:202323506	PPP1R12B	chr1:202317836-202557697:+	0.21	4.57	6.07E-6	Sex ratio	
LUAD	cis	1	rs10800833	chr1:202330653	PPP1R12B	chr1:202317836-202557697:+	0.22	4.86	1.59E-6	Sex ratio	
LUAD	cis	1	rs10800836	chr1:202410429	PPP1R12B	chr1:202317836-202557697:+	0.21	4.65	4.34E-6	Sex ratio	
LUAD	cis	1	rs10800839	chr1:202518950	PPP1R12B	chr1:202317836-202557697:+	0.22	4.9	1.3E-6	Sex ratio	
LUAD	cis	1	rs10803369	chr1:15550525	FHAD1	chr1:15573768-15726776:+	-0.13	-3.86	0.000127	Migraine	
LUAD	cis	1	rs10804111	chr2:202145612	ALS2CR12	chr2:202153148-202222101:-	-0.17	-4.54	7.13E-6	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs10804111	chr2:202145612	CASP8	chr2:202098166-202152434:+	0.22	4.55	6.66E-6	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.51	9.88	4.28E-21	Height	
LUAD	cis	1	rs1080698	chr10:102295114	SEC31B	chr10:102246403-102289636:-	-0.22	-6.89	1.76E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.35	-6.91	1.55E-11	Rheumatoid arthritis	
LUAD	cis	1	rs10819464	chr9:131876277	CRAT	chr9:131857075-131873070:-	0.32	6.16	1.56E-9	Blood metabolite ratios	
LUAD	cis	1	rs10819466	chr9:131881492	CRAT	chr9:131857075-131873070:-	0.32	6.13	1.81E-9	Blood metabolite ratios	
LUAD	cis	1	rs10819469	chr9:131882067	CRAT	chr9:131857075-131873070:-	0.34	6.52	1.71E-10	Blood metabolite ratios	
LUAD	cis	1	rs10819469	chr9:131882067	PPP2R4	chr9:131873244-131911223:+	0.21	4.11	4.68E-5	Blood metabolite ratios	
LUAD	cis	1	rs10819471	chr9:131896325	CRAT	chr9:131857075-131873070:-	0.3	5.69	2.15E-8	Blood metabolite ratios	
LUAD	cis	1	rs10819861	chr9:98867813	C9orf130	chr9:98568372-98638259:-	-0.17	-3.67	0.000269	Electrocardiographic traits	
LUAD	cis	1	rs10822145	chr10:64934548	NRBF2	chr10:64893007-64914785:+	-0.21	-4.58	5.91E-6	Triglycerides	
LUAD	cis	1	rs10822149	chr10:64987412	NRBF2	chr10:64893007-64914785:+	-0.21	-4.68	3.72E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs10822161	chr10:65118203	NRBF2	chr10:64893007-64914785:+	-0.22	-4.89	1.36E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs10822163	chr10:65124098	NRBF2	chr10:64893007-64914785:+	-0.22	-4.94	1.08E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs10824026	chr10:75421208	NUDT13	chr10:74870210-74891580:+	-0.21	-4.17	3.68E-5	Atrial fibrillation	
LUAD	cis	1	rs10824076	chr10:75886956	ADK	chr10:75910965-76469059:+	0.24	4.03	6.4E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824083	chr10:75911342	ADK	chr10:75910965-76469059:+	0.25	4.12	4.43E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824084	chr10:75911415	ADK	chr10:75910965-76469059:+	0.25	4.12	4.43E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824085	chr10:75911984	ADK	chr10:75910965-76469059:+	0.23	3.7	0.000236	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824090	chr10:75923446	ADK	chr10:75910965-76469059:+	0.24	4.03	6.42E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824098	chr10:75943579	ADK	chr10:75910965-76469059:+	0.24	3.98	7.91E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824102	chr10:75948915	ADK	chr10:75910965-76469059:+	0.24	3.69	0.00025	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824103	chr10:75949415	ADK	chr10:75910965-76469059:+	0.24	3.69	0.00025	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824105	chr10:75952881	ADK	chr10:75910965-76469059:+	0.24	3.69	0.00025	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824110	chr10:75968098	ADK	chr10:75910965-76469059:+	0.24	3.79	0.000171	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824112	chr10:75969003	ADK	chr10:75910965-76469059:+	0.24	3.96	8.48E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824113	chr10:75969018	ADK	chr10:75910965-76469059:+	0.24	3.79	0.000171	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824114	chr10:75970503	ADK	chr10:75910965-76469059:+	0.24	3.96	8.48E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10824130	chr10:76008931	ADK	chr10:75910965-76469059:+	0.24	4.02	6.73E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.27	5.18	3.27E-7	Pancreatic cancer	
LUAD	cis	1	rs10832956	chr11:18645668	SPTY2D1	chr11:18627949-18656020:-	-0.23	-5.08	5.37E-7	Cholesterol, total	
LUAD	cis	1	rs10832962	chr11:18656271	SPTY2D1	chr11:18627949-18656020:-	-0.22	-4.96	9.97E-7	Cholesterol, total	
LUAD	cis	1	rs10833824	chr11:22847485	SVIP	chr11:22843600-22851382:-	-0.24	-4.69	3.51E-6	Dialysis-related mortality	
LUAD	cis	1	rs10833825	chr11:22850753	SVIP	chr11:22843600-22851382:-	-0.24	-4.73	2.96E-6	Dialysis-related mortality	
LUAD	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.21	-4.05	5.97E-5	Subjective well-being	
LUAD	cis	1	rs10838738	chr11:47663049	MYBPC3	chr11:47352958-47374253:-	-0.22	-4.74	2.85E-6	Subjective well-being	
LUAD	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.06	5.62E-5	Subjective well-being	
LUAD	cis	1	rs10838747	chr11:47716324	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.49	8.77E-6	Subjective well-being	
LUAD	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.08	5.23E-5	Subjective well-being	
LUAD	cis	1	rs10838748	chr11:47716381	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.56	6.42E-6	Subjective well-being	
LUAD	cis	1	rs10838757	chr11:47763016	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	5.0E-5	Subjective well-being	
LUAD	cis	1	rs10838757	chr11:47763016	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.6	5.35E-6	Subjective well-being	
LUAD	cis	1	rs10848205	chr12:131280714	STX2	chr12:131274149-131323811:-	0.17	3.7	0.000243	Plasma plasminogen activator levels	
LUAD	cis	1	rs10849462	chr12:6575992	TAPBPL	chr12:6561177-6575601:+	-0.24	-4.19	3.25E-5	Hip geometry	
LUAD	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.18	-3.89	0.000116	Lung cancer	
LUAD	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.33	9.49E-13	Body mass index	
LUAD	cis	1	rs1085243	chr1:46544768	MUTYH	chr1:45794915-45806142:-	0.17	3.87	0.000126	Body mass index	
LUAD	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.23	1.82E-12	Body mass index	
LUAD	cis	1	rs1085244	chr1:46563680	MUTYH	chr1:45794915-45806142:-	0.16	3.84	0.000137	Body mass index	
LUAD	cis	1	rs10853057	chr17:62998023	AMZ2P1	chr17:62962668-62971703:-	0.48	6.49	2.12E-10	White matter microstructure (global fractional anisotropy)	
LUAD	cis	1	rs10857712	chr10:135225666	MTG1	chr10:135207621-135234173:+	0.42	7.54	2.27E-13	Systemic lupus erythematosus	
LUAD	cis	1	rs10857712	chr10:135225666	SPRN	chr10:135234171-135238121:-	0.21	4.28	2.27E-5	Systemic lupus erythematosus	
LUAD	cis	1	rs10857811	chr1:110617688	ALX3	chr1:110602998-110613322:-	0.21	4.07	5.51E-5	Blood metabolite levels	
LUAD	cis	1	rs10859106	chr12:91476568	KERA	chr12:91444273-91452131:-	0.23	3.83	0.000144	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.72	-13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs10866659	chr5:156937043	ADAM19	chr5:156822542-157002768:-	-0.15	-4.77	2.38E-6	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs10871290	chr16:74472696	RFWD3	chr16:74655298-74700779:-	0.19	4.08	5.25E-5	Breast cancer	
LUAD	cis	1	rs10872032	chr6:109676776	AKD1	chr6:109814059-110012415:-	-0.19	-3.87	0.000122	Height	
LUAD	cis	1	rs10872032	chr6:109676776	SMPD2	chr6:109761931-109765121:+	0.22	4.42	1.21E-5	Height	
LUAD	cis	1	rs10873275	chr14:75531460	EIF2B2	chr14:75469612-75476292:+	0.2	3.7	0.000238	Height	
LUAD	cis	1	rs10873275	chr14:75531460	MLH3	chr14:75480467-75518235:-	0.23	4.43	1.18E-5	Height	
LUAD	cis	1	rs10874656	chr1:92947024	EVI5	chr1:92974255-93257961:-	-0.26	-4.18	3.4E-5	Cholesterol, total	
LUAD	cis	1	rs10874910	chr1:95707567	TMEM56	chr1:95582894-95663159:+	0.24	4.31	1.96E-5	Non-alcoholic fatty liver disease histology (AST)	
LUAD	cis	1	rs10876480	chr12:54066271	ATP5G2	chr12:54058945-54070512:-	0.27	5.99	4.04E-9	Height	
LUAD	cis	1	rs10876481	chr12:54066743	ATP5G2	chr12:54058945-54070512:-	0.27	5.99	4.04E-9	Height	
LUAD	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.47	8.29	1.13E-15	Multiple sclerosis	
LUAD	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.22	-4.51	8.12E-6	Multiple sclerosis	
LUAD	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.47	8.45	3.34E-16	Multiple sclerosis	
LUAD	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.21	-4.48	9.4E-6	Multiple sclerosis	
LUAD	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.48	8.65	7.29E-17	Multiple sclerosis	
LUAD	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.2	-4.1	4.91E-5	Multiple sclerosis	
LUAD	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.47	8.44	3.67E-16	Multiple sclerosis	
LUAD	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.21	-4.35	1.66E-5	Multiple sclerosis	
LUAD	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.45	-8.09	4.67E-15	Multiple sclerosis	
LUAD	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.24	4.9	1.29E-6	Multiple sclerosis	
LUAD	cis	1	rs10882644	chr10:97388579	ENTPD1	chr10:97471536-97637022:+	0.2	5.53	5.17E-8	Blood metabolite levels	
LUAD	cis	1	rs10883492	chr10:102206089	SEC31B	chr10:102246403-102289636:-	-0.21	-6.86	2.16E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883493	chr10:102208188	SEC31B	chr10:102246403-102289636:-	-0.21	-6.86	2.16E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883496	chr10:102221931	SEC31B	chr10:102246403-102289636:-	-0.22	-7.03	7.21E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883497	chr10:102228519	SEC31B	chr10:102246403-102289636:-	-0.22	-6.99	9.29E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883499	chr10:102232188	SEC31B	chr10:102246403-102289636:-	-0.21	-6.9	1.58E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883500	chr10:102238324	SEC31B	chr10:102246403-102289636:-	-0.22	-6.94	1.25E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883501	chr10:102238326	SEC31B	chr10:102246403-102289636:-	-0.22	-6.94	1.25E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883502	chr10:102238343	SEC31B	chr10:102246403-102289636:-	-0.22	-6.94	1.25E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883503	chr10:102275504	SEC31B	chr10:102246403-102289636:-	-0.22	-7.05	6.32E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883504	chr10:102280687	SEC31B	chr10:102246403-102289636:-	-0.22	-6.92	1.43E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883505	chr10:102280772	SEC31B	chr10:102246403-102289636:-	-0.21	-6.63	9.01E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883506	chr10:102289743	SEC31B	chr10:102246403-102289636:-	-0.2	-6.5	1.95E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883507	chr10:102291275	SEC31B	chr10:102246403-102289636:-	-0.2	-6.44	2.85E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883508	chr10:102294413	SEC31B	chr10:102246403-102289636:-	-0.18	-5.89	7.21E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883509	chr10:102296461	SEC31B	chr10:102246403-102289636:-	-0.2	-6.46	2.49E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883510	chr10:102297018	SEC31B	chr10:102246403-102289636:-	-0.24	-7.4	6.0E-13	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883511	chr10:102299407	SEC31B	chr10:102246403-102289636:-	-0.19	-5.9	6.66E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883512	chr10:102308516	SEC31B	chr10:102246403-102289636:-	-0.2	-6.39	3.89E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10883513	chr10:102316964	SEC31B	chr10:102246403-102289636:-	-0.21	-6.1	2.17E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs10888527	chr1:153001363	SPRR1A	chr1:152956557-152958289:+	-0.24	-4.79	2.25E-6	Inflammatory skin disease	
LUAD	cis	1	rs10888527	chr1:153001363	SPRR2D	chr1:153012201-153113969:-	-0.2	-4.12	4.49E-5	Inflammatory skin disease	
LUAD	cis	1	rs10889661	chr1:67625309	C1orf141	chr1:67557859-67600653:-	-0.2	-6.06	2.68E-9	Psoriasis	
LUAD	cis	1	rs10889664	chr1:67635475	C1orf141	chr1:67557859-67600653:-	-0.19	-5.88	7.55E-9	Psoriasis	
LUAD	cis	1	rs1088984	chr11:2377581	C11orf21	chr11:2317507-2323143:-	-0.19	-4.46	1.04E-5	Bacteremia	
LUAD	cis	1	rs1088985	chr11:2377852	C11orf21	chr11:2317507-2323143:-	-0.19	-4.4	1.31E-5	Bacteremia	
LUAD	cis	1	rs1088986	chr11:2377862	C11orf21	chr11:2317507-2323143:-	-0.17	-3.94	9.29E-5	Bacteremia	
LUAD	cis	1	rs1088987	chr11:2379196	C11orf21	chr11:2317507-2323143:-	-0.18	-4.06	5.71E-5	Bacteremia	
LUAD	cis	1	rs1088988	chr11:2380470	C11orf21	chr11:2317507-2323143:-	-0.2	-4.51	8.22E-6	Bacteremia	
LUAD	cis	1	rs1088990	chr11:2381771	C11orf21	chr11:2317507-2323143:-	-0.2	-4.66	4.15E-6	Bacteremia	
LUAD	cis	1	rs1088993	chr11:2382631	C11orf21	chr11:2317507-2323143:-	-0.2	-4.66	4.09E-6	Bacteremia	
LUAD	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.03E-12	Body mass index	
LUAD	cis	1	rs10890352	chr1:46283628	MUTYH	chr1:45794915-45806142:-	0.18	4.21	3.01E-5	Body mass index	
LUAD	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.74E-12	Body mass index	
LUAD	cis	1	rs10890354	chr1:46305347	MUTYH	chr1:45794915-45806142:-	0.18	4.21	3.1E-5	Body mass index	
LUAD	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.34	-6.37	4.48E-10	Body mass index	
LUAD	cis	1	rs10890361	chr1:46346234	MUTYH	chr1:45794915-45806142:-	0.21	4.99	8.38E-7	Body mass index	
LUAD	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.38	7.11	4.26E-12	Body mass index	
LUAD	cis	1	rs10890363	chr1:46356148	MUTYH	chr1:45794915-45806142:-	-0.18	-4.14	4.11E-5	Body mass index	
LUAD	cis	1	rs10890383	chr1:46588503	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.38	6.88E-13	Body mass index	
LUAD	cis	1	rs10896043	chr11:65543827	SNX32	chr11:65601410-65621170:+	-0.28	-3.91	0.000107	Systemic lupus erythematosus	
LUAD	cis	1	rs10900224	chr10:46024534	OR13A1	chr10:45798102-45811056:-	-0.25	-3.74	0.000207	HDL cholesterol;Cholesterol, total	
LUAD	cis	1	rs10901520	chr10:127718837	UROS	chr10:127477148-127511837:-	-0.2	-3.73	0.000216	Visceral fat	
LUAD	cis	1	rs10901837	chr10:126614618	UROS	chr10:127477148-127511837:-	0.29	3.88	0.000118	Height	
LUAD	cis	1	rs10902853	chr10:124740621	C10orf88	chr10:124690419-124713919:-	-0.21	-4.25	2.56E-5	Migraine without aura	
LUAD	cis	1	rs10903	chr1:171673236	VAMP4	chr1:171669298-171711214:-	0.24	3.93	9.87E-5	Hippocampal atrophy	
LUAD	cis	1	rs10908494	chr1:156263097	CCT3	chr1:156278752-156308195:-	-0.17	-4.18	3.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs10908495	chr1:156263940	CCT3	chr1:156278752-156308195:-	-0.17	-4.09	5.06E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs10908496	chr1:156264000	CCT3	chr1:156278752-156308195:-	-0.16	-3.89	0.000113	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs10908498	chr1:156278175	CCT3	chr1:156278752-156308195:-	-0.17	-4.12	4.39E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs10908499	chr1:156279176	CCT3	chr1:156278752-156308195:-	-0.17	-4.12	4.39E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs10908500	chr1:156280671	CCT3	chr1:156278752-156308195:-	-0.16	-4.04	6.23E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs10908502	chr1:156300082	CCT3	chr1:156278752-156308195:-	-0.16	-3.99	7.69E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs10910092	chr1:2501516	MMEL1	chr1:2522081-2564481:-	-0.29	-5.73	1.78E-8	Ulcerative colitis	
LUAD	cis	1	rs10913511	chr1:171668951	VAMP4	chr1:171669298-171711214:-	0.26	4.5	8.67E-6	Hippocampal atrophy	
LUAD	cis	1	rs10913514	chr1:171670823	VAMP4	chr1:171669298-171711214:-	0.25	4.17	3.55E-5	Hippocampal atrophy	
LUAD	cis	1	rs10913565	chr1:171706706	VAMP4	chr1:171669298-171711214:-	0.24	3.91	0.000105	Hippocampal atrophy	
LUAD	cis	1	rs10913582	chr1:171715585	VAMP4	chr1:171669298-171711214:-	0.24	3.96	8.52E-5	Hippocampal atrophy	
LUAD	cis	1	rs10917002	chr1:21836340	HSPC157	chr1:22351707-22357713:+	-0.27	-3.68	0.000262	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	
LUAD	cis	1	rs10918605	chr1:166955638	GPA33	chr1:167022082-167059868:-	-0.23	-4.32	1.9E-5	Refractive astigmatism	
LUAD	cis	1	rs10918606	chr1:166957249	GPA33	chr1:167022082-167059868:-	-0.23	-4.32	1.9E-5	Refractive astigmatism	
LUAD	cis	1	rs10920392	chr1:202321123	PPP1R12B	chr1:202317836-202557697:+	0.22	4.8	2.08E-6	Sex ratio	
LUAD	cis	1	rs10920409	chr1:202443663	PPP1R12B	chr1:202317836-202557697:+	0.22	4.9	1.33E-6	Sex ratio	
LUAD	cis	1	rs10920410	chr1:202445856	PPP1R12B	chr1:202317836-202557697:+	-0.23	-5.18	3.31E-7	Sex ratio	
LUAD	cis	1	rs10920412	chr1:202454413	PPP1R12B	chr1:202317836-202557697:+	0.23	5.11	4.52E-7	Sex ratio	
LUAD	cis	1	rs10920414	chr1:202476924	PPP1R12B	chr1:202317836-202557697:+	0.23	5.04	6.46E-7	Sex ratio	
LUAD	cis	1	rs10920421	chr1:202517196	PPP1R12B	chr1:202317836-202557697:+	0.22	4.9	1.3E-6	Sex ratio	
LUAD	cis	1	rs10925069	chr1:247681313	C1orf229	chr1:247273462-247275719:-	0.24	3.74	0.000202	Acute lymphoblastic leukemia (childhood)	
LUAD	cis	1	rs10927875	chr1:16299312	HSPB7	chr1:16340523-16346089:-	-0.24	-5.81	1.11E-8	Dilated cardiomyopathy	
LUAD	cis	1	rs10929965	chr2:160906931	LY75	chr2:160625141-160761262:-	-0.2	-4.34	1.74E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs10929966	chr2:160908341	LY75	chr2:160625141-160761262:-	0.2	4.34	1.7E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs10933518	chr2:241838091	C2orf54	chr2:241825466-241835573:-	0.32	5.8	1.22E-8	Urinary metabolites	
LUAD	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.29	1.26E-22	Height	
LUAD	cis	1	rs10935186	chr3:136346206	PCCB	chr3:135969167-136056737:+	0.28	6.1	2.12E-9	Schizophrenia	
LUAD	cis	1	rs10937463	chr3:190985247	UTS2D	chr3:190984945-191048325:-	0.31	6.65	7.78E-11	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs10937464	chr3:190985274	UTS2D	chr3:190984945-191048325:-	-0.31	-6.55	1.45E-10	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs10937465	chr3:190985279	UTS2D	chr3:190984945-191048325:-	-0.31	-6.55	1.45E-10	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs10939749	chr4:17692319	MED28	chr4:17616273-17629791:+	0.16	3.68	0.000256	Parasitemia in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs10939750	chr4:17692422	MED28	chr4:17616273-17629791:+	0.16	3.68	0.000256	Parasitemia in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.62	-11.49	3.16E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.68	-12.16	6.28E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.62	-11.32	1.49E-26	Response to antipsychotic treatment	
LUAD	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.63	-11.58	1.43E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs10954226	chr7:128953095	LOC407835	chr7:128766325-128768041:+	0.23	3.78	0.000175	White matter hyperintensity burden	
LUAD	cis	1	rs10954872	chr8:29978612	MBOAT4	chr8:29989188-30002200:-	-0.4	-5.67	2.43E-8	Migraine	
LUAD	cis	1	rs10972789	chr9:36212560	GLIPR2	chr9:36136742-36163902:+	-0.22	-4.49	8.92E-6	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs10972790	chr9:36212592	GLIPR2	chr9:36136742-36163902:+	0.2	3.79	0.000169	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs10984361	chr9:100681490	C9orf156	chr9:100666772-100684852:-	-0.2	-3.97	8.26E-5	Quantitative traits	
LUAD	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.28	6.44	2.87E-10	Blood metabolite levels	
LUAD	cis	1	rs10988214	chr9:131883752	CRAT	chr9:131857075-131873070:-	0.32	6.13	1.85E-9	Blood metabolite ratios	
LUAD	cis	1	rs10988223	chr9:131903021	CRAT	chr9:131857075-131873070:-	0.35	6.83	2.55E-11	Blood metabolite ratios	
LUAD	cis	1	rs10988223	chr9:131903021	PPP2R4	chr9:131873244-131911223:+	0.22	4.44	1.13E-5	Blood metabolite ratios	
LUAD	cis	1	rs10988224	chr9:131903334	CRAT	chr9:131857075-131873070:-	0.32	6.27	8.05E-10	Blood metabolite ratios	
LUAD	cis	1	rs10988232	chr9:131915348	CRAT	chr9:131857075-131873070:-	0.33	6.29	6.85E-10	Blood metabolite ratios	
LUAD	cis	1	rs10988232	chr9:131915348	PPP2R4	chr9:131873244-131911223:+	0.19	3.69	0.00025	Blood metabolite ratios	
LUAD	cis	1	rs10988920	chr9:102673982	STX17	chr9:102668915-102736817:+	-0.17	-3.68	0.000264	Alopecia areata	
LUAD	cis	1	rs10988978	chr9:102893755	TMEFF1	chr9:103204188-103339914:+	0.26	3.91	0.000106	Preeclampsia	
LUAD	cis	1	rs11000887	chr10:75897542	ADK	chr10:75910965-76469059:+	0.26	4.08	5.36E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11000888	chr10:75901929	ADK	chr10:75910965-76469059:+	0.23	3.71	0.000227	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11000890	chr10:75904073	ADK	chr10:75910965-76469059:+	0.23	3.74	0.00021	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11000897	chr10:75911276	ADK	chr10:75910965-76469059:+	0.26	4.08	5.36E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11000900	chr10:75918440	ADK	chr10:75910965-76469059:+	0.26	4.05	6.08E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11000902	chr10:75920483	ADK	chr10:75910965-76469059:+	0.25	3.7	0.000236	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11000916	chr10:75953909	ADK	chr10:75910965-76469059:+	0.23	3.67	0.000269	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11000924	chr10:75972311	ADK	chr10:75910965-76469059:+	0.24	3.96	8.48E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11000925	chr10:75972601	ADK	chr10:75910965-76469059:+	0.24	3.96	8.48E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11000936	chr10:75992383	ADK	chr10:75910965-76469059:+	0.23	3.9	0.000111	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11024739	chr11:18645843	SPTY2D1	chr11:18627949-18656020:-	0.21	4.72	3.14E-6	Cholesterol, total	
LUAD	cis	1	rs11026804	chr11:22841582	SVIP	chr11:22843600-22851382:-	0.2	3.98	8.1E-5	Dialysis-related mortality	
LUAD	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.23	-4.33	1.8E-5	Subjective well-being	
LUAD	cis	1	rs11039255	chr11:47495746	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.5	8.68E-6	Subjective well-being	
LUAD	cis	1	rs11039390	chr11:47796295	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	5.1E-5	Subjective well-being	
LUAD	cis	1	rs11039390	chr11:47796295	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.46	1.03E-5	Subjective well-being	
LUAD	cis	1	rs11039412	chr11:47841581	C1QTNF4	chr11:47611216-47615961:-	-0.21	-4.05	5.93E-5	Subjective well-being	
LUAD	cis	1	rs11039412	chr11:47841581	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.53	7.49E-6	Subjective well-being	
LUAD	cis	1	rs11039426	chr11:47863119	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	4.96E-5	Subjective well-being	
LUAD	cis	1	rs11039426	chr11:47863119	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.5	8.33E-6	Subjective well-being	
LUAD	cis	1	rs11045982	chr12:8665760	CLEC4D	chr12:8666136-8674958:+	0.22	4.16	3.82E-5	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
LUAD	cis	1	rs11045983	chr12:8666118	CLEC4D	chr12:8666136-8674958:+	0.22	4.16	3.82E-5	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
LUAD	cis	1	rs11054376	chr12:7693399	C12orf57	chr12:7052141-7055164:+	0.19	3.7	0.000243	Hematological and biochemical traits	
LUAD	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.49	8.2	2.17E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs1106369	chr12:131300095	STX2	chr12:131274149-131323811:-	0.18	4.07	5.47E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs11064881	chr12:120146925	PRKAB1	chr12:120105757-120119428:+	-0.4	-4.55	6.68E-6	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs11064881	chr12:120146925	TRIAP1	chr12:120881765-120884215:-	0.3	3.84	0.00014	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs1106565	chr10:102211613	SEC31B	chr10:102246403-102289636:-	-0.22	-6.98	9.94E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11067231	chr12:109993603	MYO1H	chr12:109826524-109886176:+	0.39	7.25	1.61E-12	HDL cholesterol	
LUAD	cis	1	rs11072603	chr15:76881138	SCAPER	chr15:76640529-77197744:-	-0.21	-4.94	1.07E-6	Blood metabolite levels	
LUAD	cis	1	rs11072800	chr15:79045857	CHRNB4	chr15:78916636-78952874:-	-0.21	-3.68	0.00026	Coronary artery disease or large artery stroke	
LUAD	cis	1	rs1107328	chr9:131917534	CRAT	chr9:131857075-131873070:-	-0.37	-6.81	2.93E-11	Blood metabolite ratios	
LUAD	cis	1	rs1107328	chr9:131917534	PPP2R4	chr9:131873244-131911223:+	-0.26	-4.83	1.82E-6	Blood metabolite ratios	
LUAD	cis	1	rs1107767	chr16:68020063	PARD6A	chr16:67694851-67696680:+	-0.4	-3.98	8.01E-5	Crohn's disease	
LUAD	cis	1	rs11079034	chr17:40288890	DHX58	chr17:40253422-40264751:-	-0.3	-5.6	3.65E-8	Fibrinogen levels	
LUAD	cis	1	rs11079508	chr17:61750066	FTSJ3	chr17:61896795-61905031:-	0.21	4.47	9.89E-6	Body mass index	
LUAD	cis	1	rs11079509	chr17:61762148	FTSJ3	chr17:61896795-61905031:-	0.22	4.41	1.3E-5	Body mass index	
LUAD	cis	1	rs11079511	chr17:61858537	FTSJ3	chr17:61896795-61905031:-	0.21	4.3	2.02E-5	Body mass index	
LUAD	cis	1	rs11079706	chr17:65835470	LOC440461	chr17:66194801-66196436:+	0.25	3.97	8.4E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs11079707	chr17:65835617	LOC440461	chr17:66194801-66196436:+	-0.25	-4.04	6.33E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs11080114	chr17:28407287	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.98	4.2E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs11080114	chr17:28407287	SSH2	chr17:27952965-28257018:-	-0.16	-4.26	2.42E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs11087520	chr20:25436827	FAM182A	chr20:26035250-26067552:+	-0.18	-3.67	0.000268	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs11087521	chr20:25440648	FAM182A	chr20:26035250-26067552:+	-0.2	-3.99	7.47E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs11088226	chr21:33925531	TCP10L	chr21:33947152-33957845:-	-0.25	-3.91	0.000106	Gastritis	
LUAD	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.32	-8.04	6.99E-15	Longevity	
LUAD	cis	1	rs1109619	chr8:8571616	CLDN23	chr8:8559666-8561616:+	-0.32	-5.46	7.68E-8	Obesity-related traits	
LUAD	cis	1	rs11097901	chr4:106729933	INTS12	chr4:106603787-106629881:-	-0.63	-6.66	7.58E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11097912	chr4:107000462	TBCK	chr4:106967233-107237861:-	0.25	4.72	3.03E-6	Airflow obstruction	
LUAD	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.5	8.26	1.35E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs11100	chr20:25281184	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs11105972	chr12:91471955	KERA	chr12:91444273-91452131:-	0.21	3.75	0.000198	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs11105973	chr12:91472347	KERA	chr12:91444273-91452131:-	0.21	3.75	0.000198	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs11105974	chr12:91476481	KERA	chr12:91444273-91452131:-	0.23	3.83	0.000144	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs11105983	chr12:91480976	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs11105988	chr12:91498299	KERA	chr12:91444273-91452131:-	0.23	3.89	0.000114	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.77	-15.06	2.2E-42	Renal function-related traits (BUN)	
LUAD	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.58	-10.63	6.74E-24	Renal function-related traits (BUN)	
LUAD	cis	1	rs11124575	chr2:37500435	CEBPZ	chr2:37428778-37458740:-	-0.17	-3.72	0.000226	Chronic lymphocytic leukemia	
LUAD	cis	1	rs111248783	chr4:106770998	INTS12	chr4:106603787-106629881:-	-0.58	-5.75	1.53E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs111252524	chr2:203199188	NOP58	chr2:203130515-203168382:+	0.31	4.73	3.0E-6	Urate levels	
LUAD	cis	1	rs11126254	chr2:70182491	ASPRV1	chr2:70187226-70314147:-	-0.27	-3.85	0.000136	Obesity-related traits	
LUAD	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.51	5.66E-8	Body mass index	
LUAD	cis	1	rs11128603	chr3:12385828	MKRN2	chr3:12598594-12625208:+	0.32	4.06	5.64E-5	Plasminogen activator inhibitor type 1 levels (PAI-1)	
LUAD	cis	1	rs11128797	chr3:16622354	GALNTL2	chr3:15935569-16271252:+	-0.17	-3.82	0.000153	Testicular germ cell tumor	
LUAD	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.31	-7.82	3.24E-14	Longevity	
LUAD	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.28	-7.14	3.29E-12	Longevity	
LUAD	cis	1	rs11130338	chr3:53120924	RFT1	chr3:53122503-53164470:-	-0.2	-3.93	9.69E-5	Height	
LUAD	cis	1	rs11130537	chr3:56685904	CCDC66	chr3:56591184-56655846:+	0.18	5.21	2.75E-7	Height	
LUAD	cis	1	rs111315781	chr2:201738724	CFLAR	chr2:201980816-202029001:+	-0.28	-4.86	1.58E-6	Triptolide cytotoxicity	
LUAD	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.74	-11.69	5.32E-28	Triptolide cytotoxicity	
LUAD	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.38	-10.13	4.9E-22	Kawasaki disease	
LUAD	cis	1	rs11134779	chr5:156936766	ADAM19	chr5:156822542-157002768:-	-0.14	-4.46	1.0E-5	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs11134789	chr5:156944199	ADAM19	chr5:156822542-157002768:-	0.13	4.14	4.1E-5	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs1114380	chr2:73804708	ALMS1	chr2:73612886-73837046:+	0.19	4.51	8.17E-6	Metabolite levels	
LUAD	cis	1	rs1114380	chr2:73804708	ALMS1P	chr2:73872046-73912692:+	0.4	7.57	1.91E-13	Metabolite levels	
LUAD	cis	1	rs11148252	chr13:53009048	CKAP2	chr13:53029495-53050763:+	-0.16	-5.09	5.01E-7	Lewy body disease	
LUAD	cis	1	rs11149710	chr16:74472546	RFWD3	chr16:74655298-74700779:-	0.19	4.04	6.18E-5	Breast cancer	
LUAD	cis	1	rs11153285	chr6:97413151	GPR63	chr6:97245889-97285353:-	-0.25	-3.96	8.48E-5	Body mass index	
LUAD	cis	1	rs11153286	chr6:97413636	GPR63	chr6:97245889-97285353:-	-0.26	-4.08	5.21E-5	Body mass index	
LUAD	cis	1	rs111542497	chr2:203195092	NOP58	chr2:203130515-203168382:+	0.22	3.8	0.000165	Urate levels	
LUAD	cis	1	rs11156875	chr14:35619816	PPP2R3C	chr14:35554679-35591679:-	0.25	3.88	0.000118	Atopic dermatitis	
LUAD	cis	1	rs11159067	chr14:74637444	C14orf45	chr14:74486059-74549566:+	0.17	3.85	0.000133	Common traits (Other)	
LUAD	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.42	9.38	2.56E-19	Common traits (Other)	
LUAD	cis	1	rs11159117	chr14:75584867	EIF2B2	chr14:75469612-75476292:+	0.22	4.1	4.79E-5	Height	
LUAD	cis	1	rs11159117	chr14:75584867	MLH3	chr14:75480467-75518235:-	0.29	5.48	6.84E-8	Height	
LUAD	cis	1	rs11164654	chr1:92968312	EVI5	chr1:92974255-93257961:-	-0.27	-4.29	2.11E-5	Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs111649495	chr5:118356415	DTWD2	chr5:118172571-118324240:-	-0.32	-4.72	3.1E-6	Response to amphetamines	
LUAD	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.34	4.17	3.66E-5	Crohn's disease	
LUAD	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.37	3.96	8.55E-5	Crohn's disease	
LUAD	cis	1	rs11168936	chr12:49645240	TUBA1C	chr12:49621709-49667113:+	-0.15	-4.6	5.32E-6	Cancer (pleiotropy)	
LUAD	cis	1	rs111696803	chr9:100696636	C9orf156	chr9:100666772-100684852:-	-0.2	-3.95	8.87E-5	Quantitative traits	
LUAD	cis	1	rs1117010	chr4:48410949	NIPAL1	chr4:48018791-48039078:+	0.19	3.87	0.000125	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs111704178	chr10:75957251	ADK	chr10:75910965-76469059:+	0.23	3.85	0.000135	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11171806	chr12:56733531	MIP	chr12:56843885-56848429:-	-0.38	-3.7	0.000244	Psoriasis vulgaris	
LUAD	cis	1	rs11172254	chr12:57968738	FAM119B	chr12:58166383-58176323:+	-0.21	-3.82	0.000153	Rheumatoid arthritis	
LUAD	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.47	8.36	6.68E-16	Multiple sclerosis	
LUAD	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.24	-4.86	1.62E-6	Multiple sclerosis	
LUAD	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.47	8.15	3.05E-15	Multiple sclerosis	
LUAD	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.24	-4.84	1.73E-6	Multiple sclerosis	
LUAD	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.47	8.15	3.05E-15	Multiple sclerosis	
LUAD	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.24	-4.84	1.73E-6	Multiple sclerosis	
LUAD	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.47	8.15	3.05E-15	Multiple sclerosis	
LUAD	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.24	-4.84	1.73E-6	Multiple sclerosis	
LUAD	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.47	8.32	9.11E-16	Multiple sclerosis	
LUAD	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.23	-4.83	1.84E-6	Multiple sclerosis	
LUAD	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.47	8.16	2.86E-15	Multiple sclerosis	
LUAD	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.23	-4.56	6.45E-6	Multiple sclerosis	
LUAD	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.47	8.14	3.26E-15	Multiple sclerosis	
LUAD	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.23	-4.55	6.84E-6	Multiple sclerosis	
LUAD	cis	1	rs1117367	chr15:76872330	SCAPER	chr15:76640529-77197744:-	-0.22	-5.07	5.61E-7	Blood metabolite levels	
LUAD	cis	1	rs11180559	chr12:75920285	GLIPR1L2	chr12:75784889-75825591:+	0.28	3.68	0.000257	Daytime sleep phenotypes	
LUAD	cis	1	rs111873045	chr4:106639712	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.5E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11188394	chr10:97365458	ENTPD1	chr10:97471536-97637022:+	0.21	5.62	3.13E-8	Blood metabolite levels	
LUAD	cis	1	rs11188396	chr10:97367510	ENTPD1	chr10:97471536-97637022:+	0.19	5.21	2.73E-7	Blood metabolite levels	
LUAD	cis	1	rs11188398	chr10:97369093	ENTPD1	chr10:97471536-97637022:+	0.19	5.02	7.29E-7	Blood metabolite levels	
LUAD	cis	1	rs11188400	chr10:97371327	ENTPD1	chr10:97471536-97637022:+	0.19	5.17	3.39E-7	Blood metabolite levels	
LUAD	cis	1	rs11188406	chr10:97390195	ENTPD1	chr10:97471536-97637022:+	0.2	5.5	6.2E-8	Blood metabolite levels	
LUAD	cis	1	rs11188407	chr10:97390533	ENTPD1	chr10:97471536-97637022:+	0.2	5.5	6.2E-8	Blood metabolite levels	
LUAD	cis	1	rs11188411	chr10:97397344	ENTPD1	chr10:97471536-97637022:+	0.21	5.68	2.35E-8	Blood metabolite levels	
LUAD	cis	1	rs11188417	chr10:97411680	ENTPD1	chr10:97471536-97637022:+	-0.18	-4.91	1.27E-6	Blood metabolite levels	
LUAD	cis	1	rs111899361	chr7:1112348	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.82	1.08E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs111901203	chr11:58297542	CNTF	chr11:58390146-58393203:+	0.33	4.5	8.39E-6	Lymphoma	
LUAD	cis	1	rs11190130	chr10:101275206	NKX2-3	chr10:101292690-101296278:+	-0.28	-5.35	1.38E-7	Dental caries	
LUAD	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.79	7.88	2.07E-14	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs11190540	chr10:102202629	SEC31B	chr10:102246403-102289636:-	-0.2	-6.67	6.97E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190541	chr10:102203071	SEC31B	chr10:102246403-102289636:-	-0.22	-7.04	6.55E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190551	chr10:102204734	SEC31B	chr10:102246403-102289636:-	-0.21	-6.86	2.16E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190552	chr10:102206607	SEC31B	chr10:102246403-102289636:-	-0.22	-6.94	1.22E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190555	chr10:102209160	SEC31B	chr10:102246403-102289636:-	-0.21	-6.86	2.16E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190556	chr10:102209223	SEC31B	chr10:102246403-102289636:-	-0.21	-6.86	2.16E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190557	chr10:102209369	SEC31B	chr10:102246403-102289636:-	-0.21	-6.73	4.65E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190558	chr10:102209397	SEC31B	chr10:102246403-102289636:-	-0.21	-6.86	2.16E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190569	chr10:102227409	SEC31B	chr10:102246403-102289636:-	-0.21	-6.87	1.99E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190570	chr10:102227702	SEC31B	chr10:102246403-102289636:-	-0.22	-7.03	7.21E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190572	chr10:102232879	SEC31B	chr10:102246403-102289636:-	-0.21	-6.9	1.58E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190578	chr10:102238953	SEC31B	chr10:102246403-102289636:-	-0.22	-6.95	1.16E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190587	chr10:102266638	SEC31B	chr10:102246403-102289636:-	-0.22	-6.94	1.28E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190589	chr10:102275471	SEC31B	chr10:102246403-102289636:-	-0.19	-6.1	2.18E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190592	chr10:102291059	SEC31B	chr10:102246403-102289636:-	-0.2	-6.44	2.85E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190595	chr10:102291761	SEC31B	chr10:102246403-102289636:-	-0.2	-6.44	2.85E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190596	chr10:102293238	SEC31B	chr10:102246403-102289636:-	-0.21	-6.58	1.2E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190597	chr10:102293676	SEC31B	chr10:102246403-102289636:-	-0.2	-6.44	2.85E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190599	chr10:102295420	SEC31B	chr10:102246403-102289636:-	-0.2	-6.4	3.59E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190601	chr10:102296730	SEC31B	chr10:102246403-102289636:-	-0.21	-6.6	1.08E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190602	chr10:102297256	SEC31B	chr10:102246403-102289636:-	-0.2	-6.4	3.56E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190604	chr10:102302457	SEC31B	chr10:102246403-102289636:-	-0.22	-6.78	3.42E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190607	chr10:102303614	SEC31B	chr10:102246403-102289636:-	-0.2	-6.36	4.72E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11190613	chr10:102313997	SEC31B	chr10:102246403-102289636:-	0.17	5.62	3.15E-8	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11191416	chr10:104604916	SFXN2	chr10:104474298-104498946:+	0.34	3.78	0.000179	Hypertension;Systolic blood pressure;Diastolic blood pressure	
LUAD	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.28	-6.79	3.35E-11	Schizophrenia	
LUAD	cis	1	rs11191425	chr10:104625970	SFXN2	chr10:104474298-104498946:+	-0.41	-4.49	8.93E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
LUAD	cis	1	rs11200985	chr10:81732653	MBL1P	chr10:81664654-81710783:+	0.3	3.97	8.21E-5	Rheumatoid arthritis	
LUAD	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-0.61	-7.39	6.21E-13	Chronic obstructive pulmonary disease-related biomarkers	
LUAD	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.53	-6.58	1.2E-10	Chronic obstructive pulmonary disease-related biomarkers	
LUAD	cis	1	rs11204971	chr1:152259078	FLG	chr1:152274651-152297679:-	0.28	4.17	3.57E-5	Atopic dermatitis	
LUAD	cis	1	rs11209006	chr1:67619259	C1orf141	chr1:67557859-67600653:-	-0.18	-5.75	1.54E-8	Psoriasis	
LUAD	cis	1	rs11209007	chr1:67619345	C1orf141	chr1:67557859-67600653:-	-0.18	-5.75	1.54E-8	Psoriasis	
LUAD	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.89	-18.18	8.21E-57	Homocysteine levels	
LUAD	cis	1	rs11211132	chr1:45990516	MUTYH	chr1:45794915-45806142:-	0.21	4.44	1.13E-5	Homocysteine levels	
LUAD	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.38	-7.08	4.98E-12	Body mass index	
LUAD	cis	1	rs11211199	chr1:46287869	MUTYH	chr1:45794915-45806142:-	0.18	4.16	3.78E-5	Body mass index	
LUAD	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.01E-12	Body mass index	
LUAD	cis	1	rs11211208	chr1:46334256	MUTYH	chr1:45794915-45806142:-	0.18	4.31	1.99E-5	Body mass index	
LUAD	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.79E-12	Body mass index	
LUAD	cis	1	rs11211230	chr1:46406767	MUTYH	chr1:45794915-45806142:-	0.17	4.01	6.9E-5	Body mass index	
LUAD	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.21	2.15E-12	Body mass index	
LUAD	cis	1	rs11211234	chr1:46438787	MUTYH	chr1:45794915-45806142:-	0.17	3.97	8.34E-5	Body mass index	
LUAD	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.21	2.15E-12	Body mass index	
LUAD	cis	1	rs11211241	chr1:46452683	MUTYH	chr1:45794915-45806142:-	0.17	3.97	8.34E-5	Body mass index	
LUAD	cis	1	rs112143304	chr17:61822401	FTSJ3	chr17:61896795-61905031:-	0.23	4.63	4.6E-6	Body mass index	
LUAD	cis	1	rs11215031	chr11:114390447	FAM55D	chr11:114441314-114466484:-	0.38	4.84	1.78E-6	IgG glycosylation	
LUAD	cis	1	rs11227288	chr11:65516588	SNX32	chr11:65601410-65621170:+	0.31	4.21	3.02E-5	Systemic lupus erythematosus	
LUAD	cis	1	rs112293138	chr1:171714002	VAMP4	chr1:171669298-171711214:-	0.26	4.14	4.06E-5	Hippocampal atrophy	
LUAD	cis	1	rs11229535	chr11:58348386	CNTF	chr11:58390146-58393203:+	0.3	4.04	6.29E-5	Lymphoma	
LUAD	cis	1	rs112306637	chr2:203198918	NOP58	chr2:203130515-203168382:+	0.31	4.73	3.0E-6	Urate levels	
LUAD	cis	1	rs1123072	chr16:67898797	C16orf86	chr16:67700717-67702659:+	-0.31	-3.67	0.000269	Crohn's disease	
LUAD	cis	1	rs11239544	chr10:46007533	OR13A1	chr10:45798102-45811056:-	-0.26	-3.84	0.000137	Cholesterol, total	
LUAD	cis	1	rs11242	chr3:53125922	RFT1	chr3:53122503-53164470:-	0.19	3.8	0.000163	Height	
LUAD	cis	1	rs11247277	chr15:101784664	LINS1	chr15:101109436-101142404:-	0.21	4.08	5.21E-5	Corneal structure	
LUAD	cis	1	rs11247915	chr1:26650550	TRIM63	chr1:26377798-26394121:-	0.21	4.09	4.97E-5	Obesity-related traits	
LUAD	cis	1	rs11248009	chr4:220149	ZNF718	chr4:53272-156488:+	0.28	4.15	3.96E-5	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11248348	chr10:124730840	C10orf88	chr10:124690419-124713919:-	-0.2	-4.07	5.42E-5	Migraine without aura	
LUAD	cis	1	rs112528936	chr4:106633029	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.5E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11264203	chr1:36239234	C1orf216	chr1:36179477-36184790:-	-0.35	-4.9	1.31E-6	Schizophrenia	
LUAD	cis	1	rs11264211	chr1:36270607	C1orf216	chr1:36179477-36184790:-	-0.3	-4.19	3.31E-5	Schizophrenia	
LUAD	cis	1	rs11264213	chr1:36283954	C1orf216	chr1:36179477-36184790:-	-0.3	-4.29	2.11E-5	Schizophrenia	
LUAD	cis	1	rs11264462	chr1:156241728	CCT3	chr1:156278752-156308195:-	-0.17	-4.24	2.7E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs11264464	chr1:156250887	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs11264467	chr1:156273061	CCT3	chr1:156278752-156308195:-	0.15	3.71	0.000228	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs11264468	chr1:156274585	CCT3	chr1:156278752-156308195:-	-0.15	-3.77	0.000186	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs112654776	chr4:106765058	INTS12	chr4:106603787-106629881:-	-0.56	-6.08	2.44E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs112753638	chr2:203199219	NOP58	chr2:203130515-203168382:+	0.31	4.73	3.0E-6	Urate levels	
LUAD	cis	1	rs11292	chr10:102313607	SEC31B	chr10:102246403-102289636:-	-0.19	-6.56	1.41E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs1129448	chr22:38170026	TRIOBP	chr22:38082344-38172562:+	0.2	4.39	1.36E-5	Optic cup area;Vertical cup-disc ratio	
LUAD	cis	1	rs113066613	chr7:1094128	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.78	1.34E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs113134232	chr17:61715461	FTSJ3	chr17:61896795-61905031:-	0.23	4.71	3.27E-6	Body mass index	
LUAD	cis	1	rs113143821	chr5:127893353	FBN2	chr5:127593602-127873916:-	0.59	7.86	2.46E-14	Multiple system atrophy	
LUAD	cis	1	rs113146460	chr7:1105164	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.8	1.19E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs113315674	chr9:100720053	C9orf156	chr9:100666772-100684852:-	-0.19	-3.74	0.000209	Quantitative traits	
LUAD	cis	1	rs1133483	chr4:100023923	ADH4	chr4:100044835-100065449:-	-0.35	-7.34	9.15E-13	HDL cholesterol	
LUAD	cis	1	rs11344	chr16:29910518	LOC440356	chr16:29875004-29879374:+	-0.27	-5.03	6.77E-7	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs113491584	chr2:203196447	NOP58	chr2:203130515-203168382:+	0.3	4.63	4.79E-6	Urate levels	
LUAD	cis	1	rs113575110	chr7:1084394	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.93	5.58E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs113638727	chr15:40706101	C15orf23	chr15:40674922-40686488:+	0.39	6.46	2.59E-10	Heschl's gyrus morphology	
LUAD	cis	1	rs113767110	chr4:106599814	INTS12	chr4:106603787-106629881:-	-0.64	-6.58	1.21E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.53	10.39	5.69E-23	Height	
LUAD	cis	1	rs113858334	chr7:1073476	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.9	6.66E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs113877751	chr2:203194721	NOP58	chr2:203130515-203168382:+	0.3	4.63	4.79E-6	Urate levels	
LUAD	cis	1	rs113995589	chr3:53132372	TMEM110	chr3:52867139-52931547:-	0.33	3.88	0.000118	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.26	4.88	1.46E-6	Pancreatic cancer	
LUAD	cis	1	rs114079739	chr2:203825106	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs114110842	chr2:203823400	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs114123510	chr2:203831212	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs1141321	chr6:49412433	CENPQ	chr6:49431096-49460820:+	-0.26	-6.38	4.14E-10	Folate pathway vitamin levels	
LUAD	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.34	6.87	1.99E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs114155121	chr2:203718682	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.49	8.96E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs114171212	chr4:106616191	INTS12	chr4:106603787-106629881:-	-0.64	-6.62	9.53E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs114176245	chr11:102719534	MMP12	chr11:102733465-102745712:-	-0.25	-3.79	0.000168	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
LUAD	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.26	3.87	0.000124	Atopic dermatitis	
LUAD	cis	1	rs114256679	chr4:106636598	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.5E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs114304428	chr1:152254010	FLG	chr1:152274651-152297679:-	0.28	4.17	3.57E-5	Atopic dermatitis	
LUAD	cis	1	rs114393235	chr2:203795987	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs114395475	chr2:203769112	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs114455120	chr18:70259517	CBLN2	chr18:70203915-70211723:-	0.5	4.51	8.1E-6	Airflow obstruction	
LUAD	cis	1	rs114520702	chr2:203697092	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.44	1.12E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs114527590	chr2:203787405	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs114535501	chr18:65470749	CCDC102B	chr18:66382491-66722426:+	0.42	5.21	2.8E-7	Bipolar disorder (body mass index interaction)	
LUAD	cis	1	rs114562844	chr3:52991584	TMEM110	chr3:52867139-52931547:-	0.45	4.88	1.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11465753	chr1:67631423	C1orf141	chr1:67557859-67600653:-	-0.2	-6.12	1.95E-9	Psoriasis	
LUAD	cis	1	rs11465754	chr1:67631431	C1orf141	chr1:67557859-67600653:-	-0.19	-6.01	3.59E-9	Psoriasis	
LUAD	cis	1	rs114702158	chr2:203821793	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs1148000	chr12:75936301	GLIPR1L2	chr12:75784889-75825591:+	-0.24	-4.35	1.63E-5	Polycystic ovary syndrome	
LUAD	cis	1	rs114827034	chr12:91480042	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs114899426	chr2:203771652	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.72	13.32	9.3E-35	Diastolic blood pressure	
LUAD	cis	1	rs114976176	chr2:264621	SH3YL1	chr2:218138-264810:-	-0.63	-13.75	1.37E-36	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs11513751	chr12:91482180	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs11513752	chr12:91482198	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs11513822	chr12:91482005	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs11513823	chr12:91482359	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs115170232	chr2:203281513	NOP58	chr2:203130515-203168382:+	0.26	4.09	4.99E-5	Urate levels	
LUAD	cis	1	rs11519665	chr12:91482036	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs11532322	chr12:123731423	CDK2AP1	chr12:123745542-123756687:-	0.21	3.71	0.000234	Schizophrenia	
LUAD	cis	1	rs11538349	chr7:65421871	CRCP	chr7:65579805-65619551:+	-0.32	-3.74	0.000202	Diabetic kidney disease	
LUAD	cis	1	rs115391623	chr16:68276064	ATP6V0D1	chr16:67471917-67515089:-	-0.39	-3.72	0.000224	Crohn's disease	
LUAD	cis	1	rs115396314	chr2:203721314	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.49	8.96E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs115400054	chr2:203676105	ALS2CR8	chr2:203776978-203851060:+	-0.25	-4.62	4.91E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs115418388	chr10:75976296	ADK	chr10:75910965-76469059:+	0.24	3.79	0.000171	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs11542436	chr17:61778689	FTSJ3	chr17:61896795-61905031:-	0.21	4.52	7.83E-6	Body mass index	
LUAD	cis	1	rs11547772	chr4:99992793	ADH5	chr4:99992132-100009931:-	0.29	3.69	0.000249	Smoking initiation	
LUAD	cis	1	rs115515961	chr18:51836253	POLI	chr18:51795849-51824602:+	0.19	3.68	0.000263	Psoriasis	
LUAD	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.64	-13.97	1.4E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	0.38	6.25	8.87E-10	Heschl's gyrus morphology	
LUAD	cis	1	rs115654617	chr2:203893999	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.5	8.47E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs115714874	chr2:179969471	SESTD1	chr2:179966421-180129350:-	-0.42	-3.73	0.000216	Late-onset Alzheimer's disease	
LUAD	cis	1	rs11577745	chr1:171720909	VAMP4	chr1:171669298-171711214:-	0.23	3.74	0.000207	Hippocampal atrophy	
LUAD	cis	1	rs11578336	chr1:166958710	GPA33	chr1:167022082-167059868:-	-0.22	-3.99	7.47E-5	Refractive astigmatism	
LUAD	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.4	7.43	4.73E-13	Body mass index	
LUAD	cis	1	rs11579634	chr1:46466391	MUTYH	chr1:45794915-45806142:-	-0.17	-4.11	4.56E-5	Body mass index	
LUAD	cis	1	rs11580522	chr1:171720978	VAMP4	chr1:171669298-171711214:-	-0.25	-3.92	0.0001	Hippocampal atrophy	
LUAD	cis	1	rs115808154	chr5:133464275	CDKL3	chr5:133541305-133706735:-	-0.42	-4.53	7.34E-6	Systemic lupus erythematosus	
LUAD	cis	1	rs115810193	chr2:203943168	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.69	3.6E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs11583043	chr1:101466054	CCDC76	chr1:100598706-100616053:+	0.18	3.75	0.0002	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs11583920	chr1:171683611	VAMP4	chr1:171669298-171711214:-	0.24	3.84	0.000138	Hippocampal atrophy	
LUAD	cis	1	rs11584222	chr1:101480110	CCDC76	chr1:100598706-100616053:+	0.18	3.74	0.000203	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs11588170	chr1:152286032	FLG	chr1:152274651-152297679:-	0.28	4.05	5.86E-5	Atopic dermatitis	
LUAD	cis	1	rs11589562	chr1:46466721	CCDC163P	chr1:45960581-45965646:-	0.35	6.2	1.17E-9	Body mass index	
LUAD	cis	1	rs11589562	chr1:46466721	MUTYH	chr1:45794915-45806142:-	-0.22	-4.98	8.72E-7	Body mass index	
LUAD	cis	1	rs11589562	chr1:46466721	TMEM69	chr1:46153847-46160108:+	-0.19	-3.83	0.000142	Body mass index	
LUAD	cis	1	rs11590365	chr1:152165489	FLG	chr1:152274651-152297679:-	0.27	4.09	5.01E-5	Atopic dermatitis	
LUAD	cis	1	rs11590680	chr1:171716574	VAMP4	chr1:171669298-171711214:-	0.23	3.69	0.000246	Hippocampal atrophy	
LUAD	cis	1	rs11592213	chr10:97396103	ENTPD1	chr10:97471536-97637022:+	0.2	5.5	6.1E-8	Blood metabolite levels	
LUAD	cis	1	rs115953525	chr2:203744445	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs11595684	chr10:38083804	LOC399744	chr10:38717074-38741080:+	0.26	3.74	0.000207	Obesity (extreme)	
LUAD	cis	1	rs115965884	chr22:24594662	SUSD2	chr22:24577444-24585074:+	0.25	3.77	0.000185	Amyotrophic lateral sclerosis	
LUAD	cis	1	rs11600543	chr11:65298939	POLA2	chr11:65029432-65065087:+	-0.33	-3.82	0.000152	Height	
LUAD	cis	1	rs11602375	chr11:65296540	POLA2	chr11:65029432-65065087:+	-0.33	-3.82	0.000152	Height	
LUAD	cis	1	rs116034011	chr4:106735622	INTS12	chr4:106603787-106629881:-	-0.62	-6.61	1.01E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11605774	chr11:47832793	C1QTNF4	chr11:47611216-47615961:-	-0.21	-4.06	5.82E-5	Subjective well-being	
LUAD	cis	1	rs11605774	chr11:47832793	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.54	7.09E-6	Subjective well-being	
LUAD	cis	1	rs11606049	chr11:112033129	IL18	chr11:112013976-112034840:-	-0.28	-6.49	2.06E-10	Interleukin-18 levels	
LUAD	cis	1	rs11611670	chr12:9385535	LOC642846	chr12:9436253-9466684:+	0.17	5.11	4.61E-7	Breast size	
LUAD	cis	1	rs116139393	chr7:6771660	PMS2CL	chr7:6749757-6793492:+	-0.33	-4.93	1.12E-6	Alzheimer's disease (APOE e4 interaction)	
LUAD	cis	1	rs11623413	chr14:75588824	MLH3	chr14:75480467-75518235:-	-0.27	-5.23	2.56E-7	Height	
LUAD	cis	1	rs11625034	chr14:54349976	FERMT2	chr14:53323990-53417815:-	0.16	3.98	7.98E-5	Waist-to-hip ratio adjusted for body mass index	
LUAD	cis	1	rs11625697	chr14:104464800	TDRD9	chr14:104394817-104519002:+	0.27	4.18	3.52E-5	Bipolar disorder	
LUAD	cis	1	rs11628710	chr14:74649280	C14orf45	chr14:74486059-74549566:+	0.18	4.05	6.03E-5	Common traits (Other)	
LUAD	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.46	10.22	2.46E-22	Common traits (Other)	
LUAD	cis	1	rs11628710	chr14:74649280	ZNF410	chr14:74318674-74398803:+	0.18	3.7	0.000238	Common traits (Other)	
LUAD	cis	1	rs11631963	chr15:83318202	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.15	4.84	1.77E-6	Schizophrenia	
LUAD	cis	1	rs11632465	chr15:85282045	LOC388152	chr15:84867600-84898920:-	-0.32	-6.11	2.05E-9	Schizophrenia	
LUAD	cis	1	rs11636578	chr15:101787969	LINS1	chr15:101109436-101142404:-	0.22	4.25	2.53E-5	Corneal structure	
LUAD	cis	1	rs11637142	chr15:85295927	LOC388152	chr15:84867600-84898920:-	-0.31	-5.91	6.45E-9	Schizophrenia	
LUAD	cis	1	rs11637433	chr15:83321336	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.14	4.54	7.19E-6	Schizophrenia	
LUAD	cis	1	rs11637852	chr15:63397151	LACTB	chr15:63414032-63434254:+	0.21	3.99	7.67E-5	HDL cholesterol	
LUAD	cis	1	rs116382857	chr2:203751932	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.63	4.65E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs11638290	chr15:85227636	LOC388152	chr15:84867600-84898920:-	-0.32	-5.97	4.61E-9	Schizophrenia	
LUAD	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.36	-6.68	6.58E-11	Schizophrenia	
LUAD	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.38	-7	8.64E-12	Schizophrenia	
LUAD	cis	1	rs116439150	chr2:203388537	NOP58	chr2:203130515-203168382:+	0.27	4.21	3.06E-5	Urate levels	
LUAD	cis	1	rs11644601	chr16:15172118	RRN3	chr16:15153881-15188158:-	-0.24	-3.85	0.000134	Metabolite levels (lipid measures)	
LUAD	cis	1	rs11645002	chr16:20617841	ACSM1	chr16:20634559-20709066:-	0.39	5.76	1.53E-8	Urinary metabolites	
LUAD	cis	1	rs11647589	chr16:20449616	ACSM1	chr16:20634559-20709066:-	0.23	4.54	6.94E-6	Blood metabolite levels	
LUAD	cis	1	rs11650372	chr17:45721795	C17orf57	chr17:45401142-45518675:+	0.33	6.64	8.38E-11	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.52	-10.73	3.03E-24	Eye color traits	
LUAD	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.51	10.65	5.77E-24	Eye color traits	
LUAD	cis	1	rs11654335	chr17:61797579	FTSJ3	chr17:61896795-61905031:-	0.23	4.8	2.12E-6	Body mass index	
LUAD	cis	1	rs11657081	chr17:61792339	FTSJ3	chr17:61896795-61905031:-	0.21	4.42	1.24E-5	Body mass index	
LUAD	cis	1	rs11657120	chr17:61857218	FTSJ3	chr17:61896795-61905031:-	0.22	4.69	3.5E-6	Body mass index	
LUAD	cis	1	rs11658168	chr17:7406134	CHRNB1	chr17:7348406-7360931:+	0.2	3.75	0.000201	Height	
LUAD	cis	1	rs11658175	chr17:61923838	FTSJ3	chr17:61896795-61905031:-	0.22	4.72	3.1E-6	Body mass index	
LUAD	cis	1	rs11658329	chr17:61763031	FTSJ3	chr17:61896795-61905031:-	-0.19	-4.08	5.21E-5	Body mass index	
LUAD	cis	1	rs11658740	chr17:61751069	FTSJ3	chr17:61896795-61905031:-	0.2	4.25	2.62E-5	Body mass index	
LUAD	cis	1	rs11660238	chr18:65470134	CCDC102B	chr18:66382491-66722426:+	0.38	4.02	6.62E-5	Bipolar disorder (body mass index interaction)	
LUAD	cis	1	rs116616340	chr3:53132371	TMEM110	chr3:52867139-52931547:-	0.33	3.88	0.000118	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs116635509	chr2:203324750	NOP58	chr2:203130515-203168382:+	0.27	4.32	1.85E-5	Urate levels	
LUAD	cis	1	rs11665924	chr19:44286982	ZNF155	chr19:44488355-44502477:+	-0.23	-4.16	3.74E-5	Breast cancer	
LUAD	cis	1	rs11666415	chr19:24228512	LOC100101266	chr19:24344995-24346249:-	0.26	3.97	8.42E-5	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs116678869	chr2:203819471	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs11671653	chr19:10838486	RAVER1	chr19:10426891-10444314:-	0.24	3.86	0.000131	LDL cholesterol	
LUAD	cis	1	rs11674602	chr2:73723185	ALMS1	chr2:73612886-73837046:+	0.19	4.63	4.6E-6	Metabolite levels	
LUAD	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.39	7.36	7.65E-13	Metabolite levels	
LUAD	cis	1	rs11674602	chr2:73723185	FBXO41	chr2:73481800-73498043:-	0.2	3.76	0.000191	Metabolite levels	
LUAD	cis	1	rs1167613	chr7:65487439	CRCP	chr7:65579805-65619551:+	-0.32	-3.69	0.000254	Diabetic kidney disease	
LUAD	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.32	-7.95	1.32E-14	Body mass index	
LUAD	cis	1	rs1167827	chr7:75163169	SPDYE5	chr7:75124299-75133627:+	0.19	4.43	1.14E-5	Body mass index	
LUAD	cis	1	rs11681497	chr2:242344333	SEPT2	chr2:242254723-242293439:+	0.57	6.69	6.13E-11	Chronic lymphocytic leukemia	
LUAD	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.27	5.51	5.78E-8	Body mass index	
LUAD	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.27	5.46	7.46E-8	Body mass index	
LUAD	cis	1	rs116971206	chr16:68173156	ATP6V0D1	chr16:67471917-67515089:-	-0.42	-4.18	3.42E-5	Crohn's disease	
LUAD	cis	1	rs116971206	chr16:68173156	C16orf86	chr16:67700717-67702659:+	-0.36	-3.82	0.000148	Crohn's disease	
LUAD	cis	1	rs11697767	chr20:4743859	PRND	chr20:4702556-4709105:+	0.22	3.9	0.000108	Systemic lupus erythematosus	
LUAD	cis	1	rs116988148	chr16:68146952	ATP6V0D1	chr16:67471917-67515089:-	-0.38	-3.72	0.000227	Crohn's disease	
LUAD	cis	1	rs116988148	chr16:68146952	C16orf86	chr16:67700717-67702659:+	-0.37	-3.78	0.000173	Crohn's disease	
LUAD	cis	1	rs11699253	chr20:4743955	PRND	chr20:4702556-4709105:+	0.22	3.9	0.000108	Systemic lupus erythematosus	
LUAD	cis	1	rs11701091	chr21:33920244	TCP10L	chr21:33947152-33957845:-	-0.27	-4.07	5.45E-5	Gastritis	
LUAD	cis	1	rs11701627	chr21:33927794	TCP10L	chr21:33947152-33957845:-	-0.25	-3.94	9.38E-5	Gastritis	
LUAD	cis	1	rs11703914	chr22:24767602	POM121L9P	chr22:24647589-24661490:+	-0.25	-5.33	1.52E-7	Gut microbiome composition (summer)	
LUAD	cis	1	rs11705483	chr22:46630544	PKDREJ	chr22:46651561-46659219:-	-0.47	-5.57	4.28E-8	Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs11706035	chr3:53011868	TMEM110	chr3:52867139-52931547:-	0.38	4.16	3.72E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.52	10.06	9.34E-22	Height	
LUAD	cis	1	rs11707575	chr3:53113762	TMEM110	chr3:52867139-52931547:-	0.3	3.78	0.000174	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11707780	chr3:53084326	TNNC1	chr3:52485108-52488057:-	0.25	3.86	0.000127	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.52	10.08	7.5E-22	Height	
LUAD	cis	1	rs11709077	chr3:12336507	MKRN2	chr3:12598594-12625208:+	0.31	3.88	0.000121	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs11709077	chr3:12336507	RAF1	chr3:12625102-12705700:-	0.31	3.79	0.00017	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs11710136	chr3:190985993	UTS2D	chr3:190984945-191048325:-	-0.3	-6.22	1.08E-9	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs11710292	chr3:53117798	TMEM110	chr3:52867139-52931547:-	0.47	5.13	4.12E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11710707	chr3:52975916	TMEM110	chr3:52867139-52931547:-	0.51	5.3	1.78E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.29	-7.29	1.22E-12	Longevity	
LUAD	cis	1	rs11712653	chr3:53070875	TMEM110	chr3:52867139-52931547:-	-0.39	-4.35	1.64E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11713206	chr3:52999243	TMEM110	chr3:52867139-52931547:-	0.49	5.04	6.51E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11713290	chr3:52971579	TMEM110	chr3:52867139-52931547:-	0.45	4.88	1.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11713859	chr3:53042080	TMEM110	chr3:52867139-52931547:-	0.46	4.86	1.6E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.37	7.27	1.42E-12	Cognitive performance	
LUAD	cis	1	rs11714876	chr3:53101640	TMEM110	chr3:52867139-52931547:-	-0.45	-5.01	7.46E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11717619	chr3:53003179	TMEM110	chr3:52867139-52931547:-	0.37	4.17	3.65E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11718538	chr3:52975987	TMEM110	chr3:52867139-52931547:-	0.45	4.88	1.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11718752	chr3:53130745	TMEM110	chr3:52867139-52931547:-	0.34	4.16	3.68E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11718834	chr3:52963668	TMEM110	chr3:52867139-52931547:-	0.45	4.8	2.13E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.38	7.45	4.4E-13	Cognitive performance	
LUAD	cis	1	rs11720191	chr3:53013839	TMEM110	chr3:52867139-52931547:-	0.4	4.35	1.68E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.36	7.13	3.57E-12	Cognitive performance	
LUAD	cis	1	rs11722197	chr4:281707	ZNF718	chr4:53272-156488:+	0.27	3.9	0.000111	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11722225	chr4:106766430	INTS12	chr4:106603787-106629881:-	-0.59	-6.08	2.41E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs11722521	chr4:276765	ZNF718	chr4:53272-156488:+	0.26	3.88	0.00012	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11723225	chr4:106746065	INTS12	chr4:106603787-106629881:-	-0.62	-6.61	1.01E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11723240	chr4:106736936	INTS12	chr4:106603787-106629881:-	-0.62	-6.61	1.01E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11723261	chr4:282499	ZNF718	chr4:53272-156488:+	0.27	3.9	0.000111	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11723639	chr4:106741163	INTS12	chr4:106603787-106629881:-	-0.62	-6.31	6.1E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11723803	chr4:292369	ZNF718	chr4:53272-156488:+	0.3	5.23	2.49E-7	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11724176	chr4:224901	ZNF718	chr4:53272-156488:+	0.28	4.15	3.96E-5	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11724417	chr4:223352	ZNF718	chr4:53272-156488:+	0.28	4.15	3.96E-5	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11724839	chr4:106638256	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.35E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11724884	chr4:106677384	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs117249133	chr20:33773630	PROCR	chr20:33758727-33765164:+	-0.3	-3.86	0.000126	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
LUAD	cis	1	rs11726094	chr4:106773387	INTS12	chr4:106603787-106629881:-	-0.58	-5.75	1.53E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs11726124	chr4:106766496	INTS12	chr4:106603787-106629881:-	0.58	6.24	9.77E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11726569	chr4:106606608	INTS12	chr4:106603787-106629881:-	-0.64	-6.62	9.53E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11726829	chr4:224948	ZNF718	chr4:53272-156488:+	0.34	5.39	1.12E-7	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11727189	chr4:106619140	INTS12	chr4:106603787-106629881:-	-0.64	-6.62	9.53E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11727348	chr4:106679848	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11727500	chr4:106745948	INTS12	chr4:106603787-106629881:-	-0.62	-6.61	1.01E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11727735	chr4:106631870	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.59E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11727745	chr4:106716527	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.43E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11727803	chr4:88213158	HSD17B13	chr4:88224941-88244056:-	-0.27	-5.7	2.07E-8	Platelet count	
LUAD	cis	1	rs11727835	chr4:88213244	HSD17B13	chr4:88224941-88244056:-	-0.27	-5.7	2.07E-8	Platelet count	
LUAD	cis	1	rs11728044	chr4:106604786	INTS12	chr4:106603787-106629881:-	-0.64	-6.58	1.21E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11728716	chr4:106755996	INTS12	chr4:106603787-106629881:-	0.53	5.61	3.33E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs11729365	chr4:272524	ZNF718	chr4:53272-156488:+	0.26	3.85	0.000134	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11729657	chr4:1737585	FAM53A	chr4:1641609-1685854:-	-0.32	-5.59	3.69E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs117300105	chr16:68170298	ATP6V0D1	chr16:67471917-67515089:-	-0.42	-4.18	3.42E-5	Crohn's disease	
LUAD	cis	1	rs117300105	chr16:68170298	C16orf86	chr16:67700717-67702659:+	-0.36	-3.82	0.000148	Crohn's disease	
LUAD	cis	1	rs11730354	chr4:106773435	INTS12	chr4:106603787-106629881:-	-0.59	-6.08	2.46E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs11731386	chr4:106600338	INTS12	chr4:106603787-106629881:-	-0.64	-6.58	1.21E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11731417	chr4:106746012	INTS12	chr4:106603787-106629881:-	-0.62	-6.61	1.01E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11731714	chr4:106675946	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11731938	chr4:106725140	INTS12	chr4:106603787-106629881:-	-0.63	-6.26	8.56E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11732213	chr4:1704244	FAM53A	chr4:1641609-1685854:-	0.33	5.46	7.44E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs11732298	chr4:106701679	INTS12	chr4:106603787-106629881:-	0.64	6.67	6.89E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11732629	chr4:106754347	INTS12	chr4:106603787-106629881:-	-0.57	-5.9	6.79E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs11732650	chr4:106754231	INTS12	chr4:106603787-106629881:-	-0.57	-6.21	1.16E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs11733093	chr4:106765063	INTS12	chr4:106603787-106629881:-	-0.56	-5.77	1.41E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs11733124	chr4:106677541	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11733150	chr4:106765351	INTS12	chr4:106603787-106629881:-	-0.56	-6.08	2.44E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs11733223	chr4:106765525	INTS12	chr4:106603787-106629881:-	0.52	5.97	4.6E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs11733225	chr4:106705363	INTS12	chr4:106603787-106629881:-	-0.64	-6.39	3.97E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11733284	chr4:48028097	NIPAL1	chr4:48018791-48039078:+	0.34	6.79	3.36E-11	Renal underexcretion gout;Gout	
LUAD	cis	1	rs11733287	chr4:106705339	INTS12	chr4:106603787-106629881:-	-0.64	-6.68	6.38E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11733654	chr4:106730710	INTS12	chr4:106603787-106629881:-	-0.62	-6.65	8.06E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11734571	chr4:106703557	INTS12	chr4:106603787-106629881:-	-0.64	-6.68	6.38E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11735092	chr4:88226231	HSD17B13	chr4:88224941-88244056:-	-0.25	-5.47	7.27E-8	Platelet count	
LUAD	cis	1	rs11735213	chr4:106527508	INTS12	chr4:106603787-106629881:-	-0.53	-5.12	4.39E-7	Post bronchodilator FEV1	
LUAD	cis	1	rs11735527	chr4:106679692	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11735851	chr4:106697254	INTS12	chr4:106603787-106629881:-	-0.64	-6.38	4.04E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11736834	chr4:106708764	INTS12	chr4:106603787-106629881:-	-0.64	-6.39	3.97E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs11736859	chr4:106708785	INTS12	chr4:106603787-106629881:-	-0.64	-6.68	6.38E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs11737268	chr4:224452	ZNF718	chr4:53272-156488:+	0.34	5.39	1.12E-7	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs11737950	chr5:156436211	TIMD4	chr5:156346293-156390266:-	-0.25	-4.42	1.2E-5	Hypertriglyceridemia	
LUAD	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.81	14.16	2.22E-38	Type 2 diabetes	
LUAD	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.42	5.01	7.5E-7	Crohn's disease	
LUAD	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.39	4.66	4.1E-6	Crohn's disease	
LUAD	cis	1	rs11740496	chr5:156435402	TIMD4	chr5:156346293-156390266:-	0.24	4.27	2.39E-5	Hypertriglyceridemia	
LUAD	cis	1	rs11740499	chr5:156431741	TIMD4	chr5:156346293-156390266:-	-0.23	-4.07	5.55E-5	Hypertriglyceridemia	
LUAD	cis	1	rs11741688	chr5:178395850	ZNF454	chr5:178368224-178393434:+	-0.2	-3.85	0.000134	Sleep duration	
LUAD	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.45	-5.3	1.71E-7	Crohn's disease	
LUAD	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.4	4.5	8.38E-6	Crohn's disease	
LUAD	cis	1	rs11746128	chr5:156421250	TIMD4	chr5:156346293-156390266:-	-0.24	-4.36	1.61E-5	Hypertriglyceridemia	
LUAD	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.38	4.63	4.67E-6	Crohn's disease	
LUAD	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.4	4.81	1.97E-6	Crohn's disease	
LUAD	cis	1	rs117477371	chr12:21108021	SLCO1B3	chr12:20963638-21243038:+	0.22	4.21	3.07E-5	Bilirubin levels	
LUAD	cis	1	rs11749391	chr5:150229066	LOC134466	chr5:150310000-150326146:-	0.29	3.7	0.00024	Crohn's disease	
LUAD	cis	1	rs11753834	chr6:97414756	GPR63	chr6:97245889-97285353:-	-0.26	-4.15	4.0E-5	Body mass index	
LUAD	cis	1	rs11754336	chr6:97414775	GPR63	chr6:97245889-97285353:-	-0.26	-4.15	4.0E-5	Body mass index	
LUAD	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.64	-11.26	2.67E-26	Response to antipsychotic treatment	
LUAD	cis	1	rs11759804	chr6:151875122	C6orf97	chr6:151815175-151942327:+	0.16	3.74	0.000203	Bone mineral density (spine)	
LUAD	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.67	-12.33	1.34E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs11761941	chr7:1097183	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.73	1.73E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs11763020	chr7:1060288	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.44	8.3E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs11763056	chr7:128960871	LOC407835	chr7:128766325-128768041:+	0.23	3.69	0.000252	White matter hyperintensity burden	
LUAD	cis	1	rs11763793	chr7:1094342	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.71	1.95E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs11763835	chr7:1094513	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.71	1.95E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs11764748	chr7:1094508	ZFAND2A	chr7:1192544-1199855:-	-0.38	-6.01	3.71E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs11765693	chr7:75985373	UPK3B	chr7:76139745-76157197:+	-0.2	-3.87	0.000122	Multiple sclerosis	
LUAD	cis	1	rs11766526	chr7:1101433	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.82	1.09E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs11767527	chr7:1097394	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.73	1.73E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs11768309	chr7:97773812	BHLHA15	chr7:97840778-97842271:+	-0.19	-4.78	2.3E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
LUAD	cis	1	rs11768761	chr7:1069807	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.78	1.34E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs11770909	chr7:1086716	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.9	6.84E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs117802529	chr20:33786677	PROCR	chr20:33758727-33765164:+	-0.3	-3.79	0.000168	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
LUAD	cis	1	rs11782107	chr8:11115503	TDH	chr8:11197146-11225961:+	0.25	3.82	0.000151	Response to antipsychotic therapy (extrapyramidal side effects)	
LUAD	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-0.8	-9.67	2.26E-20	Epithelial ovarian cancer;Ovarian cancer	
LUAD	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.64	-12.01	2.67E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs11792861	chr9:111809295	C9orf5	chr9:111777416-111882225:-	0.2	3.94	9.27E-5	Menarche (age at onset)	
LUAD	cis	1	rs1179502	chr2:36672661	PRKD3	chr2:37477648-37544222:-	-0.19	-3.77	0.000184	IgE levels in asthmatics	
LUAD	cis	1	rs11801695	chr1:205916175	PM20D1	chr1:205797154-205819245:-	-0.23	-4.28	2.25E-5	Cystic fibrosis-related diabetes	
LUAD	cis	1	rs11801846	chr1:171674241	VAMP4	chr1:171669298-171711214:-	0.24	3.93	9.87E-5	Hippocampal atrophy	
LUAD	cis	1	rs11803174	chr1:171674338	VAMP4	chr1:171669298-171711214:-	0.24	3.84	0.000141	Hippocampal atrophy	
LUAD	cis	1	rs118059236	chr7:1073202	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.9	6.66E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.14	3.4E-12	Body mass index	
LUAD	cis	1	rs11810993	chr1:46478793	MUTYH	chr1:45794915-45806142:-	0.16	3.79	0.000169	Body mass index	
LUAD	cis	1	rs118143176	chr16:68184250	ATP6V0D1	chr16:67471917-67515089:-	-0.42	-4.18	3.42E-5	Crohn's disease	
LUAD	cis	1	rs118143176	chr16:68184250	C16orf86	chr16:67700717-67702659:+	-0.36	-3.82	0.000148	Crohn's disease	
LUAD	cis	1	rs11816840	chr10:102309220	SEC31B	chr10:102246403-102289636:-	-0.2	-6.45	2.63E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs11845639	chr14:75570293	MLH3	chr14:75480467-75518235:-	0.24	4.54	7.18E-6	Height	
LUAD	cis	1	rs11853024	chr15:91514797	UNC45A	chr15:91473410-91497322:+	0.19	3.82	0.000149	Type 2 diabetes	
LUAD	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.31	-4.4	1.33E-5	Tumor biomarkers	
LUAD	cis	1	rs11856184	chr15:43919162	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.29	2.11E-5	Tumor biomarkers	
LUAD	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	0.37	6	3.95E-9	Heschl's gyrus morphology	
LUAD	cis	1	rs11861657	chr16:67824395	ATP6V0D1	chr16:67471917-67515089:-	-0.37	-4.23	2.73E-5	Crohn's disease	
LUAD	cis	1	rs11869069	chr17:40287101	DHX58	chr17:40253422-40264751:-	-0.29	-5.32	1.55E-7	Fibrinogen levels	
LUAD	cis	1	rs11870797	chr17:61804622	FTSJ3	chr17:61896795-61905031:-	0.23	4.8	2.12E-6	Body mass index	
LUAD	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.32	-6.51	1.9E-10	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs11871767	chr17:61698723	FTSJ3	chr17:61896795-61905031:-	0.24	5.09	5.14E-7	Body mass index	
LUAD	cis	1	rs1187446	chr14:104409896	TDRD9	chr14:104394817-104519002:+	0.27	4.2	3.15E-5	Bipolar disorder	
LUAD	cis	1	rs1187448	chr14:104406627	TDRD9	chr14:104394817-104519002:+	0.24	3.69	0.000245	Bipolar disorder	
LUAD	cis	1	rs11879853	chr19:23029434	ZNF492	chr19:22817126-22850472:+	0.24	3.76	0.000188	Bronchopulmonary dysplasia	
LUAD	cis	1	rs11880539	chr19:41918949	BCKDHA	chr19:41882438-41930909:+	-0.2	-3.94	9.22E-5	Height	
LUAD	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.57	12.21	4.17E-30	Schizophrenia	
LUAD	cis	1	rs11891	chr17:76988785	LGALS3BP	chr17:76967336-76976061:-	-0.26	-3.71	0.000229	Magnesium levels	
LUAD	cis	1	rs11893118	chr2:241828308	C2orf54	chr2:241825466-241835573:-	0.34	6.12	1.96E-9	Urinary metabolites	
LUAD	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.76	-8.87	1.39E-17	Plasma clusterin levels	
LUAD	cis	1	rs11893881	chr2:73824373	ALMS1	chr2:73612886-73837046:+	0.2	4.83	1.84E-6	Metabolite levels	
LUAD	cis	1	rs11893881	chr2:73824373	ALMS1P	chr2:73872046-73912692:+	0.38	7.29	1.25E-12	Metabolite levels	
LUAD	cis	1	rs11898716	chr2:241828311	C2orf54	chr2:241825466-241835573:-	0.33	5.96	4.84E-9	Urinary metabolites	
LUAD	cis	1	rs11899740	chr2:73631212	ALMS1	chr2:73612886-73837046:+	0.19	4.51	8.0E-6	Metabolite levels	
LUAD	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.39	7.3	1.17E-12	Metabolite levels	
LUAD	cis	1	rs11899836	chr2:203236039	NOP58	chr2:203130515-203168382:+	0.23	3.69	0.000249	Urate levels	
LUAD	cis	1	rs11899902	chr2:73631564	ALMS1	chr2:73612886-73837046:+	0.18	4.29	2.2E-5	Metabolite levels	
LUAD	cis	1	rs11899902	chr2:73631564	ALMS1P	chr2:73872046-73912692:+	0.38	7.23	1.88E-12	Metabolite levels	
LUAD	cis	1	rs11899902	chr2:73631564	FBXO41	chr2:73481800-73498043:-	0.19	3.72	0.00022	Metabolite levels	
LUAD	cis	1	rs11902295	chr2:70084599	SNRNP27	chr2:70121090-70132348:+	0.22	4.05	6.0E-5	Colorectal or endometrial cancer	
LUAD	cis	1	rs11903034	chr2:70060278	SNRNP27	chr2:70121090-70132348:+	0.21	3.91	0.000107	Colorectal or endometrial cancer	
LUAD	cis	1	rs11903916	chr2:73815328	ALMS1	chr2:73612886-73837046:+	0.18	4.36	1.55E-5	Metabolite levels	
LUAD	cis	1	rs11903916	chr2:73815328	ALMS1P	chr2:73872046-73912692:+	0.34	6.67	7.05E-11	Metabolite levels	
LUAD	cis	1	rs11906148	chr20:33784021	PROCR	chr20:33758727-33765164:+	-0.3	-3.79	0.000168	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
LUAD	cis	1	rs11907011	chr20:33767770	PROCR	chr20:33758727-33765164:+	-0.29	-3.7	0.000241	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
LUAD	cis	1	rs11919303	chr3:16608556	GALNTL2	chr3:15935569-16271252:+	-0.17	-3.75	0.000201	Testicular germ cell tumor	
LUAD	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.51	-10.01	1.36E-21	Height	
LUAD	cis	1	rs11920570	chr3:122090102	WDR5B	chr3:122130700-122134882:-	0.35	6.72	4.97E-11	Resting heart rate	
LUAD	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.51	-10.03	1.21E-21	Height	
LUAD	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.72	13.32	9.3E-35	Diastolic blood pressure	
LUAD	cis	1	rs11942153	chr4:106960172	TBCK	chr4:106967233-107237861:-	0.24	4.45	1.07E-5	Airflow obstruction	
LUAD	cis	1	rs11950957	chr5:150253914	LOC134466	chr5:150310000-150326146:-	0.3	3.82	0.000151	Crohn's disease	
LUAD	cis	1	rs11951694	chr5:150254338	LOC134466	chr5:150310000-150326146:-	0.3	3.77	0.000183	Crohn's disease	
LUAD	cis	1	rs11955172	chr5:150254378	LOC134466	chr5:150310000-150326146:-	0.3	3.77	0.000183	Crohn's disease	
LUAD	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.33	-4.06	5.8E-5	Crohn's disease	
LUAD	cis	1	rs11961560	chr6:170130121	C6orf208	chr6:170190169-170202969:+	-0.31	-3.67	0.00027	Thiazide-induced adverse metabolic effects in hypertensive patients	
LUAD	cis	1	rs11965538	chr6:28239915	ZNF187	chr6:28234788-28245978:+	-0.23	-4.08	5.37E-5	Depression	
LUAD	cis	1	rs11974409	chr7:72989390	MLXIPL	chr7:73007524-73038870:-	0.28	4.17	3.63E-5	Triglycerides	
LUAD	cis	1	rs11975942	chr7:143740580	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.38	4.13E-10	Obesity-related traits	
LUAD	cis	1	rs11975942	chr7:143740580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.26	-4.56	6.42E-6	Obesity-related traits	
LUAD	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	1.02	20.38	2.86E-67	Educational attainment (years of education)	
LUAD	cis	1	rs11976037	chr7:143741024	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.17	1.4E-9	Obesity-related traits	
LUAD	cis	1	rs11976037	chr7:143741024	OR2A9P	chr7:143991573-143997832:+;chr7	-0.24	-4.26	2.41E-5	Obesity-related traits	
LUAD	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.38	4.12E-10	Obesity-related traits	
LUAD	cis	1	rs11976180	chr7:143741580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.26	-4.69	3.61E-6	Obesity-related traits	
LUAD	cis	1	rs1199095	chr10:59950760	IPMK	chr10:59955618-60027694:-	0.17	4.2	3.24E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1199096	chr10:59950234	IPMK	chr10:59955618-60027694:-	0.17	4.11	4.62E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1199099	chr10:59948335	IPMK	chr10:59955618-60027694:-	0.17	4.2	3.24E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1199100	chr10:59948044	IPMK	chr10:59955618-60027694:-	0.17	4.2	3.24E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1199101	chr10:59947901	IPMK	chr10:59955618-60027694:-	0.17	4.13	4.29E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1199103	chr10:59947231	IPMK	chr10:59955618-60027694:-	-0.17	-4.18	3.51E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1199104	chr10:59946781	IPMK	chr10:59955618-60027694:-	0.17	4.2	3.24E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1199107	chr10:59943709	IPMK	chr10:59955618-60027694:-	0.17	4.13	4.31E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1199108	chr10:59942324	IPMK	chr10:59955618-60027694:-	0.17	4.11	4.71E-5	Inflammatory bowel disease	
LUAD	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.38	-7.09	4.59E-12	Body mass index	
LUAD	cis	1	rs12021587	chr1:46472759	MUTYH	chr1:45794915-45806142:-	0.16	3.84	0.000137	Body mass index	
LUAD	cis	1	rs12022194	chr1:156312331	CCT3	chr1:156278752-156308195:-	-0.15	-3.67	0.000271	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12023106	chr1:202365332	PPP1R12B	chr1:202317836-202557697:+	0.21	4.54	7.06E-6	Sex ratio	
LUAD	cis	1	rs12023438	chr1:156254358	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12023704	chr1:156294149	CCT3	chr1:156278752-156308195:-	-0.15	-3.75	0.0002	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12024813	chr1:156224529	CCT3	chr1:156278752-156308195:-	-0.17	-4.04	6.2E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12027103	chr1:156244856	CCT3	chr1:156278752-156308195:-	-0.16	-3.92	0.000101	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12027741	chr1:156248148	CCT3	chr1:156278752-156308195:-	-0.16	-3.92	0.000101	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.52	8.24	1.58E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.52	8.24	1.58E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs12031720	chr1:202449706	PPP1R12B	chr1:202317836-202557697:+	0.22	4.76	2.56E-6	Sex ratio	
LUAD	cis	1	rs12036501	chr1:202336996	PPP1R12B	chr1:202317836-202557697:+	0.23	5.08	5.34E-7	Sex ratio	
LUAD	cis	1	rs12037876	chr1:202469970	PPP1R12B	chr1:202317836-202557697:+	0.22	4.72	3.05E-6	Sex ratio	
LUAD	cis	1	rs12038203	chr1:156248265	CCT3	chr1:156278752-156308195:-	-0.16	-3.93	9.86E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12038217	chr1:156248297	CCT3	chr1:156278752-156308195:-	-0.16	-3.92	0.000101	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12038481	chr1:156284815	CCT3	chr1:156278752-156308195:-	-0.16	-3.98	8.03E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12040868	chr1:156284803	CCT3	chr1:156278752-156308195:-	-0.16	-3.79	0.000171	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.52	8.2	2.17E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs12041164	chr1:156279811	CCT3	chr1:156278752-156308195:-	-0.17	-4.12	4.39E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12041202	chr1:202457177	PPP1R12B	chr1:202317836-202557697:+	0.23	5.12	4.45E-7	Sex ratio	
LUAD	cis	1	rs12042669	chr1:202453928	PPP1R12B	chr1:202317836-202557697:+	0.23	5.03	6.92E-7	Sex ratio	
LUAD	cis	1	rs12043240	chr1:67624304	C1orf141	chr1:67557859-67600653:-	-0.2	-6.12	1.96E-9	Psoriasis	
LUAD	cis	1	rs12045339	chr1:156294211	CCT3	chr1:156278752-156308195:-	-0.17	-4.13	4.2E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.38	-7.09	4.78E-12	Body mass index	
LUAD	cis	1	rs12049588	chr1:46472422	MUTYH	chr1:45794915-45806142:-	0.16	3.84	0.000139	Body mass index	
LUAD	cis	1	rs12052257	chr2:202241594	CASP8	chr2:202098166-202152434:+	-0.22	-4.97	9.22E-7	Basal cell carcinoma	
LUAD	cis	1	rs12053514	chr2:219167965	DIRC3	chr2:218148748-218621316:-	-0.18	-3.98	7.92E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs12069782	chr1:67600101	C1orf141	chr1:67557859-67600653:-	-0.17	-4.31	1.96E-5	Leprosy	
LUAD	cis	1	rs12083902	chr1:36275112	C1orf216	chr1:36179477-36184790:-	-0.3	-4.29	2.11E-5	Schizophrenia	
LUAD	cis	1	rs12090164	chr1:67600163	C1orf141	chr1:67557859-67600653:-	-0.16	-4.23	2.81E-5	Leprosy	
LUAD	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.89	-8.83	1.9E-17	Coronary heart disease	
LUAD	cis	1	rs12112374	chr7:128950071	LOC407835	chr7:128766325-128768041:+	0.24	3.91	0.000105	White matter hyperintensity burden	
LUAD	cis	1	rs12117903	chr1:156311165	CCT3	chr1:156278752-156308195:-	-0.16	-3.99	7.69E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12117947	chr1:156244058	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12117951	chr1:156305286	CCT3	chr1:156278752-156308195:-	-0.15	-3.67	0.000271	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12118238	chr1:156235221	CCT3	chr1:156278752-156308195:-	-0.17	-4.13	4.25E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.52	8.2	2.07E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs12121805	chr1:156257876	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12122180	chr1:156244559	CCT3	chr1:156278752-156308195:-	-0.16	-3.92	0.000101	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12123006	chr1:202435228	PPP1R12B	chr1:202317836-202557697:+	0.22	4.85	1.64E-6	Sex ratio	
LUAD	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.51	8.05	6.34E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs12128536	chr1:171674607	VAMP4	chr1:171669298-171711214:-	0.23	3.83	0.000146	Hippocampal atrophy	
LUAD	cis	1	rs12130219	chr1:152162106	FLG	chr1:152274651-152297679:-	0.43	7.97	1.1E-14	Inflammatory skin disease	
LUAD	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.53	8.25	1.44E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs12130361	chr1:156260301	CCT3	chr1:156278752-156308195:-	-0.16	-3.96	8.77E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12130629	chr1:166953284	GPA33	chr1:167022082-167059868:-	-0.24	-4.33	1.83E-5	Refractive astigmatism	
LUAD	cis	1	rs12132221	chr1:171685694	VAMP4	chr1:171669298-171711214:-	0.24	3.87	0.000125	Hippocampal atrophy	
LUAD	cis	1	rs12132794	chr1:156281020	CCT3	chr1:156278752-156308195:-	0.16	4.02	6.66E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12132919	chr1:156318141	C1orf85	chr1:156259882-156265449:-	-0.21	-3.67	0.000269	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12132919	chr1:156318141	CCT3	chr1:156278752-156308195:-	-0.17	-4.02	6.79E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.49	8.21	2.03E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs12134983	chr1:156290409	CCT3	chr1:156278752-156308195:-	-0.16	-4.01	7.13E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12138117	chr1:16305279	HSPB7	chr1:16340523-16346089:-	0.22	5.21	2.84E-7	Dilated cardiomyopathy	
LUAD	cis	1	rs12139321	chr1:156230429	CCT3	chr1:156278752-156308195:-	-0.17	-4.17	3.62E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.31	1.13E-12	Body mass index	
LUAD	cis	1	rs12139630	chr1:46350935	MUTYH	chr1:45794915-45806142:-	0.18	4.16	3.71E-5	Body mass index	
LUAD	cis	1	rs12141236	chr1:156302575	CCT3	chr1:156278752-156308195:-	-0.16	-3.99	7.69E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12142808	chr1:156230546	CCT3	chr1:156278752-156308195:-	-0.17	-4.12	4.38E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.31	1.13E-12	Body mass index	
LUAD	cis	1	rs12144263	chr1:46352446	MUTYH	chr1:45794915-45806142:-	0.18	4.16	3.71E-5	Body mass index	
LUAD	cis	1	rs12148786	chr15:76800362	SCAPER	chr15:76640529-77197744:-	-0.2	-4.68	3.65E-6	Blood metabolite levels	
LUAD	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.62	-11.49	3.16E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.45	7.31	1.08E-12	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs12185102	chr15:75352201	SCAMP5	chr15:75287901-75313836:+	0.37	6.56	1.34E-10	Blood trace element (Zn levels)	
LUAD	cis	1	rs12189567	chr6:55933942	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12189571	chr6:55933987	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.63	-11.23	3.48E-26	Response to antipsychotic treatment	
LUAD	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.66	-11.9	7.26E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs12191865	chr6:56014006	COL21A1	chr6:55921389-56258892:-	-0.23	-3.76	0.000194	Psychosis (atypical)	
LUAD	cis	1	rs12192223	chr6:76398209	IMPG1	chr6:76631062-76782335:-	0.31	4.26	2.47E-5	Height	
LUAD	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.67	-12.19	5.07E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs12195417	chr6:84173028	PRSS35	chr6:84222274-84235419:+	-0.18	-3.69	0.000254	Schizophrenia	
LUAD	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.68	-12	2.88E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs12196213	chr6:55932547	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.67	-11.6	1.15E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12196937	chr6:49382808	CENPQ	chr6:49431096-49460820:+	-0.26	-6.6	1.09E-10	Folate pathway vitamin levels	
LUAD	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.34	6.96	1.09E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs12197114	chr6:109735498	AKD1	chr6:109814059-110012415:-	-0.27	-5.03	6.86E-7	Height	
LUAD	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.25	4.66	4.07E-6	Height	
LUAD	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.64	-11.63	9.13E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.63	-11.62	9.93E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.67	-12.17	6.04E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs12201305	chr6:76283622	IMPG1	chr6:76631062-76782335:-	0.3	4.05	5.92E-5	Height	
LUAD	cis	1	rs12201413	chr6:55933348	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.67	-12.33	1.34E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.64	-11.66	6.83E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.62	-11.49	3.17E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.62	-11.49	3.16E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.28	-7.03	6.77E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.33	6.91	1.5E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs12203464	chr6:55934339	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.66	-11.77	2.44E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.66	-11.77	2.44E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.65	-12.3	1.8E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.63	-11.57	1.55E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.65	-11.63	9.07E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.66	-11.6	1.2E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.63	-11.62	9.93E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.63	-11.73	3.67E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12208368	chr6:76417786	IMPG1	chr6:76631062-76782335:-	0.27	3.79	0.00017	Height	
LUAD	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.67	-12.29	1.87E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs12208500	chr6:55933259	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12208615	chr6:55933489	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.65	-11.63	9.07E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12209420	chr6:55937876	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12209464	chr6:55985189	COL21A1	chr6:55921389-56258892:-	-0.23	-3.7	0.000241	Psychosis (atypical)	
LUAD	cis	1	rs12209529	chr6:55932278	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12210468	chr6:55934393	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs12211619	chr6:56014005	COL21A1	chr6:55921389-56258892:-	-0.23	-3.76	0.000194	Psychosis (atypical)	
LUAD	cis	1	rs12212171	chr6:76419736	IMPG1	chr6:76631062-76782335:-	0.29	3.99	7.56E-5	Height	
LUAD	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.66	-11.78	2.24E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.67	-12.29	1.87E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs12213476	chr6:76291373	IMPG1	chr6:76631062-76782335:-	0.3	4.05	5.92E-5	Height	
LUAD	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.63	-11.73	3.62E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs12214738	chr6:76343783	IMPG1	chr6:76631062-76782335:-	0.3	4.15	3.92E-5	Height	
LUAD	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.65	-11.48	3.4E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.63	-11.61	1.08E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.68	-12.38	8.37E-31	Response to antipsychotic treatment	
LUAD	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.68	-12.21	3.97E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs12219158	chr10:102302923	SEC31B	chr10:102246403-102289636:-	-0.2	-6.36	4.72E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs12219789	chr10:102213778	SEC31B	chr10:102246403-102289636:-	-0.22	-6.98	9.94E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.55	-6.73	4.62E-11	Chronic obstructive pulmonary disease-related biomarkers	
LUAD	cis	1	rs12243433	chr10:81732777	MBL1P	chr10:81664654-81710783:+	-0.32	-4.21	3.0E-5	Rheumatoid arthritis	
LUAD	cis	1	rs12245535	chr10:81733004	MBL1P	chr10:81664654-81710783:+	-0.32	-4.21	3.0E-5	Rheumatoid arthritis	
LUAD	cis	1	rs12252705	chr10:75984863	ADK	chr10:75910965-76469059:+	0.23	3.73	0.000213	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs12256105	chr10:75909634	ADK	chr10:75910965-76469059:+	0.25	4.12	4.43E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs12257549	chr10:46029631	OR13A1	chr10:45798102-45811056:-	-0.26	-3.88	0.000117	HDL cholesterol;Cholesterol, total	
LUAD	cis	1	rs12260159	chr10:100702737	HPSE2	chr10:100218877-100995619:-	0.41	6.34	5.36E-10	Migraine	
LUAD	cis	1	rs12264259	chr10:81732788	MBL1P	chr10:81664654-81710783:+	-0.32	-4.21	3.0E-5	Rheumatoid arthritis	
LUAD	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.26	4.88	1.44E-6	Pancreatic cancer	
LUAD	cis	1	rs1229854	chr4:100282550	ADH1C	chr4:100257651-100273917:-	-0.19	-3.7	0.000239	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs12299125	chr12:123862447	CDK2AP1	chr12:123745542-123756687:-	-0.35	-5.63	2.98E-8	Educational attainment;Height;Head circumference (infant)	
LUAD	cis	1	rs1229978	chr4:100256199	ADH1C	chr4:100257651-100273917:-	-0.19	-3.83	0.000142	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs12315195	chr12:108795458	SELPLG	chr12:109015682-109027670:-	0.14	3.96	8.54E-5	Obesity-related traits	
LUAD	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.36	6.43	3.13E-10	Blood trace element (Zn levels)	
LUAD	cis	1	rs12325866	chr17:61755974	FTSJ3	chr17:61896795-61905031:-	0.21	4.47	9.89E-6	Body mass index	
LUAD	cis	1	rs1235415	chr4:100281159	ADH1C	chr4:100257651-100273917:-	-0.19	-3.7	0.000239	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs12354411	chr10:102294537	SEC31B	chr10:102246403-102289636:-	-0.2	-6.4	3.59E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs12355721	chr10:102244911	SEC31B	chr10:102246403-102289636:-	-0.22	-7	8.72E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs12355784	chr10:65121565	NRBF2	chr10:64893007-64914785:+	-0.23	-5.14	4.07E-7	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs12355869	chr10:126645231	UROS	chr10:127477148-127511837:-	0.29	3.93	9.83E-5	Height	
LUAD	cis	1	rs12358187	chr10:102284449	SEC31B	chr10:102246403-102289636:-	-0.21	-6.63	9.01E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs12359272	chr10:97365163	ENTPD1	chr10:97471536-97637022:+	0.2	5.33	1.5E-7	Blood metabolite levels	
LUAD	cis	1	rs12361031	chr11:47783076	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	5.1E-5	Subjective well-being	
LUAD	cis	1	rs12361031	chr11:47783076	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.46	1.03E-5	Subjective well-being	
LUAD	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.23	-4.41	1.28E-5	Subjective well-being	
LUAD	cis	1	rs12363232	chr11:47623890	MYBPC3	chr11:47352958-47374253:-	-0.22	-4.8	2.16E-6	Subjective well-being	
LUAD	cis	1	rs12365551	chr11:58358368	CNTF	chr11:58390146-58393203:+	0.3	4.03	6.37E-5	Lymphoma	
LUAD	cis	1	rs12372754	chr12:91481578	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs12374256	chr4:106617361	INTS12	chr4:106603787-106629881:-	-0.64	-6.57	1.3E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs12377604	chr9:100697287	C9orf156	chr9:100666772-100684852:-	-0.2	-3.95	8.87E-5	Quantitative traits	
LUAD	cis	1	rs12405278	chr1:152282267	FLG	chr1:152274651-152297679:-	0.28	4.05	5.86E-5	Atopic dermatitis	
LUAD	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.18	2.56E-12	Body mass index	
LUAD	cis	1	rs12405451	chr1:46384326	MUTYH	chr1:45794915-45806142:-	0.17	4.08	5.34E-5	Body mass index	
LUAD	cis	1	rs12405771	chr1:202464280	PPP1R12B	chr1:202317836-202557697:+	0.23	5.12	4.47E-7	Sex ratio	
LUAD	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.26	1.56E-12	Body mass index	
LUAD	cis	1	rs12409773	chr1:46358831	MUTYH	chr1:45794915-45806142:-	0.18	4.18	3.43E-5	Body mass index	
LUAD	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.26	1.56E-12	Body mass index	
LUAD	cis	1	rs12410071	chr1:46358886	MUTYH	chr1:45794915-45806142:-	0.18	4.18	3.43E-5	Body mass index	
LUAD	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.03E-12	Body mass index	
LUAD	cis	1	rs12411269	chr1:46271052	MUTYH	chr1:45794915-45806142:-	0.18	4.21	3.01E-5	Body mass index	
LUAD	cis	1	rs12414891	chr10:81690385	PLAC9	chr10:81892258-81904784:+	-0.3	-4.58	5.8E-6	Chronic obstructive pulmonary disease-related biomarkers	
LUAD	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.4	-8.98	5.99E-18	Arsenic metabolism	
LUAD	cis	1	rs12418852	chr11:47868853	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	4.96E-5	Subjective well-being	
LUAD	cis	1	rs12418852	chr11:47868853	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.5	8.33E-6	Subjective well-being	
LUAD	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.24	4.67	3.87E-6	Subjective well-being	
LUAD	cis	1	rs12419692	chr11:47624714	MYBPC3	chr11:47352958-47374253:-	0.23	5.1	4.78E-7	Subjective well-being	
LUAD	cis	1	rs12421210	chr11:47779586	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	5.1E-5	Subjective well-being	
LUAD	cis	1	rs12421210	chr11:47779586	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.46	1.03E-5	Subjective well-being	
LUAD	cis	1	rs12422267	chr12:132601596	DDX51	chr12:132621142-132628880:-	0.49	5.66	2.59E-8	Plasma amyloid beta peptide concentrations (ABx-40)	
LUAD	cis	1	rs12422267	chr12:132601596	EP400NL	chr12:132568828-132600084:+;chr12	-0.37	-4.86	1.57E-6	Plasma amyloid beta peptide concentrations (ABx-40)	
LUAD	cis	1	rs12422771	chr12:6580273	TAPBPL	chr12:6561177-6575601:+	-0.22	-3.86	0.000129	Hip geometry	
LUAD	cis	1	rs12428	chr20:25433821	NINL	chr20:25433338-25566153:-	0.15	3.8	0.000162	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs12435391	chr14:75601737	EIF2B2	chr14:75469612-75476292:+	0.21	4	7.25E-5	Height	
LUAD	cis	1	rs12435391	chr14:75601737	MLH3	chr14:75480467-75518235:-	0.26	5.03	6.89E-7	Height	
LUAD	cis	1	rs12435835	chr14:65499909	CHURC1	chr14:65381140-65411309:+	0.33	7.14	3.44E-12	Red blood cell traits	
LUAD	cis	1	rs12440915	chr15:100509915	C15orf51	chr15:100330361-100347132:-	0.2	3.88	0.00012	Urate levels in lean individuals	
LUAD	cis	1	rs12441433	chr15:76816015	SCAPER	chr15:76640529-77197744:-	-0.21	-4.99	8.55E-7	Blood metabolite levels	
LUAD	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.35	-4.89	1.4E-6	Tumor biomarkers	
LUAD	cis	1	rs12443137	chr15:76840832	SCAPER	chr15:76640529-77197744:-	-0.21	-4.88	1.43E-6	Blood metabolite levels	
LUAD	cis	1	rs12443730	chr16:68804342	NFATC3	chr16:68118654-68260837:+	-0.16	-3.75	0.000196	Colorectal cancer	
LUAD	cis	1	rs12446407	chr16:68804068	NFATC3	chr16:68118654-68260837:+	-0.16	-3.74	0.000204	Colorectal cancer	
LUAD	cis	1	rs12446575	chr16:68791644	NFATC3	chr16:68118654-68260837:+	-0.18	-3.96	8.61E-5	Colorectal cancer	
LUAD	cis	1	rs12446632	chr16:19935389	C16orf88	chr16:19717676-19729492:-	0.24	3.79	0.000168	Body mass index;Menarche (age at onset);Childhood body mass index;Obesity	
LUAD	cis	1	rs12448448	chr16:68802516	NFATC3	chr16:68118654-68260837:+	-0.16	-3.71	0.000228	Colorectal cancer	
LUAD	cis	1	rs12451721	chr17:65939075	LOC440461	chr17:66194801-66196436:+	0.24	3.81	0.000155	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs12452225	chr17:33266431	LIG3	chr17:33307538-33332088:+	0.35	4.22	2.96E-5	Night sleep phenotypes	
LUAD	cis	1	rs12453104	chr17:33264248	LIG3	chr17:33307538-33332088:+	0.33	3.86	0.00013	Night sleep phenotypes	
LUAD	cis	1	rs12459123	chr19:12689741	MAN2B1	chr19:12757322-12777591:-	0.21	4.91	1.24E-6	Bipolar disorder	
LUAD	cis	1	rs12459222	chr19:46859301	CCDC9	chr19:47759731-47775208:+	-0.24	-5.32	1.56E-7	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs12460161	chr19:44293986	ZNF155	chr19:44488355-44502477:+	-0.27	-4.76	2.6E-6	Breast cancer	
LUAD	cis	1	rs12467409	chr2:203394348	NOP58	chr2:203130515-203168382:+	0.27	4.21	3.06E-5	Urate levels	
LUAD	cis	1	rs12468226	chr2:203337001	NOP58	chr2:203130515-203168382:+	0.27	4.34	1.73E-5	Urate levels	
LUAD	cis	1	rs12470450	chr2:232113888	HTR2B	chr2:231972952-231989824:-	0.23	4.17	3.59E-5	Food antigen IgG levels	
LUAD	cis	1	rs12470864	chr2:102926362	IL1RL1	chr2:102927962-102968497:+	-0.22	-4.08	5.37E-5	Serum protein levels (sST2)	
LUAD	cis	1	rs12472408	chr2:203278696	NOP58	chr2:203130515-203168382:+	0.25	3.99	7.7E-5	Urate levels	
LUAD	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.81	-9.82	6.65E-21	Plasma clusterin levels	
LUAD	cis	1	rs12478744	chr2:23947589	LOC375190	chr2:24299728-24397519:+	0.25	4.92	1.16E-6	Obesity-related traits	
LUAD	cis	1	rs12479210	chr2:102949161	IL1RL1	chr2:102927962-102968497:+	-0.23	-4.28	2.29E-5	Serum protein levels (sST2)	
LUAD	cis	1	rs12479491	chr20:30265450	FRG1B	chr20:29611879-29653908:+	0.22	3.9	0.000111	Subcortical brain region volumes	
LUAD	cis	1	rs12480328	chr20:49527922	KCNG1	chr20:49620194-49639675:-	-0.38	-3.69	0.000252	Prostate cancer	
LUAD	cis	1	rs12483517	chr21:42691920	FAM3B	chr21:42676177-42729654:+	0.36	6.12	1.92E-9	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
LUAD	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.29	-7.03	6.81E-12	Longevity	
LUAD	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.52	10.08	7.44E-22	Height	
LUAD	cis	1	rs12498808	chr4:165906905	C4orf39	chr4:165878100-165880273:+	0.29	5.72	1.81E-8	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs12498808	chr4:165906905	TRIM61	chr4:165875600-165898818:-	0.19	3.89	0.000116	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs12509366	chr4:107003343	TBCK	chr4:106967233-107237861:-	0.25	4.57	6.1E-6	Airflow obstruction	
LUAD	cis	1	rs12509640	chr4:106996677	TBCK	chr4:106967233-107237861:-	-0.24	-4.5	8.66E-6	Airflow obstruction	
LUAD	cis	1	rs12510415	chr4:81548353	C4orf22	chr4:81256874-81884896:+	-0.2	-5.25	2.28E-7	Obesity-related traits	
LUAD	cis	1	rs12510966	chr4:106983604	TBCK	chr4:106967233-107237861:-	0.25	4.62	4.83E-6	Airflow obstruction	
LUAD	cis	1	rs12512283	chr4:165908927	C4orf39	chr4:165878100-165880273:+	0.32	6.2	1.18E-9	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs12512283	chr4:165908927	TRIM61	chr4:165875600-165898818:-	0.19	3.89	0.000116	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs12512683	chr4:106999471	TBCK	chr4:106967233-107237861:-	0.26	4.8	2.07E-6	Airflow obstruction	
LUAD	cis	1	rs12515585	chr5:156430150	TIMD4	chr5:156346293-156390266:-	-0.24	-4.23	2.82E-5	Hypertriglyceridemia	
LUAD	cis	1	rs12517431	chr5:156392248	TIMD4	chr5:156346293-156390266:-	-0.19	-3.74	0.000204	Triglycerides;Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs12522248	chr5:156479426	TIMD4	chr5:156346293-156390266:-	-0.26	-4.7	3.41E-6	Hypertriglyceridemia	
LUAD	cis	1	rs12538946	chr7:33670032	BBS9	chr7:33169152-33645680:+	-0.39	-3.81	0.000157	Cytomegalovirus antibody response	
LUAD	cis	1	rs12545771	chr8:8567977	CLDN23	chr8:8559666-8561616:+	-0.34	-5.74	1.65E-8	Obesity-related traits	
LUAD	cis	1	rs12547721	chr8:8570671	CLDN23	chr8:8559666-8561616:+	-0.33	-5.63	3.0E-8	Obesity-related traits	
LUAD	cis	1	rs12547941	chr8:29980332	MBOAT4	chr8:29989188-30002200:-	0.36	5.18	3.24E-7	Migraine	
LUAD	cis	1	rs12550458	chr8:8567832	CLDN23	chr8:8559666-8561616:+	-0.34	-5.74	1.65E-8	Obesity-related traits	
LUAD	cis	1	rs12550762	chr8:8576535	CLDN23	chr8:8559666-8561616:+	-0.31	-5.36	1.31E-7	Obesity-related traits	
LUAD	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.19	2.43E-12	Body mass index	
LUAD	cis	1	rs12561806	chr1:46396776	MUTYH	chr1:45794915-45806142:-	0.17	4.07	5.49E-5	Body mass index	
LUAD	cis	1	rs12563631	chr1:156258953	CCT3	chr1:156278752-156308195:-	-0.17	-4.23	2.8E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.71E-12	Body mass index	
LUAD	cis	1	rs12564541	chr1:46380237	MUTYH	chr1:45794915-45806142:-	0.18	4.22	2.9E-5	Body mass index	
LUAD	cis	1	rs12567136	chr1:11883731	CLCN6	chr1:11866207-11907674:+	-0.21	-4.1	4.85E-5	QRS complex (12-leadsum)	
LUAD	cis	1	rs12567463	chr1:152180128	FLG	chr1:152274651-152297679:-	0.25	4.07	5.57E-5	Atopic dermatitis	
LUAD	cis	1	rs12569017	chr1:111287581	ALX3	chr1:110602998-110613322:-	0.34	3.81	0.000156	Acute lymphoblastic leukemia (childhood)	
LUAD	cis	1	rs12569084	chr1:166943352	GPA33	chr1:167022082-167059868:-	-0.24	-4.43	1.14E-5	Refractive astigmatism	
LUAD	cis	1	rs12569106	chr1:111285394	ALX3	chr1:110602998-110613322:-	-0.34	-3.68	0.00026	Acute lymphoblastic leukemia (childhood)	
LUAD	cis	1	rs12569940	chr10:126592684	UROS	chr10:127477148-127511837:-	0.27	3.69	0.000247	Height	
LUAD	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.5	-9.78	9.69E-21	Forced vital capacity	
LUAD	cis	1	rs12588240	chr14:75612083	MLH3	chr14:75480467-75518235:-	0.26	5.04	6.52E-7	Height	
LUAD	cis	1	rs12589376	chr14:75561152	MLH3	chr14:75480467-75518235:-	0.24	4.57	6.13E-6	Height	
LUAD	cis	1	rs12589815	chr14:75544101	EIF2B2	chr14:75469612-75476292:+	0.19	3.67	0.000268	Height	
LUAD	cis	1	rs12589815	chr14:75544101	MLH3	chr14:75480467-75518235:-	0.24	4.69	3.52E-6	Height	
LUAD	cis	1	rs12589876	chr14:75544189	MLH3	chr14:75480467-75518235:-	0.24	4.47	9.65E-6	Height	
LUAD	cis	1	rs12590407	chr14:24835115	ADCY4	chr14:24787571-24804277:-	0.21	4.81	2.02E-6	Height	
LUAD	cis	1	rs12590452	chr14:75548756	MLH3	chr14:75480467-75518235:-	0.24	4.57	6.25E-6	Height	
LUAD	cis	1	rs1259180	chr15:83244680	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.12	-3.93	9.85E-5	Schizophrenia	
LUAD	cis	1	rs12594212	chr15:76802014	SCAPER	chr15:76640529-77197744:-	-0.2	-4.58	5.79E-6	Blood metabolite levels	
LUAD	cis	1	rs12594541	chr15:76834368	SCAPER	chr15:76640529-77197744:-	-0.21	-4.89	1.39E-6	Blood metabolite levels	
LUAD	cis	1	rs12595570	chr15:51539737	CYP19A1	chr15:51500255-51630795:-	0.39	3.88	0.000118	Height	
LUAD	cis	1	rs12599517	chr16:68814590	NFATC3	chr16:68118654-68260837:+	-0.16	-3.77	0.00018	Colorectal cancer	
LUAD	cis	1	rs12600855	chr17:28279591	EFCAB5	chr17:28256874-28435469:+	0.34	6.1	2.17E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs12600855	chr17:28279591	SSH2	chr17:27952965-28257018:-	0.17	4.49	9.09E-6	Coffee consumption (cups per day)	
LUAD	cis	1	rs12600993	chr17:28291222	EFCAB5	chr17:28256874-28435469:+	0.34	6.16	1.54E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs12600993	chr17:28291222	SSH2	chr17:27952965-28257018:-	0.17	4.53	7.51E-6	Coffee consumption (cups per day)	
LUAD	cis	1	rs12602286	chr17:19236954	RNF112	chr17:19314523-19320587:+	-0.26	-4.04	6.17E-5	Schizophrenia	
LUAD	cis	1	rs12602655	chr17:65909442	LOC440461	chr17:66194801-66196436:+	0.24	3.75	0.000195	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs12603327	chr17:40290552	DHX58	chr17:40253422-40264751:-	-0.29	-5.56	4.34E-8	Fibrinogen levels	
LUAD	cis	1	rs12603330	chr17:40290589	DHX58	chr17:40253422-40264751:-	-0.29	-5.53	5.14E-8	Fibrinogen levels	
LUAD	cis	1	rs12611088	chr19:44072802	ZNF575	chr19:44029649-44040282:+	-0.22	-4.3	2.07E-5	Plasma amyloid beta peptide concentrations (ABx-42)	
LUAD	cis	1	rs12614581	chr2:70079400	SNRNP27	chr2:70121090-70132348:+	0.22	4.04	6.21E-5	Colorectal or endometrial cancer	
LUAD	cis	1	rs12617717	chr2:86342303	LOC90784	chr2:86247339-86250991:-	-0.55	-4.85	1.66E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs12620810	chr2:86391481	LOC90784	chr2:86247339-86250991:-	-0.49	-4.45	1.07E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs12621280	chr2:232132984	HTR2B	chr2:231972952-231989824:-	0.37	6.47	2.36E-10	Food antigen IgG levels	
LUAD	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.67	12.05	1.92E-29	Diastolic blood pressure	
LUAD	cis	1	rs12642900	chr4:107010329	TBCK	chr4:106967233-107237861:-	0.25	4.75	2.65E-6	Airflow obstruction	
LUAD	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.34	4.05	5.92E-5	Crohn's disease	
LUAD	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.36	4.21	2.99E-5	Crohn's disease	
LUAD	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.39	4.67	3.94E-6	Crohn's disease	
LUAD	cis	1	rs12657266	chr5:156396003	TIMD4	chr5:156346293-156390266:-	-0.21	-4.19	3.38E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs12659118	chr5:150324622	LOC134466	chr5:150310000-150326146:-	0.43	4.93	1.15E-6	Crohn's disease	
LUAD	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.67	-12.1	1.18E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.63	-11.57	1.55E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.61	11.12	9.38E-26	Response to antipsychotic treatment	
LUAD	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.66	12.24	3.1E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.66	-11.6	1.2E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs12674777	chr8:28843721	EXTL3	chr8:28559153-28611202:+	-0.2	-3.76	0.000188	Obesity-related traits	
LUAD	cis	1	rs12675542	chr8:29986454	MBOAT4	chr8:29989188-30002200:-	-0.37	-5.13	4.09E-7	Migraine	
LUAD	cis	1	rs1267657	chr15:83215251	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.13	-4	7.21E-5	Schizophrenia	
LUAD	cis	1	rs1267817	chr7:66110040	CCT6P1	chr7:65216092-65228661:+	0.24	3.79	0.000169	Gout	
LUAD	cis	1	rs1267818	chr7:66107024	CCT6P1	chr7:65216092-65228661:+	0.24	3.79	0.000172	Gout	
LUAD	cis	1	rs12681963	chr8:29982518	MBOAT4	chr8:29989188-30002200:-	-0.39	-5.29	1.83E-7	Migraine	
LUAD	cis	1	rs12683072	chr9:36192912	GLIPR2	chr9:36136742-36163902:+	-0.22	-3.81	0.00016	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs12710454	chr21:40656919	PSMG1	chr21:40547390-40555440:-	-0.21	-4.54	7.07E-6	Cognitive function	
LUAD	cis	1	rs12712530	chr2:37505561	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.89	0.000116	Chronic lymphocytic leukemia	
LUAD	cis	1	rs12725198	chr1:16080171	FBLIM1	chr1:16083154-16114431:+	-0.2	-3.9	0.000111	Cardiac Troponin-T levels	
LUAD	cis	1	rs12725694	chr1:16080501	FBLIM1	chr1:16083154-16114431:+	0.22	4.07	5.37E-5	Cardiac Troponin-T levels	
LUAD	cis	1	rs12725833	chr1:16080618	FBLIM1	chr1:16083154-16114431:+	0.22	4.07	5.37E-5	Cardiac Troponin-T levels	
LUAD	cis	1	rs12733173	chr1:152173972	FLG	chr1:152274651-152297679:-	0.43	8.1	4.54E-15	Inflammatory skin disease	
LUAD	cis	1	rs12744104	chr1:207819000	CR1L	chr1:207818458-207898053:+	0.21	3.68	0.000262	Erythrocyte sedimentation rate	
LUAD	cis	1	rs12744221	chr1:145645606	NUDT17	chr1:145586494-145590461:-	0.21	4.13	4.2E-5	Epilepsy (remission after treatment)	
LUAD	cis	1	rs1275468	chr12:75935157	GLIPR1L2	chr12:75784889-75825591:+	-0.29	-5.25	2.27E-7	Polycystic ovary syndrome	
LUAD	cis	1	rs1275469	chr12:75935230	GLIPR1L2	chr12:75784889-75825591:+	-0.26	-4.63	4.7E-6	Polycystic ovary syndrome	
LUAD	cis	1	rs1275530	chr2:27432547	C2orf28	chr2:27434899-27440044:+	-0.15	-3.67	0.000265	Blood metabolite levels	
LUAD	cis	1	rs1275986	chr2:26912079	SLC5A6	chr2:27422459-27435071:-	-0.18	-3.77	0.000182	Mean arterial pressure	
LUAD	cis	1	rs1275988	chr2:26914364	SLC5A6	chr2:27422459-27435071:-	-0.18	-3.81	0.000159	Mean arterial pressure	
LUAD	cis	1	rs12760175	chr1:46447840	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.34	8.72E-13	Body mass index	
LUAD	cis	1	rs12763390	chr10:38084432	LOC399744	chr10:38717074-38741080:+	0.26	3.74	0.000207	Obesity (extreme)	
LUAD	cis	1	rs12768613	chr10:81916566	PLAC9	chr10:81892258-81904784:+	-0.21	-4.8	2.07E-6	Chronic obstructive pulmonary disease-related biomarkers	
LUAD	cis	1	rs1278493	chr3:135814009	PCCB	chr3:135969167-136056737:+	-0.23	-4.99	8.21E-7	Gestational age at birth (child effect)	
LUAD	cis	1	rs12787330	chr11:47812311	C1QTNF4	chr11:47611216-47615961:-	-0.21	-4.05	5.93E-5	Subjective well-being	
LUAD	cis	1	rs12787330	chr11:47812311	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.53	7.49E-6	Subjective well-being	
LUAD	cis	1	rs12789145	chr11:94407736	FUT4	chr11:94277017-94283062:+	0.31	3.76	0.000189	Mood disorder and prion disease;Mood disorder in prion disease	
LUAD	cis	1	rs1281121	chr4:8202211	SH3TC1	chr4:8201060-8242828:+	-0.27	-4.33	1.83E-5	Response to metformin (IC50)	
LUAD	cis	1	rs1281124	chr4:8203416	SH3TC1	chr4:8201060-8242828:+	0.26	4.11	4.59E-5	Response to metformin (IC50)	
LUAD	cis	1	rs1281125	chr4:8203537	SH3TC1	chr4:8201060-8242828:+	0.25	3.89	0.000115	Response to metformin (IC50)	
LUAD	cis	1	rs12828040	chr12:7326541	PEX5	chr12:7341759-7371167:+	0.25	4.79	2.16E-6	IgG glycosylation	
LUAD	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.25	-4.78	2.31E-6	IgG glycosylation	
LUAD	cis	1	rs12879542	chr14:75507525	MLH3	chr14:75480467-75518235:-	0.23	4.46	1.02E-5	Height	
LUAD	cis	1	rs12889168	chr14:104481957	TDRD9	chr14:104394817-104519002:+	0.26	4	7.39E-5	Bipolar disorder	
LUAD	cis	1	rs12889309	chr14:75593902	EIF2B2	chr14:75469612-75476292:+	0.21	4.03	6.38E-5	Height	
LUAD	cis	1	rs12889309	chr14:75593902	MLH3	chr14:75480467-75518235:-	0.28	5.41	9.96E-8	Height	
LUAD	cis	1	rs12889472	chr14:75543979	MLH3	chr14:75480467-75518235:-	0.25	4.84	1.74E-6	Height	
LUAD	cis	1	rs12897094	chr14:75579416	EIF2B2	chr14:75469612-75476292:+	0.22	4.1	4.86E-5	Height	
LUAD	cis	1	rs12897094	chr14:75579416	MLH3	chr14:75480467-75518235:-	0.26	5.1	4.92E-7	Height	
LUAD	cis	1	rs12898259	chr15:75369780	SCAMP5	chr15:75287901-75313836:+	0.34	6.04	3.08E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs12898311	chr15:91517780	UNC45A	chr15:91473410-91497322:+	0.19	3.76	0.000188	Type 2 diabetes	
LUAD	cis	1	rs12898430	chr15:76874923	SCAPER	chr15:76640529-77197744:-	-0.21	-4.93	1.13E-6	Blood metabolite levels	
LUAD	cis	1	rs12899981	chr15:85302373	LOC388152	chr15:84867600-84898920:-	-0.31	-5.88	7.67E-9	Schizophrenia	
LUAD	cis	1	rs12901243	chr15:75374233	SCAMP5	chr15:75287901-75313836:+	0.34	6.04	3.08E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs12902672	chr15:84716986	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.06	5.72E-5	Schizophrenia	
LUAD	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.38	-7.13	3.64E-12	Schizophrenia	
LUAD	cis	1	rs12903084	chr15:100510081	C15orf51	chr15:100330361-100347132:-	0.2	3.88	0.000119	Urate levels in lean individuals	
LUAD	cis	1	rs12903134	chr15:85337699	LOC388152	chr15:84867600-84898920:-	-0.3	-5.85	8.94E-9	Schizophrenia	
LUAD	cis	1	rs12903201	chr15:75370776	SCAMP5	chr15:75287901-75313836:+	0.34	6.04	3.08E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs12903820	chr15:84723820	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.06	5.73E-5	Schizophrenia	
LUAD	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.39	-7.21	2.11E-12	Schizophrenia	
LUAD	cis	1	rs12905057	chr15:85210765	LOC388152	chr15:84867600-84898920:-	-0.32	-5.92	6.23E-9	Schizophrenia	
LUAD	cis	1	rs12908161	chr15:85207825	LOC388152	chr15:84867600-84898920:-	-0.31	-5.91	6.24E-9	Schizophrenia	
LUAD	cis	1	rs12908549	chr15:85322351	LOC388152	chr15:84867600-84898920:-	-0.3	-5.85	9.04E-9	Schizophrenia	
LUAD	cis	1	rs12910012	chr15:85298662	LOC388152	chr15:84867600-84898920:-	-0.31	-5.88	7.67E-9	Schizophrenia	
LUAD	cis	1	rs12910644	chr15:75358388	SCAMP5	chr15:75287901-75313836:+	0.38	6.62	9.61E-11	Blood trace element (Zn levels)	
LUAD	cis	1	rs12910992	chr15:90372465	AP3S2	chr15:90373832-90456222:-	-0.63	-12.55	1.63E-31	Type 2 diabetes	
LUAD	cis	1	rs12911132	chr15:43560436	STRC	chr15:43891762-43924561:-	0.19	3.75	0.000198	Lung cancer	
LUAD	cis	1	rs12911736	chr15:85240008	LOC388152	chr15:84867600-84898920:-	-0.32	-5.99	4.17E-9	Schizophrenia	
LUAD	cis	1	rs12912388	chr15:85344550	LOC388152	chr15:84867600-84898920:-	-0.31	-5.88	7.7E-9	Schizophrenia	
LUAD	cis	1	rs12915234	chr15:84758301	GOLGA6L5	chr15:85047738-85060078:-	-0.17	-3.72	0.000219	Schizophrenia	
LUAD	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.38	-7.06	5.59E-12	Schizophrenia	
LUAD	cis	1	rs12916348	chr15:84765527	GOLGA6L5	chr15:85047738-85060078:-	-0.17	-3.71	0.000229	Schizophrenia	
LUAD	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.38	-7.07	5.25E-12	Schizophrenia	
LUAD	cis	1	rs12930371	chr16:68802936	NFATC3	chr16:68118654-68260837:+	0.16	3.71	0.00023	Colorectal cancer	
LUAD	cis	1	rs12937756	chr17:40576813	NAGLU	chr17:40687951-40696464:+	-0.2	-3.71	0.000235	Crohn's disease	
LUAD	cis	1	rs12943498	chr17:40593901	NAGLU	chr17:40687951-40696464:+	-0.21	-3.77	0.000185	Crohn's disease	
LUAD	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.5	10.16	3.84E-22	Eye color traits	
LUAD	cis	1	rs12951549	chr17:40593502	NAGLU	chr17:40687951-40696464:+	-0.21	-3.77	0.000185	Crohn's disease	
LUAD	cis	1	rs12951640	chr17:40594298	NAGLU	chr17:40687951-40696464:+	-0.21	-3.77	0.000185	Crohn's disease	
LUAD	cis	1	rs1296028	chr8:11698747	CTSB	chr8:11700036-11725646:-	0.2	4.19	3.34E-5	Parkinson's disease	
LUAD	cis	1	rs1298472	chr4:8202841	SH3TC1	chr4:8201060-8242828:+	-0.27	-4.57	6.32E-6	Response to metformin (IC50)	
LUAD	cis	1	rs12995491	chr2:88527414	THNSL2	chr2:88469835-88486145:+	-0.38	-6.87	1.99E-11	Response to metformin (IC50)	
LUAD	cis	1	rs13001325	chr2:102939036	IL1RL1	chr2:102927962-102968497:+	-0.23	-4.26	2.43E-5	Serum protein levels (sST2)	
LUAD	cis	1	rs13003464	chr2:61186829	AHSA2	chr2:61404553-61414058:+	-0.14	-5.66	2.53E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.46	8.49	2.51E-16	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs13006833	chr2:191205499	HIBCH	chr2:191069361-191184559:-	0.37	7.49	3.21E-13	Urinary metabolites	
LUAD	cis	1	rs13008738	chr2:61078921	C2orf74	chr2:61372243-61391964:+	0.37	5.68	2.29E-8	Inflammatory skin disease	
LUAD	cis	1	rs13014235	chr2:202215492	ALS2CR12	chr2:202153148-202222101:-	-0.15	-4.06	5.83E-5	Basal cell carcinoma	
LUAD	cis	1	rs13014235	chr2:202215492	CASP8	chr2:202098166-202152434:+	0.21	4.82	1.89E-6	Basal cell carcinoma	
LUAD	cis	1	rs13016963	chr2:202162811	ALS2CR12	chr2:202153148-202222101:-	-0.17	-4.56	6.45E-6	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs13016963	chr2:202162811	CASP8	chr2:202098166-202152434:+	0.22	4.82	1.89E-6	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs13019081	chr2:102950822	IL1RL1	chr2:102927962-102968497:+	0.22	4.17	3.53E-5	Serum protein levels (sST2)	
LUAD	cis	1	rs13020991	chr2:70068642	SNRNP27	chr2:70121090-70132348:+	0.22	4.15	3.9E-5	Colorectal or endometrial cancer	
LUAD	cis	1	rs13025205	chr2:70044159	SNRNP27	chr2:70121090-70132348:+	0.21	3.87	0.000125	Colorectal or endometrial cancer	
LUAD	cis	1	rs13033143	chr2:61161095	C2orf74	chr2:61372243-61391964:+	0.37	5.9	6.66E-9	Inflammatory skin disease	
LUAD	cis	1	rs13037594	chr20:55040168	RBM38	chr20:55966463-55984384:+	-0.17	-3.82	0.000151	Refractive astigmatism	
LUAD	cis	1	rs13038834	chr20:25441433	FAM182A	chr20:26035250-26067552:+	-0.19	-3.96	8.69E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs1304037	chr2:113532236	IL1A	chr2:113531493-113542971:-	-0.22	-4.13	4.24E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs13056719	chr22:24724099	POM121L9P	chr22:24647589-24661490:+	-0.26	-5.41	1.0E-7	Gut microbiome composition (summer)	
LUAD	cis	1	rs13058817	chr3:53024139	TMEM110	chr3:52867139-52931547:-	0.48	5.08	5.29E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13058903	chr3:38513365	XYLB	chr3:38388251-38456467:+	-0.23	-4.23	2.83E-5	Electrocardiographic conduction measures	
LUAD	cis	1	rs13059623	chr3:16616432	GALNTL2	chr3:15935569-16271252:+	-0.17	-3.77	0.000185	Testicular germ cell tumor	
LUAD	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs13064760	chr3:12369401	MKRN2	chr3:12598594-12625208:+	0.39	4.73	2.94E-6	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs13064760	chr3:12369401	RAF1	chr3:12625102-12705700:-	0.34	3.94	9.16E-5	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs13069006	chr3:52973305	TMEM110	chr3:52867139-52931547:-	0.51	5.3	1.78E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.31	-7.84	2.87E-14	Longevity	
LUAD	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.28	-7.01	7.78E-12	Longevity	
LUAD	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.51	-9.96	2.21E-21	Height	
LUAD	cis	1	rs13072395	chr3:52980573	TMEM110	chr3:52867139-52931547:-	0.49	5.08	5.46E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13072457	chr3:53102389	TMEM110	chr3:52867139-52931547:-	0.48	5.22	2.66E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13072809	chr3:38468171	XYLB	chr3:38388251-38456467:+	0.2	3.68	0.00026	Electrocardiographic conduction measures	
LUAD	cis	1	rs13072818	chr3:53074263	TMEM110	chr3:52867139-52931547:-	0.45	5.04	6.6E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13074524	chr3:52974184	TMEM110	chr3:52867139-52931547:-	0.45	4.88	1.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13076033	chr3:52898427	TMEM110	chr3:52867139-52931547:-	0.46	4.86	1.61E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.28	-7.15	3.23E-12	Longevity	
LUAD	cis	1	rs13077359	chr3:190983412	UTS2D	chr3:190984945-191048325:-	-0.25	-5.3	1.75E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs13078971	chr3:53103645	TMEM110	chr3:52867139-52931547:-	0.47	5.19	3.02E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.02	1.27E-21	Height	
LUAD	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs13083375	chr3:12365308	MKRN2	chr3:12598594-12625208:+	0.39	4.73	2.94E-6	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs13083375	chr3:12365308	RAF1	chr3:12625102-12705700:-	0.34	3.94	9.16E-5	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.36	7.13	3.57E-12	Cognitive performance	
LUAD	cis	1	rs13085211	chr3:12383265	MKRN2	chr3:12598594-12625208:+	0.32	4.05	6.04E-5	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.35	7.12	3.76E-12	Cognitive performance	
LUAD	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs13088281	chr3:53147576	TMEM110	chr3:52867139-52931547:-	-0.44	-4.98	8.79E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13089394	chr3:38446309	XYLB	chr3:38388251-38456467:+	0.21	3.88	0.000119	Electrocardiographic conduction measures	
LUAD	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.16	3.95E-22	Height	
LUAD	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.51	-9.96	2.21E-21	Height	
LUAD	cis	1	rs13091073	chr3:16614948	GALNTL2	chr3:15935569-16271252:+	-0.17	-3.82	0.000149	Testicular germ cell tumor	
LUAD	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.32	-8.14	3.37E-15	Longevity	
LUAD	cis	1	rs13091844	chr3:53010271	TMEM110	chr3:52867139-52931547:-	0.38	4.16	3.72E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13092352	chr3:52969697	TMEM110	chr3:52867139-52931547:-	0.45	4.88	1.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs13096474	chr3:49443081	CCDC36	chr3:49235861-49295537:+	-0.21	-3.89	0.000116	Menarche (age at onset)	
LUAD	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs13099	chr14:75599155	MLH3	chr14:75480467-75518235:-	-0.25	-4.82	1.9E-6	Height	
LUAD	cis	1	rs13105385	chr4:48404094	NIPAL1	chr4:48018791-48039078:+	0.19	3.87	0.000126	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs13111449	chr4:81549364	C4orf22	chr4:81256874-81884896:+	-0.2	-5.25	2.28E-7	Obesity-related traits	
LUAD	cis	1	rs13119927	chr4:17691640	MED28	chr4:17616273-17629791:+	-0.17	-3.82	0.000153	Parasitemia in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs13120847	chr4:48030036	NIPAL1	chr4:48018791-48039078:+	0.33	6.62	9.4E-11	Renal underexcretion gout;Gout	
LUAD	cis	1	rs13123545	chr4:76535466	CXCL9	chr4:76922623-76928641:-	0.15	3.79	0.000171	Magnesium levels	
LUAD	cis	1	rs13125949	chr4:48026560	NIPAL1	chr4:48018791-48039078:+	0.33	6.7	5.6E-11	Renal underexcretion gout;Gout	
LUAD	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.46	-8.15	3.1E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs13133311	chr4:88217223	HSD17B13	chr4:88224941-88244056:-	-0.27	-5.78	1.36E-8	Platelet count	
LUAD	cis	1	rs13134489	chr4:165889437	C4orf39	chr4:165878100-165880273:+	0.3	5.84	9.58E-9	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs13134489	chr4:165889437	TRIM61	chr4:165875600-165898818:-	0.22	4.35	1.68E-5	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs13136090	chr4:76534792	CXCL9	chr4:76922623-76928641:-	0.15	3.67	0.00027	Magnesium levels	
LUAD	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.22	3.78	0.000174	Renal underexcretion gout;Gout	
LUAD	cis	1	rs13140968	chr4:48025095	NIPAL1	chr4:48018791-48039078:+	0.34	6.86	2.06E-11	Renal underexcretion gout;Gout	
LUAD	cis	1	rs13142655	chr4:88195494	HSD17B13	chr4:88224941-88244056:-	-0.28	-5.99	4.17E-9	Platelet count	
LUAD	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.21	3.7	0.000237	Renal underexcretion gout;Gout	
LUAD	cis	1	rs13142905	chr4:48025298	NIPAL1	chr4:48018791-48039078:+	0.33	6.66	7.2E-11	Renal underexcretion gout;Gout	
LUAD	cis	1	rs13146416	chr4:99999160	ADH5	chr4:99992132-100009931:-	0.3	3.73	0.000218	Smoking initiation	
LUAD	cis	1	rs13146880	chr4:48031499	CNGA1	chr4:47937996-48018610:-	0.21	3.75	0.000194	Renal underexcretion gout;Gout	
LUAD	cis	1	rs13146880	chr4:48031499	NIPAL1	chr4:48018791-48039078:+	0.35	6.95	1.15E-11	Renal underexcretion gout;Gout	
LUAD	cis	1	rs13151390	chr4:68422349	STAP1	chr4:68424446-68473053:+	-0.18	-3.79	0.000172	Parkinson's disease	
LUAD	cis	1	rs13153099	chr5:156436195	TIMD4	chr5:156346293-156390266:-	-0.26	-4.55	6.89E-6	Hypertriglyceridemia	
LUAD	cis	1	rs13169155	chr5:156426663	TIMD4	chr5:156346293-156390266:-	-0.22	-3.9	0.000112	Hypertriglyceridemia	
LUAD	cis	1	rs13169465	chr5:156426916	TIMD4	chr5:156346293-156390266:-	-0.23	-4.08	5.33E-5	Hypertriglyceridemia	
LUAD	cis	1	rs13169621	chr5:156426974	TIMD4	chr5:156346293-156390266:-	-0.23	-4.07	5.45E-5	Hypertriglyceridemia	
LUAD	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.23	-4.24	2.62E-5	Subjective well-being	
LUAD	cis	1	rs1317149	chr11:47486885	MYBPC3	chr11:47352958-47374253:-	-0.22	-4.65	4.22E-6	Subjective well-being	
LUAD	cis	1	rs131801	chr22:50966634	TYMP	chr22:50964184-50968514:-	0.22	5.27	2.07E-7	Mean corpuscular hemoglobin	
LUAD	cis	1	rs13181803	chr5:156429177	TIMD4	chr5:156346293-156390266:-	-0.24	-4.19	3.26E-5	Hypertriglyceridemia	
LUAD	cis	1	rs13192767	chr6:97411114	GPR63	chr6:97245889-97285353:-	-0.25	-3.81	0.000154	Body mass index	
LUAD	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.67	-12.26	2.68E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs13195401	chr6:26463574	BTN3A2	chr6:26365398-26378546:+	-0.79	-10.81	1.44E-24	Schizophrenia	
LUAD	cis	1	rs13195402	chr6:26463575	BTN3A2	chr6:26365398-26378546:+	-0.79	-10.81	1.44E-24	Schizophrenia	
LUAD	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.68	-12.25	2.71E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.64	-12.01	2.68E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.31	-5.62	3.17E-8	Obesity-related traits	
LUAD	cis	1	rs1320893	chr7:143752112	OR2A7	chr7:143955790-143974852:-	0.23	4.07	5.55E-5	Obesity-related traits	
LUAD	cis	1	rs1320893	chr7:143752112	OR2A9P	chr7:143991573-143997832:+;chr7	-0.24	-4.37	1.5E-5	Obesity-related traits	
LUAD	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.44	2.93E-10	Obesity-related traits	
LUAD	cis	1	rs1320894	chr7:143751802	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.0002	Obesity-related traits	
LUAD	cis	1	rs1320894	chr7:143751802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.97	9.08E-7	Obesity-related traits	
LUAD	cis	1	rs13213522	chr6:111705341	KIAA1919	chr6:111580482-111590259:+	0.47	4.11	4.7E-5	Psoriasis	
LUAD	cis	1	rs13213582	chr6:151873896	C6orf97	chr6:151815175-151942327:+	0.16	3.69	0.000248	Bone mineral density (spine)	
LUAD	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.62	-11.49	3.14E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs1321798	chr6:117731192	DCBLD1	chr6:117803820-117891018:+	0.18	3.94	9.15E-5	Lung cancer	
LUAD	cis	1	rs1321799	chr6:117731177	DCBLD1	chr6:117803820-117891018:+	-0.17	-3.84	0.000138	Lung cancer	
LUAD	cis	1	rs13220495	chr6:26441640	BTN3A2	chr6:26365398-26378546:+	-0.8	-10.86	9.25E-25	Schizophrenia	
LUAD	cis	1	rs13220510	chr6:56779141	BEND6	chr6:56819773-56892138:+	-0.27	-5.66	2.65E-8	Menarche (age at onset)	
LUAD	cis	1	rs13220979	chr7:65363204	CRCP	chr7:65579805-65619551:+	-0.34	-3.85	0.000133	Diabetic kidney disease	
LUAD	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.37	-6.82	2.62E-11	Obesity-related traits	
LUAD	cis	1	rs13226728	chr7:143746578	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.85	1.63E-6	Obesity-related traits	
LUAD	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.37	-6.72	5.2E-11	Obesity-related traits	
LUAD	cis	1	rs13243677	chr7:143746572	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.83	1.79E-6	Obesity-related traits	
LUAD	cis	1	rs13248727	chr8:21842063	FGF17	chr8:21900428-21906317:+	-0.15	-3.71	0.00023	Mean corpuscular volume	
LUAD	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.89	22.1	1.53E-75	Bone mineral density	
LUAD	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.89	22.14	9.24E-76	Bone mineral density	
LUAD	cis	1	rs13254600	chr8:124089526	WDYHV1	chr8:124428965-124454260:+	-0.18	-3.73	0.000213	Diabetic kidney disease	
LUAD	cis	1	rs13256369	chr8:8577379	CLDN23	chr8:8559666-8561616:+	-0.33	-5.57	4.17E-8	Obesity-related traits	
LUAD	cis	1	rs13266699	chr8:8570313	CLDN23	chr8:8559666-8561616:+	0.34	5.67	2.5E-8	Obesity-related traits	
LUAD	cis	1	rs13267501	chr8:8574058	CLDN23	chr8:8559666-8561616:+	-0.32	-5.48	6.88E-8	Obesity-related traits	
LUAD	cis	1	rs13268130	chr8:11116321	TDH	chr8:11197146-11225961:+	0.25	3.93	9.82E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
LUAD	cis	1	rs13271966	chr8:8575472	CLDN23	chr8:8559666-8561616:+	-0.32	-5.44	8.64E-8	Obesity-related traits	
LUAD	cis	1	rs1327866	chr1:166952910	GPA33	chr1:167022082-167059868:-	0.21	3.79	0.000168	Refractive astigmatism	
LUAD	cis	1	rs13282915	chr8:8570891	CLDN23	chr8:8559666-8561616:+	-0.32	-5.47	7.3E-8	Obesity-related traits	
LUAD	cis	1	rs1331215	chr20:3376565	ITPA	chr20:3190056-3204504:+	-0.26	-4.81	2.0E-6	IFN-related cytopenia	
LUAD	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.29	7.42	5.18E-13	Longevity	
LUAD	cis	1	rs13319597	chr3:10126312	IL17RE	chr3:9944303-9958082:+	0.21	3.98	8.0E-5	Alzheimer's disease	
LUAD	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.51	9.83	6.51E-21	Height	
LUAD	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.68	11.65	7.21E-28	Diastolic blood pressure	
LUAD	cis	1	rs13330350	chr16:68800849	NFATC3	chr16:68118654-68260837:+	-0.16	-3.71	0.000229	Colorectal cancer	
LUAD	cis	1	rs13331733	chr16:29848417	LOC440356	chr16:29875004-29879374:+	-0.26	-3.68	0.000261	Multiple sclerosis	
LUAD	cis	1	rs13332078	chr16:29850705	LOC440356	chr16:29875004-29879374:+	-0.27	-3.84	0.000139	Multiple sclerosis	
LUAD	cis	1	rs13333528	chr16:68790502	NFATC3	chr16:68118654-68260837:+	-0.18	-3.9	0.000108	Colorectal cancer	
LUAD	cis	1	rs13334294	chr16:68809278	NFATC3	chr16:68118654-68260837:+	-0.16	-3.68	0.000264	Colorectal cancer	
LUAD	cis	1	rs13334326	chr16:68809207	NFATC3	chr16:68118654-68260837:+	-0.16	-3.68	0.000264	Colorectal cancer	
LUAD	cis	1	rs13334471	chr16:68800452	NFATC3	chr16:68118654-68260837:+	-0.16	-3.71	0.000229	Colorectal cancer	
LUAD	cis	1	rs13339591	chr16:68809273	NFATC3	chr16:68118654-68260837:+	-0.16	-3.68	0.000264	Colorectal cancer	
LUAD	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.63	-11.74	3.31E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.65	-11.63	9.07E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs13380863	chr17:61780793	FTSJ3	chr17:61896795-61905031:-	0.24	4.89	1.4E-6	Body mass index	
LUAD	cis	1	rs13383871	chr2:73631779	ALMS1	chr2:73612886-73837046:+	0.18	4.24	2.73E-5	Metabolite levels	
LUAD	cis	1	rs13383871	chr2:73631779	ALMS1P	chr2:73872046-73912692:+	0.39	7.37	7.26E-13	Metabolite levels	
LUAD	cis	1	rs13384952	chr2:73723959	ALMS1P	chr2:73872046-73912692:+	-0.32	-5.12	4.33E-7	Metabolite levels	
LUAD	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.44	-7.18	2.66E-12	Prostate cancer	
LUAD	cis	1	rs13387221	chr2:44135314	LRPPRC	chr2:44113363-44223144:-	-0.25	-5.05	6.24E-7	Intelligence (childhood)	
LUAD	cis	1	rs13389798	chr2:203213093	NOP58	chr2:203130515-203168382:+	0.3	4.62	5.0E-6	Urate levels	
LUAD	cis	1	rs1339580	chr10:60027122	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1339582	chr10:59937183	IPMK	chr10:59955618-60027694:-	0.17	4.13	4.32E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1339583	chr10:59937003	IPMK	chr10:59955618-60027694:-	0.18	4.19	3.36E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1339584	chr10:59936857	IPMK	chr10:59955618-60027694:-	0.17	4.13	4.32E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1339585	chr10:59936841	IPMK	chr10:59955618-60027694:-	0.17	4.04	6.19E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1339586	chr10:60017646	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1339588	chr10:59998210	IPMK	chr10:59955618-60027694:-	0.17	4.18	3.39E-5	Inflammatory bowel disease	
LUAD	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.5	5.76	1.46E-8	Rheumatoid arthritis	
LUAD	cis	1	rs13398956	chr2:73720258	ALMS1	chr2:73612886-73837046:+	0.18	4.35	1.68E-5	Metabolite levels	
LUAD	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.39	7.31	1.1E-12	Metabolite levels	
LUAD	cis	1	rs13398956	chr2:73720258	FBXO41	chr2:73481800-73498043:-	0.19	3.68	0.000263	Metabolite levels	
LUAD	cis	1	rs13401391	chr2:137340034	THSD7B	chr2:137523115-138435287:+	0.28	4.14	4.06E-5	Cognitive test performance	
LUAD	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.5	-7.4	5.96E-13	Rheumatoid arthritis	
LUAD	cis	1	rs13408569	chr2:102955056	IL1RL1	chr2:102927962-102968497:+	0.34	4.95	1.01E-6	Asthma	
LUAD	cis	1	rs13408661	chr2:102955082	IL1RL1	chr2:102927962-102968497:+	0.34	4.95	1.01E-6	Asthma	
LUAD	cis	1	rs13409250	chr2:37463642	CEBPZ	chr2:37428778-37458740:-	-0.17	-3.69	0.000247	Chronic lymphocytic leukemia	
LUAD	cis	1	rs13415839	chr2:232126534	HTR2B	chr2:231972952-231989824:-	0.23	4.07	5.42E-5	Food antigen IgG levels	
LUAD	cis	1	rs13421462	chr2:73719875	ALMS1	chr2:73612886-73837046:+	0.17	4.14	4.08E-5	Metabolite levels	
LUAD	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.38	7.2	2.35E-12	Metabolite levels	
LUAD	cis	1	rs13428235	chr2:73633430	ALMS1	chr2:73612886-73837046:+	0.18	4.29	2.2E-5	Metabolite levels	
LUAD	cis	1	rs13428235	chr2:73633430	ALMS1P	chr2:73872046-73912692:+	0.38	7.23	1.88E-12	Metabolite levels	
LUAD	cis	1	rs13428235	chr2:73633430	FBXO41	chr2:73481800-73498043:-	0.19	3.72	0.00022	Metabolite levels	
LUAD	cis	1	rs13431267	chr2:73782200	ALMS1	chr2:73612886-73837046:+	0.17	4.22	2.96E-5	Metabolite levels	
LUAD	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.39	7.43	4.94E-13	Metabolite levels	
LUAD	cis	1	rs13431828	chr2:102954653	IL1RL1	chr2:102927962-102968497:+	0.34	4.95	1.01E-6	Asthma	
LUAD	cis	1	rs13432605	chr2:73810981	ALMS1	chr2:73612886-73837046:+	0.19	4.47	9.55E-6	Metabolite levels	
LUAD	cis	1	rs13432605	chr2:73810981	ALMS1P	chr2:73872046-73912692:+	0.4	7.59	1.66E-13	Metabolite levels	
LUAD	cis	1	rs1346719	chr3:53077372	TMEM110	chr3:52867139-52931547:-	0.36	4.4	1.32E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.31	-6.21	1.14E-9	Cognitive function	
LUAD	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.31	-6.23	9.9E-10	Cognitive function	
LUAD	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.3	-5.94	5.57E-9	Cognitive function	
LUAD	cis	1	rs134900	chr22:42683343	C22orf32	chr22:42475699-42480287:+	0.13	3.7	0.000241	Cognitive function	
LUAD	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.31	-6.15	1.6E-9	Cognitive function	
LUAD	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.32	-6.45	2.71E-10	Cognitive function	
LUAD	cis	1	rs1352076	chr4:81535083	C4orf22	chr4:81256874-81884896:+	-0.21	-5.29	1.85E-7	Obesity-related traits	
LUAD	cis	1	rs1352433	chr4:48393680	NIPAL1	chr4:48018791-48039078:+	-0.18	-3.71	0.00023	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs1355412	chr8:29985683	LEPROTL1	chr8:29952922-29995222:+	0.24	4.04	6.17E-5	Migraine	
LUAD	cis	1	rs1355412	chr8:29985683	MBOAT4	chr8:29989188-30002200:-	0.34	5.15	3.75E-7	Migraine	
LUAD	cis	1	rs1357481	chr4:8496221	CPZ	chr4:8582291-8621486:+	0.16	3.9	0.000109	Response to antineoplastic agents	
LUAD	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.51	9.97	1.88E-21	Height	
LUAD	cis	1	rs1360172	chr9:131907980	CRAT	chr9:131857075-131873070:-	0.32	6.15	1.64E-9	Blood metabolite ratios	
LUAD	cis	1	rs1361353	chr10:59938091	IPMK	chr10:59955618-60027694:-	0.17	4.17	3.62E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.68	-14.43	1.46E-39	Type 2 diabetes	
LUAD	cis	1	rs1374469	chr4:1724799	FAM53A	chr4:1641609-1685854:-	-0.31	-5.36	1.25E-7	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs1374531	chr4:106523932	INTS12	chr4:106603787-106629881:-	-0.49	-4.85	1.67E-6	Post bronchodilator FEV1	
LUAD	cis	1	rs138209	chr22:50539413	MLC1	chr22:50497820-50524358:-	-0.21	-4.79	2.21E-6	Gestational age at birth in labor-initiated deliveries (child effect)	
LUAD	cis	1	rs138244	chr22:50565367	MLC1	chr22:50497820-50524358:-	-0.23	-5.34	1.43E-7	Gestational age at birth in labor-initiated deliveries (child effect)	
LUAD	cis	1	rs138249	chr22:50569790	MLC1	chr22:50497820-50524358:-	-0.24	-5.43	8.71E-8	Gestational age at birth in labor-initiated deliveries (child effect)	
LUAD	cis	1	rs138250	chr22:50570361	MLC1	chr22:50497820-50524358:-	-0.23	-5.18	3.22E-7	Gestational age at birth in labor-initiated deliveries (child effect)	
LUAD	cis	1	rs138252	chr22:50570873	MLC1	chr22:50497820-50524358:-	-0.23	-5.27	2.09E-7	Gestational age at birth in labor-initiated deliveries (child effect)	
LUAD	cis	1	rs1385890	chr4:81535393	C4orf22	chr4:81256874-81884896:+	-0.19	-4.96	9.62E-7	Obesity-related traits	
LUAD	cis	1	rs1387017	chr3:112500421	CCDC80	chr3:112323411-112359977:-	-0.12	-3.71	0.000233	Prostate cancer (gene x gene interaction)	
LUAD	cis	1	rs1387018	chr3:112500416	CCDC80	chr3:112323411-112359977:-	-0.12	-3.67	0.000272	Prostate cancer (gene x gene interaction)	
LUAD	cis	1	rs1387019	chr3:112500272	CCDC80	chr3:112323411-112359977:-	0.12	3.72	0.000225	Prostate cancer (gene x gene interaction)	
LUAD	cis	1	rs138702	chr22:39132601	JOSD1	chr22:39081549-39096459:-	0.21	3.78	0.00018	Resting heart rate	
LUAD	cis	1	rs1388527	chr11:6948441	ZNF215	chr11:6947654-7005861:+	-0.27	-3.69	0.000253	Response to cytadine analogues (cytosine arabinoside)	
LUAD	cis	1	rs138879185	chr17:6707261	FBXO39	chr17:6679552-6700420:+	-0.24	-4.32	1.91E-5	Mild influenza (H1N1) infection	
LUAD	cis	1	rs1390006	chr17:56890663	RAD51C	chr17:56769963-56811690:+	-0.23	-4.75	2.72E-6	Cognitive test performance	
LUAD	cis	1	rs1393244	chr5:132186007	UQCRQ	chr5:132202319-132204536:+	-0.16	-4.02	6.82E-5	Apolipoprotein A-IV levels	
LUAD	cis	1	rs1403284	chr2:73726662	ALMS1	chr2:73612886-73837046:+	-0.17	-4.06	5.81E-5	Metabolite levels	
LUAD	cis	1	rs1403284	chr2:73726662	ALMS1P	chr2:73872046-73912692:+	-0.36	-6.78	3.42E-11	Metabolite levels	
LUAD	cis	1	rs1404147	chr7:65264524	CCT6P1	chr7:65216092-65228661:+	0.24	4.23	2.79E-5	Diabetic kidney disease	
LUAD	cis	1	rs1406947	chr20:33969530	UQCC	chr20:33890383-33999833:-	0.3	5.42	9.2E-8	Height	
LUAD	cis	1	rs1407185	chr6:117733650	DCBLD1	chr6:117803820-117891018:+	0.18	3.99	7.74E-5	Lung cancer	
LUAD	cis	1	rs1407644	chr6:111802098	KIAA1919	chr6:111580482-111590259:+	-0.39	-3.73	0.000216	Psoriasis	
LUAD	cis	1	rs1408916	chr1:92992627	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs1412444	chr10:91002927	LIPA	chr10:90973328-91174382:-	0.19	5.46	7.77E-8	Fibrinogen levels	
LUAD	cis	1	rs1412445	chr10:91002804	LIPA	chr10:90973328-91174382:-	0.18	5.29	1.83E-7	Fibrinogen levels	
LUAD	cis	1	rs1414896	chr1:95692310	TMEM56	chr1:95582894-95663159:+	0.25	4.59	5.68E-6	Non-alcoholic fatty liver disease histology (AST)	
LUAD	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.66	-11.77	2.44E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs1416763	chr10:60029163	IPMK	chr10:59955618-60027694:-	0.17	4.09	5.07E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1416764	chr10:60040351	IPMK	chr10:59955618-60027694:-	0.16	3.96	8.65E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1416766	chr10:59978237	IPMK	chr10:59955618-60027694:-	0.18	4.26	2.45E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1417611	chr6:46312648	CLIC5	chr6:45866190-46048085:-	0.15	3.68	0.000264	Body mass index	
LUAD	cis	1	rs1417823	chr10:102227886	SEC31B	chr10:102246403-102289636:-	0.18	5.97	4.44E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs14178	chr16:67969531	ATP6V0D1	chr16:67471917-67515089:-	-0.38	-4.48	9.37E-6	Crohn's disease	
LUAD	cis	1	rs1419183	chr6:28242794	ZNF187	chr6:28234788-28245978:+	-0.22	-3.95	8.96E-5	Depression	
LUAD	cis	1	rs1420101	chr2:102957716	IL1RL1	chr2:102927962-102968497:+	-0.2	-3.93	9.77E-5	Serum protein levels (sST2)	
LUAD	cis	1	rs1420872	chr16:50807779	CYLD	chr16:50775961-50835846:+	-0.14	-3.67	0.000269	Leprosy	
LUAD	cis	1	rs1422795	chr5:156936364	ADAM19	chr5:156822542-157002768:-	-0.13	-4.25	2.51E-5	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.75	13.29	1.31E-34	Type 2 diabetes	
LUAD	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.74	13.14	5.47E-34	Type 2 diabetes	
LUAD	cis	1	rs1428551	chr5:150259832	LOC134466	chr5:150310000-150326146:-	0.3	3.86	0.000128	Crohn's disease	
LUAD	cis	1	rs1428555	chr5:150257391	LOC134466	chr5:150310000-150326146:-	-0.29	-3.82	0.000154	Crohn's disease	
LUAD	cis	1	rs144073979	chr22:18886814	DGCR6	chr22:18893541-18899600:+	-0.58	-6.31	6.15E-10	3-hydroxypropylmercapturic acid levels in smokers	
LUAD	cis	1	rs144098432	chr18:51816394	POLI	chr18:51795849-51824602:+	0.19	3.93	9.54E-5	Inflammatory skin disease	
LUAD	cis	1	rs14451	chr1:202304868	PPP1R12B	chr1:202317836-202557697:+	-0.19	-4.25	2.61E-5	Sex ratio	
LUAD	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.28	-5.71	1.93E-8	Menarche (age at onset)	
LUAD	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.29	-5.8	1.22E-8	Menarche (age at onset)	
LUAD	cis	1	rs1453414	chr11:5829084	OR52N2	chr11:5841566-5842530:+	-0.39	-5.05	6.35E-7	Oropharynx cancer;Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs145358377	chr1:6272136	ICMT	chr1:6281255-6296044:-	-0.44	-4.13	4.18E-5	Resting heart rate	
LUAD	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.25	6.12	1.95E-9	Longevity	
LUAD	cis	1	rs1460561	chr6:56797574	BEND6	chr6:56819773-56892138:+	-0.27	-5.53	5.33E-8	Menarche (age at onset)	
LUAD	cis	1	rs1466389	chr17:2096384	SRR	chr17:2207248-2228553:+	-0.46	-8.5	2.34E-16	Esophageal cancer (squamous cell)	
LUAD	cis	1	rs1466788	chr1:110618730	ALX3	chr1:110602998-110613322:-	-0.2	-3.93	9.86E-5	Blood metabolite levels	
LUAD	cis	1	rs1469712	chr19:19528821	HAPLN4	chr19:19366453-19384074:-	0.17	3.72	0.000225	Schizophrenia	
LUAD	cis	1	rs1471399	chr4:88774073	SPP1	chr4:88896802-88904562:+	-0.2	-4.11	4.72E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
LUAD	cis	1	rs1471401	chr4:88774340	SPP1	chr4:88896802-88904562:+	-0.2	-4.05	5.88E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
LUAD	cis	1	rs1471403	chr4:88775243	SPP1	chr4:88896802-88904562:+	0.19	3.84	0.00014	Bone mineral density;Bone mineral density (paediatric, total body less head)	
LUAD	cis	1	rs1475695	chr9:100691168	C9orf156	chr9:100666772-100684852:-	-0.2	-4.07	5.4E-5	Quantitative traits	
LUAD	cis	1	rs1475696	chr9:100691397	C9orf156	chr9:100666772-100684852:-	-0.2	-4.07	5.4E-5	Quantitative traits	
LUAD	cis	1	rs1484994	chr20:30305975	FRG1B	chr20:29611879-29653908:+	0.22	3.84	0.00014	Subcortical brain region volumes	
LUAD	cis	1	rs1486022	chr4:81539257	C4orf22	chr4:81256874-81884896:+	-0.21	-5.27	2.06E-7	Obesity-related traits	
LUAD	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.5	9.79	8.72E-21	Height	
LUAD	cis	1	rs1499614	chr7:65730798	CCT6P1	chr7:65216092-65228661:+	0.23	3.75	0.000198	Diabetic kidney disease	
LUAD	cis	1	rs1501908	chr5:156398169	TIMD4	chr5:156346293-156390266:-	0.21	4.14	4.05E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs1511218	chr2:160906390	LY75	chr2:160625141-160761262:-	0.2	4.34	1.72E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs151222	chr16:20674492	ACSM1	chr16:20634559-20709066:-	-0.48	-6.14	1.75E-9	Schizophrenia	
LUAD	cis	1	rs151317012	chr4:106806194	INTS12	chr4:106603787-106629881:-	-0.6	-5.81	1.12E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs1516790	chr2:113531291	IL1A	chr2:113531493-113542971:-	0.22	4.15	3.9E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.44	-10.96	3.84E-25	Ankylosing spondylitis	
LUAD	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.47	8.92	9.41E-18	Ankylosing spondylitis	
LUAD	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.25	-4.7	3.31E-6	Pancreatic cancer	
LUAD	cis	1	rs1529957	chr19:37739801	ZNF585B	chr19:37675724-37701451:-	0.26	3.86	0.000131	Coronary artery calcification	
LUAD	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.57	1.31E-10	Obesity-related traits	
LUAD	cis	1	rs1533266	chr7:143766714	OR2A7	chr7:143955790-143974852:-	0.21	3.72	0.000222	Obesity-related traits	
LUAD	cis	1	rs1533266	chr7:143766714	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.19	3.12E-7	Obesity-related traits	
LUAD	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.55	1.5E-10	Obesity-related traits	
LUAD	cis	1	rs1533267	chr7:143766440	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.000201	Obesity-related traits	
LUAD	cis	1	rs1533267	chr7:143766440	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.15	3.88E-7	Obesity-related traits	
LUAD	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.55	1.5E-10	Obesity-related traits	
LUAD	cis	1	rs1533268	chr7:143766358	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.000201	Obesity-related traits	
LUAD	cis	1	rs1533268	chr7:143766358	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.15	3.88E-7	Obesity-related traits	
LUAD	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.51	-9.98	1.8E-21	Height	
LUAD	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.52	10.08	7.71E-22	Height	
LUAD	cis	1	rs1534471	chr2:73647508	ALMS1	chr2:73612886-73837046:+	0.2	4.92	1.19E-6	Metabolite levels	
LUAD	cis	1	rs1534471	chr2:73647508	ALMS1P	chr2:73872046-73912692:+	0.35	6.78	3.43E-11	Metabolite levels	
LUAD	cis	1	rs1538767	chr3:195007852	C3orf21	chr3:194789015-194991895:-	0.16	3.85	0.000136	Body mass index	
LUAD	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.51	1.9E-10	Obesity-related traits	
LUAD	cis	1	rs1540894	chr7:143767676	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.09	5.12E-7	Obesity-related traits	
LUAD	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.31	5.74	1.63E-8	Height	
LUAD	cis	1	rs1541853	chr2:203835177	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs1546059	chr7:65654709	CCT6P1	chr7:65216092-65228661:+	-0.24	-3.9	0.000111	Diabetic kidney disease	
LUAD	cis	1	rs1550773	chr10:60044441	IPMK	chr10:59955618-60027694:-	0.17	4.07	5.56E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1552994	chr1:152171461	FLG	chr1:152274651-152297679:-	0.43	8.1	4.54E-15	Inflammatory skin disease	
LUAD	cis	1	rs1554120	chr3:150935371	P2RY12	chr3:151055238-151102544:-	0.16	3.7	0.000242	Heschl's gyrus morphology	
LUAD	cis	1	rs1555337	chr20:61863641	BIRC7	chr20:61867276-61871853:+	-0.37	-4.33	1.84E-5	Response to cytadine analogues (cytosine arabinoside)	
LUAD	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.48	-8.54	1.72E-16	Esophageal cancer (squamous cell)	
LUAD	cis	1	rs1556562	chr1:93034023	EVI5	chr1:92974255-93257961:-	0.25	4.11	4.64E-5	Cholesterol, total	
LUAD	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.75	13.59	6.3E-36	Type 2 diabetes	
LUAD	cis	1	rs1560706	chr19:10838004	RAVER1	chr19:10426891-10444314:-	-0.24	-4.01	7.09E-5	LDL cholesterol	
LUAD	cis	1	rs1561288	chr2:25369002	POMC	chr2:25383722-25391559:-	0.22	3.75	0.000196	Body mass index	
LUAD	cis	1	rs1561289	chr2:25369040	DNAJC27	chr2:25166505-25194824:-	-0.16	-3.74	0.000205	Body mass index	
LUAD	cis	1	rs1561289	chr2:25369040	POMC	chr2:25383722-25391559:-	-0.24	-4.19	3.33E-5	Body mass index	
LUAD	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.29	-7.05	6.07E-12	Longevity	
LUAD	cis	1	rs15637	chr17:61772050	FTSJ3	chr17:61896795-61905031:-	0.2	4.23	2.81E-5	Body mass index	
LUAD	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.67	12.04	2.03E-29	Diastolic blood pressure	
LUAD	cis	1	rs15655	chr1:171673272	VAMP4	chr1:171669298-171711214:-	0.24	3.93	9.87E-5	Hippocampal atrophy	
LUAD	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.28	-6.58	1.19E-10	Blood metabolite levels	
LUAD	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.32	5.98	4.37E-9	Height	
LUAD	cis	1	rs1570059	chr6:26573325	BTN2A3	chr6:26422317-26431927:+	0.16	3.7	0.000241	Educational attainment	
LUAD	cis	1	rs1570836	chr1:92972457	EVI5	chr1:92974255-93257961:-	-0.27	-4.35	1.66E-5	Cholesterol, total	
LUAD	cis	1	rs1570837	chr1:93006816	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs1571229	chr9:131913711	CRAT	chr9:131857075-131873070:-	0.33	6.26	8.19E-10	Blood metabolite ratios	
LUAD	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.66	-11.68	5.9E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.66	-11.77	2.44E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs1599280	chr6:56792576	BEND6	chr6:56819773-56892138:+	-0.27	-5.49	6.52E-8	Menarche (age at onset)	
LUAD	cis	1	rs1599281	chr6:56789311	BEND6	chr6:56819773-56892138:+	0.22	4.97	9.39E-7	Menarche (age at onset)	
LUAD	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.47	8.15	3.05E-15	Multiple sclerosis	
LUAD	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.24	-4.84	1.73E-6	Multiple sclerosis	
LUAD	cis	1	rs160634	chr7:65528664	CCT6P1	chr7:65216092-65228661:+	-0.24	-4.11	4.6E-5	Diabetic kidney disease	
LUAD	cis	1	rs160642	chr7:65558373	CCT6P1	chr7:65216092-65228661:+	0.25	3.93	9.83E-5	Diabetic kidney disease	
LUAD	cis	1	rs160643	chr7:65558222	CCT6P1	chr7:65216092-65228661:+	0.22	3.75	0.000195	Diabetic kidney disease	
LUAD	cis	1	rs160644	chr7:65558186	CCT6P1	chr7:65216092-65228661:+	0.25	3.93	9.83E-5	Diabetic kidney disease	
LUAD	cis	1	rs160646	chr7:65556280	CCT6P1	chr7:65216092-65228661:+	0.25	3.94	9.21E-5	Diabetic kidney disease	
LUAD	cis	1	rs160648	chr7:65543384	CCT6P1	chr7:65216092-65228661:+	0.24	3.92	0.000102	Diabetic kidney disease	
LUAD	cis	1	rs160652	chr7:65538431	CCT6P1	chr7:65216092-65228661:+	0.24	3.75	0.000198	Diabetic kidney disease	
LUAD	cis	1	rs160655	chr7:65533214	CCT6P1	chr7:65216092-65228661:+	0.23	3.72	0.000224	Diabetic kidney disease	
LUAD	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.35	-6.91	1.55E-11	Rheumatoid arthritis	
LUAD	cis	1	rs1609985	chr12:131320170	STX2	chr12:131274149-131323811:-	0.19	4.15	3.93E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.71	-12.42	5.72E-31	Diastolic blood pressure	
LUAD	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.72	-13.08	1.02E-33	Diastolic blood pressure	
LUAD	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1618814	chr10:59963477	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1623294	chr10:59939025	IPMK	chr10:59955618-60027694:-	0.17	4.17	3.62E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1625439	chr4:100265325	ADH1C	chr4:100257651-100273917:-	-0.19	-3.71	0.000232	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1630731	chr10:59959530	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.36	-6.52	1.78E-10	Rheumatoid arthritis	
LUAD	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.19	4.01	7.0E-5	Rheumatoid arthritis	
LUAD	cis	1	rs1634409	chr17:18836177	FAM18B	chr17:18684582-18710026:+	-0.2	-3.89	0.000112	Educational attainment (years of education)	
LUAD	cis	1	rs1634409	chr17:18836177	FBXW10	chr17:18647326-18682661:+	-0.21	-4.27	2.36E-5	Educational attainment (years of education)	
LUAD	cis	1	rs1634409	chr17:18836177	LOC220594	chr17:18414577-18445234:-	-0.24	-3.9	0.000108	Educational attainment (years of education)	
LUAD	cis	1	rs1634411	chr17:18833810	FAM18B	chr17:18684582-18710026:+	-0.2	-3.86	0.000129	Educational attainment (years of education)	
LUAD	cis	1	rs1634411	chr17:18833810	FBXW10	chr17:18647326-18682661:+	-0.21	-4.23	2.84E-5	Educational attainment (years of education)	
LUAD	cis	1	rs1634411	chr17:18833810	LOC220594	chr17:18414577-18445234:-	-0.24	-3.93	9.73E-5	Educational attainment (years of education)	
LUAD	cis	1	rs1638734	chr7:66097539	CCT6P1	chr7:65216092-65228661:+	0.24	3.73	0.000211	Diabetic kidney disease	
LUAD	cis	1	rs164106	chr17:74290566	FAM100B	chr17:74261286-74267379:+	-0.2	-3.94	9.17E-5	White matter hyperintensities in ischemic stroke	
LUAD	cis	1	rs1652804	chr10:71264325	LRRC20	chr10:72058729-72142382:-	-0.19	-3.74	0.000207	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs1659695	chr2:27406944	C2orf28	chr2:27434899-27440044:+	-0.17	-3.98	7.89E-5	Blood metabolite levels	
LUAD	cis	1	rs1662039	chr4:100279684	ADH1C	chr4:100257651-100273917:-	-0.19	-3.7	0.000239	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1662048	chr4:100272032	ADH1C	chr4:100257651-100273917:-	-0.19	-3.74	0.00021	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1662049	chr4:100271849	ADH1C	chr4:100257651-100273917:-	-0.19	-3.7	0.000239	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1662058	chr4:100262759	ADH1C	chr4:100257651-100273917:-	-0.19	-3.74	0.000207	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1665362	chr4:1726367	FAM53A	chr4:1641609-1685854:-	-0.32	-5.55	4.57E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs1665364	chr4:1727206	FAM53A	chr4:1641609-1685854:-	0.31	5.42	9.36E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs1665366	chr4:1728381	FAM53A	chr4:1641609-1685854:-	0.32	5.54	4.84E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs166870	chr15:80069762	MTHFS	chr15:80137320-80189370:-	0.19	4.02	6.67E-5	Disease-free survival in breast cancer	
LUAD	cis	1	rs1679381	chr12:75946124	GLIPR1L2	chr12:75784889-75825591:+	-0.25	-4.63	4.66E-6	Polycystic ovary syndrome	
LUAD	cis	1	rs1679709	chr6:28228342	ZNF187	chr6:28234788-28245978:+	0.22	4.04	6.33E-5	Depression	
LUAD	cis	1	rs1679732	chr6:28221264	ZNF187	chr6:28234788-28245978:+	0.21	3.75	0.000198	Depression	
LUAD	cis	1	rs1682361	chr3:136734014	STAG1	chr3:136055999-136471245:-	0.14	3.7	0.000238	Schizophrenia	
LUAD	cis	1	rs16824599	chr2:203222966	NOP58	chr2:203130515-203168382:+	0.3	4.44	1.1E-5	Urate levels	
LUAD	cis	1	rs16826864	chr3:156580033	LEKR1	chr3:156544076-156763918:+	-0.27	-4.07	5.53E-5	Bone mineral density	
LUAD	cis	1	rs16830920	chr2:135465466	TMEM163	chr2:135213331-135525334:-	-0.22	-4.07	5.51E-5	Gut microbiome composition (winter)	
LUAD	cis	1	rs16830945	chr2:135471748	TMEM163	chr2:135213331-135525334:-	0.22	4.11	4.71E-5	Gut microbiome composition (winter)	
LUAD	cis	1	rs16835604	chr2:137332789	THSD7B	chr2:137523115-138435287:+	-0.32	-5.02	7.28E-7	Cognitive test performance	
LUAD	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.51	6.86	2.05E-11	Rheumatoid arthritis	
LUAD	cis	1	rs16839077	chr2:203208693	NOP58	chr2:203130515-203168382:+	0.32	4.87	1.5E-6	Urate levels	
LUAD	cis	1	rs16839090	chr2:203213061	NOP58	chr2:203130515-203168382:+	0.3	4.54	7.24E-6	Urate levels	
LUAD	cis	1	rs16839149	chr2:203292344	NOP58	chr2:203130515-203168382:+	0.26	4.09	4.99E-5	Urate levels	
LUAD	cis	1	rs16844715	chr2:160915106	LY75	chr2:160625141-160761262:-	-0.19	-4.22	2.92E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs16863064	chr3:187887577	FLJ42393	chr3:187896331-187898596:+	0.37	5.78	1.35E-8	Schizophrenia	
LUAD	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.67	-12.5	2.75E-31	Response to antipsychotic treatment	
LUAD	cis	1	rs16928809	chr11:2936952	SLC22A18	chr11:2920951-2946475:+	-0.32	-5.58	3.93E-8	Bilirubin levels	
LUAD	cis	1	rs1693426	chr4:100266330	ADH1C	chr4:100257651-100273917:-	-0.19	-3.7	0.000241	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1693470	chr4:100279489	ADH1C	chr4:100257651-100273917:-	-0.19	-3.7	0.000239	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1693471	chr4:100261952	ADH1C	chr4:100257651-100273917:-	-0.19	-3.74	0.000207	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1693477	chr4:100263062	ADH1C	chr4:100257651-100273917:-	-0.19	-3.74	0.000207	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1693483	chr4:100264946	ADH1C	chr4:100257651-100273917:-	-0.19	-3.71	0.000232	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs16947005	chr17:61702989	FTSJ3	chr17:61896795-61905031:-	-0.24	-5.17	3.39E-7	Body mass index	
LUAD	cis	1	rs16947014	chr17:61719032	FTSJ3	chr17:61896795-61905031:-	0.22	4.56	6.5E-6	Body mass index	
LUAD	cis	1	rs16947042	chr17:61766457	FTSJ3	chr17:61896795-61905031:-	0.2	4.23	2.81E-5	Body mass index	
LUAD	cis	1	rs16948048	chr17:47440466	ZNF652	chr17:47366569-47439835:-	0.17	4.31	1.94E-5	Diastolic blood pressure	
LUAD	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.45	-8.37	6.21E-16	Esophageal cancer (squamous cell)	
LUAD	cis	1	rs16952611	chr18:48382668	MRO	chr18:48321491-48351754:-	-0.36	-5.88	7.66E-9	Entorhinal cortical thickness	
LUAD	cis	1	rs16957524	chr16:67798005	ATP6V0D1	chr16:67471917-67515089:-	-0.31	-3.83	0.000142	Crohn's disease	
LUAD	cis	1	rs16957590	chr16:67934725	ATP6V0D1	chr16:67471917-67515089:-	0.36	4.41	1.29E-5	Crohn's disease	
LUAD	cis	1	rs16957590	chr16:67934725	RANBP10	chr16:67757006-67840555:-	0.3	3.75	0.000197	Crohn's disease	
LUAD	cis	1	rs16958445	chr15:74176557	CLK3	chr15:74890843-74922541:+	0.34	3.87	0.000126	Exfoliation glaucoma or exfoliation syndrome	
LUAD	cis	1	rs16958445	chr15:74176557	UBL7	chr15:74738318-74753529:-	0.46	4.71	3.24E-6	Exfoliation glaucoma or exfoliation syndrome	
LUAD	cis	1	rs16960499	chr17:19203032	RNF112	chr17:19314523-19320587:+	0.27	3.93	9.6E-5	Schizophrenia	
LUAD	cis	1	rs1698392	chr10:59967089	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1698395	chr10:59938724	IPMK	chr10:59955618-60027694:-	0.17	4.17	3.62E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1698396	chr10:59937308	IPMK	chr10:59955618-60027694:-	0.17	4.13	4.32E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1698402	chr10:59936444	IPMK	chr10:59955618-60027694:-	0.17	3.99	7.67E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1698468	chr10:59961590	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs16987832	chr22:29978749	NIPSNAP1	chr22:29950800-29977144:-	0.28	4.29	2.14E-5	Lipid traits	
LUAD	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.46	-8.15	3.1E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.44	-7.57	1.87E-13	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.45	-7.85	2.6E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs16995592	chr20:49524451	KCNG1	chr20:49620194-49639675:-	-0.38	-3.71	0.000227	Prostate cancer	
LUAD	cis	1	rs17001074	chr19:11104121	SMARCA4	chr19:11071598-11172959:+	-0.33	-3.87	0.000124	LDL cholesterol	
LUAD	cis	1	rs17018691	chr12:91473900	KERA	chr12:91444273-91452131:-	0.21	3.75	0.000198	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs17018694	chr12:91474052	KERA	chr12:91444273-91452131:-	0.21	3.75	0.000198	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs17018731	chr12:91499367	KERA	chr12:91444273-91452131:-	0.22	3.88	0.000119	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.52	8.18	2.5E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.5	8.03	7.21E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs17032299	chr3:10087638	IL17RE	chr3:9944303-9958082:+	-0.2	-3.73	0.000215	Alzheimer's disease	
LUAD	cis	1	rs17032414	chr3:10158302	IL17RE	chr3:9944303-9958082:+	-0.2	-3.79	0.000166	Alzheimer's disease	
LUAD	cis	1	rs17035960	chr4:106531846	INTS12	chr4:106603787-106629881:-	-0.58	-5.56	4.5E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs17036023	chr1:117129711	ATP1A1	chr1:116915004-116947394:+	0.4	4.41	1.25E-5	Asthma (childhood onset)	
LUAD	cis	1	rs17036023	chr1:117129711	CD58	chr1:117057157-117113715:-	0.33	4.25	2.51E-5	Asthma (childhood onset)	
LUAD	cis	1	rs17036023	chr1:117129711	IGSF3	chr1:117117031-117210314:-	0.47	5.2	2.94E-7	Asthma (childhood onset)	
LUAD	cis	1	rs17036023	chr1:117129711	PTGFRN	chr1:117452689-117532972:+	0.43	4.96	9.94E-7	Asthma (childhood onset)	
LUAD	cis	1	rs17036023	chr1:117129711	TTF2	chr1:117602949-117645489:+	0.45	5.21	2.82E-7	Asthma (childhood onset)	
LUAD	cis	1	rs17036023	chr1:117129711	VANGL1	chr1:116184574-116240845:+	0.37	4.19	3.3E-5	Asthma (childhood onset)	
LUAD	cis	1	rs17036105	chr4:106603272	INTS12	chr4:106603787-106629881:-	-0.64	-6.31	6.25E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs17036120	chr4:106621508	INTS12	chr4:106603787-106629881:-	-0.64	-6.62	9.53E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs17036123	chr4:106622190	INTS12	chr4:106603787-106629881:-	-0.64	-6.59	1.11E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs17036125	chr4:106623674	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.5E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs17036129	chr4:106624529	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.59E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs17036139	chr4:106632657	INTS12	chr4:106603787-106629881:-	-0.63	-6.76	3.91E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs17036177	chr4:106672511	INTS12	chr4:106603787-106629881:-	-0.64	-6.37	4.26E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs17036189	chr4:106687959	INTS12	chr4:106603787-106629881:-	-0.64	-6.68	6.5E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs17036225	chr4:106710092	INTS12	chr4:106603787-106629881:-	-0.59	-6.34	5.27E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs17036230	chr4:106715148	INTS12	chr4:106603787-106629881:-	-0.63	-6.85	2.18E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs17036230	chr4:106715148	NPNT	chr4:106816605-106892827:+	-0.36	-4.01	6.9E-5	Post bronchodilator FEV1	
LUAD	cis	1	rs17036258	chr4:106737382	INTS12	chr4:106603787-106629881:-	-0.62	-6.31	6.1E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs17036308	chr4:106749593	INTS12	chr4:106603787-106629881:-	-0.59	-6.45	2.76E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs17036310	chr4:106752340	INTS12	chr4:106603787-106629881:-	-0.57	-6.22	1.08E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs17036328	chr3:12390484	MKRN2	chr3:12598594-12625208:+	0.31	3.89	0.000113	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs17037427	chr1:11873416	CLCN6	chr1:11866207-11907674:+	0.19	3.83	0.000146	QRS complex (12-leadsum)	
LUAD	cis	1	rs17037452	chr1:11895675	CLCN6	chr1:11866207-11907674:+	0.2	4.09	5.04E-5	QRS complex (12-leadsum)	
LUAD	cis	1	rs17052727	chr3:53070914	TMEM110	chr3:52867139-52931547:-	0.45	5.02	7.25E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs17053637	chr5:156011426	SGCD	chr5:155135063-156194796:+	0.15	3.85	0.000136	Airway responsiveness in chronic obstructive pulmonary disease	
LUAD	cis	1	rs17057164	chr6:97410536	GPR63	chr6:97245889-97285353:-	-0.26	-4.01	6.92E-5	Body mass index	
LUAD	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.68	12.59	1.15E-31	Diastolic blood pressure	
LUAD	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.68	12.15	7.0E-30	Diastolic blood pressure	
LUAD	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.67	12.05	1.92E-29	Diastolic blood pressure	
LUAD	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.67	12.04	2.03E-29	Diastolic blood pressure	
LUAD	cis	1	rs17070580	chr6:109738714	AKD1	chr6:109814059-110012415:-	0.21	4.07	5.47E-5	Height	
LUAD	cis	1	rs17070580	chr6:109738714	SMPD2	chr6:109761931-109765121:+	-0.21	-4.17	3.55E-5	Height	
LUAD	cis	1	rs17072683	chr6:111731210	KIAA1919	chr6:111580482-111590259:+	0.47	4.1	4.74E-5	Psoriasis	
LUAD	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.33	9.58E-13	Body mass index	
LUAD	cis	1	rs1707304	chr1:46598269	MUTYH	chr1:45794915-45806142:-	0.16	3.83	0.000146	Body mass index	
LUAD	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.41	-7.59	1.69E-13	Body mass index	
LUAD	cis	1	rs1707321	chr1:46505309	MUTYH	chr1:45794915-45806142:-	0.18	4.29	2.16E-5	Body mass index	
LUAD	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.23	1.82E-12	Body mass index	
LUAD	cis	1	rs1707335	chr1:46571921	MUTYH	chr1:45794915-45806142:-	0.16	3.84	0.000137	Body mass index	
LUAD	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.27	1.42E-12	Body mass index	
LUAD	cis	1	rs1707336	chr1:46493460	MUTYH	chr1:45794915-45806142:-	0.17	3.89	0.000115	Body mass index	
LUAD	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.41	-7.63	1.27E-13	Body mass index	
LUAD	cis	1	rs1707340	chr1:46514942	MUTYH	chr1:45794915-45806142:-	0.17	3.91	0.000107	Body mass index	
LUAD	cis	1	rs17086197	chr18:70253746	CBLN2	chr18:70203915-70211723:-	0.5	4.45	1.08E-5	Airflow obstruction	
LUAD	cis	1	rs17086200	chr18:70255058	CBLN2	chr18:70203915-70211723:-	0.52	4.63	4.6E-6	Airflow obstruction	
LUAD	cis	1	rs17090837	chr6:111751853	KIAA1919	chr6:111580482-111590259:+	0.45	4.02	6.68E-5	Psoriasis	
LUAD	cis	1	rs17093474	chr14:74342413	LIN52	chr14:74551656-74667117:+	0.25	3.68	0.000258	Morning vs. evening chronotype	
LUAD	cis	1	rs17094021	chr14:74394295	LIN52	chr14:74551656-74667117:+	0.28	4.14	4.14E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs17096228	chr14:74558669	C14orf45	chr14:74486059-74549566:+	0.2	4.42	1.22E-5	Common traits (Other)	
LUAD	cis	1	rs17096228	chr14:74558669	COQ6	chr14:74416643-74429811:+	0.21	4.08	5.34E-5	Common traits (Other)	
LUAD	cis	1	rs17096228	chr14:74558669	DLST	chr14:75348594-75370450:+	0.22	3.84	0.000142	Common traits (Other)	
LUAD	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.5	11.14	7.86E-26	Common traits (Other)	
LUAD	cis	1	rs17096228	chr14:74558669	ZNF410	chr14:74318674-74398803:+	0.22	4.48	9.27E-6	Common traits (Other)	
LUAD	cis	1	rs17100939	chr1:101443701	CCDC76	chr1:100598706-100616053:+	0.18	3.72	0.000221	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs17111161	chr1:94610395	F3	chr1:94994732-95007371:-	-0.33	-3.79	0.000166	D-dimer levels	
LUAD	cis	1	rs17113137	chr10:102241998	SEC31B	chr10:102246403-102289636:-	-0.21	-6.64	8.52E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs17115100	chr10:104591393	SFXN2	chr10:104474298-104498946:+	-0.43	-4.78	2.29E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
LUAD	cis	1	rs17115231	chr12:75933675	GLIPR1L2	chr12:75784889-75825591:+	-0.27	-4.96	9.94E-7	Polycystic ovary syndrome	
LUAD	cis	1	rs17123612	chr1:101476814	CCDC76	chr1:100598706-100616053:+	0.18	3.78	0.000179	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs17149161	chr7:75978229	UPK3B	chr7:76139745-76157197:+	-0.2	-3.87	0.000122	Multiple sclerosis	
LUAD	cis	1	rs1715235	chr7:65488394	CRCP	chr7:65579805-65619551:+	-0.32	-3.69	0.000254	Diabetic kidney disease	
LUAD	cis	1	rs17164747	chr4:260587	ZNF718	chr4:53272-156488:+	0.26	3.74	0.000203	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.57	9.37	2.65E-19	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs17166268	chr5:132180990	UQCRQ	chr5:132202319-132204536:+	0.16	4.04	6.09E-5	Apolipoprotein A-IV levels	
LUAD	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.72	-13.08	1.02E-33	Diastolic blood pressure	
LUAD	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.71	-12.42	5.72E-31	Diastolic blood pressure	
LUAD	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.72	-13.08	1.02E-33	Diastolic blood pressure	
LUAD	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.72	-13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.72	-13.08	1.02E-33	Diastolic blood pressure	
LUAD	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.71	13.21	2.83E-34	Diastolic blood pressure	
LUAD	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.72	13.33	8.39E-35	Diastolic blood pressure	
LUAD	cis	1	rs17168512	chr7:128955033	LOC407835	chr7:128766325-128768041:+	0.24	3.82	0.000153	White matter hyperintensity burden	
LUAD	cis	1	rs1716984	chr3:41965532	ULK4	chr3:41288091-42003660:-	-0.71	-12.78	1.79E-32	Diastolic blood pressure	
LUAD	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.71	-12.42	5.72E-31	Diastolic blood pressure	
LUAD	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.71	-12.42	5.72E-31	Diastolic blood pressure	
LUAD	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.72	-13.08	1.02E-33	Diastolic blood pressure	
LUAD	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.72	12.95	3.63E-33	Diastolic blood pressure	
LUAD	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs1721359	chr2:228751874	WDR69	chr2:228736327-228789026:+	0.26	5.66	2.52E-8	Blood pressure	
LUAD	cis	1	rs17218267	chr6:55935111	COL21A1	chr6:55921389-56258892:-	-0.22	-3.69	0.00025	Psychosis (atypical)	
LUAD	cis	1	rs17218309	chr6:55935196	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs17219382	chr6:56009638	COL21A1	chr6:55921389-56258892:-	0.23	3.85	0.000132	Psychosis (atypical)	
LUAD	cis	1	rs17223195	chr16:50820263	CYLD	chr16:50775961-50835846:+	-0.14	-3.74	0.000203	Leprosy	
LUAD	cis	1	rs1723267	chr7:65473314	CRCP	chr7:65579805-65619551:+	-0.32	-3.69	0.000248	Diabetic kidney disease	
LUAD	cis	1	rs1723269	chr7:65472786	CCT6P1	chr7:65216092-65228661:+	0.23	3.68	0.000259	Diabetic kidney disease	
LUAD	cis	1	rs1723270	chr7:65469830	CCT6P1	chr7:65216092-65228661:+	0.24	3.78	0.000177	Diabetic kidney disease	
LUAD	cis	1	rs17272586	chr3:16624959	GALNTL2	chr3:15935569-16271252:+	-0.17	-3.82	0.000153	Testicular germ cell tumor	
LUAD	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.68	-7.09	4.66E-12	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs17314544	chr16:50820078	CYLD	chr16:50775961-50835846:+	-0.14	-3.71	0.000228	Leprosy	
LUAD	cis	1	rs17318866	chr6:3837198	SERPINB1	chr6:2833736-2842081:-	0.16	3.76	0.000193	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	
LUAD	cis	1	rs17341301	chr2:160902420	LY75	chr2:160625141-160761262:-	0.2	4.32	1.92E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs17407324	chr4:10273043	SLC2A9	chr4:9827850-10041872:-	-0.17	-3.77	0.000186	Schizophrenia (age at onset)	
LUAD	cis	1	rs17431934	chr9:100695776	C9orf156	chr9:100666772-100684852:-	-0.2	-4.07	5.4E-5	Quantitative traits	
LUAD	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.84	25.29	7.06E-91	Carotid intima media thickness	
LUAD	cis	1	rs17435590	chr7:97784061	BHLHA15	chr7:97840778-97842271:+	-0.18	-4.5	8.66E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
LUAD	cis	1	rs17435847	chr7:97792820	BHLHA15	chr7:97840778-97842271:+	-0.19	-4.66	4.02E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
LUAD	cis	1	rs17450853	chr6:56788004	BEND6	chr6:56819773-56892138:+	-0.25	-5.37	1.19E-7	Menarche (age at onset)	
LUAD	cis	1	rs17454087	chr2:179977723	SESTD1	chr2:179966421-180129350:-	-0.42	-3.73	0.000216	Late-onset Alzheimer's disease	
LUAD	cis	1	rs17454527	chr2:180134018	SESTD1	chr2:179966421-180129350:-	-0.43	-3.97	8.13E-5	Late-onset Alzheimer's disease	
LUAD	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.54	10.46	2.98E-23	Sex hormone-binding globulin levels	
LUAD	cis	1	rs17510733	chr6:111710918	KIAA1919	chr6:111580482-111590259:+	0.47	4.1	4.74E-5	Psoriasis	
LUAD	cis	1	rs17510761	chr6:111708583	KIAA1919	chr6:111580482-111590259:+	0.47	4.11	4.64E-5	Psoriasis	
LUAD	cis	1	rs17515241	chr7:74132014	STAG3L2	chr7:74298846-74306731:-	0.23	3.83	0.000145	Menarche (age at onset)	
LUAD	cis	1	rs17538840	chr2:61077817	C2orf74	chr2:61372243-61391964:+	-0.4	-6.36	4.58E-10	Inflammatory skin disease	
LUAD	cis	1	rs175425	chr14:75626131	MLH3	chr14:75480467-75518235:-	-0.25	-4.75	2.64E-6	Height	
LUAD	cis	1	rs175426	chr14:75624134	MLH3	chr14:75480467-75518235:-	-0.24	-4.67	3.88E-6	Height	
LUAD	cis	1	rs175436	chr14:75608683	MLH3	chr14:75480467-75518235:-	-0.23	-4.4	1.32E-5	Height	
LUAD	cis	1	rs175442	chr14:75603564	MLH3	chr14:75480467-75518235:-	-0.25	-4.86	1.58E-6	Height	
LUAD	cis	1	rs175443	chr14:75601963	MLH3	chr14:75480467-75518235:-	-0.23	-4.4	1.36E-5	Height	
LUAD	cis	1	rs175449	chr14:75590846	MLH3	chr14:75480467-75518235:-	-0.26	-5.06	6.06E-7	Height	
LUAD	cis	1	rs175492	chr14:75545220	MLH3	chr14:75480467-75518235:-	0.22	4.32	1.89E-5	Height	
LUAD	cis	1	rs17549954	chr17:61707032	FTSJ3	chr17:61896795-61905031:-	0.24	5.07	5.58E-7	Body mass index	
LUAD	cis	1	rs175512	chr14:75523382	MLH3	chr14:75480467-75518235:-	-0.24	-4.55	6.74E-6	Height	
LUAD	cis	1	rs17551703	chr1:166957879	GPA33	chr1:167022082-167059868:-	-0.24	-4.35	1.64E-5	Refractive astigmatism	
LUAD	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.46	-8.01	8.52E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.45	8	9.34E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.46	-8.16	2.9E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.46	-8.15	3.1E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.43	-7.48	3.4E-13	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.46	-8.15	3.1E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs17584578	chr2:86307624	LOC90784	chr2:86247339-86250991:-	0.53	5.05	6.29E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs17595424	chr4:99993869	ADH5	chr4:99992132-100009931:-	0.28	3.7	0.000236	Smoking initiation	
LUAD	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.5	-10.42	4.46E-23	Forced vital capacity	
LUAD	cis	1	rs17600551	chr15:85319258	LOC388152	chr15:84867600-84898920:-	-0.3	-5.87	8.26E-9	Schizophrenia	
LUAD	cis	1	rs17601029	chr15:85347709	LOC388152	chr15:84867600-84898920:-	-0.3	-5.84	9.51E-9	Schizophrenia	
LUAD	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.81	8.26	1.33E-15	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.43	-9.8	8.34E-21	Temperament	
LUAD	cis	1	rs17649068	chr1:171713893	VAMP4	chr1:171669298-171711214:-	0.24	3.96	8.57E-5	Hippocampal atrophy	
LUAD	cis	1	rs17649250	chr1:171720586	VAMP4	chr1:171669298-171711214:-	0.23	3.71	0.000234	Hippocampal atrophy	
LUAD	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.54	-6.22	1.07E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs17671250	chr15:40673124	C15orf23	chr15:40674922-40686488:+	-0.25	-4.7	3.41E-6	Heschl's gyrus morphology	
LUAD	cis	1	rs17685143	chr6:56774788	BEND6	chr6:56819773-56892138:+	-0.28	-5.77	1.41E-8	Menarche (age at onset)	
LUAD	cis	1	rs17685	chr7:75616105	MDH2	chr7:75677393-75695928:+	-0.2	-4.21	3.1E-5	Coffee consumption;Coffee consumption (cups per day)	
LUAD	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.34	9.1E-13	Body mass index	
LUAD	cis	1	rs1768803	chr1:46546208	MUTYH	chr1:45794915-45806142:-	0.17	3.87	0.000122	Body mass index	
LUAD	cis	1	rs1768816	chr1:46528599	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.36	7.72E-13	Body mass index	
LUAD	cis	1	rs1768816	chr1:46528599	MUTYH	chr1:45794915-45806142:-	0.17	3.95	9.05E-5	Body mass index	
LUAD	cis	1	rs1769003	chr10:59937590	IPMK	chr10:59955618-60027694:-	0.17	4.17	3.62E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1769005	chr10:59935940	IPMK	chr10:59955618-60027694:-	0.17	4.08	5.29E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1769006	chr10:59935547	IPMK	chr10:59955618-60027694:-	0.17	4.08	5.29E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1769040	chr10:59954081	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1769042	chr10:59956734	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1769044	chr10:59958956	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1769045	chr10:59960522	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1769046	chr10:59960630	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1769047	chr10:59963046	IPMK	chr10:59955618-60027694:-	0.17	3.98	7.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.37	7.35	8.35E-13	Cognitive performance	
LUAD	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.52	10.27	1.57E-22	Height	
LUAD	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.64	-13.96	1.6E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.63	-14.25	8.33E-39	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.64	-14.1	4.1E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.47	5.28	1.97E-7	Crohn's disease	
LUAD	cis	1	rs17737030	chr18:48775644	MBD1	chr18:47793256-47808144:-	-0.29	-3.77	0.000185	Immune response to anthrax vaccine	
LUAD	cis	1	rs17737030	chr18:48775644	ME2	chr18:48405435-48474258:+	-0.32	-4.3	2.07E-5	Immune response to anthrax vaccine	
LUAD	cis	1	rs177377	chr14:73753519	HEATR4	chr14:73945193-74025651:-	-0.25	-4.67	3.85E-6	Bipolar disorder with mood-incongruent psychosis	
LUAD	cis	1	rs17746014	chr10:102315354	SEC31B	chr10:102246403-102289636:-	-0.2	-6.44	2.8E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs1775148	chr1:205757824	PM20D1	chr1:205797154-205819245:-	-0.42	-8.33	8.19E-16	Prostate cancer	
LUAD	cis	1	rs1775148	chr1:205757824	RAB7L1	chr1:205737115-205744610:-	0.22	3.95	8.96E-5	Prostate cancer	
LUAD	cis	1	rs1775151	chr1:205745684	PM20D1	chr1:205797154-205819245:-	-0.28	-5.08	5.46E-7	Parkinson's disease	
LUAD	cis	1	rs17752459	chr6:56798755	BEND6	chr6:56819773-56892138:+	-0.27	-5.5	6.25E-8	Menarche (age at onset)	
LUAD	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.45	8.2	2.14E-15	Esophageal cancer (squamous cell)	
LUAD	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.5	-9.93	2.8E-21	Esophageal cancer (squamous cell)	
LUAD	cis	1	rs17772363	chr16:68788909	NFATC3	chr16:68118654-68260837:+	-0.18	-3.94	9.36E-5	Colorectal cancer	
LUAD	cis	1	rs1778508	chr6:28229881	ZNF187	chr6:28234788-28245978:+	0.21	3.92	0.000101	Depression	
LUAD	cis	1	rs1778511	chr6:28229411	ZNF187	chr6:28234788-28245978:+	0.24	4.28	2.22E-5	Depression	
LUAD	cis	1	rs17790938	chr20:49509184	KCNG1	chr20:49620194-49639675:-	-0.37	-3.7	0.000239	Prostate cancer	
LUAD	cis	1	rs17792773	chr6:76428495	IMPG1	chr6:76631062-76782335:-	0.3	4.14	4.12E-5	Height	
LUAD	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.36	4.32	1.89E-5	Crohn's disease	
LUAD	cis	1	rs17800987	chr5:150323428	LOC134466	chr5:150310000-150326146:-	0.42	5.24	2.36E-7	Crohn's disease	
LUAD	cis	1	rs17818399	chr2:46826026	ATP6V1E2	chr2:46738988-46769696:-	-0.25	-4.78	2.3E-6	Height	
LUAD	cis	1	rs17831161	chr2:160909360	LY75	chr2:160625141-160761262:-	0.2	4.31	1.96E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs17831191	chr2:160911332	LY75	chr2:160625141-160761262:-	0.19	4.31	1.99E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs17831251	chr2:160914156	LY75	chr2:160625141-160761262:-	0.2	4.39	1.38E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs1789892	chr4:100250658	ADH1C	chr4:100257651-100273917:-	-0.19	-3.75	0.000198	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1789898	chr4:100258336	ADH1C	chr4:100257651-100273917:-	-0.2	-3.96	8.74E-5	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1789911	chr4:100263778	ADH1C	chr4:100257651-100273917:-	-0.19	-3.74	0.000206	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1789912	chr4:100263942	ADH1C	chr4:100257651-100273917:-	-0.19	-3.73	0.000213	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1789913	chr4:100265348	ADH1C	chr4:100257651-100273917:-	-0.19	-3.71	0.000232	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1789924	chr4:100274286	ADH1C	chr4:100257651-100273917:-	-0.19	-3.7	0.000239	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs1795379	chr12:75941042	GLIPR1L2	chr12:75784889-75825591:+	-0.35	-6.14	1.71E-9	Polycystic ovary syndrome	
LUAD	cis	1	rs1796220	chr7:66062100	CCT6P1	chr7:65216092-65228661:+	0.24	3.67	0.000271	Diabetic kidney disease	
LUAD	cis	1	rs1800587	chr2:113542960	IL1A	chr2:113531493-113542971:-	0.24	4.44	1.11E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs1800615	chr1:15832281	CASP9	chr1:15817324-15851384:-	0.24	4.42	1.21E-5	Glomerular filtration rate (creatinine)	
LUAD	cis	1	rs1800662	chr10:102289078	SEC31B	chr10:102246403-102289636:-	-0.2	-6.5	1.95E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs1801282	chr3:12393125	MKRN2	chr3:12598594-12625208:+	0.31	3.82	0.000148	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs1803037	chr4:99993151	ADH4	chr4:100044835-100065449:-	0.27	3.67	0.000268	Smoking initiation	
LUAD	cis	1	rs1806606	chr1:202442385	PPP1R12B	chr1:202317836-202557697:+	0.21	4.65	4.35E-6	Sex ratio	
LUAD	cis	1	rs1807019	chr18:48378106	MRO	chr18:48321491-48351754:-	-0.34	-5.74	1.65E-8	Entorhinal cortical thickness	
LUAD	cis	1	rs1810563	chr1:12054030	MFN2	chr1:12040238-12073571:+	0.2	4.01	6.89E-5	Platelet count	
LUAD	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.52	10.16	4.01E-22	Height	
LUAD	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.52	10.23	2.26E-22	Height	
LUAD	cis	1	rs1818462	chr1:202459114	PPP1R12B	chr1:202317836-202557697:+	0.23	5.06	5.97E-7	Sex ratio	
LUAD	cis	1	rs1818950	chr15:84722521	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-3.72	0.00022	Schizophrenia	
LUAD	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.39	-7.26	1.5E-12	Schizophrenia	
LUAD	cis	1	rs1818950	chr15:84722521	WDR73	chr15:85186012-85197524:-	-0.21	-3.75	0.000201	Schizophrenia	
LUAD	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.31	-6.39	3.8E-10	IgG glycosylation	
LUAD	cis	1	rs1830074	chr7:6718674	PMS2CL	chr7:6749757-6793492:+	-0.23	-4.38	1.42E-5	Body mass index	
LUAD	cis	1	rs1830454	chr9:102718133	STX17	chr9:102668915-102736817:+	-0.18	-3.87	0.000125	Alopecia areata	
LUAD	cis	1	rs1832556	chr10:60028248	IPMK	chr10:59955618-60027694:-	0.17	4.08	5.31E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1832719	chr1:202447026	PPP1R12B	chr1:202317836-202557697:+	0.22	4.76	2.56E-6	Sex ratio	
LUAD	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.76	13.81	7.58E-37	Type 2 diabetes	
LUAD	cis	1	rs1834481	chr11:112023827	IL18	chr11:112013976-112034840:-	0.29	7.04	6.69E-12	Interleukin-18 levels	
LUAD	cis	1	rs183618	chr17:53235974	COX11	chr17:53029259-53046064:-	0.19	3.88	0.000118	Menarche (age at onset)	
LUAD	cis	1	rs1839622	chr12:7334534	PEX5	chr12:7341759-7371167:+	0.25	4.65	4.28E-6	IgG glycosylation	
LUAD	cis	1	rs1848093	chr15:84755527	GOLGA6L5	chr15:85047738-85060078:-	-0.17	-3.74	0.000208	Schizophrenia	
LUAD	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.38	-7.03	7.2E-12	Schizophrenia	
LUAD	cis	1	rs1852863	chr9:102712416	STX17	chr9:102668915-102736817:+	-0.18	-3.78	0.000176	Alopecia areata	
LUAD	cis	1	rs185538822	chr4:106803682	INTS12	chr4:106603787-106629881:-	-0.59	-5.8	1.19E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs1856564	chr10:60017452	IPMK	chr10:59955618-60027694:-	0.17	4.07	5.55E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1856859	chr6:151860110	C6orf97	chr6:151815175-151942327:+	-0.16	-4.21	3.08E-5	Bone mineral density (spine)	
LUAD	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.67	-12.26	2.49E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.62	-11.49	3.16E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs1858482	chr1:152306921	FLG	chr1:152274651-152297679:-	-0.24	-3.89	0.000116	Atopic dermatitis	
LUAD	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.76	13.81	7.58E-37	Type 2 diabetes	
LUAD	cis	1	rs1863808	chr2:137334985	THSD7B	chr2:137523115-138435287:+	0.31	4.69	3.57E-6	Cognitive test performance	
LUAD	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.51	9.97	1.9E-21	Height	
LUAD	cis	1	rs1864367	chr3:53111704	RFT1	chr3:53122503-53164470:-	-0.21	-4.1	4.81E-5	Height	
LUAD	cis	1	rs1867146	chr15:75354971	SCAMP5	chr15:75287901-75313836:+	0.38	6.6	1.06E-10	Blood trace element (Zn levels)	
LUAD	cis	1	rs1867571	chr10:60038850	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.75E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1867572	chr10:60038940	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.75E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1867573	chr10:60042972	IPMK	chr10:59955618-60027694:-	-0.17	-4.15	3.95E-5	Inflammatory bowel disease	
LUAD	cis	1	rs1869365	chr17:40293865	DHX58	chr17:40253422-40264751:-	-0.3	-5.89	7.1E-9	Fibrinogen levels	
LUAD	cis	1	rs1869596	chr1:110624104	ALX3	chr1:110602998-110613322:-	-0.21	-4.03	6.52E-5	Blood metabolite levels	
LUAD	cis	1	rs1873494	chr7:65649899	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.92	0.000102	Diabetic kidney disease	
LUAD	cis	1	rs187455071	chr4:106805884	INTS12	chr4:106603787-106629881:-	-0.6	-5.81	1.12E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.52	10.09	6.94E-22	Height	
LUAD	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.47	8.15	3.05E-15	Multiple sclerosis	
LUAD	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.24	-4.84	1.73E-6	Multiple sclerosis	
LUAD	cis	1	rs1877316	chr17:61766880	FTSJ3	chr17:61896795-61905031:-	0.23	4.87	1.51E-6	Body mass index	
LUAD	cis	1	rs1878319	chr2:113544826	IL1A	chr2:113531493-113542971:-	0.22	4.19	3.31E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs1878320	chr2:113544467	IL1A	chr2:113531493-113542971:-	0.22	4.2	3.13E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs1878321	chr2:113544434	IL1A	chr2:113531493-113542971:-	0.22	4.2	3.13E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.18	3.28E-22	Height	
LUAD	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.18	3.28E-22	Height	
LUAD	cis	1	rs1881123	chr7:1084706	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.93	5.58E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs1881245	chr2:73649928	ALMS1	chr2:73612886-73837046:+	0.2	4.92	1.2E-6	Metabolite levels	
LUAD	cis	1	rs1881245	chr2:73649928	ALMS1P	chr2:73872046-73912692:+	0.36	6.92	1.39E-11	Metabolite levels	
LUAD	cis	1	rs1881797	chr1:247689532	C1orf229	chr1:247273462-247275719:-	-0.23	-3.68	0.00026	Acute lymphoblastic leukemia (childhood)	
LUAD	cis	1	rs1882099	chr4:1352685	CRIPAK	chr4:1385340-1389782:+	0.23	4.89	1.34E-6	Systolic blood pressure	
LUAD	cis	1	rs1882140	chr12:91479826	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.49	-8.93	8.79E-18	Esophageal cancer (squamous cell)	
LUAD	cis	1	rs1886682	chr1:92977275	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs1886683	chr1:92976023	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs1888510	chr21:42168974	C21orf130	chr21:42513427-42519991:-	0.2	3.67	0.000267	Neutrophil count	
LUAD	cis	1	rs1888997	chr20:25298988	FAM182A	chr20:26035250-26067552:+	0.19	3.91	0.000106	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs1888998	chr20:25291826	FAM182A	chr20:26035250-26067552:+	0.19	3.87	0.000126	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs1888999	chr20:25291848	FAM182A	chr20:26035250-26067552:+	-0.19	-3.87	0.000124	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs1889571	chr1:32195819	COL16A1	chr1:32117848-32169768:-	-0.18	-3.68	0.000259	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs1890875	chr1:202531366	PPP1R12B	chr1:202317836-202557697:+	0.22	4.89	1.36E-6	Sex ratio	
LUAD	cis	1	rs1903330	chr6:56776985	BEND6	chr6:56819773-56892138:+	0.3	6.24	9.55E-10	Menarche (age at onset)	
LUAD	cis	1	rs1903330	chr6:56776985	KIAA1586	chr6:56911384-56920021:+	0.28	3.94	9.15E-5	Menarche (age at onset)	
LUAD	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.81	14.24	9.83E-39	Type 2 diabetes	
LUAD	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.37	-6.73	4.89E-11	Schizophrenia	
LUAD	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.64	-12.14	7.8E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.62	-11.58	1.44E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs1914859	chr4:165906141	C4orf39	chr4:165878100-165880273:+	0.29	5.71	1.93E-8	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs1914859	chr4:165906141	TRIM61	chr4:165875600-165898818:-	0.19	3.92	9.93E-5	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.49	-9.51	8.96E-20	Height	
LUAD	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.3	6.56E-10	Obesity-related traits	
LUAD	cis	1	rs1919948	chr7:143762843	OR2A7	chr7:143955790-143974852:-	0.21	3.76	0.00019	Obesity-related traits	
LUAD	cis	1	rs1919948	chr7:143762843	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.15	3.73E-7	Obesity-related traits	
LUAD	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.41	3.53E-10	Obesity-related traits	
LUAD	cis	1	rs1919949	chr7:143767723	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.17	3.5E-7	Obesity-related traits	
LUAD	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.27	7.9E-10	Obesity-related traits	
LUAD	cis	1	rs1919950	chr7:143767898	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-5	8.16E-7	Obesity-related traits	
LUAD	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.37	-6.78	3.49E-11	Obesity-related traits	
LUAD	cis	1	rs1919951	chr7:143768891	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.15	3.82E-7	Obesity-related traits	
LUAD	cis	1	rs1920790	chr12:91492788	KERA	chr12:91444273-91452131:-	0.24	4.02	6.6E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs1933182	chr1:109999838	AMIGO1	chr1:110049447-110052336:-	-0.19	-3.74	0.000205	Chronic kidney disease	
LUAD	cis	1	rs1933182	chr1:109999838	SYPL2	chr1:110009100-110024763:+	-0.44	-7.36	7.97E-13	Chronic kidney disease	
LUAD	cis	1	rs1935	chr10:64927823	NRBF2	chr10:64893007-64914785:+	-0.22	-4.87	1.51E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs1936365	chr6:28268452	ZNF187	chr6:28234788-28245978:+	0.21	3.81	0.000154	Depression	
LUAD	cis	1	rs1941027	chr11:60312863	PGA5	chr11:61008669-61018913:+	0.3	3.71	0.000233	Metabolite levels  (X-11787)	
LUAD	cis	1	rs1947861	chr6:49482687	CENPQ	chr6:49431096-49460820:+	-0.16	-3.97	8.42E-5	Brain structure	
LUAD	cis	1	rs1950500	chr14:24830850	ADCY4	chr14:24787571-24804277:-	-0.2	-4.39	1.38E-5	Height	
LUAD	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.34	-6.82	2.73E-11	Rheumatoid arthritis	
LUAD	cis	1	rs1954308	chr14:53940700	GPR137C	chr14:53019866-53104430:+	0.17	3.69	0.00025	Optic cup area	
LUAD	cis	1	rs1958589	chr14:34844376	C14orf147	chr14:34902145-34931468:-	-0.27	-3.82	0.000152	Celiac disease	
LUAD	cis	1	rs1958589	chr14:34844376	CFL2	chr14:35179588-35184029:-	-0.27	-4.01	7.07E-5	Celiac disease	
LUAD	cis	1	rs1961779	chr12:91483139	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.66	-12.72	3.11E-32	Response to antipsychotic treatment	
LUAD	cis	1	rs1966423	chr2:202216661	CASP8	chr2:202098166-202152434:+	0.21	4.77	2.49E-6	Basal cell carcinoma	
LUAD	cis	1	rs1971762	chr12:54058238	ATP5G2	chr12:54058945-54070512:-	0.29	6.34	5.37E-10	Height	
LUAD	cis	1	rs1976053	chr17:65833002	LOC440461	chr17:66194801-66196436:+	0.23	3.77	0.000184	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.83	-13.43	3.15E-35	Schizophrenia	
LUAD	cis	1	rs1986557	chr4:283118	ZNF718	chr4:53272-156488:+	0.25	3.74	0.000203	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs198723	chr7:24179027	MPP6	chr7:24613085-24727497:+	-0.18	-3.73	0.000215	Aggressive periodontitis (sex interaction)	
LUAD	cis	1	rs198806	chr6:26133616	BTN3A2	chr6:26365398-26378546:+	0.19	4.62	5.0E-6	Schizophrenia	
LUAD	cis	1	rs198811	chr6:26128446	BTN3A2	chr6:26365398-26378546:+	-0.19	-4.46	1.02E-5	Schizophrenia	
LUAD	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.7	12.09	1.33E-29	Diastolic blood pressure	
LUAD	cis	1	rs1994918	chr1:111290022	ALX3	chr1:110602998-110613322:-	-0.34	-3.76	0.000194	Acute lymphoblastic leukemia (childhood)	
LUAD	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.62	-11.58	1.44E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs1997243	chr7:1083777	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.93	5.58E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs1997367	chr9:102713758	STX17	chr9:102668915-102736817:+	-0.17	-3.71	0.000234	Alopecia areata	
LUAD	cis	1	rs1997368	chr9:102713580	STX17	chr9:102668915-102736817:+	-0.17	-3.71	0.000234	Alopecia areata	
LUAD	cis	1	rs1998207	chr14:94957714	SERPINA9	chr14:94929060-94942670:-	-0.39	-7.47	3.62E-13	Obesity-related traits	
LUAD	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.65	-11.92	5.93E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs1999997	chr10:59996969	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2001483	chr12:131318645	STX2	chr12:131274149-131323811:-	0.2	4.28	2.27E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs2003284	chr10:102202338	SEC31B	chr10:102246403-102289636:-	-0.22	-7.04	6.55E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.5	-9.91	3.3E-21	Forced vital capacity	
LUAD	cis	1	rs2013288	chr17:61785904	FTSJ3	chr17:61896795-61905031:-	0.21	4.52	7.64E-6	Body mass index	
LUAD	cis	1	rs2014521	chr17:40283413	DHX58	chr17:40253422-40264751:-	-0.29	-5.31	1.63E-7	Fibrinogen levels	
LUAD	cis	1	rs2015336	chr17:18073610	MYO15A	chr17:18012020-18083115:+	0.26	4.98	8.93E-7	Obesity-related traits	
LUAD	cis	1	rs2016366	chr1:2513678	MMEL1	chr1:2522081-2564481:-	-0.29	-5.79	1.23E-8	Ulcerative colitis	
LUAD	cis	1	rs2019022	chr10:60024052	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.49	-7.24	1.72E-12	Rheumatoid arthritis	
LUAD	cis	1	rs2019814	chr11:93168885	CCDC67	chr11:93063156-93171634:+	-0.25	-4.2	3.22E-5	Pulmonary function decline	
LUAD	cis	1	rs2020010	chr1:202510881	PPP1R12B	chr1:202317836-202557697:+	0.22	4.9	1.29E-6	Sex ratio	
LUAD	cis	1	rs2024825	chr1:67597977	C1orf141	chr1:67557859-67600653:-	-0.16	-4.03	6.36E-5	Leprosy	
LUAD	cis	1	rs2025880	chr9:36191760	CLTA	chr9:36190892-36304778:+	-0.32	-3.75	0.000197	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs2025880	chr9:36191760	GLIPR2	chr9:36136742-36163902:+	-0.27	-4.76	2.5E-6	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs2027003	chr20:25350498	FAM182A	chr20:26035250-26067552:+	0.19	3.87	0.000125	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2027004	chr20:25350618	FAM182A	chr20:26035250-26067552:+	0.19	3.87	0.000125	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.68	-13.79	9.23E-37	Type 2 diabetes	
LUAD	cis	1	rs2028669	chr1:202517364	PPP1R12B	chr1:202317836-202557697:+	0.21	4.51	7.94E-6	Sex ratio	
LUAD	cis	1	rs2030973	chr1:202307863	PPP1R12B	chr1:202317836-202557697:+	0.21	4.49	8.94E-6	Sex ratio	
LUAD	cis	1	rs2031035	chr9:102711698	STX17	chr9:102668915-102736817:+	-0.18	-3.88	0.000117	Alopecia areata	
LUAD	cis	1	rs2031494	chr1:92965969	EVI5	chr1:92974255-93257961:-	-0.27	-4.29	2.11E-5	Cholesterol, total	
LUAD	cis	1	rs2036402	chr5:156464242	TIMD4	chr5:156346293-156390266:-	-0.25	-4.44	1.11E-5	Hypertriglyceridemia	
LUAD	cis	1	rs2038227	chr16:539140	DECR2	chr16:451858-462486:+	-0.22	-4.98	8.88E-7	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs2039415	chr1:160854445	ITLN1	chr1:160846332-160854960:-	0.24	4.61	5.07E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs2041837	chr2:37468564	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.87	0.000125	Chronic lymphocytic leukemia	
LUAD	cis	1	rs2041840	chr2:37467264	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.94	9.2E-5	Chronic lymphocytic leukemia	
LUAD	cis	1	rs2042947	chr19:12693103	MAN2B1	chr19:12757322-12777591:-	0.22	5.3	1.74E-7	Bipolar disorder	
LUAD	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.28	7.02	7.67E-12	Longevity	
LUAD	cis	1	rs2050265	chr1:11879699	CLCN6	chr1:11866207-11907674:+	0.2	3.9	0.000109	QRS complex (12-leadsum)	
LUAD	cis	1	rs2052187	chr17:65834737	LOC440461	chr17:66194801-66196436:+	0.22	3.7	0.000243	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs2056544	chr15:76826003	SCAPER	chr15:76640529-77197744:-	-0.2	-4.73	2.92E-6	Blood metabolite levels	
LUAD	cis	1	rs2056566	chr2:228713241	WDR69	chr2:228736327-228789026:+	0.28	5.87	8.06E-9	Blood pressure	
LUAD	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.51	9.88	4.25E-21	Height	
LUAD	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.51	9.83	6.51E-21	Height	
LUAD	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.54	-8.26	1.37E-15	Subcutaneous adipose tissue	
LUAD	cis	1	rs2058805	chr12:109998591	MYO1H	chr12:109826524-109886176:+	0.4	7.35	8.43E-13	HDL cholesterol	
LUAD	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.26	4.88	1.46E-6	Pancreatic cancer	
LUAD	cis	1	rs2061973	chr6:49487125	CENPQ	chr6:49431096-49460820:+	0.17	4.26	2.49E-5	Brain structure	
LUAD	cis	1	rs2068737	chr10:59999575	IPMK	chr10:59955618-60027694:-	0.17	4.22	2.86E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.45	-7.92	1.64E-14	Multiple sclerosis	
LUAD	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.24	4.95	1.02E-6	Multiple sclerosis	
LUAD	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.35	-6.78	3.37E-11	Cognitive performance	
LUAD	cis	1	rs2070488	chr3:38442490	XYLB	chr3:38388251-38456467:+	-0.21	-3.85	0.000132	Electrocardiographic conduction measures	
LUAD	cis	1	rs2071214	chr17:76219591	BIRC5	chr17:76210277-76221715:+	0.22	4.01	7.17E-5	Behavioural disinhibition (generation interaction)	
LUAD	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.47	8.17	2.71E-15	Multiple sclerosis	
LUAD	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.24	-4.84	1.76E-6	Multiple sclerosis	
LUAD	cis	1	rs2072293	chr14:74537885	C14orf45	chr14:74486059-74549566:+	0.19	4.13	4.21E-5	Common traits (Other)	
LUAD	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.5	11.23	3.48E-26	Common traits (Other)	
LUAD	cis	1	rs2072293	chr14:74537885	ZNF410	chr14:74318674-74398803:+	0.22	4.56	6.47E-6	Common traits (Other)	
LUAD	cis	1	rs2072435	chr7:75959188	UPK3B	chr7:76139745-76157197:+	-0.21	-3.91	0.000107	Multiple sclerosis	
LUAD	cis	1	rs2072794	chr22:39150543	JOSD1	chr22:39081549-39096459:-	-0.22	-3.79	0.000172	Resting heart rate	
LUAD	cis	1	rs2072795	chr22:39064209	JOSD1	chr22:39081549-39096459:-	0.22	3.73	0.00021	Resting heart rate	
LUAD	cis	1	rs2072883	chr22:43435668	ARFGAP3	chr22:43192532-43253408:-	0.27	4.79	2.21E-6	Schizophrenia	
LUAD	cis	1	rs2074018	chr11:2309634	C11orf21	chr11:2317507-2323143:-	0.29	5.54	4.97E-8	Obesity-related traits	
LUAD	cis	1	rs2074771	chr2:242350944	SEPT2	chr2:242254723-242293439:+	0.57	6.65	7.88E-11	Chronic lymphocytic leukemia	
LUAD	cis	1	rs2075555	chr17:48274291	SGCA	chr17:48243366-48253292:+	0.22	3.72	0.000226	Breast cancer	
LUAD	cis	1	rs2076028	chr22:39150450	JOSD1	chr22:39081549-39096459:-	-0.22	-3.82	0.000152	Resting heart rate	
LUAD	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.89	-18.18	8.21E-57	Homocysteine levels	
LUAD	cis	1	rs2077808	chr1:45988115	MUTYH	chr1:45794915-45806142:-	0.21	4.44	1.13E-5	Homocysteine levels	
LUAD	cis	1	rs2080303	chr2:202165206	ALS2CR12	chr2:202153148-202222101:-	-0.2	-4.87	1.51E-6	Basal cell carcinoma	
LUAD	cis	1	rs2080303	chr2:202165206	CASP8	chr2:202098166-202152434:+	0.33	6.56	1.38E-10	Basal cell carcinoma	
LUAD	cis	1	rs2081302	chr2:23945355	C2orf84	chr2:24397531-24414566:+	-0.24	-4.1	4.83E-5	Obesity-related traits	
LUAD	cis	1	rs2083731	chr15:75368538	PPCDC	chr15:75315927-75343066:+	0.18	3.77	0.000182	Blood trace element (Zn levels)	
LUAD	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.34	5.97	4.44E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs2084220	chr11:18656932	SPTY2D1	chr11:18627949-18656020:-	-0.22	-4.96	9.97E-7	Cholesterol, total	
LUAD	cis	1	rs2091899	chr21:42174700	C21orf130	chr21:42513427-42519991:-	0.2	3.68	0.000264	Neutrophil count	
LUAD	cis	1	rs2092990	chr20:3346338	ITPA	chr20:3190056-3204504:+	-0.27	-4.91	1.26E-6	IFN-related cytopenia	
LUAD	cis	1	rs2093395	chr6:41155026	LOC221442	chr6:41068773-41108567:+	-0.26	-5.92	5.97E-9	Alzheimer's disease (late onset)	
LUAD	cis	1	rs2093396	chr6:41155000	LOC221442	chr6:41068773-41108567:+	0.25	5.68	2.32E-8	Alzheimer's disease (late onset)	
LUAD	cis	1	rs2095892	chr10:60023719	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2095893	chr10:59969551	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2095894	chr10:59968671	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2098297	chr14:75619118	MLH3	chr14:75480467-75518235:-	-0.25	-4.76	2.51E-6	Height	
LUAD	cis	1	rs2103232	chr7:128951232	LOC407835	chr7:128766325-128768041:+	0.24	3.91	0.000105	White matter hyperintensity burden	
LUAD	cis	1	rs2103876	chr1:12053100	MFN2	chr1:12040238-12073571:+	-0.19	-3.89	0.000114	Platelet count	
LUAD	cis	1	rs2105220	chr10:59969064	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2110309	chr7:110953303	IMMP2L	chr7:110303110-111202538:-	0.2	3.7	0.000242	Schizophrenia	
LUAD	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.81	14.22	1.23E-38	Type 2 diabetes	
LUAD	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.81	14.53	4.88E-40	Type 2 diabetes	
LUAD	cis	1	rs2113199	chr16:68814502	NFATC3	chr16:68118654-68260837:+	-0.16	-3.7	0.000245	Colorectal cancer	
LUAD	cis	1	rs2113422	chr2:23939007	C2orf84	chr2:24397531-24414566:+	-0.23	-4.06	5.63E-5	Obesity-related traits	
LUAD	cis	1	rs2113422	chr2:23939007	LOC375190	chr2:24299728-24397519:+	0.22	4.15	3.97E-5	Obesity-related traits	
LUAD	cis	1	rs2113423	chr2:23942287	C2orf84	chr2:24397531-24414566:+	-0.23	-4.1	4.84E-5	Obesity-related traits	
LUAD	cis	1	rs2113423	chr2:23942287	LOC375190	chr2:24299728-24397519:+	0.22	4.16	3.77E-5	Obesity-related traits	
LUAD	cis	1	rs2117032	chr12:21074122	SLCO1B3	chr12:20963638-21243038:+	0.2	3.85	0.000135	Bilirubin levels	
LUAD	cis	1	rs2120019	chr15:75334184	C15orf39	chr15:75491233-75504508:+	0.21	3.7	0.000243	Blood trace element (Zn levels)	
LUAD	cis	1	rs2120019	chr15:75334184	SCAMP5	chr15:75287901-75313836:+	0.35	5.96	4.84E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs2120107	chr15:76869789	SCAPER	chr15:76640529-77197744:-	-0.21	-4.93	1.14E-6	Blood metabolite levels	
LUAD	cis	1	rs2126129	chr2:212548	SH3YL1	chr2:218138-264810:-	-0.63	-13.92	2.51E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.65	11.9	7.21E-29	Diastolic blood pressure	
LUAD	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.67	12.04	2.03E-29	Diastolic blood pressure	
LUAD	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.41	-11.68	5.97E-28	Kawasaki disease	
LUAD	cis	1	rs2134265	chr15:63398196	LACTB	chr15:63414032-63434254:+	0.21	4.03	6.36E-5	HDL cholesterol	
LUAD	cis	1	rs2135481	chr2:228706657	WDR69	chr2:228736327-228789026:+	0.28	6.04	3.14E-9	Blood pressure	
LUAD	cis	1	rs2137435	chr1:202499321	PPP1R12B	chr1:202317836-202557697:+	0.21	4.51	8.03E-6	Sex ratio	
LUAD	cis	1	rs2140195	chr2:73702344	ALMS1	chr2:73612886-73837046:+	0.19	4.78	2.34E-6	Metabolite levels	
LUAD	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.35	6.88	1.85E-11	Metabolite levels	
LUAD	cis	1	rs2140337	chr4:8502112	CPZ	chr4:8582291-8621486:+	0.16	3.71	0.000231	Response to antineoplastic agents	
LUAD	cis	1	rs2143389	chr6:97422681	GPR63	chr6:97245889-97285353:-	-0.26	-3.95	9.09E-5	Body mass index	
LUAD	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.26	3.92	0.000103	Atopic dermatitis	
LUAD	cis	1	rs2152916	chr10:97392265	ENTPD1	chr10:97471536-97637022:+	0.2	5.36	1.31E-7	Blood metabolite levels	
LUAD	cis	1	rs2153281	chr10:59972453	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2153282	chr10:59972416	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2153283	chr10:59972299	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.36	-8.27	1.28E-15	Eye color traits	
LUAD	cis	1	rs2154536	chr21:38492147	TTC3	chr21:38445571-38575406:+	0.19	4.14	4.04E-5	Eye color traits	
LUAD	cis	1	rs2160392	chr2:37527393	CEBPZ	chr2:37428778-37458740:-	-0.18	-4.02	6.83E-5	Chronic lymphocytic leukemia	
LUAD	cis	1	rs2160393	chr2:37516950	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.91	0.000105	Chronic lymphocytic leukemia	
LUAD	cis	1	rs2160395	chr2:37479862	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.91	0.000106	Chronic lymphocytic leukemia	
LUAD	cis	1	rs2163167	chr3:53131772	RFT1	chr3:53122503-53164470:-	-0.2	-3.96	8.53E-5	Height	
LUAD	cis	1	rs216345	chr9:33799370	NUDT2	chr9:34329504-34343695:+	-0.23	-5.34	1.46E-7	Bipolar disorder	
LUAD	cis	1	rs2166580	chr4:1743169	FAM53A	chr4:1641609-1685854:-	-0.31	-5.26	2.15E-7	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.64	-11.85	1.22E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs2168154	chr3:190987963	UTS2D	chr3:190984945-191048325:-	-0.29	-5.98	4.33E-9	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.29	5.73	1.8E-8	Body mass index	
LUAD	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.46	7.46E-8	Body mass index	
LUAD	cis	1	rs2175416	chr2:160904021	LY75	chr2:160625141-160761262:-	0.2	4.34	1.72E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs2187143	chr18:48371565	MRO	chr18:48321491-48351754:-	0.39	6.39	3.77E-10	Entorhinal cortical thickness	
LUAD	cis	1	rs2195155	chr3:16638810	GALNTL2	chr3:15935569-16271252:+	-0.17	-3.74	0.000202	Testicular germ cell tumor	
LUAD	cis	1	rs2197423	chr3:12391583	MKRN2	chr3:12598594-12625208:+	0.31	3.89	0.000113	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs2203513	chr16:27056568	KIAA0556	chr16:27561468-27791691:+	0.27	3.95	9.01E-5	Cognitive performance	
LUAD	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.3	8.93	8.45E-18	Type 1 diabetes autoantibodies	
LUAD	cis	1	rs2217203	chr3:16616328	GALNTL2	chr3:15935569-16271252:+	-0.17	-3.77	0.000185	Testicular germ cell tumor	
LUAD	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.62	-12.25	2.75E-30	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.39	10.8	1.61E-24	Homocysteine levels	
LUAD	cis	1	rs2231626	chr20:44002665	SYS1	chr20:43991701-44004724:+	0.23	3.67	0.000265	Psoriasis	
LUAD	cis	1	rs2235230	chr22:39124467	JOSD1	chr22:39081549-39096459:-	0.24	3.98	8.08E-5	Resting heart rate	
LUAD	cis	1	rs2236087	chr20:3255905	ITPA	chr20:3190056-3204504:+	-0.23	-4.22	2.91E-5	IFN-related cytopenia	
LUAD	cis	1	rs2236089	chr20:3257194	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	5.99E-5	IFN-related cytopenia	
LUAD	cis	1	rs2236092	chr20:3258188	ITPA	chr20:3190056-3204504:+	-0.23	-4.12	4.46E-5	IFN-related cytopenia	
LUAD	cis	1	rs2236098	chr20:3267133	ITPA	chr20:3190056-3204504:+	-0.25	-4.51	8.06E-6	IFN-related cytopenia	
LUAD	cis	1	rs2236104	chr20:3277602	ITPA	chr20:3190056-3204504:+	-0.25	-4.48	9.29E-6	IFN-related cytopenia	
LUAD	cis	1	rs2236106	chr20:3278410	ITPA	chr20:3190056-3204504:+	-0.25	-4.51	8.06E-6	IFN-related cytopenia	
LUAD	cis	1	rs2236107	chr20:3285821	ITPA	chr20:3190056-3204504:+	-0.21	-3.82	0.000149	IFN-related cytopenia	
LUAD	cis	1	rs2236108	chr20:3286331	ITPA	chr20:3190056-3204504:+	-0.25	-4.54	7.18E-6	IFN-related cytopenia	
LUAD	cis	1	rs2236117	chr20:3302021	ITPA	chr20:3190056-3204504:+	-0.25	-4.56	6.55E-6	IFN-related cytopenia	
LUAD	cis	1	rs2236118	chr20:3302058	ITPA	chr20:3190056-3204504:+	-0.26	-4.78	2.32E-6	IFN-related cytopenia	
LUAD	cis	1	rs2236122	chr20:3305240	ITPA	chr20:3190056-3204504:+	-0.25	-4.47	9.57E-6	IFN-related cytopenia	
LUAD	cis	1	rs2236123	chr20:3305305	ITPA	chr20:3190056-3204504:+	0.28	5.07	5.8E-7	IFN-related cytopenia	
LUAD	cis	1	rs2236352	chr14:24610733	FAM158A	chr14:24608175-24610797:-	-0.43	-10.18	3.25E-22	IgG glycosylation	
LUAD	cis	1	rs2236786	chr4:1719294	FAM53A	chr4:1641609-1685854:-	0.31	5.17	3.49E-7	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs2239557	chr14:74551970	C14orf45	chr14:74486059-74549566:+	0.2	4.47	9.53E-6	Common traits (Other)	
LUAD	cis	1	rs2239557	chr14:74551970	COQ6	chr14:74416643-74429811:+	0.21	4.12	4.42E-5	Common traits (Other)	
LUAD	cis	1	rs2239557	chr14:74551970	DLST	chr14:75348594-75370450:+	0.22	3.85	0.000135	Common traits (Other)	
LUAD	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.5	11.26	2.66E-26	Common traits (Other)	
LUAD	cis	1	rs2239557	chr14:74551970	ZNF410	chr14:74318674-74398803:+	0.22	4.58	5.95E-6	Common traits (Other)	
LUAD	cis	1	rs2240009	chr17:40283142	DHX58	chr17:40253422-40264751:-	-0.28	-5.28	1.94E-7	Fibrinogen levels	
LUAD	cis	1	rs2240010	chr17:40278081	DHX58	chr17:40253422-40264751:-	-0.29	-5.32	1.54E-7	Fibrinogen levels	
LUAD	cis	1	rs2241106	chr1:156218910	CCT3	chr1:156278752-156308195:-	-0.16	-3.84	0.000137	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs2241435	chr2:86360916	LOC90784	chr2:86247339-86250991:-	-0.42	-3.83	0.000148	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.28	7.03	6.85E-12	Longevity	
LUAD	cis	1	rs2242330	chr4:68447249	STAP1	chr4:68424446-68473053:+	-0.18	-3.86	0.000131	Parkinson's disease	
LUAD	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.36	7.13	3.56E-12	Longevity	
LUAD	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.36	7.13	3.56E-12	Longevity	
LUAD	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.36	7.13	3.56E-12	Longevity	
LUAD	cis	1	rs224329	chr20:34019579	UQCC	chr20:33890383-33999833:-	-0.29	-5.36	1.26E-7	Height	
LUAD	cis	1	rs224333	chr20:34023962	UQCC	chr20:33890383-33999833:-	-0.29	-5.12	4.5E-7	Height	
LUAD	cis	1	rs2245715	chr15:43818052	ADAL	chr15:43622872-43646094:+	-0.33	-4.83	1.82E-6	Tumor biomarkers	
LUAD	cis	1	rs2245715	chr15:43818052	CATSPER2	chr15:43922774-43959900:-	-0.23	-3.82	0.000148	Tumor biomarkers	
LUAD	cis	1	rs2246833	chr10:91005854	LIPA	chr10:90973328-91174382:-	0.18	5.33	1.51E-7	Fibrinogen levels	
LUAD	cis	1	rs2246942	chr10:91004886	LIPA	chr10:90973328-91174382:-	0.18	5.04	6.66E-7	Fibrinogen levels	
LUAD	cis	1	rs2247753	chr22:30022936	NIPSNAP1	chr22:29950800-29977144:-	0.28	4.43	1.18E-5	Lipid traits	
LUAD	cis	1	rs2248393	chr20:33926103	UQCC	chr20:33890383-33999833:-	-0.29	-5.31	1.71E-7	Height	
LUAD	cis	1	rs2249811	chr1:202531741	PPP1R12B	chr1:202317836-202557697:+	-0.2	-4.6	5.31E-6	Sex ratio	
LUAD	cis	1	rs2250644	chr10:91008879	LIPA	chr10:90973328-91174382:-	0.18	5.09	5.06E-7	Fibrinogen levels	
LUAD	cis	1	rs2251039	chr10:60028894	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.37	-10.38	6.24E-23	Homocysteine levels	
LUAD	cis	1	rs2251844	chr15:43836478	ADAL	chr15:43622872-43646094:+	-0.34	-5.07	5.76E-7	Tumor biomarkers	
LUAD	cis	1	rs2251844	chr15:43836478	CATSPER2	chr15:43922774-43959900:-	-0.23	-3.71	0.000228	Tumor biomarkers	
LUAD	cis	1	rs2253192	chr10:59999323	IPMK	chr10:59955618-60027694:-	-0.17	-4.28	2.28E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2253209	chr3:53115160	RFT1	chr3:53122503-53164470:-	-0.2	-3.92	0.000103	Height	
LUAD	cis	1	rs2253612	chr2:201568433	CASP8	chr2:202098166-202152434:+	-0.29	-4.39	1.36E-5	Alcohol dependence	
LUAD	cis	1	rs2253656	chr3:53119099	RFT1	chr3:53122503-53164470:-	-0.2	-3.97	8.43E-5	Height	
LUAD	cis	1	rs2253685	chr3:53119703	RFT1	chr3:53122503-53164470:-	-0.2	-3.92	0.000103	Height	
LUAD	cis	1	rs2253796	chr3:53120098	RFT1	chr3:53122503-53164470:-	-0.2	-3.93	9.75E-5	Height	
LUAD	cis	1	rs2253826	chr1:202408800	PPP1R12B	chr1:202317836-202557697:+	0.2	4.39	1.41E-5	Sex ratio	
LUAD	cis	1	rs2254230	chr9:131905177	CRAT	chr9:131857075-131873070:-	-0.37	-6.77	3.8E-11	Blood metabolite ratios	
LUAD	cis	1	rs2254230	chr9:131905177	PPP2R4	chr9:131873244-131911223:+	-0.24	-4.65	4.26E-6	Blood metabolite ratios	
LUAD	cis	1	rs2254545	chr10:60034981	IPMK	chr10:59955618-60027694:-	0.17	4.1	4.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2254775	chr10:60036815	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.75E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2255042	chr15:43834318	ADAL	chr15:43622872-43646094:+	0.29	4.32	1.89E-5	Tumor biomarkers	
LUAD	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.3	-4.46	1.04E-5	Tumor biomarkers	
LUAD	cis	1	rs2257420	chr20:25275890	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2257432	chr20:25271086	FAM182A	chr20:26035250-26067552:+	-0.18	-3.7	0.000242	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2257496	chr20:25279315	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2257808	chr20:25266450	FAM182A	chr20:26035250-26067552:+	-0.18	-3.7	0.00024	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2257809	chr20:25266476	FAM182A	chr20:26035250-26067552:+	-0.18	-3.7	0.00024	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2257982	chr20:25269630	FAM182A	chr20:26035250-26067552:+	-0.18	-3.7	0.00024	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2257985	chr20:25269743	FAM182A	chr20:26035250-26067552:+	-0.18	-3.7	0.00024	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2257988	chr20:25270003	FAM182A	chr20:26035250-26067552:+	-0.18	-3.7	0.00024	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258066	chr20:25271326	FAM182A	chr20:26035250-26067552:+	-0.18	-3.7	0.000242	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258135	chr20:25272323	FAM182A	chr20:26035250-26067552:+	-0.18	-3.7	0.000242	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258201	chr20:25272490	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258563	chr20:25273435	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258617	chr20:25274318	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000258	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258719	chr20:25275843	FAM182A	chr20:26035250-26067552:+	-0.19	-3.93	9.88E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258719	chr20:25275843	NINL	chr20:25433338-25566153:-	-0.15	-3.69	0.000254	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258769	chr20:25276680	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258879	chr20:25279213	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2258884	chr20:25279539	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2259837	chr20:25280205	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2259873	chr20:25280781	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2259926	chr20:25281733	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2259928	chr20:25281834	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2259956	chr20:25282433	FAM182A	chr20:26035250-26067552:+	-0.18	-3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2268617	chr14:75608728	EIF2B2	chr14:75469612-75476292:+	0.22	4.05	5.84E-5	Height	
LUAD	cis	1	rs2268617	chr14:75608728	MLH3	chr14:75480467-75518235:-	0.26	5	8.05E-7	Height	
LUAD	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.31	6.26	8.25E-10	Height	
LUAD	cis	1	rs2270291	chr1:156244992	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.73	-13.69	2.34E-36	Diastolic blood pressure	
LUAD	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.48	-5.54	5.04E-8	Rheumatoid arthritis	
LUAD	cis	1	rs2273602	chr6:117730592	DCBLD1	chr6:117803820-117891018:+	0.17	3.73	0.000213	Lung cancer	
LUAD	cis	1	rs2273610	chr14:104387642	TDRD9	chr14:104394817-104519002:+	0.25	3.78	0.000174	Bipolar disorder	
LUAD	cis	1	rs2273694	chr10:102256496	SEC31B	chr10:102246403-102289636:-	-0.18	-5.87	8.25E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2273695	chr10:102259568	SEC31B	chr10:102246403-102289636:-	-0.2	-6.78	3.51E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2273832	chr1:156233143	CCT3	chr1:156278752-156308195:-	-0.17	-4.09	5.01E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs2273833	chr1:156233189	CCT3	chr1:156278752-156308195:-	-0.17	-4.09	5.11E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.37	7.24	1.79E-12	Longevity	
LUAD	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.17	2.7E-12	Body mass index	
LUAD	cis	1	rs2275426	chr1:46487552	MUTYH	chr1:45794915-45806142:-	0.16	3.84	0.000142	Body mass index	
LUAD	cis	1	rs2276161	chr2:135470735	TMEM163	chr2:135213331-135525334:-	-0.23	-4.32	1.89E-5	Gut microbiome composition (winter)	
LUAD	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.46	7.68E-8	Body mass index	
LUAD	cis	1	rs2277027	chr5:156932376	ADAM19	chr5:156822542-157002768:-	0.14	4.24	2.65E-5	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.61	-8.33	8.36E-16	Cholesterol, total	
LUAD	cis	1	rs2277862	chr20:34152782	ERGIC3	chr20:34129778-34145404:+	-0.26	-3.88	0.000119	Cholesterol, total	
LUAD	cis	1	rs2277870	chr1:156246792	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs2277871	chr1:156246742	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.32	-8.04	6.99E-15	Longevity	
LUAD	cis	1	rs2280017	chr16:15151361	RRN3	chr16:15153881-15188158:-	0.3	5.42	9.29E-8	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
LUAD	cis	1	rs2280018	chr16:15150833	RRN3	chr16:15153881-15188158:-	-0.26	-4.81	2.02E-6	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
LUAD	cis	1	rs2281006	chr1:171110869	FMO3	chr1:171060018-171086957:+	-0.2	-4.22	2.87E-5	Blood metabolite levels	
LUAD	cis	1	rs2281494	chr20:3235494	ITPA	chr20:3190056-3204504:+	-0.24	-4.25	2.6E-5	IFN-related cytopenia	
LUAD	cis	1	rs2281497	chr20:3258874	ITPA	chr20:3190056-3204504:+	-0.23	-4.19	3.34E-5	IFN-related cytopenia	
LUAD	cis	1	rs2281500	chr20:3262824	ITPA	chr20:3190056-3204504:+	-0.25	-4.61	5.07E-6	IFN-related cytopenia	
LUAD	cis	1	rs2281503	chr20:3263636	ITPA	chr20:3190056-3204504:+	-0.25	-4.5	8.34E-6	IFN-related cytopenia	
LUAD	cis	1	rs2285087	chr4:3088211	C4orf44	chr4:3250767-3265839:+	-0.21	-4.49	8.71E-6	Parental longevity (mother's age at death)	
LUAD	cis	1	rs2285657	chr17:40272594	DHX58	chr17:40253422-40264751:-	-0.29	-5.33	1.5E-7	Fibrinogen levels	
LUAD	cis	1	rs2285946	chr7:21583329	DNAH11	chr7:21582833-21941455:+	-0.42	-9.27	6.09E-19	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
LUAD	cis	1	rs2285947	chr7:21584088	DNAH11	chr7:21582833-21941455:+	0.39	8.63	8.43E-17	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
LUAD	cis	1	rs2285949	chr7:21584243	DNAH11	chr7:21582833-21941455:+	-0.4	-8.85	1.67E-17	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
LUAD	cis	1	rs2285950	chr7:21584432	DNAH11	chr7:21582833-21941455:+	0.38	8.29	1.06E-15	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
LUAD	cis	1	rs2286719	chr3:42446440	CCDC13	chr3:42749875-42814745:-	0.28	4.35	1.63E-5	Response to antipsychotic treatment in schizophrenia (reasoning)	
LUAD	cis	1	rs2286719	chr3:42446440	FAM198A	chr3:43020759-43101703:+	0.3	4.16	3.71E-5	Response to antipsychotic treatment in schizophrenia (reasoning)	
LUAD	cis	1	rs2286720	chr3:42448471	CCDC13	chr3:42749875-42814745:-	-0.25	-4.06	5.81E-5	Response to antipsychotic treatment in schizophrenia (reasoning)	
LUAD	cis	1	rs2286720	chr3:42448471	FAM198A	chr3:43020759-43101703:+	-0.26	-3.96	8.72E-5	Response to antipsychotic treatment in schizophrenia (reasoning)	
LUAD	cis	1	rs2286809	chr11:22851455	SVIP	chr11:22843600-22851382:-	0.22	4.31	1.96E-5	Dialysis-related mortality	
LUAD	cis	1	rs2287679	chr19:33600764	GPATCH1	chr19:33571786-33621318:+	0.22	4.09	5.08E-5	Bone properties (heel)	
LUAD	cis	1	rs2287679	chr19:33600764	RHPN2	chr19:33469499-33555824:-	-0.2	-4.16	3.77E-5	Bone properties (heel)	
LUAD	cis	1	rs2287680	chr19:33608566	GPATCH1	chr19:33571786-33621318:+	-0.2	-3.79	0.000173	Bone properties (heel)	
LUAD	cis	1	rs2287680	chr19:33608566	RHPN2	chr19:33469499-33555824:-	0.22	4.54	7.22E-6	Bone properties (heel)	
LUAD	cis	1	rs2288073	chr2:24413298	C2orf84	chr2:24397531-24414566:+	-0.38	-6.85	2.23E-11	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs2288073	chr2:24413298	LOC375190	chr2:24299728-24397519:+	0.25	4.76	2.56E-6	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs2289329	chr15:40705159	DISP2	chr15:40650434-40663256:+	0.35	5.77	1.39E-8	Blood metabolite levels;Blood metabolite ratios	
LUAD	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.28	-7.15	3.22E-12	Longevity	
LUAD	cis	1	rs2290850	chr11:47807774	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.1	4.81E-5	Subjective well-being	
LUAD	cis	1	rs2290850	chr11:47807774	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.44	1.1E-5	Subjective well-being	
LUAD	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.65	-14.46	1.0E-39	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.62	15.76	1.51E-45	Cognitive function	
LUAD	cis	1	rs2292489	chr1:202536848	PPP1R12B	chr1:202317836-202557697:+	0.21	4.56	6.55E-6	Sex ratio	
LUAD	cis	1	rs2293551	chr1:202408594	PPP1R12B	chr1:202317836-202557697:+	0.22	4.9	1.33E-6	Sex ratio	
LUAD	cis	1	rs2293552	chr1:202408751	PPP1R12B	chr1:202317836-202557697:+	0.22	4.9	1.33E-6	Sex ratio	
LUAD	cis	1	rs2294008	chr8:143761931	PSCA	chr8:143761875-143764142:+	0.3	7.93	1.48E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2294010	chr8:143762430	PSCA	chr8:143761875-143764142:+	0.3	7.9	1.85E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2295359	chr1:67635950	C1orf141	chr1:67557859-67600653:-	-0.19	-5.83	1.01E-8	Psoriasis	
LUAD	cis	1	rs2295770	chr10:102239829	SEC31B	chr10:102246403-102289636:-	-0.22	-6.93	1.31E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2295772	chr10:102265183	SEC31B	chr10:102246403-102289636:-	-0.21	-6.71	5.52E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2295773	chr10:102265815	SEC31B	chr10:102246403-102289636:-	-0.21	-6.71	5.52E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2295774	chr10:102265847	SEC31B	chr10:102246403-102289636:-	-0.22	-6.94	1.28E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2295776	chr10:102295629	SEC31B	chr10:102246403-102289636:-	-0.2	-6.4	3.59E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2295779	chr10:102296061	SEC31B	chr10:102246403-102289636:-	-0.19	-6.34	5.18E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2295780	chr10:102305965	SEC31B	chr10:102246403-102289636:-	-0.22	-6.71	5.24E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2296691	chr10:97370989	ENTPD1	chr10:97471536-97637022:+	0.19	5.09	5.01E-7	Blood metabolite levels	
LUAD	cis	1	rs2296837	chr1:166958601	GPA33	chr1:167022082-167059868:-	-0.24	-4.39	1.41E-5	Refractive astigmatism	
LUAD	cis	1	rs2297112	chr9:131900180	CRAT	chr9:131857075-131873070:-	0.33	6.45	2.71E-10	Blood metabolite ratios	
LUAD	cis	1	rs2297316	chr13:28490211	PDX1	chr13:28494168-28500451:+	-0.17	-3.92	0.000101	Pancreatic cancer	
LUAD	cis	1	rs2297496	chr20:25295787	FAM182A	chr20:26035250-26067552:+	0.18	3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2297497	chr20:25297909	FAM182A	chr20:26035250-26067552:+	0.19	3.86	0.000129	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2298074	chr10:102247526	SEC31B	chr10:102246403-102289636:-	-0.23	-7.16	2.99E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2298075	chr10:102247408	SEC31B	chr10:102246403-102289636:-	-0.22	-7.07	5.41E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2298914	chr1:171710405	VAMP4	chr1:171669298-171711214:-	0.25	3.98	8.02E-5	Hippocampal atrophy	
LUAD	cis	1	rs2300601	chr14:75639571	MLH3	chr14:75480467-75518235:-	0.28	5.44	8.54E-8	Height	
LUAD	cis	1	rs2302138	chr14:74363305	LIN52	chr14:74551656-74667117:+	0.26	3.92	0.000101	Morning vs. evening chronotype	
LUAD	cis	1	rs2302139	chr14:74362935	LIN52	chr14:74551656-74667117:+	0.25	3.71	0.000228	Morning vs. evening chronotype	
LUAD	cis	1	rs2303339	chr2:86346180	LOC90784	chr2:86247339-86250991:-	0.52	4.6	5.51E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs2303340	chr2:86333193	LOC90784	chr2:86247339-86250991:-	-0.47	-4.55	6.89E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs2303759	chr19:49869051	CCDC155	chr19:49891506-49921246:+	-0.45	-7.95	1.29E-14	Multiple sclerosis	
LUAD	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.44	-7.53	2.51E-13	Multiple sclerosis	
LUAD	cis	1	rs2305188	chr4:1739592	FAM53A	chr4:1641609-1685854:-	-0.3	-5.32	1.59E-7	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs2306694	chr12:56680636	STAT2	chr12:56735384-56753909:-	-0.31	-3.67	0.000272	Psoriasis vulgaris	
LUAD	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.5	7.85	2.74E-14	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.49	8.13	3.59E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs2312462	chr3:49601255	RHOA	chr3:49396581-49449526:-	0.18	3.73	0.000211	Menarche (age at onset)	
LUAD	cis	1	rs231518	chr17:41961451	AARSD1	chr17:41102545-41132545:-	-0.29	-4.19	3.25E-5	Cognitive function	
LUAD	cis	1	rs2315281	chr19:19480099	HAPLN4	chr19:19366453-19384074:-	-0.18	-3.93	9.88E-5	Schizophrenia	
LUAD	cis	1	rs2317134	chr3:56648363	CCDC66	chr3:56591184-56655846:+	0.19	5.32	1.57E-7	Height	
LUAD	cis	1	rs2317252	chr3:56687708	CCDC66	chr3:56591184-56655846:+	0.18	5.21	2.75E-7	Height	
LUAD	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.67	-12.03	2.32E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs2333194	chr14:73767214	HEATR4	chr14:73945193-74025651:-	-0.25	-4.52	7.63E-6	Bipolar disorder with mood-incongruent psychosis	
LUAD	cis	1	rs2336540	chr3:52974589	TMEM110	chr3:52867139-52931547:-	0.45	4.88	1.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs2336541	chr3:52974630	TMEM110	chr3:52867139-52931547:-	0.45	4.88	1.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs2336880	chr5:139063728	DNAJC18	chr5:138747381-138775139:-	-0.16	-3.69	0.000246	Schizophrenia	
LUAD	cis	1	rs2338555	chr1:152309380	FLG	chr1:152274651-152297679:-	0.24	3.96	8.63E-5	Atopic dermatitis	
LUAD	cis	1	rs2338556	chr1:152309427	FLG	chr1:152274651-152297679:-	0.24	3.96	8.63E-5	Atopic dermatitis	
LUAD	cis	1	rs2340775	chr8:29082611	KIF13B	chr8:28924796-29120610:-	-0.35	-3.8	0.000163	PR interval in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs2346676	chr16:67223803	DPEP2	chr16:68021295-68034489:-	0.2	4.16	3.74E-5	HDL cholesterol	
LUAD	cis	1	rs2349075	chr2:202223566	ALS2CR12	chr2:202153148-202222101:-	-0.14	-3.75	0.0002	Basal cell carcinoma	
LUAD	cis	1	rs2349075	chr2:202223566	CASP8	chr2:202098166-202152434:+	0.24	5.25	2.25E-7	Basal cell carcinoma	
LUAD	cis	1	rs2350809	chr2:203328933	NOP58	chr2:203130515-203168382:+	0.27	4.22	2.91E-5	Urate levels	
LUAD	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.68	-14.26	7.95E-39	Type 2 diabetes	
LUAD	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.68	-14.13	2.91E-38	Type 2 diabetes	
LUAD	cis	1	rs2353605	chr4:219538	ZNF718	chr4:53272-156488:+	0.3	4.51	8.01E-6	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.84	-17.26	1.86E-52	Homocysteine levels	
LUAD	cis	1	rs2356559	chr1:45981512	MUTYH	chr1:45794915-45806142:-	0.2	4.24	2.69E-5	Homocysteine levels	
LUAD	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.79	-16.18	1.76E-47	Homocysteine levels	
LUAD	cis	1	rs2356561	chr1:45980862	MUTYH	chr1:45794915-45806142:-	0.18	3.89	0.000114	Homocysteine levels	
LUAD	cis	1	rs2358628	chr14:74631757	C14orf45	chr14:74486059-74549566:+	-0.17	-3.77	0.00018	Common traits (Other)	
LUAD	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.44	-9.65	2.78E-20	Common traits (Other)	
LUAD	cis	1	rs2358633	chr14:74647418	C14orf45	chr14:74486059-74549566:+	-0.19	-4.31	1.98E-5	Common traits (Other)	
LUAD	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.47	-10.39	5.37E-23	Common traits (Other)	
LUAD	cis	1	rs2358633	chr14:74647418	ZNF410	chr14:74318674-74398803:+	-0.19	-3.89	0.000112	Common traits (Other)	
LUAD	cis	1	rs236104	chr20:5958960	MCM8	chr20:5931298-5975829:+	-0.21	-5.02	7.4E-7	HIV-1 viral setpoint	
LUAD	cis	1	rs236121	chr20:5972594	MCM8	chr20:5931298-5975829:+	-0.21	-4.92	1.16E-6	HIV-1 viral setpoint	
LUAD	cis	1	rs2361453	chr1:202336314	PPP1R12B	chr1:202317836-202557697:+	0.22	4.95	1.03E-6	Sex ratio	
LUAD	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.28	-6.81	2.81E-11	Longevity	
LUAD	cis	1	rs2362452	chr3:48418214	ATRIP	chr3:48488141-48507708:+	-0.21	-3.85	0.000132	Longevity	
LUAD	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.25	5.93	5.84E-9	Longevity	
LUAD	cis	1	rs2363286	chr7:1091625	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.91	6.44E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.82	-10.51	1.95E-23	Plasma clusterin levels	
LUAD	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.51	10.01	1.35E-21	Height	
LUAD	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.52	10.3	1.25E-22	Height	
LUAD	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.52	10.23	2.17E-22	Height	
LUAD	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.36	4.58E-10	Obesity-related traits	
LUAD	cis	1	rs2371244	chr7:143757611	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.000198	Obesity-related traits	
LUAD	cis	1	rs2371244	chr7:143757611	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-5.01	7.5E-7	Obesity-related traits	
LUAD	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.33	5.68E-10	Obesity-related traits	
LUAD	cis	1	rs2371247	chr7:143764179	OR2A7	chr7:143955790-143974852:-	0.21	3.73	0.000215	Obesity-related traits	
LUAD	cis	1	rs2371247	chr7:143764179	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.89	1.36E-6	Obesity-related traits	
LUAD	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.35	4.92E-10	Obesity-related traits	
LUAD	cis	1	rs2371248	chr7:143764189	OR2A7	chr7:143955790-143974852:-	0.21	3.76	0.000194	Obesity-related traits	
LUAD	cis	1	rs2371248	chr7:143764189	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.13	4.18E-7	Obesity-related traits	
LUAD	cis	1	rs2371454	chr12:56647243	STAT2	chr12:56735384-56753909:-	-0.31	-3.68	0.00026	Psoriasis vulgaris	
LUAD	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.02	1.27E-21	Height	
LUAD	cis	1	rs237711	chr20:47926856	C20orf199	chr20:47894715-47905793:+	0.18	3.72	0.00022	Height	
LUAD	cis	1	rs237743	chr20:47903019	C20orf199	chr20:47894715-47905793:+	-0.19	-3.84	0.000138	Height	
LUAD	cis	1	rs2382818	chr2:219155907	DIRC3	chr2:218148748-218621316:-	-0.18	-3.85	0.000132	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs2382819	chr2:219155909	DIRC3	chr2:218148748-218621316:-	-0.18	-3.85	0.000132	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs2387762	chr6:97424463	GPR63	chr6:97245889-97285353:-	-0.26	-3.95	9.09E-5	Body mass index	
LUAD	cis	1	rs2391159	chr1:92971951	EVI5	chr1:92974255-93257961:-	-0.26	-4.18	3.38E-5	Cholesterol, total	
LUAD	cis	1	rs2391160	chr1:92992797	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs2391573	chr1:101489698	CCDC76	chr1:100598706-100616053:+	0.18	3.72	0.000224	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs2392510	chr7:37746569	TXNDC3	chr7:37888199-37940000:+	0.17	3.8	0.000161	Periodontitis	
LUAD	cis	1	rs2392511	chr7:37746587	TXNDC3	chr7:37888199-37940000:+	0.17	3.8	0.000161	Periodontitis	
LUAD	cis	1	rs2393969	chr10:65140440	NRBF2	chr10:64893007-64914785:+	-0.2	-4.47	9.71E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2396499	chr2:228724368	WDR69	chr2:228736327-228789026:+	-0.28	-5.77	1.43E-8	Blood pressure	
LUAD	cis	1	rs2402945	chr7:128956256	LOC407835	chr7:128766325-128768041:+	0.24	3.82	0.000153	White matter hyperintensity burden	
LUAD	cis	1	rs2404602	chr15:77030792	SCAPER	chr15:76640529-77197744:-	-0.21	-5.02	7.42E-7	Blood metabolite levels	
LUAD	cis	1	rs2404740	chr15:76852143	SCAPER	chr15:76640529-77197744:-	-0.21	-4.99	8.22E-7	Blood metabolite levels	
LUAD	cis	1	rs2404741	chr15:76851735	SCAPER	chr15:76640529-77197744:-	-0.21	-4.99	8.22E-7	Blood metabolite levels	
LUAD	cis	1	rs2408482	chr5:125017930	GRAMD3	chr5:125695788-125829851:+	0.26	3.89	0.000115	Gut microbiome composition (winter)	
LUAD	cis	1	rs2413546	chr22:39107001	JOSD1	chr22:39081549-39096459:-	-0.21	-3.68	0.000264	Resting heart rate	
LUAD	cis	1	rs2413547	chr22:39107338	JOSD1	chr22:39081549-39096459:-	-0.22	-3.77	0.000181	Resting heart rate	
LUAD	cis	1	rs2413740	chr22:43419325	ARFGAP3	chr22:43192532-43253408:-	0.27	4.7	3.37E-6	Schizophrenia	
LUAD	cis	1	rs2415253	chr15:75375699	SCAMP5	chr15:75287901-75313836:+	0.33	5.86	8.57E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs2415255	chr15:75332412	C15orf39	chr15:75491233-75504508:+	0.21	3.7	0.000243	Blood trace element (Zn levels)	
LUAD	cis	1	rs2415255	chr15:75332412	SCAMP5	chr15:75287901-75313836:+	0.35	5.96	4.84E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs2416935	chr9:102669557	STX17	chr9:102668915-102736817:+	-0.18	-3.9	0.000109	Alopecia areata	
LUAD	cis	1	rs2416937	chr9:102680637	STX17	chr9:102668915-102736817:+	-0.17	-3.73	0.000217	Alopecia areata	
LUAD	cis	1	rs2416942	chr9:102706489	STX17	chr9:102668915-102736817:+	-0.18	-3.92	9.96E-5	Alopecia areata	
LUAD	cis	1	rs2417940	chr12:21017875	SLCO1B3	chr12:20963638-21243038:+	-0.27	-4.29	2.18E-5	Bilirubin levels	
LUAD	cis	1	rs2420170	chr7:65656053	CCT6P1	chr7:65216092-65228661:+	-0.24	-3.85	0.000135	Diabetic kidney disease	
LUAD	cis	1	rs2420171	chr7:65637760	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.93	9.89E-5	Diabetic kidney disease	
LUAD	cis	1	rs2421143	chr10:124737546	C10orf88	chr10:124690419-124713919:-	-0.2	-4.18	3.39E-5	Migraine without aura	
LUAD	cis	1	rs2421144	chr10:124733066	C10orf88	chr10:124690419-124713919:-	-0.2	-4.04	6.1E-5	Migraine without aura	
LUAD	cis	1	rs2421145	chr10:124730565	C10orf88	chr10:124690419-124713919:-	-0.2	-4.2	3.2E-5	Migraine without aura	
LUAD	cis	1	rs2421146	chr10:124730505	C10orf88	chr10:124690419-124713919:-	0.2	4.06	5.64E-5	Migraine without aura	
LUAD	cis	1	rs2421147	chr10:124730432	C10orf88	chr10:124690419-124713919:-	-0.19	-3.98	8.05E-5	Migraine without aura	
LUAD	cis	1	rs2421148	chr10:124728874	C10orf88	chr10:124690419-124713919:-	-0.2	-3.94	9.18E-5	Migraine without aura	
LUAD	cis	1	rs2421154	chr10:124747108	C10orf88	chr10:124690419-124713919:-	-0.22	-4.43	1.14E-5	Migraine without aura	
LUAD	cis	1	rs2421155	chr10:124725481	C10orf88	chr10:124690419-124713919:-	-0.2	-4.07	5.38E-5	Migraine without aura	
LUAD	cis	1	rs2421158	chr10:124721098	C10orf88	chr10:124690419-124713919:-	-0.2	-4.06	5.64E-5	Migraine without aura	
LUAD	cis	1	rs2424704	chr20:25273929	FAM182A	chr20:26035250-26067552:+	-0.18	-3.74	0.000202	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2424710	chr20:25283886	FAM182A	chr20:26035250-26067552:+	-0.19	-3.91	0.000106	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2424713	chr20:25418482	FAM182A	chr20:26035250-26067552:+	-0.19	-3.97	8.31E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2425065	chr20:33926268	UQCC	chr20:33890383-33999833:-	-0.3	-5.64	2.88E-8	Height	
LUAD	cis	1	rs2425066	chr20:33927006	UQCC	chr20:33890383-33999833:-	-0.31	-5.83	1.03E-8	Height	
LUAD	cis	1	rs2430494	chr2:37463620	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.86	0.00013	Chronic lymphocytic leukemia	
LUAD	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.81	14.61	2.25E-40	Type 2 diabetes	
LUAD	cis	1	rs2440845	chr10:59971884	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2440846	chr10:59974293	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2440847	chr10:59996176	IPMK	chr10:59955618-60027694:-	0.18	4.27	2.32E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2440848	chr10:59996403	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2440849	chr10:60002164	IPMK	chr10:59955618-60027694:-	0.17	4.12	4.37E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2440850	chr10:60011731	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2440855	chr10:59964744	IPMK	chr10:59955618-60027694:-	0.17	4.19	3.37E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2440856	chr10:60030789	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs244288	chr17:53231841	COX11	chr17:53029259-53046064:-	-0.18	-3.67	0.000267	Menarche (age at onset)	
LUAD	cis	1	rs244316	chr17:53215223	COX11	chr17:53029259-53046064:-	-0.21	-4.28	2.21E-5	Menarche (age at onset)	
LUAD	cis	1	rs2447097	chr17:2278064	MNT	chr17:2287355-2304258:-	-0.18	-4.17	3.59E-5	Autism spectrum disorder	
LUAD	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.29	4.41	1.26E-5	Tumor biomarkers	
LUAD	cis	1	rs2447196	chr15:43893818	CATSPER2	chr15:43922774-43959900:-	0.24	4.04	6.22E-5	Tumor biomarkers	
LUAD	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.31	-4.44	1.09E-5	Tumor biomarkers	
LUAD	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.25	-4.07	5.42E-5	Tumor biomarkers	
LUAD	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.3	-4.3	2.06E-5	Tumor biomarkers	
LUAD	cis	1	rs2447211	chr15:43936351	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.3	2.06E-5	Tumor biomarkers	
LUAD	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.39	10.66	5.39E-24	Homocysteine levels	
LUAD	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.28	7.06	5.79E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.32	-6.66	7.57E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs245914	chr7:29218159	WIPF3	chr7:29874341-29945791:+	-0.26	-4.26	2.45E-5	Psychosis (atypical);Obesity-related traits	
LUAD	cis	1	rs2462569	chr7:65474846	CRCP	chr7:65579805-65619551:+	0.32	3.9	0.000111	Diabetic kidney disease	
LUAD	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.44	-11.1	1.07E-25	Ankylosing spondylitis	
LUAD	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.45	8.57	1.34E-16	Ankylosing spondylitis	
LUAD	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.33	4.6	5.31E-6	Tumor biomarkers	
LUAD	cis	1	rs2482911	chr20:25395528	FAM182A	chr20:26035250-26067552:+	0.19	3.88	0.000118	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2482919	chr20:25299756	FAM182A	chr20:26035250-26067552:+	0.19	3.87	0.000126	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2482927	chr20:25327151	FAM182A	chr20:26035250-26067552:+	0.19	3.87	0.000123	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2482928	chr20:25331530	FAM182A	chr20:26035250-26067552:+	0.19	3.91	0.000104	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2482930	chr20:25334115	FAM182A	chr20:26035250-26067552:+	0.19	3.91	0.000106	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2482931	chr20:25334445	FAM182A	chr20:26035250-26067552:+	0.19	3.87	0.000125	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2482937	chr20:25340786	FAM182A	chr20:26035250-26067552:+	0.19	3.91	0.000106	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2482940	chr20:25349830	FAM182A	chr20:26035250-26067552:+	0.19	3.87	0.000125	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2482941	chr20:25361216	FAM182A	chr20:26035250-26067552:+	0.19	3.84	0.000139	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2482943	chr20:25380593	FAM182A	chr20:26035250-26067552:+	0.19	3.88	0.000118	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.74E-12	Body mass index	
LUAD	cis	1	rs2486447	chr1:46545724	MUTYH	chr1:45794915-45806142:-	0.16	3.85	0.000133	Body mass index	
LUAD	cis	1	rs2486483	chr10:60003000	IPMK	chr10:59955618-60027694:-	0.17	4.12	4.37E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2486486	chr10:60046654	IPMK	chr10:59955618-60027694:-	0.17	4.05	6.04E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2489034	chr10:102319192	SEC31B	chr10:102246403-102289636:-	-0.2	-6.28	7.57E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489035	chr10:102319395	SEC31B	chr10:102246403-102289636:-	-0.2	-6.18	1.32E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489036	chr10:102319581	SEC31B	chr10:102246403-102289636:-	-0.2	-6.28	7.57E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489037	chr10:102319918	SEC31B	chr10:102246403-102289636:-	0.2	6.34	5.32E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489039	chr10:102328036	SEC31B	chr10:102246403-102289636:-	-0.22	-6.89	1.75E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489040	chr10:102331298	SEC31B	chr10:102246403-102289636:-	-0.22	-6.94	1.25E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489043	chr10:102334327	SEC31B	chr10:102246403-102289636:-	-0.2	-6.35	4.84E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489045	chr10:102344754	SEC31B	chr10:102246403-102289636:-	-0.22	-6.75	4.24E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489046	chr10:102346282	SEC31B	chr10:102246403-102289636:-	-0.19	-6.05	2.83E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489047	chr10:102347028	SEC31B	chr10:102246403-102289636:-	-0.21	-6.65	7.92E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489048	chr10:102348497	SEC31B	chr10:102246403-102289636:-	-0.21	-6.65	8.02E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489049	chr10:102350732	SEC31B	chr10:102246403-102289636:-	-0.2	-6.51	1.89E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489050	chr10:102350898	SEC31B	chr10:102246403-102289636:-	-0.22	-6.78	3.57E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489051	chr10:102351785	SEC31B	chr10:102246403-102289636:-	0.2	6.37	4.49E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2489053	chr10:102353341	SEC31B	chr10:102246403-102289636:-	-0.19	-5.94	5.43E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495732	chr10:102357780	SEC31B	chr10:102246403-102289636:-	-0.2	-6.26	8.6E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495734	chr10:102338686	SEC31B	chr10:102246403-102289636:-	-0.22	-6.95	1.14E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495736	chr10:102338410	SEC31B	chr10:102246403-102289636:-	-0.21	-6.58	1.18E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495737	chr10:102338344	SEC31B	chr10:102246403-102289636:-	-0.22	-6.86	2.12E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495739	chr10:102335507	SEC31B	chr10:102246403-102289636:-	-0.21	-6.61	9.93E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495741	chr10:102331795	SEC31B	chr10:102246403-102289636:-	-0.2	-6.42	3.16E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495742	chr10:102331364	SEC31B	chr10:102246403-102289636:-	-0.21	-6.62	9.34E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495743	chr10:102329739	SEC31B	chr10:102246403-102289636:-	-0.2	-6.27	7.85E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495745	chr10:102329075	SEC31B	chr10:102246403-102289636:-	-0.21	-6.8	3.01E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495747	chr10:102328247	SEC31B	chr10:102246403-102289636:-	-0.22	-7	8.43E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495750	chr10:102327708	SEC31B	chr10:102246403-102289636:-	-0.22	-7.09	4.87E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495751	chr10:102327260	SEC31B	chr10:102246403-102289636:-	-0.22	-6.94	1.25E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495752	chr10:102326115	SEC31B	chr10:102246403-102289636:-	-0.2	-6.38	4.09E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495753	chr10:102325640	SEC31B	chr10:102246403-102289636:-	-0.2	-6.25	8.96E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495754	chr10:102324812	SEC31B	chr10:102246403-102289636:-	-0.19	-6.09	2.26E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495755	chr10:102324649	SEC31B	chr10:102246403-102289636:-	-0.21	-6.41	3.36E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495758	chr10:102321900	SEC31B	chr10:102246403-102289636:-	-0.21	-6.41	3.36E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495759	chr10:102320363	SEC31B	chr10:102246403-102289636:-	-0.19	-5.67	2.48E-8	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2495760	chr10:102318771	SEC31B	chr10:102246403-102289636:-	-0.22	-6.58	1.2E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs2498471	chr6:49484433	CENPQ	chr6:49431096-49460820:+	0.17	4.23	2.85E-5	Brain structure	
LUAD	cis	1	rs2500404	chr20:25359758	FAM182A	chr20:26035250-26067552:+	0.19	3.84	0.000139	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2500405	chr20:25360826	FAM182A	chr20:26035250-26067552:+	0.19	3.84	0.000139	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2500418	chr20:25382268	FAM182A	chr20:26035250-26067552:+	0.2	3.99	7.76E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2500424	chr20:25391969	FAM182A	chr20:26035250-26067552:+	0.19	3.89	0.000114	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2500432	chr20:25290512	FAM182A	chr20:26035250-26067552:+	-0.19	-3.92	0.000101	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2500436	chr20:25406366	FAM182A	chr20:26035250-26067552:+	0.19	3.91	0.000106	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2500443	chr20:25331442	FAM182A	chr20:26035250-26067552:+	0.19	3.91	0.000104	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2500446	chr20:25339664	FAM182A	chr20:26035250-26067552:+	0.19	3.91	0.000104	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2500448	chr20:25404027	FAM182A	chr20:26035250-26067552:+	0.19	3.94	9.24E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs2501276	chr1:22373624	HSPC157	chr1:22351707-22357713:+	0.32	3.75	0.000195	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.27	6.91	1.57E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.33	-6.73	4.75E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.27	6.96	1.13E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.33	-6.71	5.28E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs2502757	chr9:136586954	SARDH	chr9:136528686-136605077:-	-0.38	-7.47	3.7E-13	Asthma	
LUAD	cis	1	rs2521263	chr11:2308762	C11orf21	chr11:2317507-2323143:-	-0.29	-5.28	1.97E-7	Obesity-related traits	
LUAD	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.41	-7.26	1.53E-12	Bipolar disorder and schizophrenia	
LUAD	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.54	8.76	3.18E-17	Bipolar disorder and schizophrenia	
LUAD	cis	1	rs2527199	chr7:158737113	WDR60	chr7:158649269-158738882:+	0.2	3.82	0.000149	Height	
LUAD	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.8	13.96	1.61E-37	Type 2 diabetes	
LUAD	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.81	14.36	2.88E-39	Type 2 diabetes	
LUAD	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.8	14.29	6.08E-39	Type 2 diabetes	
LUAD	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.81	14.93	8.77E-42	Type 2 diabetes	
LUAD	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.81	14.3	5.28E-39	Type 2 diabetes	
LUAD	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.86	15.03	2.98E-42	Type 2 diabetes	
LUAD	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.8	-14.56	3.59E-40	Type 2 diabetes	
LUAD	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.81	14.55	4.16E-40	Type 2 diabetes	
LUAD	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.81	14.24	9.42E-39	Type 2 diabetes	
LUAD	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.8	14.39	2.07E-39	Type 2 diabetes	
LUAD	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.81	14.57	3.27E-40	Type 2 diabetes	
LUAD	cis	1	rs2530664	chr22:30038152	NIPSNAP1	chr22:29950800-29977144:-	0.27	4.31	2.01E-5	Lipid traits	
LUAD	cis	1	rs2531848	chr22:30032484	NIPSNAP1	chr22:29950800-29977144:-	0.28	4.45	1.05E-5	Lipid traits	
LUAD	cis	1	rs2531849	chr22:30037900	NIPSNAP1	chr22:29950800-29977144:-	0.27	4.31	2.01E-5	Lipid traits	
LUAD	cis	1	rs2540977	chr2:37462228	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.84	0.000141	Chronic lymphocytic leukemia	
LUAD	cis	1	rs2541161	chr9:131884802	CRAT	chr9:131857075-131873070:-	-0.36	-6.82	2.69E-11	Blood metabolite ratios	
LUAD	cis	1	rs2541161	chr9:131884802	PPP2R4	chr9:131873244-131911223:+	-0.23	-4.53	7.51E-6	Blood metabolite ratios	
LUAD	cis	1	rs2541164	chr9:131876908	CRAT	chr9:131857075-131873070:-	0.37	7.04	6.53E-12	Blood metabolite ratios	
LUAD	cis	1	rs2541164	chr9:131876908	PPP2R4	chr9:131873244-131911223:+	0.23	4.46	1.01E-5	Blood metabolite ratios	
LUAD	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.81	14.26	7.7E-39	Type 2 diabetes	
LUAD	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.81	14.26	7.7E-39	Type 2 diabetes	
LUAD	cis	1	rs2564926	chr3:53094730	TMEM110	chr3:52867139-52931547:-	-0.44	-4.93	1.13E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs2564940	chr3:53107569	RFT1	chr3:53122503-53164470:-	-0.19	-3.76	0.00019	Height	
LUAD	cis	1	rs2572910	chr8:143770135	LYNX1	chr8:143845758-143859640:-	-0.18	-3.87	0.000122	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2572910	chr8:143770135	PSCA	chr8:143761875-143764142:+	0.29	7.37	7.3E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.2	-3.94	9.52E-5	Height	
LUAD	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.2	-3.94	9.52E-5	Height	
LUAD	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.2	-3.99	7.66E-5	Height	
LUAD	cis	1	rs2581800	chr3:53109352	RFT1	chr3:53122503-53164470:-	-0.2	-3.87	0.000122	Height	
LUAD	cis	1	rs2585179	chr8:143774193	LYNX1	chr8:143845758-143859640:-	-0.18	-3.91	0.000104	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2585179	chr8:143774193	PSCA	chr8:143761875-143764142:+	0.29	7.35	8.23E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2586759	chr18:48379064	MRO	chr18:48321491-48351754:-	-0.35	-5.81	1.16E-8	Entorhinal cortical thickness	
LUAD	cis	1	rs2590299	chr10:59969000	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590305	chr10:59973844	IPMK	chr10:59955618-60027694:-	0.18	4.31	2.0E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590306	chr10:59976966	IPMK	chr10:59955618-60027694:-	0.18	4.35	1.64E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590307	chr10:59977161	IPMK	chr10:59955618-60027694:-	0.18	4.26	2.46E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590308	chr10:59977569	IPMK	chr10:59955618-60027694:-	0.18	4.26	2.45E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590311	chr10:59983565	IPMK	chr10:59955618-60027694:-	0.18	4.36	1.59E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590313	chr10:59986383	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590315	chr10:59986492	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590317	chr10:59987658	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590321	chr10:59996693	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590323	chr10:60000781	IPMK	chr10:59955618-60027694:-	0.17	4.12	4.37E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590330	chr10:60008219	IPMK	chr10:59955618-60027694:-	0.17	4.12	4.37E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590335	chr10:60009389	IPMK	chr10:59955618-60027694:-	0.17	4.12	4.37E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590336	chr10:60010497	IPMK	chr10:59955618-60027694:-	0.17	4.12	4.37E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590339	chr10:60012231	IPMK	chr10:59955618-60027694:-	0.15	3.69	0.000245	Inflammatory bowel disease	
LUAD	cis	1	rs2590340	chr10:60012271	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590344	chr10:60013067	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590348	chr10:60014595	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590349	chr10:60014646	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590356	chr10:60019047	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590357	chr10:60019964	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590358	chr10:60020982	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590359	chr10:60021247	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590364	chr10:60038406	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.75E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590367	chr10:60041574	IPMK	chr10:59955618-60027694:-	0.16	3.94	9.17E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590368	chr10:60043482	IPMK	chr10:59955618-60027694:-	0.17	4.05	6.04E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590370	chr10:60049020	IPMK	chr10:59955618-60027694:-	0.17	4.05	6.04E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2590371	chr10:60054487	IPMK	chr10:59955618-60027694:-	0.17	4.1	4.88E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2602836	chr4:100014805	ADH4	chr4:100044835-100065449:-	0.35	7.56	1.97E-13	HDL cholesterol	
LUAD	cis	1	rs2605582	chr11:93163799	CCDC67	chr11:93063156-93171634:+	-0.26	-4.55	6.71E-6	Pulmonary function decline	
LUAD	cis	1	rs2605583	chr11:93164957	CCDC67	chr11:93063156-93171634:+	-0.24	-4.14	4.18E-5	Pulmonary function decline	
LUAD	cis	1	rs2605585	chr11:93171862	CCDC67	chr11:93063156-93171634:+	-0.23	-3.9	0.00011	Pulmonary function decline	
LUAD	cis	1	rs2608216	chr11:93149172	CCDC67	chr11:93063156-93171634:+	-0.24	-4.13	4.25E-5	Pulmonary function decline	
LUAD	cis	1	rs261360	chr20:5037774	C20orf30	chr20:5049130-5093733:-	-0.23	-4.52	7.71E-6	Hair morphology	
LUAD	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.27	-3.67	0.000271	Tumor biomarkers	
LUAD	cis	1	rs2617170	chr12:10560957	KLRC2	chr12:10579193-10588592:-	-0.31	-6.98	9.75E-12	Behcet's disease	
LUAD	cis	1	rs2617170	chr12:10560957	KLRC4	chr12:10559985-10562356:-	-0.18	-3.94	9.5E-5	Behcet's disease	
LUAD	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs2628313	chr17:53235352	COX11	chr17:53029259-53046064:-	-0.19	-3.72	0.000227	Menarche (age at onset)	
LUAD	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.27	4.48	9.21E-6	Cocaine dependence	
LUAD	cis	1	rs2637678	chr6:116787378	FAM26F	chr6:116782556-116784933:+	0.13	4.05	6.08E-5	Ulcerative colitis	
LUAD	cis	1	rs2638092	chr11:6961746	ZNF215	chr11:6947654-7005861:+	-0.27	-3.72	0.000225	Response to cytadine analogues (cytosine arabinoside)	
LUAD	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.44	-11.03	2.03E-25	Ankylosing spondylitis	
LUAD	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.46	8.67	6.36E-17	Ankylosing spondylitis	
LUAD	cis	1	rs2651807	chr11:2378840	C11orf21	chr11:2317507-2323143:-	-0.18	-4.06	5.71E-5	Bacteremia	
LUAD	cis	1	rs2651829	chr11:2308304	C11orf21	chr11:2317507-2323143:-	0.25	4.99	8.42E-7	Obesity-related traits	
LUAD	cis	1	rs2652816	chr15:63403368	LACTB	chr15:63414032-63434254:+	0.21	3.97	8.18E-5	HDL cholesterol	
LUAD	cis	1	rs2652832	chr15:63396928	LACTB	chr15:63414032-63434254:+	0.22	4.1	4.86E-5	HDL cholesterol	
LUAD	cis	1	rs2652833	chr15:63396885	LACTB	chr15:63414032-63434254:+	0.22	4.11	4.71E-5	HDL cholesterol	
LUAD	cis	1	rs2652834	chr15:63396867	LACTB	chr15:63414032-63434254:+	0.21	4.07	5.54E-5	HDL cholesterol	
LUAD	cis	1	rs2652835	chr15:63396408	LACTB	chr15:63414032-63434254:+	0.22	4.12	4.43E-5	HDL cholesterol	
LUAD	cis	1	rs2652838	chr15:63396088	LACTB	chr15:63414032-63434254:+	0.21	4.07	5.41E-5	HDL cholesterol	
LUAD	cis	1	rs2653503	chr10:59964034	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2653504	chr10:59964042	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2653505	chr10:59964142	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.46	-8	9.05E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs2658778	chr11:93148948	CCDC67	chr11:93063156-93171634:+	-0.25	-4.18	3.46E-5	Pulmonary function decline	
LUAD	cis	1	rs2658779	chr11:93163137	CCDC67	chr11:93063156-93171634:+	0.25	4.49	8.96E-6	Pulmonary function decline	
LUAD	cis	1	rs2658781	chr11:93166368	CCDC67	chr11:93063156-93171634:+	0.24	4.2	3.12E-5	Pulmonary function decline	
LUAD	cis	1	rs2658782	chr11:93166731	CCDC67	chr11:93063156-93171634:+	-0.25	-4.26	2.5E-5	Pulmonary function decline	
LUAD	cis	1	rs2664035	chr4:48220839	NIPAL1	chr4:48018791-48039078:+	-0.19	-3.94	9.25E-5	Rheumatoid arthritis	
LUAD	cis	1	rs2665826	chr17:61944924	FTSJ3	chr17:61896795-61905031:-	0.19	4.07	5.38E-5	Body mass index	
LUAD	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.72	13.4	4.26E-35	Diastolic blood pressure	
LUAD	cis	1	rs2707831	chr7:66062511	CCT6P1	chr7:65216092-65228661:+	0.24	3.67	0.000271	Diabetic kidney disease	
LUAD	cis	1	rs2707832	chr7:66136549	CCT6P1	chr7:65216092-65228661:+	0.23	3.72	0.000218	Gout	
LUAD	cis	1	rs2714470	chr2:37486527	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.87	0.000123	Chronic lymphocytic leukemia	
LUAD	cis	1	rs2717562	chr8:143776668	LYNX1	chr8:143845758-143859640:-	-0.19	-4.09	4.99E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2717562	chr8:143776668	PSCA	chr8:143761875-143764142:+	0.28	7.09	4.86E-12	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2729780	chr15:63404639	LACTB	chr15:63414032-63434254:+	0.22	4.21	2.98E-5	HDL cholesterol	
LUAD	cis	1	rs2729781	chr15:63404265	LACTB	chr15:63414032-63434254:+	0.21	4.02	6.84E-5	HDL cholesterol	
LUAD	cis	1	rs2729782	chr15:63403354	LACTB	chr15:63414032-63434254:+	0.21	3.97	8.18E-5	HDL cholesterol	
LUAD	cis	1	rs2729783	chr15:63403316	LACTB	chr15:63414032-63434254:+	0.2	3.89	0.000115	HDL cholesterol	
LUAD	cis	1	rs2729784	chr15:63402735	LACTB	chr15:63414032-63434254:+	0.21	4.02	6.84E-5	HDL cholesterol	
LUAD	cis	1	rs2729785	chr15:63402574	LACTB	chr15:63414032-63434254:+	0.21	4.02	6.84E-5	HDL cholesterol	
LUAD	cis	1	rs2729788	chr15:63400378	LACTB	chr15:63414032-63434254:+	0.2	3.89	0.000116	HDL cholesterol	
LUAD	cis	1	rs2729830	chr15:63395812	LACTB	chr15:63414032-63434254:+	0.21	4.05	5.88E-5	HDL cholesterol	
LUAD	cis	1	rs2729833	chr15:63397044	LACTB	chr15:63414032-63434254:+	0.22	4.1	4.91E-5	HDL cholesterol	
LUAD	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.37	-7.58	1.77E-13	Information processing speed	
LUAD	cis	1	rs2736371	chr8:11105529	TDH	chr8:11197146-11225961:+	0.2	3.98	7.97E-5	Retinal vascular caliber	
LUAD	cis	1	rs2736377	chr8:11118997	TDH	chr8:11197146-11225961:+	0.26	3.9	0.00011	Response to antipsychotic therapy (extrapyramidal side effects)	
LUAD	cis	1	rs2741852	chr1:202404277	PPP1R12B	chr1:202317836-202557697:+	0.19	4.35	1.65E-5	Sex ratio	
LUAD	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.42	-10.78	1.83E-24	Ankylosing spondylitis	
LUAD	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.43	8.4	4.82E-16	Ankylosing spondylitis	
LUAD	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.43	10.82	1.3E-24	Ankylosing spondylitis	
LUAD	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.45	-8.62	9.13E-17	Ankylosing spondylitis	
LUAD	cis	1	rs2774920	chr1:94611300	F3	chr1:94994732-95007371:-	-0.34	-4.07	5.48E-5	D-dimer levels	
LUAD	cis	1	rs2790145	chr10:59976277	IPMK	chr10:59955618-60027694:-	0.18	4.26	2.45E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790146	chr10:59975743	IPMK	chr10:59955618-60027694:-	0.18	4.48	9.1E-6	Inflammatory bowel disease	
LUAD	cis	1	rs2790157	chr10:59973396	IPMK	chr10:59955618-60027694:-	0.18	4.29	2.17E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790159	chr10:60018794	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790161	chr10:59968090	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790167	chr10:60024470	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790168	chr10:60025448	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790169	chr10:60025654	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790170	chr10:60028507	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790172	chr10:60008464	IPMK	chr10:59955618-60027694:-	0.17	4.12	4.37E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790173	chr10:60031575	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790174	chr10:60031931	IPMK	chr10:59955618-60027694:-	0.17	4.06	5.78E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790178	chr10:60034083	IPMK	chr10:59955618-60027694:-	0.17	4.11	4.69E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790179	chr10:60035372	IPMK	chr10:59955618-60027694:-	-0.16	-4	7.4E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790185	chr10:60041840	IPMK	chr10:59955618-60027694:-	0.16	3.94	9.17E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790188	chr10:60042186	IPMK	chr10:59955618-60027694:-	0.16	3.94	9.17E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790189	chr10:60042576	IPMK	chr10:59955618-60027694:-	0.17	4.09	4.97E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790191	chr10:60045091	IPMK	chr10:59955618-60027694:-	0.17	4.05	6.04E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790193	chr10:60046226	IPMK	chr10:59955618-60027694:-	0.17	4.05	6.04E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790212	chr10:60013138	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790214	chr10:60013404	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790216	chr10:59997926	IPMK	chr10:59955618-60027694:-	0.17	4.22	2.86E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790217	chr10:59997644	IPMK	chr10:59955618-60027694:-	0.17	4.22	2.86E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790218	chr10:59997301	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790219	chr10:60013849	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790222	chr10:59995438	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790228	chr10:60014325	IPMK	chr10:59955618-60027694:-	0.17	4.02	6.83E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790230	chr10:59989772	IPMK	chr10:59955618-60027694:-	0.17	4.19	3.29E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790231	chr10:59989010	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790235	chr10:59985274	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790238	chr10:59983573	IPMK	chr10:59955618-60027694:-	0.18	4.36	1.59E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790240	chr10:59982139	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790241	chr10:60015313	IPMK	chr10:59955618-60027694:-	0.17	4.26	2.44E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2790242	chr10:59980652	IPMK	chr10:59955618-60027694:-	-0.16	-4.01	7.09E-5	Inflammatory bowel disease	
LUAD	cis	1	rs2799077	chr6:28234597	ZNF187	chr6:28234788-28245978:+	-0.23	-4.11	4.6E-5	Depression	
LUAD	cis	1	rs2799079	chr6:28235176	ZNF187	chr6:28234788-28245978:+	-0.22	-4.08	5.21E-5	Depression	
LUAD	cis	1	rs2811518	chr3:128013645	RUVBL1	chr3:127783627-127872757:-	-0.23	-3.86	0.00013	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
LUAD	cis	1	rs2811519	chr3:128012876	RUVBL1	chr3:127783627-127872757:-	-0.23	-3.87	0.000123	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
LUAD	cis	1	rs2811523	chr3:128011397	RUVBL1	chr3:127783627-127872757:-	0.21	3.69	0.000245	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
LUAD	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.65	-12.4	6.81E-31	Response to antipsychotic treatment	
LUAD	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.61	-11.45	4.85E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.65	-12.34	1.21E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs282522	chr3:56629678	CCDC66	chr3:56591184-56655846:+	0.18	5.24	2.39E-7	Height	
LUAD	cis	1	rs282523	chr3:56630166	CCDC66	chr3:56591184-56655846:+	-0.19	-5.43	9.08E-8	Height	
LUAD	cis	1	rs282804	chr15:80071108	MTHFS	chr15:80137320-80189370:-	-0.18	-3.7	0.000242	Disease-free survival in breast cancer	
LUAD	cis	1	rs2833888	chr21:33927560	TCP10L	chr21:33947152-33957845:-	-0.26	-3.96	8.71E-5	Gastritis	
LUAD	cis	1	rs2833890	chr21:33927886	TCP10L	chr21:33947152-33957845:-	0.26	4.2	3.14E-5	Gastritis	
LUAD	cis	1	rs2834018	chr21:34314478	GART	chr21:34876239-34915198:-	0.18	3.83	0.000143	Life satisfaction;Subjective well-being	
LUAD	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.36	-8.26	1.34E-15	Eye color traits	
LUAD	cis	1	rs2835607	chr21:38491973	TTC3	chr21:38445571-38575406:+	0.19	4.06	5.74E-5	Eye color traits	
LUAD	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.37	-8.32	9.08E-16	Eye color traits	
LUAD	cis	1	rs2835608	chr21:38493455	TTC3	chr21:38445571-38575406:+	0.19	4.06	5.72E-5	Eye color traits	
LUAD	cis	1	rs28360661	chr21:40681972	PSMG1	chr21:40547390-40555440:-	-0.19	-4.02	6.83E-5	Cognitive function	
LUAD	cis	1	rs28362672	chr2:70056866	SNRNP27	chr2:70121090-70132348:+	0.22	3.98	8.05E-5	Colorectal or endometrial cancer	
LUAD	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.26	3.89	0.000116	Atopic dermatitis	
LUAD	cis	1	rs28367503	chr16:67854534	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-4.13	4.24E-5	Crohn's disease	
LUAD	cis	1	rs2836974	chr21:40663181	PSMG1	chr21:40547390-40555440:-	0.2	4.46	1.04E-5	Cognitive function	
LUAD	cis	1	rs28371412	chr4:68415525	STAP1	chr4:68424446-68473053:+	-0.18	-3.75	0.0002	Parkinson's disease	
LUAD	cis	1	rs28372828	chr1:156253031	CCT3	chr1:156278752-156308195:-	-0.16	-3.92	0.000101	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs28374715	chr15:41563950	NDUFAF1	chr15:41679553-41694642:-	0.39	7.55	2.13E-13	Ulcerative colitis	
LUAD	cis	1	rs2837821	chr21:42161844	C21orf130	chr21:42513427-42519991:-	-0.2	-3.75	0.000201	Neutrophil count	
LUAD	cis	1	rs28379681	chr7:1070539	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.87	8.02E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs2838009	chr21:42694284	FAM3B	chr21:42676177-42729654:+	-0.32	-5.54	4.95E-8	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
LUAD	cis	1	rs28391259	chr4:107014012	TBCK	chr4:106967233-107237861:-	0.24	4.48	9.31E-6	Airflow obstruction	
LUAD	cis	1	rs2839181	chr21:47685939	C21orf56	chr21:47581063-47604373:-	-0.21	-3.91	0.000105	Testicular germ cell tumor	
LUAD	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.26	-5.48	6.7E-8	Testicular germ cell tumor	
LUAD	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.26	-5.58	4.01E-8	Testicular germ cell tumor	
LUAD	cis	1	rs2839337	chr21:47987167	C21orf56	chr21:47581063-47604373:-	0.26	4.91	1.27E-6	Lymphocyte counts	
LUAD	cis	1	rs28399702	chr14:35625217	KIAA0391	chr14:35591776-35786673:+	0.24	3.69	0.000248	Atopic dermatitis	
LUAD	cis	1	rs28399702	chr14:35625217	PPP2R3C	chr14:35554679-35591679:-	0.27	4.22	2.88E-5	Atopic dermatitis	
LUAD	cis	1	rs28399710	chr7:1070631	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.87	8.02E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs2843409	chr1:202359976	PPP1R12B	chr1:202317836-202557697:+	-0.19	-4.32	1.9E-5	Sex ratio	
LUAD	cis	1	rs28436199	chr17:18751730	FAM18B	chr17:18684582-18710026:+	-0.19	-3.73	0.000217	Educational attainment (years of education)	
LUAD	cis	1	rs28436199	chr17:18751730	FBXW10	chr17:18647326-18682661:+	-0.22	-4.44	1.13E-5	Educational attainment (years of education)	
LUAD	cis	1	rs28450087	chr16:68803726	NFATC3	chr16:68118654-68260837:+	-0.16	-3.74	0.000204	Colorectal cancer	
LUAD	cis	1	rs28463311	chr17:61919643	FTSJ3	chr17:61896795-61905031:-	0.21	4.36	1.56E-5	Body mass index	
LUAD	cis	1	rs2847577	chr18:48364819	MRO	chr18:48321491-48351754:-	-0.34	-5.89	7.1E-9	Entorhinal cortical thickness	
LUAD	cis	1	rs28485881	chr17:80690014	FN3K	chr17:80693452-80709073:+	-0.19	-3.9	0.000108	Glycated hemoglobin levels	
LUAD	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.33	-5.46	7.57E-8	Glycated hemoglobin levels	
LUAD	cis	1	rs28488297	chr4:106767226	INTS12	chr4:106603787-106629881:-	-0.49	-5.59	3.82E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs2849246	chr18:48371896	MRO	chr18:48321491-48351754:-	-0.35	-5.81	1.11E-8	Entorhinal cortical thickness	
LUAD	cis	1	rs28502530	chr14:65850968	PLEKHG3	chr14:65171193-65211060:+	-0.3	-3.73	0.000212	Ischemic stroke	
LUAD	cis	1	rs2851300	chr4:100279824	ADH1C	chr4:100257651-100273917:-	-0.19	-3.7	0.000239	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs28517362	chr6:151876387	C6orf97	chr6:151815175-151942327:+	0.17	3.81	0.000156	Bone mineral density (spine)	
LUAD	cis	1	rs28522614	chr10:102323141	SEC31B	chr10:102246403-102289636:-	-0.2	-6.21	1.15E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs28528096	chr7:1070912	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.87	8.02E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs2854218	chr17:61942940	FTSJ3	chr17:61896795-61905031:-	0.21	4.42	1.19E-5	Body mass index	
LUAD	cis	1	rs2854219	chr17:61942682	FTSJ3	chr17:61896795-61905031:-	0.2	4.19	3.35E-5	Body mass index	
LUAD	cis	1	rs2854223	chr17:61939014	FTSJ3	chr17:61896795-61905031:-	0.19	4.15	3.84E-5	Body mass index	
LUAD	cis	1	rs28599680	chr16:29860685	LOC440356	chr16:29875004-29879374:+	-0.27	-3.84	0.000139	Multiple sclerosis	
LUAD	cis	1	rs2859998	chr8:59324162	UBXN2B	chr8:59323823-59364059:+	-0.2	-3.83	0.000146	Narcolepsy with cataplexy	
LUAD	cis	1	rs28626045	chr14:75589195	EIF2B2	chr14:75469612-75476292:+	0.21	3.93	9.82E-5	Height	
LUAD	cis	1	rs28626045	chr14:75589195	MLH3	chr14:75480467-75518235:-	0.28	5.44	8.54E-8	Height	
LUAD	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.5	9.96	2.07E-21	Forced vital capacity	
LUAD	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.51	10.33	9.05E-23	Forced vital capacity	
LUAD	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.5	-10.1	6.43E-22	Forced vital capacity	
LUAD	cis	1	rs2864527	chr18:9288456	PPP4R1	chr18:9546792-9614600:-	0.54	3.95	8.94E-5	Dental caries	
LUAD	cis	1	rs28660361	chr16:68800838	NFATC3	chr16:68118654-68260837:+	-0.16	-3.71	0.000229	Colorectal cancer	
LUAD	cis	1	rs28661978	chr3:156579739	LEKR1	chr3:156544076-156763918:+	-0.27	-4.07	5.53E-5	Bone mineral density	
LUAD	cis	1	rs28664971	chr17:28437410	EFCAB5	chr17:28256874-28435469:+	0.33	5.98	4.24E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs28664971	chr17:28437410	SSH2	chr17:27952965-28257018:-	0.16	4.29	2.11E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs2867781	chr4:81529154	C4orf22	chr4:81256874-81884896:+	-0.21	-5.36	1.3E-7	Obesity-related traits	
LUAD	cis	1	rs28683528	chr12:123845351	CDK2AP1	chr12:123745542-123756687:-	-0.36	-5.87	8.14E-9	Educational attainment;Height;Head circumference (infant)	
LUAD	cis	1	rs2870024	chr20:49538921	KCNG1	chr20:49620194-49639675:-	-0.37	-3.68	0.000259	Prostate cancer	
LUAD	cis	1	rs2870025	chr20:49539058	KCNG1	chr20:49620194-49639675:-	-0.37	-3.68	0.000259	Prostate cancer	
LUAD	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.7	12.09	1.33E-29	Diastolic blood pressure	
LUAD	cis	1	rs28730640	chr4:99994053	ADH5	chr4:99992132-100009931:-	0.29	3.69	0.000249	Smoking initiation	
LUAD	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.67	12.04	2.03E-29	Diastolic blood pressure	
LUAD	cis	1	rs2874121	chr17:61731024	FTSJ3	chr17:61896795-61905031:-	0.21	4.53	7.34E-6	Body mass index	
LUAD	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.31	-4.84	1.75E-6	Bone mineral density	
LUAD	cis	1	rs2874491	chr3:156649111	LEKR1	chr3:156544076-156763918:+	-0.33	-5.3	1.78E-7	Bone mineral density	
LUAD	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.65	10.71	3.31E-24	Diastolic blood pressure	
LUAD	cis	1	rs28757156	chr15:51545455	CYP19A1	chr15:51500255-51630795:-	0.41	4.01	6.94E-5	Height	
LUAD	cis	1	rs28757157	chr15:51545401	CYP19A1	chr15:51500255-51630795:-	0.41	4.02	6.61E-5	Height	
LUAD	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.29	-7.03	6.81E-12	Longevity	
LUAD	cis	1	rs2885510	chr3:48418226	ATRIP	chr3:48488141-48507708:+	-0.19	-3.68	0.000258	Longevity	
LUAD	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.25	6.25	8.98E-10	Longevity	
LUAD	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.52	9.97	1.9E-21	Height	
LUAD	cis	1	rs28897193	chr4:107005529	TBCK	chr4:106967233-107237861:-	0.25	4.78	2.32E-6	Airflow obstruction	
LUAD	cis	1	rs2896954	chr15:76851692	SCAPER	chr15:76640529-77197744:-	-0.22	-5.18	3.26E-7	Blood metabolite levels	
LUAD	cis	1	rs2901354	chr10:124733038	C10orf88	chr10:124690419-124713919:-	-0.19	-3.81	0.000156	Migraine without aura	
LUAD	cis	1	rs2901355	chr10:124731766	C10orf88	chr10:124690419-124713919:-	-0.2	-4.07	5.42E-5	Migraine without aura	
LUAD	cis	1	rs2901438	chr2:73665656	ALMS1	chr2:73612886-73837046:+	0.19	4.7	3.38E-6	Metabolite levels	
LUAD	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.36	6.9	1.57E-11	Metabolite levels	
LUAD	cis	1	rs2902783	chr18:9288497	PPP4R1	chr18:9546792-9614600:-	0.54	3.95	8.94E-5	Dental caries	
LUAD	cis	1	rs2905425	chr19:19475717	HAPLN4	chr19:19366453-19384074:-	-0.18	-4.05	5.96E-5	Schizophrenia	
LUAD	cis	1	rs2913995	chr19:48117028	SLC8A2	chr19:47931280-47975307:-	-0.24	-3.77	0.00018	Parental longevity (mother's age at death)	
LUAD	cis	1	rs2913996	chr19:48116694	SLC8A2	chr19:47931280-47975307:-	-0.24	-3.68	0.000256	Parental longevity (mother's age at death)	
LUAD	cis	1	rs2920282	chr8:143757763	PSCA	chr8:143761875-143764142:+	0.29	7.59	1.6E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920283	chr8:143757037	PSCA	chr8:143761875-143764142:+	0.3	7.65	1.11E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920292	chr8:143765699	LYNX1	chr8:143845758-143859640:-	-0.17	-3.71	0.000233	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920292	chr8:143765699	PSCA	chr8:143761875-143764142:+	0.3	7.67	9.65E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920293	chr8:143765414	LYNX1	chr8:143845758-143859640:-	-0.17	-3.71	0.000233	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920293	chr8:143765414	PSCA	chr8:143761875-143764142:+	0.3	7.67	9.65E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920294	chr8:143765326	LYNX1	chr8:143845758-143859640:-	-0.17	-3.71	0.000233	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920294	chr8:143765326	PSCA	chr8:143761875-143764142:+	0.3	7.67	9.65E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920295	chr8:143764937	LYNX1	chr8:143845758-143859640:-	-0.18	-3.77	0.000181	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920295	chr8:143764937	PSCA	chr8:143761875-143764142:+	0.3	7.65	1.06E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920296	chr8:143763109	PSCA	chr8:143761875-143764142:+	0.3	7.94	1.36E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920297	chr8:143763083	PSCA	chr8:143761875-143764142:+	0.3	7.94	1.36E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920298	chr8:143763043	PSCA	chr8:143761875-143764142:+	0.3	7.94	1.36E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.3	-4.36	1.61E-5	Tumor biomarkers	
LUAD	cis	1	rs2920781	chr15:43924682	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.24	2.63E-5	Tumor biomarkers	
LUAD	cis	1	rs2924584	chr4:99988208	ADH4	chr4:100044835-100065449:-	-0.34	-7.09	4.65E-12	HDL cholesterol	
LUAD	cis	1	rs2926621	chr18:73620170	LOC284276	chr18:74240612-74271783:+	0.22	4.42	1.21E-5	Night sleep phenotypes	
LUAD	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.3	-4.36	1.61E-5	Tumor biomarkers	
LUAD	cis	1	rs2927072	chr15:43922398	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.24	2.63E-5	Tumor biomarkers	
LUAD	cis	1	rs2932538	chr1:113216543	ST7L	chr1:113066142-113162405:-	-0.38	-6.5	2.01E-10	Systolic blood pressure;Hypertension;Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs2935183	chr17:45607572	C17orf57	chr17:45401142-45518675:+	-0.31	-6.41	3.51E-10	Multiple sclerosis or amyotrophic lateral sclerosis	
LUAD	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.35	6.63	9.12E-11	Obesity-related traits	
LUAD	cis	1	rs2951308	chr7:143767149	OR2A9P	chr7:143991573-143997832:+;chr7	0.29	5.34	1.46E-7	Obesity-related traits	
LUAD	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.28	7.55E-10	Obesity-related traits	
LUAD	cis	1	rs2951353	chr7:143761116	OR2A7	chr7:143955790-143974852:-	0.21	3.73	0.000211	Obesity-related traits	
LUAD	cis	1	rs2951353	chr7:143761116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.91	1.22E-6	Obesity-related traits	
LUAD	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.3	6.56E-10	Obesity-related traits	
LUAD	cis	1	rs2951354	chr7:143761001	OR2A7	chr7:143955790-143974852:-	0.21	3.76	0.00019	Obesity-related traits	
LUAD	cis	1	rs2951354	chr7:143761001	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.15	3.73E-7	Obesity-related traits	
LUAD	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.27	8.17E-10	Obesity-related traits	
LUAD	cis	1	rs2951360	chr7:143757349	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.1	4.97E-7	Obesity-related traits	
LUAD	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.38	4.16E-10	Obesity-related traits	
LUAD	cis	1	rs2951363	chr7:143754724	OR2A7	chr7:143955790-143974852:-	0.21	3.76	0.000194	Obesity-related traits	
LUAD	cis	1	rs2951363	chr7:143754724	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.88	1.43E-6	Obesity-related traits	
LUAD	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.44	2.92E-10	Obesity-related traits	
LUAD	cis	1	rs2951364	chr7:143754483	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.000197	Obesity-related traits	
LUAD	cis	1	rs2951364	chr7:143754483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-5.01	7.77E-7	Obesity-related traits	
LUAD	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.38	4.18E-10	Obesity-related traits	
LUAD	cis	1	rs2951368	chr7:143752821	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.000197	Obesity-related traits	
LUAD	cis	1	rs2951368	chr7:143752821	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.85	1.66E-6	Obesity-related traits	
LUAD	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.44	2.93E-10	Obesity-related traits	
LUAD	cis	1	rs2951369	chr7:143752638	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.0002	Obesity-related traits	
LUAD	cis	1	rs2951369	chr7:143752638	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.97	9.08E-7	Obesity-related traits	
LUAD	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.47	2.38E-10	Obesity-related traits	
LUAD	cis	1	rs2951372	chr7:143749503	OR2A7	chr7:143955790-143974852:-	0.21	3.76	0.00019	Obesity-related traits	
LUAD	cis	1	rs2951372	chr7:143749503	OR2A9P	chr7:143991573-143997832:+;chr7	-0.26	-4.82	1.96E-6	Obesity-related traits	
LUAD	cis	1	rs2952773	chr4:170874771	MFAP3L	chr4:170907750-170947429:-	-0.2	-3.8	0.000161	Educational attainment	
LUAD	cis	1	rs2955259	chr4:170873844	MFAP3L	chr4:170907750-170947429:-	-0.2	-3.8	0.000161	Educational attainment	
LUAD	cis	1	rs2955265	chr4:170875548	MFAP3L	chr4:170907750-170947429:-	-0.2	-3.79	0.000167	Educational attainment	
LUAD	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.38	4.18E-10	Obesity-related traits	
LUAD	cis	1	rs2961115	chr7:143753371	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.000197	Obesity-related traits	
LUAD	cis	1	rs2961115	chr7:143753371	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.85	1.66E-6	Obesity-related traits	
LUAD	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.27	7.72E-10	Obesity-related traits	
LUAD	cis	1	rs2961117	chr7:143755253	OR2A9P	chr7:143991573-143997832:+;chr7	-0.29	-5.3	1.8E-7	Obesity-related traits	
LUAD	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.38	4.03E-10	Obesity-related traits	
LUAD	cis	1	rs2961118	chr7:143755443	OR2A7	chr7:143955790-143974852:-	0.21	3.76	0.000188	Obesity-related traits	
LUAD	cis	1	rs2961118	chr7:143755443	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-5.02	7.34E-7	Obesity-related traits	
LUAD	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.35	-6.4	3.68E-10	Obesity-related traits	
LUAD	cis	1	rs2961119	chr7:143755852	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.0002	Obesity-related traits	
LUAD	cis	1	rs2961119	chr7:143755852	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.16	3.68E-7	Obesity-related traits	
LUAD	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.27	8.17E-10	Obesity-related traits	
LUAD	cis	1	rs2961120	chr7:143756585	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.1	4.97E-7	Obesity-related traits	
LUAD	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.3	6.56E-10	Obesity-related traits	
LUAD	cis	1	rs2961125	chr7:143761770	OR2A7	chr7:143955790-143974852:-	0.21	3.76	0.00019	Obesity-related traits	
LUAD	cis	1	rs2961125	chr7:143761770	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.15	3.73E-7	Obesity-related traits	
LUAD	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.3	6.56E-10	Obesity-related traits	
LUAD	cis	1	rs2961126	chr7:143762736	OR2A7	chr7:143955790-143974852:-	0.21	3.76	0.00019	Obesity-related traits	
LUAD	cis	1	rs2961126	chr7:143762736	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.15	3.73E-7	Obesity-related traits	
LUAD	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.35	4.92E-10	Obesity-related traits	
LUAD	cis	1	rs2961128	chr7:143763483	OR2A7	chr7:143955790-143974852:-	0.21	3.76	0.000194	Obesity-related traits	
LUAD	cis	1	rs2961128	chr7:143763483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.28	-5.13	4.18E-7	Obesity-related traits	
LUAD	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.33	-6.09	2.33E-9	Obesity-related traits	
LUAD	cis	1	rs2961132	chr7:143768128	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.98	8.96E-7	Obesity-related traits	
LUAD	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.36	-6.82	2.77E-11	Obesity-related traits	
LUAD	cis	1	rs2961134	chr7:143771062	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-5.04	6.44E-7	Obesity-related traits	
LUAD	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.35	6.53	1.62E-10	Obesity-related traits	
LUAD	cis	1	rs2961144	chr7:143747870	OR2A7	chr7:143955790-143974852:-	-0.22	-3.85	0.000133	Obesity-related traits	
LUAD	cis	1	rs2961144	chr7:143747870	OR2A9P	chr7:143991573-143997832:+;chr7	0.26	4.74	2.79E-6	Obesity-related traits	
LUAD	cis	1	rs2965188	chr19:19522557	HAPLN4	chr19:19366453-19384074:-	0.17	3.79	0.000169	Schizophrenia	
LUAD	cis	1	rs2973114	chr5:37857227	OSMR	chr5:38846128-38934402:+	-0.19	-3.71	0.000235	World class endurance athleticism	
LUAD	cis	1	rs2973116	chr5:37854738	OSMR	chr5:38846128-38934402:+	-0.18	-3.73	0.000212	World class endurance athleticism	
LUAD	cis	1	rs2976388	chr8:143760256	LYNX1	chr8:143845758-143859640:-	-0.19	-4.13	4.29E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2976388	chr8:143760256	PSCA	chr8:143761875-143764142:+	0.28	7.19	2.52E-12	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2976392	chr8:143762932	PSCA	chr8:143761875-143764142:+	0.3	7.9	1.85E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2976394	chr8:143763622	PSCA	chr8:143761875-143764142:+	0.3	7.94	1.36E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2976396	chr8:143764001	PSCA	chr8:143761875-143764142:+	-0.3	-8.01	8.71E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2976398	chr8:143764879	LYNX1	chr8:143845758-143859640:-	-0.17	-3.73	0.000216	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2976398	chr8:143764879	PSCA	chr8:143761875-143764142:+	0.29	7.59	1.62E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.27	6.04	2.99E-9	Schizophrenia	
LUAD	cis	1	rs2978982	chr8:143763490	PSCA	chr8:143761875-143764142:+	0.3	7.9	1.85E-14	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LUAD	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.89	-18.19	7.82E-57	Homocysteine levels	
LUAD	cis	1	rs2993259	chr1:46001550	MUTYH	chr1:45794915-45806142:-	0.2	4.3	2.07E-5	Homocysteine levels	
LUAD	cis	1	rs2993834	chr10:59971616	IPMK	chr10:59955618-60027694:-	0.17	4.23	2.77E-5	Inflammatory bowel disease	
LUAD	cis	1	rs300773	chr2:115035	SH3YL1	chr2:218138-264810:-	-0.23	-3.72	0.000224	Suicide attempts in bipolar disorder	
LUAD	cis	1	rs3018302	chr11:71790942	IL18BP	chr11:71709958-71716760:+	-0.25	-3.67	0.000266	Severe influenza A (H1N1) infection	
LUAD	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.44	-11.09	1.17E-25	Ankylosing spondylitis	
LUAD	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.46	8.68	5.96E-17	Ankylosing spondylitis	
LUAD	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.44	-10.96	3.67E-25	Ankylosing spondylitis	
LUAD	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.46	8.69	5.55E-17	Ankylosing spondylitis	
LUAD	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.44	-11.07	1.49E-25	Ankylosing spondylitis	
LUAD	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.45	8.63	8.84E-17	Ankylosing spondylitis	
LUAD	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.44	-11.07	1.49E-25	Ankylosing spondylitis	
LUAD	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.45	8.63	8.84E-17	Ankylosing spondylitis	
LUAD	cis	1	rs3091242	chr1:25674785	RHCE	chr1:25688741-25756683:-	0.3	6.9	1.59E-11	Erythrocyte sedimentation rate	
LUAD	cis	1	rs3091242	chr1:25674785	RHD	chr1:25598981-25656935:+	-0.54	-11.18	5.15E-26	Erythrocyte sedimentation rate	
LUAD	cis	1	rs3097417	chr3:53088601	TMEM110	chr3:52867139-52931547:-	-0.39	-4.59	5.76E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.81	14.26	7.7E-39	Type 2 diabetes	
LUAD	cis	1	rs3099555	chr4:1725651	FAM53A	chr4:1641609-1685854:-	-0.33	-5.7	2.1E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs310124	chr1:153020275	SPRR1A	chr1:152956557-152958289:+	0.23	4.61	5.13E-6	Inflammatory skin disease	
LUAD	cis	1	rs310124	chr1:153020275	SPRR2D	chr1:153012201-153113969:-	0.19	3.91	0.000107	Inflammatory skin disease	
LUAD	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.27	-3.85	0.000135	Tumor biomarkers	
LUAD	cis	1	rs3101443	chr15:43912372	CATSPER2	chr15:43922774-43959900:-	-0.24	-3.78	0.000176	Tumor biomarkers	
LUAD	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.46	-8.15	3.1E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs3110496	chr17:27917771	EFCAB5	chr17:28256874-28435469:+	0.26	4.5	8.38E-6	Height	
LUAD	cis	1	rs3110496	chr17:27917771	SSH2	chr17:27952965-28257018:-	0.15	3.68	0.000264	Height	
LUAD	cis	1	rs3118625	chr9:131873256	CRAT	chr9:131857075-131873070:-	-0.36	-6.65	7.99E-11	Blood metabolite ratios	
LUAD	cis	1	rs3118625	chr9:131873256	PPP2R4	chr9:131873244-131911223:+	-0.23	-4.26	2.47E-5	Blood metabolite ratios	
LUAD	cis	1	rs3118632	chr9:131901284	CRAT	chr9:131857075-131873070:-	-0.36	-6.89	1.77E-11	Blood metabolite ratios	
LUAD	cis	1	rs3118632	chr9:131901284	PPP2R4	chr9:131873244-131911223:+	-0.22	-4.48	9.16E-6	Blood metabolite ratios	
LUAD	cis	1	rs3120662	chr1:152302865	FLG	chr1:152274651-152297679:-	0.23	3.76	0.00019	Atopic dermatitis	
LUAD	cis	1	rs3124510	chr9:131899690	CRAT	chr9:131857075-131873070:-	-0.37	-7.4	5.99E-13	Blood metabolite ratios	
LUAD	cis	1	rs3124510	chr9:131899690	PPP2R4	chr9:131873244-131911223:+	-0.25	-5.18	3.19E-7	Blood metabolite ratios	
LUAD	cis	1	rs3124511	chr9:131901458	CRAT	chr9:131857075-131873070:-	-0.36	-6.74	4.5E-11	Blood metabolite ratios	
LUAD	cis	1	rs3124511	chr9:131901458	PPP2R4	chr9:131873244-131911223:+	-0.24	-4.54	7.24E-6	Blood metabolite ratios	
LUAD	cis	1	rs3124512	chr9:131903881	CRAT	chr9:131857075-131873070:-	-0.38	-7.16	3.01E-12	Blood metabolite ratios	
LUAD	cis	1	rs3124512	chr9:131903881	PPP2R4	chr9:131873244-131911223:+	-0.29	-5.55	4.65E-8	Blood metabolite ratios	
LUAD	cis	1	rs3124513	chr9:131904593	CRAT	chr9:131857075-131873070:-	-0.36	-6.83	2.57E-11	Blood metabolite ratios	
LUAD	cis	1	rs3124513	chr9:131904593	PPP2R4	chr9:131873244-131911223:+	-0.23	-4.54	6.98E-6	Blood metabolite ratios	
LUAD	cis	1	rs3124514	chr9:131904608	CRAT	chr9:131857075-131873070:-	-0.36	-6.83	2.57E-11	Blood metabolite ratios	
LUAD	cis	1	rs3124514	chr9:131904608	PPP2R4	chr9:131873244-131911223:+	-0.23	-4.54	6.98E-6	Blood metabolite ratios	
LUAD	cis	1	rs3126085	chr1:152300817	FLG	chr1:152274651-152297679:-	0.23	3.78	0.000177	Atopic dermatitis	
LUAD	cis	1	rs3126092	chr1:152307955	FLG	chr1:152274651-152297679:-	0.24	3.88	0.00012	Atopic dermatitis	
LUAD	cis	1	rs3126095	chr1:152309683	FLG	chr1:152274651-152297679:-	0.24	3.83	0.000145	Atopic dermatitis	
LUAD	cis	1	rs3127447	chr10:79253261	KCNMA1	chr10:78629359-79397577:-	0.22	5.14	4.0E-7	Educational attainment	
LUAD	cis	1	rs313798	chr7:65493031	CCT6P1	chr7:65216092-65228661:+	0.23	3.68	0.000264	Diabetic kidney disease	
LUAD	cis	1	rs313802	chr7:65516373	CCT6P1	chr7:65216092-65228661:+	0.24	3.79	0.000166	Diabetic kidney disease	
LUAD	cis	1	rs313803	chr7:65514731	CCT6P1	chr7:65216092-65228661:+	0.24	3.79	0.000166	Diabetic kidney disease	
LUAD	cis	1	rs313831	chr7:65551226	CCT6P1	chr7:65216092-65228661:+	0.24	3.77	0.000182	Diabetic kidney disease	
LUAD	cis	1	rs313832	chr7:65550891	CCT6P1	chr7:65216092-65228661:+	0.24	3.77	0.000181	Diabetic kidney disease	
LUAD	cis	1	rs316331	chr7:65604622	CCT6P1	chr7:65216092-65228661:+	-0.24	-3.75	0.000198	Diabetic kidney disease	
LUAD	cis	1	rs3183928	chr9:100684719	C9orf156	chr9:100666772-100684852:-	-0.19	-3.81	0.000158	Quantitative traits	
LUAD	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.6	-9.18	1.21E-18	Dental caries	
LUAD	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.62	-12.32	1.41E-30	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.3	-7.49	3.23E-13	Longevity	
LUAD	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.22	3.87	0.000125	Renal underexcretion gout;Gout	
LUAD	cis	1	rs321622	chr4:48024380	NIPAL1	chr4:48018791-48039078:+	0.35	6.98	9.86E-12	Renal underexcretion gout;Gout	
LUAD	cis	1	rs3310	chr20:3237232	ITPA	chr20:3190056-3204504:+	-0.23	-4.18	3.41E-5	IFN-related cytopenia	
LUAD	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.79	13.83	5.84E-37	Type 2 diabetes	
LUAD	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.8	14.4	1.92E-39	Type 2 diabetes	
LUAD	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.8	14.09	4.59E-38	Type 2 diabetes	
LUAD	cis	1	rs33438	chr19:30945072	C19orf2	chr19:30414551-30506611:+	-0.23	-4.03	6.49E-5	Body mass index	
LUAD	cis	1	rs33438	chr19:30945072	POP4	chr19:30097170-30108162:+	-0.18	-3.73	0.000216	Body mass index	
LUAD	cis	1	rs33439	chr19:30945171	C19orf2	chr19:30414551-30506611:+	0.22	4.01	6.97E-5	Body mass index	
LUAD	cis	1	rs33439	chr19:30945171	POP4	chr19:30097170-30108162:+	0.18	3.75	0.000199	Body mass index	
LUAD	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.36	7.18	2.66E-12	Cognitive performance	
LUAD	cis	1	rs33997653	chr6:76332934	IMPG1	chr6:76631062-76782335:-	0.3	4.28	2.21E-5	Height	
LUAD	cis	1	rs33999310	chr3:52883332	TMEM110	chr3:52867139-52931547:-	0.38	4.21	3.1E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs34055941	chr9:131895076	CRAT	chr9:131857075-131873070:-	0.35	6.59	1.16E-10	Blood metabolite ratios	
LUAD	cis	1	rs34055941	chr9:131895076	PPP2R4	chr9:131873244-131911223:+	0.21	4.14	4.09E-5	Blood metabolite ratios	
LUAD	cis	1	rs34072732	chr4:106604364	INTS12	chr4:106603787-106629881:-	-0.64	-6.58	1.21E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.37	7.3	1.2E-12	Cognitive performance	
LUAD	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.19	2.42E-12	Body mass index	
LUAD	cis	1	rs34102169	chr1:46424864	MUTYH	chr1:45794915-45806142:-	0.17	3.98	8.1E-5	Body mass index	
LUAD	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.63	-11.76	2.67E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs34117728	chr5:156433497	TIMD4	chr5:156346293-156390266:-	-0.24	-4.21	2.99E-5	Hypertriglyceridemia	
LUAD	cis	1	rs34121720	chr3:53072167	TMEM110	chr3:52867139-52931547:-	0.43	4.7	3.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs34127220	chr16:29842891	LOC440356	chr16:29875004-29879374:+	-0.28	-4.02	6.75E-5	Multiple sclerosis	
LUAD	cis	1	rs34128973	chr11:47851376	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.1	4.82E-5	Subjective well-being	
LUAD	cis	1	rs34128973	chr11:47851376	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.53	7.55E-6	Subjective well-being	
LUAD	cis	1	rs34227865	chr4:76546525	CXCL9	chr4:76922623-76928641:-	0.15	3.77	0.000182	Magnesium levels	
LUAD	cis	1	rs34230359	chr5:156449561	TIMD4	chr5:156346293-156390266:-	-0.24	-4.3	2.06E-5	Hypertriglyceridemia	
LUAD	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.36	6.43	3.13E-10	Blood trace element (Zn levels)	
LUAD	cis	1	rs34244302	chr3:53102236	TMEM110	chr3:52867139-52931547:-	0.47	5.19	3.02E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs34252323	chr2:135486302	TMEM163	chr2:135213331-135525334:-	-0.2	-3.69	0.000252	Gut microbiome composition (winter)	
LUAD	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.68	-12.21	3.97E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs34286592	chr16:29820480	LOC440356	chr16:29875004-29879374:+	-0.31	-4.3	2.1E-5	Multiple sclerosis	
LUAD	cis	1	rs34313969	chr3:52995166	TMEM110	chr3:52867139-52931547:-	0.45	4.88	1.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs34320230	chr7:97785500	BHLHA15	chr7:97840778-97842271:+	-0.18	-4.5	8.66E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
LUAD	cis	1	rs34340609	chr3:53077276	TMEM110	chr3:52867139-52931547:-	0.4	4.84	1.73E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs34382476	chr6:111744754	KIAA1919	chr6:111580482-111590259:+	0.46	4.02	6.65E-5	Psoriasis	
LUAD	cis	1	rs34405766	chr2:135486189	TMEM163	chr2:135213331-135525334:-	-0.2	-3.69	0.000252	Gut microbiome composition (winter)	
LUAD	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.29	-4.66	4.01E-6	Bone mineral density	
LUAD	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.29	-4.66	4.01E-6	Bone mineral density	
LUAD	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.29	-4.66	4.01E-6	Bone mineral density	
LUAD	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.26	5.22	2.72E-7	Body mass index	
LUAD	cis	1	rs34409737	chr5:156457857	TIMD4	chr5:156346293-156390266:-	-0.24	-4.28	2.27E-5	Hypertriglyceridemia	
LUAD	cis	1	rs34428306	chr1:152184316	FLG	chr1:152274651-152297679:-	0.43	8.09	4.91E-15	Inflammatory skin disease	
LUAD	cis	1	rs34530577	chr3:53103796	RFT1	chr3:53122503-53164470:-	-0.19	-3.76	0.000193	Height	
LUAD	cis	1	rs34530632	chr6:111776335	KIAA1919	chr6:111580482-111590259:+	0.52	3.95	8.98E-5	Psoriasis	
LUAD	cis	1	rs34570071	chr15:85280212	LOC388152	chr15:84867600-84898920:-	-0.31	-5.98	4.34E-9	Schizophrenia	
LUAD	cis	1	rs34575783	chr15:63397686	LACTB	chr15:63414032-63434254:+	0.21	4.03	6.37E-5	HDL cholesterol	
LUAD	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.67	-12.14	7.65E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs34587942	chr2:70081501	SNRNP27	chr2:70121090-70132348:+	0.22	4.01	7.16E-5	Colorectal or endometrial cancer	
LUAD	cis	1	rs34594435	chr7:72977249	MLXIPL	chr7:73007524-73038870:-	0.27	4.07	5.45E-5	Triglycerides	
LUAD	cis	1	rs34610643	chr17:40574388	NAGLU	chr17:40687951-40696464:+	-0.2	-3.71	0.000235	Crohn's disease	
LUAD	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.62	-11.58	1.44E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs34637256	chr7:65360131	CRCP	chr7:65579805-65619551:+	-0.34	-3.85	0.000133	Diabetic kidney disease	
LUAD	cis	1	rs346785	chr17:74283769	FAM100B	chr17:74261286-74267379:+	0.18	3.76	0.00019	White matter hyperintensities in ischemic stroke	
LUAD	cis	1	rs34702770	chr7:65344823	CRCP	chr7:65579805-65619551:+	-0.33	-3.74	0.000203	Diabetic kidney disease	
LUAD	cis	1	rs34703416	chr7:65300642	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.000226	Diabetic kidney disease	
LUAD	cis	1	rs34751999	chr15:84758419	GOLGA6L5	chr15:85047738-85060078:-	-0.17	-3.72	0.000219	Schizophrenia	
LUAD	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.38	-7.06	5.59E-12	Schizophrenia	
LUAD	cis	1	rs34785390	chr4:76534481	CXCL9	chr4:76922623-76928641:-	0.15	3.85	0.000131	Magnesium levels	
LUAD	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.29	-5.83	1.03E-8	Menarche (age at onset)	
LUAD	cis	1	rs34815098	chr7:65292254	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.00022	Diabetic kidney disease	
LUAD	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.5	8.27	1.32E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.63	-11.63	9.3E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs34865093	chr5:156424767	TIMD4	chr5:156346293-156390266:-	-0.22	-3.86	0.000128	Hypertriglyceridemia	
LUAD	cis	1	rs34900908	chr15:85257599	LOC388152	chr15:84867600-84898920:-	-0.32	-5.99	4.09E-9	Schizophrenia	
LUAD	cis	1	rs34910028	chr11:47758449	C1QTNF4	chr11:47611216-47615961:-	-0.21	-4.06	5.8E-5	Subjective well-being	
LUAD	cis	1	rs34910028	chr11:47758449	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.49	8.88E-6	Subjective well-being	
LUAD	cis	1	rs34915449	chr1:101476786	CCDC76	chr1:100598706-100616053:+	0.18	3.78	0.000179	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs34933390	chr3:53006265	TMEM110	chr3:52867139-52931547:-	0.41	4.56	6.36E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs34943350	chr3:53012888	TMEM110	chr3:52867139-52931547:-	0.45	4.68	3.72E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs34949904	chr22:24695298	POM121L9P	chr22:24647589-24661490:+	-0.26	-5.45	8.03E-8	Gut microbiome composition (summer)	
LUAD	cis	1	rs34964872	chr14:104448435	TDRD9	chr14:104394817-104519002:+	0.27	4.17	3.64E-5	Bipolar disorder	
LUAD	cis	1	rs34970380	chr7:65431493	CCT6P1	chr7:65216092-65228661:+	0.24	3.76	0.000188	Diabetic kidney disease	
LUAD	cis	1	rs34974928	chr7:65364006	CRCP	chr7:65579805-65619551:+	-0.34	-3.85	0.000133	Diabetic kidney disease	
LUAD	cis	1	rs34979715	chr3:53048960	TMEM110	chr3:52867139-52931547:-	0.47	4.87	1.54E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs35000407	chr3:12351521	MKRN2	chr3:12598594-12625208:+	0.37	4.5	8.48E-6	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs35000407	chr3:12351521	RAF1	chr3:12625102-12705700:-	0.35	4.11	4.71E-5	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs35002543	chr2:70091299	SNRNP27	chr2:70121090-70132348:+	0.22	4.16	3.72E-5	Colorectal or endometrial cancer	
LUAD	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.46	7.83	3.08E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs35025342	chr6:151876661	C6orf97	chr6:151815175-151942327:+	0.17	3.81	0.000156	Bone mineral density (spine)	
LUAD	cis	1	rs35056702	chr6:109736326	AKD1	chr6:109814059-110012415:-	-0.21	-4.15	3.88E-5	Height	
LUAD	cis	1	rs35056702	chr6:109736326	SMPD2	chr6:109761931-109765121:+	0.23	4.64	4.53E-6	Height	
LUAD	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.52	-10.49	2.44E-23	Forced vital capacity	
LUAD	cis	1	rs35069703	chr16:68789445	NFATC3	chr16:68118654-68260837:+	-0.17	-3.77	0.000184	Colorectal cancer	
LUAD	cis	1	rs35084691	chr2:70094137	SNRNP27	chr2:70121090-70132348:+	0.22	4.16	3.72E-5	Colorectal or endometrial cancer	
LUAD	cis	1	rs35106985	chr10:102307542	SEC31B	chr10:102246403-102289636:-	-0.2	-6.39	3.89E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs35141484	chr4:39088341	PDS5A	chr4:39824484-39979576:-	-0.44	-4.28	2.29E-5	Asthma (childhood onset)	
LUAD	cis	1	rs35141484	chr4:39088341	RFC1	chr4:39289076-39367995:-	-0.44	-4.38	1.45E-5	Asthma (childhood onset)	
LUAD	cis	1	rs35141484	chr4:39088341	UBE2K	chr4:39699664-39784408:+	-0.46	-4.34	1.74E-5	Asthma (childhood onset)	
LUAD	cis	1	rs35146655	chr22:24605938	SUSD2	chr22:24577444-24585074:+	0.27	4.23	2.73E-5	Amyotrophic lateral sclerosis	
LUAD	cis	1	rs35151650	chr6:111757727	KIAA1919	chr6:111580482-111590259:+	0.45	4.02	6.68E-5	Psoriasis	
LUAD	cis	1	rs35159031	chr5:156475430	TIMD4	chr5:156346293-156390266:-	-0.25	-4.57	6.06E-6	Hypertriglyceridemia	
LUAD	cis	1	rs35160687	chr2:86472114	LOC90784	chr2:86247339-86250991:-	0.22	4.17	3.53E-5	Night sleep phenotypes	
LUAD	cis	1	rs35163227	chr3:53127876	TMEM110	chr3:52867139-52931547:-	0.47	5.17	3.36E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs35174175	chr3:53041509	TMEM110	chr3:52867139-52931547:-	0.46	4.86	1.6E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs35184688	chr17:40272406	DHX58	chr17:40253422-40264751:-	-0.29	-5.38	1.17E-7	Fibrinogen levels	
LUAD	cis	1	rs35202312	chr6:56788937	BEND6	chr6:56819773-56892138:+	-0.26	-5.53	5.32E-8	Menarche (age at onset)	
LUAD	cis	1	rs35208445	chr6:111756147	KIAA1919	chr6:111580482-111590259:+	0.45	4.02	6.68E-5	Psoriasis	
LUAD	cis	1	rs35212307	chr2:203765756	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs35248830	chr6:111756750	KIAA1919	chr6:111580482-111590259:+	0.45	4.02	6.68E-5	Psoriasis	
LUAD	cis	1	rs35272895	chr17:40580669	NAGLU	chr17:40687951-40696464:+	-0.2	-3.7	0.000242	Crohn's disease	
LUAD	cis	1	rs35297609	chr15:84772896	GOLGA6L5	chr15:85047738-85060078:-	-0.17	-3.72	0.00022	Schizophrenia	
LUAD	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.38	-7	8.75E-12	Schizophrenia	
LUAD	cis	1	rs35303215	chr22:24801535	POM121L9P	chr22:24647589-24661490:+	-0.27	-5.57	4.21E-8	Gut microbiome composition (summer)	
LUAD	cis	1	rs35316992	chr15:85248133	LOC388152	chr15:84867600-84898920:-	-0.32	-5.99	4.09E-9	Schizophrenia	
LUAD	cis	1	rs35370743	chr4:106604190	INTS12	chr4:106603787-106629881:-	-0.64	-6.31	6.25E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.65	-12.31	1.64E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs35391607	chr7:65360829	CRCP	chr7:65579805-65619551:+	-0.34	-3.85	0.000133	Diabetic kidney disease	
LUAD	cis	1	rs35398388	chr19:37740358	ZNF585B	chr19:37675724-37701451:-	0.25	3.7	0.00024	Coronary artery calcification	
LUAD	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.68	-12.21	3.97E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.52	10.73	3.03E-24	Eye color traits	
LUAD	cis	1	rs35454259	chr6:27254475	BTN3A2	chr6:26365398-26378546:+	-0.32	-6.4	3.56E-10	Schizophrenia	
LUAD	cis	1	rs35506374	chr20:47927883	C20orf199	chr20:47894715-47905793:+	0.19	3.77	0.000186	Height	
LUAD	cis	1	rs35507120	chr3:53053924	TMEM110	chr3:52867139-52931547:-	0.45	4.62	4.99E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs35524990	chr15:85258203	LOC388152	chr15:84867600-84898920:-	-0.32	-5.99	4.09E-9	Schizophrenia	
LUAD	cis	1	rs35527216	chr6:56791278	BEND6	chr6:56819773-56892138:+	-0.26	-5.51	5.75E-8	Menarche (age at onset)	
LUAD	cis	1	rs35564624	chr6:151876494	C6orf97	chr6:151815175-151942327:+	0.17	3.81	0.000158	Bone mineral density (spine)	
LUAD	cis	1	rs35576914	chr3:53092270	TMEM110	chr3:52867139-52931547:-	0.47	5.03	6.82E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs35577967	chr15:75354621	SCAMP5	chr15:75287901-75313836:+	0.38	6.6	1.06E-10	Blood trace element (Zn levels)	
LUAD	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.23	-4.37	1.53E-5	Subjective well-being	
LUAD	cis	1	rs35624992	chr11:47615798	MYBPC3	chr11:47352958-47374253:-	-0.22	-4.83	1.84E-6	Subjective well-being	
LUAD	cis	1	rs35630683	chr15:85349231	LOC388152	chr15:84867600-84898920:-	-0.3	-5.79	1.28E-8	Schizophrenia	
LUAD	cis	1	rs35632377	chr5:156436252	TIMD4	chr5:156346293-156390266:-	-0.25	-4.49	8.99E-6	Hypertriglyceridemia	
LUAD	cis	1	rs35648189	chr15:84740748	GOLGA6L5	chr15:85047738-85060078:-	-0.17	-3.92	9.96E-5	Schizophrenia	
LUAD	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.38	-7.02	7.5E-12	Schizophrenia	
LUAD	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.37	-6.88	1.78E-11	Schizophrenia	
LUAD	cis	1	rs35659126	chr7:72988069	MLXIPL	chr7:73007524-73038870:-	0.28	4.15	3.92E-5	Triglycerides	
LUAD	cis	1	rs35703976	chr2:135486350	TMEM163	chr2:135213331-135525334:-	-0.2	-3.69	0.000252	Gut microbiome composition (winter)	
LUAD	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.18	3.28E-22	Height	
LUAD	cis	1	rs35720014	chr3:52982110	TMEM110	chr3:52867139-52931547:-	0.51	5.28	1.98E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs35726233	chr15:85337800	LOC388152	chr15:84867600-84898920:-	-0.3	-5.85	8.94E-9	Schizophrenia	
LUAD	cis	1	rs35728690	chr4:76546789	CXCL9	chr4:76922623-76928641:-	0.15	3.76	0.000188	Magnesium levels	
LUAD	cis	1	rs35735127	chr7:65300423	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.00022	Diabetic kidney disease	
LUAD	cis	1	rs35736167	chr15:75332002	C15orf39	chr15:75491233-75504508:+	0.21	3.7	0.000243	Blood trace element (Zn levels)	
LUAD	cis	1	rs35736167	chr15:75332002	SCAMP5	chr15:75287901-75313836:+	0.35	5.96	4.84E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs35737577	chr3:53002557	TMEM110	chr3:52867139-52931547:-	0.41	4.58	5.8E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.65	-12.36	1.02E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.67	-12.04	2.09E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.65	-11.88	8.8E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs35808647	chr15:85377441	LOC388152	chr15:84867600-84898920:-	-0.28	-5.15	3.81E-7	Schizophrenia	
LUAD	cis	1	rs35808787	chr4:106681179	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs35820085	chr7:65442758	CCT6P1	chr7:65216092-65228661:+	0.24	3.81	0.000159	Diabetic kidney disease	
LUAD	cis	1	rs35825738	chr7:65318027	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.00022	Diabetic kidney disease	
LUAD	cis	1	rs35849389	chr3:53005235	TMEM110	chr3:52867139-52931547:-	0.41	4.58	5.8E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs35856111	chr6:111773468	KIAA1919	chr6:111580482-111590259:+	0.48	4.15	3.95E-5	Psoriasis	
LUAD	cis	1	rs35868174	chr5:156425303	TIMD4	chr5:156346293-156390266:-	-0.22	-3.98	7.83E-5	Hypertriglyceridemia	
LUAD	cis	1	rs35902101	chr11:47795169	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	5.1E-5	Subjective well-being	
LUAD	cis	1	rs35902101	chr11:47795169	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.46	1.03E-5	Subjective well-being	
LUAD	cis	1	rs35960805	chr15:85343980	LOC388152	chr15:84867600-84898920:-	-0.31	-5.88	7.7E-9	Schizophrenia	
LUAD	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.36	7.13	3.57E-12	Cognitive performance	
LUAD	cis	1	rs35996509	chr11:4991062	TRIM5	chr11:5684788-5959849:-	0.27	3.97	8.25E-5	Coenzyme Q10 levels	
LUAD	cis	1	rs36033486	chr15:85319692	LOC388152	chr15:84867600-84898920:-	-0.3	-5.85	9.04E-9	Schizophrenia	
LUAD	cis	1	rs36035949	chr6:109736614	AKD1	chr6:109814059-110012415:-	-0.21	-4.14	4.17E-5	Height	
LUAD	cis	1	rs36035949	chr6:109736614	SMPD2	chr6:109761931-109765121:+	0.24	4.65	4.36E-6	Height	
LUAD	cis	1	rs36090694	chr3:53010742	TMEM110	chr3:52867139-52931547:-	0.44	4.55	6.93E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.63	-11.64	8.37E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs36116701	chr15:63397494	LACTB	chr15:63414032-63434254:+	0.21	4.03	6.37E-5	HDL cholesterol	
LUAD	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.64	-14.2	1.43E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs371674	chr21:42695445	FAM3B	chr21:42676177-42729654:+	0.33	5.78	1.34E-8	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
LUAD	cis	1	rs3729639	chr16:67225501	DPEP2	chr16:68021295-68034489:-	0.2	4.01	6.89E-5	HDL cholesterol	
LUAD	cis	1	rs3730658	chr18:51794699	POLI	chr18:51795849-51824602:+	0.22	4.16	3.69E-5	Psoriasis	
LUAD	cis	1	rs3730682	chr18:51797332	POLI	chr18:51795849-51824602:+	0.22	4.16	3.72E-5	Psoriasis	
LUAD	cis	1	rs3730688	chr18:51797948	POLI	chr18:51795849-51824602:+	0.21	4.1	4.74E-5	Psoriasis	
LUAD	cis	1	rs3730721	chr18:51802928	POLI	chr18:51795849-51824602:+	0.22	4.13	4.23E-5	Psoriasis	
LUAD	cis	1	rs3730729	chr18:51804702	POLI	chr18:51795849-51824602:+	-0.24	-4.71	3.29E-6	Psoriasis	
LUAD	cis	1	rs3730758	chr18:51812048	POLI	chr18:51795849-51824602:+	0.22	4.13	4.21E-5	Psoriasis	
LUAD	cis	1	rs3730764	chr18:51812814	POLI	chr18:51795849-51824602:+	0.21	4.05	5.91E-5	Psoriasis	
LUAD	cis	1	rs3730767	chr18:51813363	POLI	chr18:51795849-51824602:+	0.22	4.13	4.21E-5	Psoriasis	
LUAD	cis	1	rs3730787	chr18:51815443	POLI	chr18:51795849-51824602:+	0.21	4.05	5.91E-5	Psoriasis	
LUAD	cis	1	rs3730814	chr18:51818901	POLI	chr18:51795849-51824602:+	0.22	4.14	4.16E-5	Psoriasis	
LUAD	cis	1	rs3730818	chr18:51819101	POLI	chr18:51795849-51824602:+	0.22	4.13	4.21E-5	Psoriasis	
LUAD	cis	1	rs3731714	chr2:202060820	PPIL3	chr2:201735680-201753999:-	0.25	4.76	2.55E-6	Trans fatty acid levels	
LUAD	cis	1	rs3732269	chr2:70046255	SNRNP27	chr2:70121090-70132348:+	0.21	3.9	0.000111	Colorectal or endometrial cancer	
LUAD	cis	1	rs3732276	chr2:242343404	SEPT2	chr2:242254723-242293439:+	0.57	6.69	6.18E-11	Chronic lymphocytic leukemia	
LUAD	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.36	7.13	3.57E-12	Cognitive performance	
LUAD	cis	1	rs3734030	chr5:156939880	ADAM19	chr5:156822542-157002768:-	0.14	4.49	8.79E-6	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs3736582	chr10:124742895	C10orf88	chr10:124690419-124713919:-	-0.2	-4.16	3.83E-5	Migraine without aura	
LUAD	cis	1	rs3736583	chr10:124742792	C10orf88	chr10:124690419-124713919:-	-0.2	-4.16	3.83E-5	Migraine without aura	
LUAD	cis	1	rs3736584	chr10:124742683	C10orf88	chr10:124690419-124713919:-	-0.2	-4.16	3.83E-5	Migraine without aura	
LUAD	cis	1	rs3736585	chr10:124742586	C10orf88	chr10:124690419-124713919:-	-0.2	-4.16	3.83E-5	Migraine without aura	
LUAD	cis	1	rs3738848	chr2:73761881	ALMS1	chr2:73612886-73837046:+	0.2	4.86	1.6E-6	Metabolite levels	
LUAD	cis	1	rs3738848	chr2:73761881	ALMS1P	chr2:73872046-73912692:+	0.35	6.81	2.9E-11	Metabolite levels	
LUAD	cis	1	rs3739036	chr2:135483534	ACMSD	chr2:135596186-135659600:+	-0.27	-3.9	0.00011	Gut microbiome composition (winter)	
LUAD	cis	1	rs3739843	chr9:131882961	CRAT	chr9:131857075-131873070:-	0.32	6.11	2.0E-9	Blood metabolite ratios	
LUAD	cis	1	rs3739847	chr9:131911574	CRAT	chr9:131857075-131873070:-	-0.36	-6.92	1.46E-11	Blood metabolite ratios	
LUAD	cis	1	rs3739847	chr9:131911574	PPP2R4	chr9:131873244-131911223:+	-0.22	-4.46	1.03E-5	Blood metabolite ratios	
LUAD	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.27	5.18	3.27E-7	Pancreatic cancer	
LUAD	cis	1	rs3742320	chr13:33164418	CG030	chr13:33078645-33083532:-	-0.13	-4.31	1.94E-5	Body mass index	
LUAD	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.41	-9.63	3.28E-20	IgG glycosylation	
LUAD	cis	1	rs3742773	chr14:75579643	EIF2B2	chr14:75469612-75476292:+	0.21	3.99	7.63E-5	Height	
LUAD	cis	1	rs3742773	chr14:75579643	MLH3	chr14:75480467-75518235:-	0.25	4.85	1.68E-6	Height	
LUAD	cis	1	rs3742778	chr14:75538217	MLH3	chr14:75480467-75518235:-	-0.24	-4.66	4.0E-6	Height	
LUAD	cis	1	rs3742780	chr14:75505008	MLH3	chr14:75480467-75518235:-	0.22	4.24	2.67E-5	Height	
LUAD	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.61	12.61	9.31E-32	Schizophrenia	
LUAD	cis	1	rs3747113	chr22:24717518	POM121L9P	chr22:24647589-24661490:+	0.26	5.77	1.38E-8	Gut microbiome composition (summer)	
LUAD	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.5	8.26	1.35E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs3750626	chr10:102266316	SEC31B	chr10:102246403-102289636:-	-0.21	-6.67	6.77E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3750627	chr10:102275642	SEC31B	chr10:102246403-102289636:-	-0.21	-6.72	5.05E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3750629	chr10:102275727	SEC31B	chr10:102246403-102289636:-	-0.18	-5.85	9.19E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3750630	chr10:102275780	SEC31B	chr10:102246403-102289636:-	-0.19	-5.93	5.89E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3750633	chr10:102308214	SEC31B	chr10:102246403-102289636:-	-0.21	-6.61	9.99E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3750719	chr10:102248950	SEC31B	chr10:102246403-102289636:-	-0.23	-7.16	3.0E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3750720	chr10:102248884	SEC31B	chr10:102246403-102289636:-	-0.22	-7.07	5.42E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3751237	chr12:27963507	LOC100133893	chr12:27915599-27924209:-	0.47	7.17	2.72E-12	Type 2 diabetes	
LUAD	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.27	6.02	3.52E-9	Fractional exhaled nitric oxide (childhood)	
LUAD	cis	1	rs3752749	chr4:1737262	FAM53A	chr4:1641609-1685854:-	-0.31	-5.25	2.32E-7	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs3753908	chr1:202511295	PPP1R12B	chr1:202317836-202557697:+	0.23	5.04	6.59E-7	Sex ratio	
LUAD	cis	1	rs3754439	chr1:110615094	ALX3	chr1:110602998-110613322:-	-0.22	-4.23	2.77E-5	Blood metabolite levels	
LUAD	cis	1	rs3754440	chr1:110613674	ALX3	chr1:110602998-110613322:-	-0.22	-4.18	3.51E-5	Blood metabolite levels	
LUAD	cis	1	rs3758253	chr9:100700654	C9orf156	chr9:100666772-100684852:-	-0.19	-3.7	0.00024	Quantitative traits	
LUAD	cis	1	rs3760891	chr19:33599708	GPATCH1	chr19:33571786-33621318:+	0.22	4.08	5.25E-5	Bone properties (heel)	
LUAD	cis	1	rs3760891	chr19:33599708	RHPN2	chr19:33469499-33555824:-	-0.21	-4.2	3.15E-5	Bone properties (heel)	
LUAD	cis	1	rs3760982	chr19:44286513	ZNF155	chr19:44488355-44502477:+	-0.25	-4.42	1.19E-5	Breast cancer	
LUAD	cis	1	rs3760983	chr19:44286660	ZNF155	chr19:44488355-44502477:+	0.24	4.23	2.83E-5	Breast cancer	
LUAD	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.3	8.91	1.02E-17	Type 1 diabetes autoantibodies	
LUAD	cis	1	rs3762318	chr1:67597119	C1orf141	chr1:67557859-67600653:-	0.16	4.05	5.9E-5	Leprosy	
LUAD	cis	1	rs3763695	chr10:102269206	SEC31B	chr10:102246403-102289636:-	-0.21	-6.7	5.81E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3767395	chr1:202536140	PPP1R12B	chr1:202317836-202557697:+	0.23	5	7.83E-7	Sex ratio	
LUAD	cis	1	rs3767397	chr1:202534389	PPP1R12B	chr1:202317836-202557697:+	0.23	5.08	5.43E-7	Sex ratio	
LUAD	cis	1	rs3767404	chr1:202519900	PPP1R12B	chr1:202317836-202557697:+	-0.21	-4.67	3.98E-6	Sex ratio	
LUAD	cis	1	rs3767405	chr1:202516875	PPP1R12B	chr1:202317836-202557697:+	0.22	4.9	1.3E-6	Sex ratio	
LUAD	cis	1	rs3767406	chr1:202512246	PPP1R12B	chr1:202317836-202557697:+	-0.23	-5.12	4.5E-7	Sex ratio	
LUAD	cis	1	rs3767408	chr1:202498111	PPP1R12B	chr1:202317836-202557697:+	0.23	4.99	8.22E-7	Sex ratio	
LUAD	cis	1	rs3767411	chr1:202471315	PPP1R12B	chr1:202317836-202557697:+	0.23	5.04	6.46E-7	Sex ratio	
LUAD	cis	1	rs3767412	chr1:202462023	PPP1R12B	chr1:202317836-202557697:+	0.22	4.81	2.02E-6	Sex ratio	
LUAD	cis	1	rs3767421	chr1:202432160	PPP1R12B	chr1:202317836-202557697:+	-0.21	-4.82	1.93E-6	Sex ratio	
LUAD	cis	1	rs3767425	chr1:202413840	PPP1R12B	chr1:202317836-202557697:+	0.23	5.12	4.41E-7	Sex ratio	
LUAD	cis	1	rs3769439	chr2:201319021	TRAK2	chr2:202241931-202316319:-	-0.18	-3.86	0.00013	Urinary albumin-to-creatinine ratio in non-diabetics	
LUAD	cis	1	rs3770066	chr2:86392350	LOC90784	chr2:86247339-86250991:-	-0.5	-4.89	1.4E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs3770752	chr2:37576136	CEBPZ	chr2:37428778-37458740:-	0.25	5.24	2.41E-7	Schizophrenia	
LUAD	cis	1	rs3771175	chr2:102960210	IL1RL1	chr2:102927962-102968497:+	-0.33	-4.96	9.89E-7	Asthma	
LUAD	cis	1	rs3771180	chr2:102953617	IL1RL1	chr2:102927962-102968497:+	0.34	4.95	1.01E-6	Asthma	
LUAD	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.37	7.33	9.52E-13	Cognitive performance	
LUAD	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.37	7.37	7.5E-13	Cognitive performance	
LUAD	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.7	11.85	1.21E-28	Diastolic blood pressure	
LUAD	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.32	-8.04	6.99E-15	Longevity	
LUAD	cis	1	rs3775870	chr4:68446421	STAP1	chr4:68424446-68473053:+	-0.19	-4.16	3.8E-5	Parkinson's disease	
LUAD	cis	1	rs3778483	chr6:46627100	SLC25A27	chr6:46620679-46645925:+	-0.18	-5.25	2.26E-7	QRS complex (Sokolow-Lyon)	
LUAD	cis	1	rs3780354	chr9:36208626	GLIPR2	chr9:36136742-36163902:+	-0.24	-4.21	3.1E-5	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs3780356	chr9:36201251	GLIPR2	chr9:36136742-36163902:+	-0.24	-3.98	8.07E-5	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.47	8.28	1.21E-15	Multiple sclerosis	
LUAD	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.23	-4.61	5.03E-6	Multiple sclerosis	
LUAD	cis	1	rs3782894	chr12:110026024	MYO1H	chr12:109826524-109886176:+	0.39	7.11	4.13E-12	HDL cholesterol	
LUAD	cis	1	rs3783555	chr2:113531093	IL1A	chr2:113531493-113542971:-	0.22	4.15	3.9E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs3786837	chr19:39172042	LGALS7	chr19:39261608-39264157:-	-0.19	-3.68	0.000264	Heart rate	
LUAD	cis	1	rs3786933	chr19:33602881	GPATCH1	chr19:33571786-33621318:+	0.22	4.09	5.08E-5	Bone properties (heel)	
LUAD	cis	1	rs3786933	chr19:33602881	RHPN2	chr19:33469499-33555824:-	-0.2	-4.16	3.77E-5	Bone properties (heel)	
LUAD	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.62	-13.95	1.85E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.63	-14.2	1.5E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.64	-14.28	6.32E-39	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.62	-13.78	9.41E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs3792574	chr7:134254029	AKR1B15	chr7:134233849-134264300:+	0.19	3.86	0.000129	Longevity	
LUAD	cis	1	rs3793706	chr10:102269085	SEC31B	chr10:102246403-102289636:-	0.18	5.88	7.55E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3793771	chr10:102222957	SEC31B	chr10:102246403-102289636:-	-0.21	-6.74	4.49E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3793772	chr10:102222825	SEC31B	chr10:102246403-102289636:-	-0.22	-6.97	1.02E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs3794742	chr17:76165548	SYNGR2	chr17:76164671-76169009:+	-0.19	-4.3	2.03E-5	Adenocarcinoma;Lung cancer	
LUAD	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.52	-8.47	2.83E-16	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs3796352	chr3:52913279	TMEM110	chr3:52867139-52931547:-	0.47	5.04	6.61E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.37	-9.87	4.54E-21	Kawasaki disease	
LUAD	cis	1	rs3798390	chr6:117726553	DCBLD1	chr6:117803820-117891018:+	0.18	3.93	9.54E-5	Lung cancer	
LUAD	cis	1	rs3798393	chr6:117731968	DCBLD1	chr6:117803820-117891018:+	0.18	3.95	9.12E-5	Lung cancer	
LUAD	cis	1	rs3798394	chr6:117732362	DCBLD1	chr6:117803820-117891018:+	0.17	3.69	0.000246	Lung cancer	
LUAD	cis	1	rs3800569	chr7:138411425	CREB3L2	chr7:137559727-137686846:-	0.2	4.03	6.59E-5	F-cell distribution	
LUAD	cis	1	rs3806407	chr1:156251742	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs3806408	chr1:156252137	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs3806409	chr1:156252291	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs3806692	chr3:53080987	TMEM110	chr3:52867139-52931547:-	0.41	4.71	3.18E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs3806988	chr6:49431569	CENPQ	chr6:49431096-49460820:+	-0.26	-6.68	6.52E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.34	7.11	4.01E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs3808894	chr9:100686129	C9orf156	chr9:100666772-100684852:-	-0.2	-4.03	6.59E-5	Quantitative traits	
LUAD	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.3	-6.1	2.16E-9	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs3813227	chr2:73651967	ALMS1	chr2:73612886-73837046:+	-0.17	-4.2	3.21E-5	Metabolite levels	
LUAD	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.34	-6.49	2.15E-10	Metabolite levels	
LUAD	cis	1	rs3814964	chr11:2999507	CARS	chr11:3022160-3078671:-	0.23	3.82	0.000151	Calcium levels	
LUAD	cis	1	rs3815824	chr16:29852860	LOC440356	chr16:29875004-29879374:+	-0.27	-3.84	0.000139	Multiple sclerosis	
LUAD	cis	1	rs3817181	chr17:61776538	FTSJ3	chr17:61896795-61905031:-	0.24	4.87	1.53E-6	Body mass index	
LUAD	cis	1	rs3818556	chr9:36204518	GLIPR2	chr9:36136742-36163902:+	-0.24	-4.04	6.14E-5	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.27	-7.03	6.99E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.33	6.9	1.66E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs3824496	chr9:100684645	C9orf156	chr9:100666772-100684852:-	-0.2	-3.99	7.57E-5	Quantitative traits	
LUAD	cis	1	rs3824754	chr10:104614350	SFXN2	chr10:104474298-104498946:+	-0.4	-4.22	2.91E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
LUAD	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.46	8.14	3.3E-15	Multiple sclerosis	
LUAD	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.23	-4.7	3.41E-6	Multiple sclerosis	
LUAD	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.64	12.53	2.05E-31	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.39	-5.36	1.3E-7	Abdominal aortic aneurysm	
LUAD	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.64	-14	1.08E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs3828496	chr4:48388292	NIPAL1	chr4:48018791-48039078:+	-0.19	-3.78	0.000179	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs3829218	chr11:58331309	CNTF	chr11:58390146-58393203:+	0.31	4.19	3.32E-5	Lymphoma	
LUAD	cis	1	rs3829251	chr11:71194559	NADSYN1	chr11:71164217-71212579:+	0.2	3.76	0.00019	Vitamin D levels	
LUAD	cis	1	rs3845800	chr2:203734365	ALS2CR8	chr2:203776978-203851060:+	0.23	4.76	2.55E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.52	10.01	1.36E-21	Height	
LUAD	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.52	10.13	5.14E-22	Height	
LUAD	cis	1	rs3847669	chr12:75949158	GLIPR1L2	chr12:75784889-75825591:+	-0.31	-5.74	1.69E-8	Polycystic ovary syndrome	
LUAD	cis	1	rs3852053	chr3:186937200	RTP1	chr3:186915274-186919251:+	-0.25	-5.16	3.68E-7	Amyotrophic lateral sclerosis (sporadic)	
LUAD	cis	1	rs3857610	chr6:56012458	COL21A1	chr6:55921389-56258892:-	-0.23	-3.77	0.000182	Psychosis (atypical)	
LUAD	cis	1	rs3858534	chr12:75947084	GLIPR1L2	chr12:75784889-75825591:+	-0.31	-5.76	1.49E-8	Polycystic ovary syndrome	
LUAD	cis	1	rs3861734	chr1:101489461	CCDC76	chr1:100598706-100616053:+	0.18	3.72	0.000224	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs3892630	chr19:33181484	C19orf40	chr19:33463148-33467955:+	0.22	3.92	0.000102	Red blood cell traits	
LUAD	cis	1	rs3892630	chr19:33181484	NUDT19	chr19:33182867-33204701:+	0.26	3.85	0.000132	Red blood cell traits	
LUAD	cis	1	rs3892761	chr12:54070445	ATP5G2	chr12:54058945-54070512:-	0.28	6.04	3.05E-9	Height	
LUAD	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.3	-3.72	0.000223	Crohn's disease	
LUAD	cis	1	rs3901668	chr1:202501761	PPP1R12B	chr1:202317836-202557697:+	0.21	4.73	2.94E-6	Sex ratio	
LUAD	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.44	-7.71	6.92E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LUAD	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.5	9.79	8.72E-21	Height	
LUAD	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.71	-12.42	5.72E-31	Diastolic blood pressure	
LUAD	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.52	10.73	3.03E-24	Eye color traits	
LUAD	cis	1	rs3936203	chr2:241834654	C2orf54	chr2:241825466-241835573:-	-0.35	-6.32	5.9E-10	Urinary metabolites	
LUAD	cis	1	rs3950155	chr6:55936254	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.68	-14.26	7.95E-39	Type 2 diabetes	
LUAD	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.27	-5.42	9.22E-8	Schizophrenia	
LUAD	cis	1	rs397119	chr20:25440187	FAM182A	chr20:26035250-26067552:+	-0.18	-3.67	0.000268	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs3976455	chr16:29861447	LOC440356	chr16:29875004-29879374:+	-0.3	-4.51	8.15E-6	Multiple sclerosis	
LUAD	cis	1	rs3979179	chr1:16306846	HSPB7	chr1:16340523-16346089:-	-0.24	-5.55	4.75E-8	Dilated cardiomyopathy	
LUAD	cis	1	rs398036	chr20:25439850	FAM182A	chr20:26035250-26067552:+	-0.18	-3.67	0.000268	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.42	-9.53	7.06E-20	Inflammatory skin disease	
LUAD	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.47	8.32	8.91E-16	Inflammatory skin disease	
LUAD	cis	1	rs401166	chr20:25446308	FAM182A	chr20:26035250-26067552:+	-0.18	-3.71	0.000232	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs402418	chr7:65509469	CCT6P1	chr7:65216092-65228661:+	0.23	3.71	0.000235	Diabetic kidney disease	
LUAD	cis	1	rs4037	chr10:97365820	ENTPD1	chr10:97471536-97637022:+	0.19	5.1	4.94E-7	Blood metabolite levels	
LUAD	cis	1	rs404394	chr20:25447896	FAM182A	chr20:26035250-26067552:+	-0.18	-3.71	0.000232	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.39	7.29	1.22E-12	Body mass index	
LUAD	cis	1	rs4073846	chr1:46462881	MUTYH	chr1:45794915-45806142:-	-0.17	-3.95	8.87E-5	Body mass index	
LUAD	cis	1	rs4074170	chr17:28381141	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.88	7.71E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4074170	chr17:28381141	SSH2	chr17:27952965-28257018:-	-0.16	-4.21	3.06E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.52	-10.81	1.41E-24	Eye color traits	
LUAD	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.51	-10.68	4.57E-24	Eye color traits	
LUAD	cis	1	rs4075623	chr17:28386526	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.89	7.37E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4075623	chr17:28386526	SSH2	chr17:27952965-28257018:-	-0.16	-4.27	2.33E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.21	2.15E-12	Body mass index	
LUAD	cis	1	rs4076006	chr1:46438076	MUTYH	chr1:45794915-45806142:-	0.17	3.97	8.34E-5	Body mass index	
LUAD	cis	1	rs4077341	chr8:22962348	TNFRSF10C	chr8:22941868-22974948:+	0.2	3.84	0.000141	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
LUAD	cis	1	rs4077468	chr1:205914757	PM20D1	chr1:205797154-205819245:-	0.24	4.78	2.28E-6	Cystic fibrosis-related diabetes	
LUAD	cis	1	rs4077469	chr1:205914885	PM20D1	chr1:205797154-205819245:-	0.24	4.78	2.28E-6	Cystic fibrosis-related diabetes	
LUAD	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.32	-4.15	3.86E-5	Urate levels in lean individuals	
LUAD	cis	1	rs4102214	chr11:63212720	C11orf83	chr11:62439126-62439850:+	0.16	3.75	0.000199	Economic and political preferences	
LUAD	cis	1	rs41266839	chr6:26409890	BTN3A2	chr6:26365398-26378546:+	-0.77	-9.66	2.6E-20	Schizophrenia	
LUAD	cis	1	rs41271355	chr3:113004155	SIDT1	chr3:113251218-113348421:+	0.23	3.83	0.000144	Dental caries	
LUAD	cis	1	rs41274692	chr20:49530928	KCNG1	chr20:49620194-49639675:-	-0.39	-3.86	0.00013	Prostate cancer	
LUAD	cis	1	rs41275472	chr1:11876300	CLCN6	chr1:11866207-11907674:+	0.2	3.92	0.000101	QRS complex (12-leadsum)	
LUAD	cis	1	rs41280035	chr22:38054038	LGALS2	chr22:37966254-37976024:-	0.18	4.28	2.26E-5	Fat distribution (HIV)	
LUAD	cis	1	rs4130590	chr9:130107964	RPL12	chr9:130209955-130213684:-	-0.18	-5.18	3.18E-7	Bipolar disorder	
LUAD	cis	1	rs4130590	chr9:130107964	ZNF79	chr9:130186653-130207650:+	0.21	3.96	8.7E-5	Bipolar disorder	
LUAD	cis	1	rs41343448	chr8:20271413	INTS10	chr8:19674918-19709584:+	0.27	3.85	0.000132	Preeclampsia	
LUAD	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.19	2.43E-12	Body mass index	
LUAD	cis	1	rs4134386	chr1:46395089	MUTYH	chr1:45794915-45806142:-	0.17	4.07	5.49E-5	Body mass index	
LUAD	cis	1	rs41363748	chr12:56696056	PAN2	chr12:56710718-56727825:-	-0.27	-3.83	0.000143	Psoriasis vulgaris	
LUAD	cis	1	rs41363748	chr12:56696056	STAT2	chr12:56735384-56753909:-	-0.32	-3.77	0.000186	Psoriasis vulgaris	
LUAD	cis	1	rs4144937	chr6:46628516	SLC25A27	chr6:46620679-46645925:+	-0.19	-5.36	1.29E-7	QRS complex (Sokolow-Lyon)	
LUAD	cis	1	rs4145008	chr7:65647511	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.92	0.000102	Diabetic kidney disease	
LUAD	cis	1	rs4146324	chr4:81531354	C4orf22	chr4:81256874-81884896:+	-0.21	-5.37	1.25E-7	Obesity-related traits	
LUAD	cis	1	rs4146667	chr1:95703597	TMEM56	chr1:95582894-95663159:+	0.24	4.4	1.31E-5	Non-alcoholic fatty liver disease histology (AST)	
LUAD	cis	1	rs4147024	chr3:38456664	XYLB	chr3:38388251-38456467:+	0.21	3.75	0.000202	Electrocardiographic conduction measures	
LUAD	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.3	5.66	2.64E-8	Pancreatic cancer	
LUAD	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.28	5.31	1.68E-7	Pancreatic cancer	
LUAD	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.26	4.88	1.44E-6	Pancreatic cancer	
LUAD	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.27	5.06	5.83E-7	Pancreatic cancer	
LUAD	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.27	5.06	5.83E-7	Pancreatic cancer	
LUAD	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.27	-5.11	4.52E-7	Pancreatic cancer	
LUAD	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.26	4.79	2.2E-6	Pancreatic cancer	
LUAD	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.29	5.57	4.15E-8	Pancreatic cancer	
LUAD	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.27	-5.24	2.34E-7	Pancreatic cancer	
LUAD	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.25	4.67	3.93E-6	Pancreatic cancer	
LUAD	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.26	4.99	8.41E-7	Pancreatic cancer	
LUAD	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.28	5.39	1.09E-7	Pancreatic cancer	
LUAD	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.28	5.43	8.96E-8	Pancreatic cancer	
LUAD	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.26	-4.88	1.41E-6	Pancreatic cancer	
LUAD	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.28	5.36	1.29E-7	Pancreatic cancer	
LUAD	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.27	5.08	5.28E-7	Pancreatic cancer	
LUAD	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.35	-6.19	1.25E-9	Bipolar disorder	
LUAD	cis	1	rs422424	chr20:25445446	FAM182A	chr20:26035250-26067552:+	-0.18	-3.71	0.000232	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs422844	chr20:25445591	FAM182A	chr20:26035250-26067552:+	-0.18	-3.71	0.000232	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4234393	chr3:56684520	CCDC66	chr3:56591184-56655846:+	0.18	5.21	2.75E-7	Height	
LUAD	cis	1	rs4234797	chr4:7219907	SORCS2	chr4:7194374-7744563:+	-0.22	-4.44	1.13E-5	Insulin-like growth factors	
LUAD	cis	1	rs4234798	chr4:7219933	SORCS2	chr4:7194374-7744563:+	0.22	4.46	1.03E-5	Insulin-like growth factors	
LUAD	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.5	10.1	6.27E-22	Forced vital capacity	
LUAD	cis	1	rs4239227	chr17:28389103	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.9	6.75E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4239227	chr17:28389103	SSH2	chr17:27952965-28257018:-	-0.16	-4.28	2.25E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs4242434	chr8:22501830	BIN3	chr8:22477949-22526661:-	0.19	3.74	0.000202	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	
LUAD	cis	1	rs4242434	chr8:22501830	C8orf58	chr8:22457122-22461660:+	0.24	4.11	4.57E-5	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	
LUAD	cis	1	rs4243775	chr1:85537281	WDR63	chr1:85527993-85598820:+	0.17	3.78	0.000174	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs4244338	chr10:102272802	SEC31B	chr10:102246403-102289636:-	-0.21	-6.57	1.25E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4245707	chr1:202391419	PPP1R12B	chr1:202317836-202557697:+	0.22	4.92	1.2E-6	Sex ratio	
LUAD	cis	1	rs4246215	chr11:61564299	FADS2	chr11:61583728-61634825:+	0.2	3.72	0.000222	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
LUAD	cis	1	rs424971	chr16:85946450	IRF8	chr16:85932774-85956209:+	0.07	3.69	0.000246	Monocyte count	
LUAD	cis	1	rs4253311	chr4:187174683	F11	chr4:187187118-187210835:+	-0.16	-3.74	0.000202	Plasma renin activity levels;Blood metabolite levels	
LUAD	cis	1	rs4253766	chr22:46623905	PKDREJ	chr22:46651561-46659219:-	-0.47	-5.86	8.47E-9	Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs4253772	chr22:46627603	PKDREJ	chr22:46651561-46659219:-	-0.47	-5.57	4.28E-8	Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.34	-4.33	1.77E-5	Urate levels in lean individuals	
LUAD	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.45	-8.32	8.77E-16	Plasma amyloid beta peptide concentrations (ABx-40)	
LUAD	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.27	6.68	6.6E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.32	-6.4	3.72E-10	Folate pathway vitamin levels	
LUAD	cis	1	rs4271626	chr17:65930133	LOC440461	chr17:66194801-66196436:+	0.23	3.72	0.000226	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs4272382	chr8:8433488	ERI1	chr8:8860314-8890849:+	-0.54	-5.59	3.84E-8	Response to cytidine analogues (gemcitabine)	
LUAD	cis	1	rs4272382	chr8:8433488	PPP1R3B	chr8:8993774-9009084:-	-0.34	-4.01	7.07E-5	Response to cytidine analogues (gemcitabine)	
LUAD	cis	1	rs4272382	chr8:8433488	TNKS	chr8:9413445-9639855:+	-0.44	-5.29	1.81E-7	Response to cytidine analogues (gemcitabine)	
LUAD	cis	1	rs4281086	chr8:10352308	PINX1	chr8:10622884-10697299:-	-0.19	-3.72	0.000224	Obesity-related traits	
LUAD	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.37	-7.3	1.16E-12	Longevity	
LUAD	cis	1	rs4282626	chr9:102690180	STX17	chr9:102668915-102736817:+	-0.18	-3.89	0.000114	Alopecia areata	
LUAD	cis	1	rs4285028	chr3:121660664	EAF2	chr3:121554034-121605372:+	-0.21	-3.73	0.000211	Multiple sclerosis	
LUAD	cis	1	rs4285028	chr3:121660664	IQCB1	chr3:121488610-121553926:-	-0.25	-4.46	9.96E-6	Multiple sclerosis	
LUAD	cis	1	rs4293565	chr2:241834770	C2orf54	chr2:241825466-241835573:-	0.32	5.7	2.04E-8	Urinary metabolites	
LUAD	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.53	9.04	3.77E-18	Paget's disease	
LUAD	cis	1	rs4294134	chr7:135293128	SLC13A4	chr7:135365993-135412933:-	-0.49	-7.64	1.16E-13	Paget's disease	
LUAD	cis	1	rs4300818	chr2:228713255	WDR69	chr2:228736327-228789026:+	0.28	5.87	8.06E-9	Blood pressure	
LUAD	cis	1	rs4307563	chr1:16313788	HSPB7	chr1:16340523-16346089:-	0.23	5.37	1.25E-7	Dilated cardiomyopathy	
LUAD	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.52	10.25	1.86E-22	Height	
LUAD	cis	1	rs4310508	chr10:65138573	NRBF2	chr10:64893007-64914785:+	-0.22	-4.95	1.0E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4311055	chr2:241821017	C2orf54	chr2:241825466-241835573:-	0.33	6.1	2.19E-9	Urinary metabolites	
LUAD	cis	1	rs431318	chr7:65511597	CCT6P1	chr7:65216092-65228661:+	0.24	3.79	0.000166	Diabetic kidney disease	
LUAD	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.8	14.09	4.59E-38	Type 2 diabetes	
LUAD	cis	1	rs4322591	chr14:75600697	EIF2B2	chr14:75469612-75476292:+	0.21	3.92	0.000103	Height	
LUAD	cis	1	rs4322591	chr14:75600697	MLH3	chr14:75480467-75518235:-	0.28	5.36	1.28E-7	Height	
LUAD	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.34	-6.77	3.73E-11	Rheumatoid arthritis	
LUAD	cis	1	rs4328498	chr17:28344276	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.94	5.47E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4328498	chr17:28344276	SSH2	chr17:27952965-28257018:-	-0.16	-4.27	2.37E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs4331881	chr5:156944475	ADAM19	chr5:156822542-157002768:-	0.14	4.3	2.07E-5	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.51	9.83	6.51E-21	Height	
LUAD	cis	1	rs433598	chr16:20680206	ACSM1	chr16:20634559-20709066:-	0.29	5.9	6.86E-9	Schizophrenia	
LUAD	cis	1	rs433852	chr19:49117104	SEC1	chr19:49141296-49185501:+	-0.33	-5.11	4.68E-7	Elevated serum carcinoembryonic antigen levels;Posterior cortical atrophy and Alzheimer's disease	
LUAD	cis	1	rs4344684	chr15:63397318	LACTB	chr15:63414032-63434254:+	0.21	3.93	9.87E-5	HDL cholesterol	
LUAD	cis	1	rs4344931	chr2:241818527	C2orf54	chr2:241825466-241835573:-	0.33	6.11	2.01E-9	Urinary metabolites	
LUAD	cis	1	rs4350617	chr17:28423088	EFCAB5	chr17:28256874-28435469:+	0.34	6.09	2.29E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4350617	chr17:28423088	SSH2	chr17:27952965-28257018:-	0.16	4.07	5.59E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.25	4.66	4.1E-6	Pancreatic cancer	
LUAD	cis	1	rs4363385	chr1:152989321	SPRR1A	chr1:152956557-152958289:+	0.23	4.67	3.87E-6	Inflammatory skin disease	
LUAD	cis	1	rs4363385	chr1:152989321	SPRR2D	chr1:153012201-153113969:-	0.19	3.81	0.000157	Inflammatory skin disease	
LUAD	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.52	10.11	6.21E-22	Height	
LUAD	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.51	-9.98	1.79E-21	Height	
LUAD	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.54	4.92E-8	Body mass index	
LUAD	cis	1	rs4373160	chr4:106648641	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.35E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs4374747	chr5:156426239	TIMD4	chr5:156346293-156390266:-	-0.22	-3.99	7.68E-5	Hypertriglyceridemia	
LUAD	cis	1	rs4375281	chr1:92987575	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.33	6.78	3.44E-11	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.71E-12	Body mass index	
LUAD	cis	1	rs4376778	chr1:46288846	MUTYH	chr1:45794915-45806142:-	0.18	4.22	2.93E-5	Body mass index	
LUAD	cis	1	rs437889	chr7:65509234	CCT6P1	chr7:65216092-65228661:+	0.23	3.71	0.000235	Diabetic kidney disease	
LUAD	cis	1	rs4379723	chr10:64963449	NRBF2	chr10:64893007-64914785:+	-0.21	-4.64	4.57E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.29	-4.71	3.19E-6	Bone mineral density	
LUAD	cis	1	rs4399232	chr10:64999490	NRBF2	chr10:64893007-64914785:+	-0.21	-4.68	3.72E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4400684	chr10:65012687	NRBF2	chr10:64893007-64914785:+	-0.21	-4.65	4.33E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.24	4.47	9.71E-6	Breast cancer (estrogen-receptor negative);Breast cancer	
LUAD	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.52	10.16	3.93E-22	Height	
LUAD	cis	1	rs441810	chr21:42698907	FAM3B	chr21:42676177-42729654:+	0.32	5.65	2.73E-8	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
LUAD	cis	1	rs4423247	chr12:91476875	KERA	chr12:91444273-91452131:-	0.23	3.83	0.000144	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.49	-9.5	9.0E-20	Height	
LUAD	cis	1	rs4431687	chr9:130111697	SLC2A8	chr9:130159465-130170161:+	-0.27	-4.67	3.87E-6	Metabolite levels (HVA)	
LUAD	cis	1	rs4449196	chr20:49521655	KCNG1	chr20:49620194-49639675:-	-0.38	-3.71	0.000227	Prostate cancer	
LUAD	cis	1	rs4452862	chr9:102706745	STX17	chr9:102668915-102736817:+	-0.18	-3.92	9.96E-5	Alopecia areata	
LUAD	cis	1	rs4465649	chr17:28394747	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.92	6.01E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4465649	chr17:28394747	SSH2	chr17:27952965-28257018:-	-0.17	-4.4	1.34E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs4465650	chr17:28396721	EFCAB5	chr17:28256874-28435469:+	0.32	5.88	7.67E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4465650	chr17:28396721	SSH2	chr17:27952965-28257018:-	0.17	4.5	8.49E-6	Coffee consumption (cups per day)	
LUAD	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.28	-7.04	6.36E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.32	6.59	1.16E-10	Folate pathway vitamin levels	
LUAD	cis	1	rs447722	chr20:25443510	FAM182A	chr20:26035250-26067552:+	-0.18	-3.71	0.000232	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4478072	chr3:53106125	TMEM110	chr3:52867139-52931547:-	0.33	4.09	5.05E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs448396	chr20:25440269	FAM182A	chr20:26035250-26067552:+	-0.18	-3.72	0.000222	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4486677	chr12:8669116	CLEC4D	chr12:8666136-8674958:+	0.22	4.07	5.42E-5	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
LUAD	cis	1	rs4487084	chr2:228713179	WDR69	chr2:228736327-228789026:+	0.28	5.86	8.38E-9	Blood pressure	
LUAD	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.29	-7.23	1.92E-12	Longevity	
LUAD	cis	1	rs449043	chr21:42700410	FAM3B	chr21:42676177-42729654:+	-0.29	-5.03	6.96E-7	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
LUAD	cis	1	rs4490669	chr6:56789465	BEND6	chr6:56819773-56892138:+	-0.25	-5.43	8.88E-8	Menarche (age at onset)	
LUAD	cis	1	rs4493873	chr8:92075643	LRRC69	chr8:92114847-92231464:+	-0.21	-3.7	0.000242	Migraine - clinic-based	
LUAD	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.62	-13.91	2.69E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.51	9.94	2.48E-21	Height	
LUAD	cis	1	rs4508401	chr15:91514721	UNC45A	chr15:91473410-91497322:+	0.19	3.83	0.000144	Type 2 diabetes	
LUAD	cis	1	rs4510208	chr2:203734866	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.79	2.24E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs451396	chr7:65484074	CRCP	chr7:65579805-65619551:+	-0.32	-3.69	0.000254	Diabetic kidney disease	
LUAD	cis	1	rs4515105	chr3:190987891	UTS2D	chr3:190984945-191048325:-	-0.28	-5.89	6.99E-9	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs4525561	chr18:51835955	POLI	chr18:51795849-51824602:+	0.2	3.71	0.000234	Psoriasis	
LUAD	cis	1	rs453329	chr20:25440593	FAM182A	chr20:26035250-26067552:+	-0.18	-3.74	0.000208	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4533340	chr17:28277951	EFCAB5	chr17:28256874-28435469:+	0.34	6.02	3.51E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4533340	chr17:28277951	SSH2	chr17:27952965-28257018:-	0.17	4.33	1.83E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs4534636	chr12:8666801	CLEC4D	chr12:8666136-8674958:+	0.24	4.28	2.25E-5	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
LUAD	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.51	-9.97	1.99E-21	Height	
LUAD	cis	1	rs454217	chr12:92718558	PLEKHG7	chr12:93130265-93165868:+	-0.19	-4.75	2.63E-6	Smoking quantity	
LUAD	cis	1	rs4544218	chr15:91520373	UNC45A	chr15:91473410-91497322:+	0.19	3.79	0.00017	Type 2 diabetes	
LUAD	cis	1	rs454422	chr20:5943693	MCM8	chr20:5931298-5975829:+	-0.17	-3.94	9.25E-5	HIV-1 viral setpoint	
LUAD	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.81E-12	Body mass index	
LUAD	cis	1	rs4545281	chr1:46360054	MUTYH	chr1:45794915-45806142:-	0.19	4.39	1.4E-5	Body mass index	
LUAD	cis	1	rs4548056	chr7:65298873	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.00022	Diabetic kidney disease	
LUAD	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.51	5.78E-8	Body mass index	
LUAD	cis	1	rs4549329	chr4:239785	ZNF718	chr4:53272-156488:+	0.29	4.4	1.32E-5	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs45559033	chr14:74341124	LIN52	chr14:74551656-74667117:+	0.26	3.76	0.00019	Morning vs. evening chronotype	
LUAD	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.29	5	7.98E-7	Hematology traits	
LUAD	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.02	1.27E-21	Height	
LUAD	cis	1	rs4575590	chr17:28361969	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.89	7.37E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4575590	chr17:28361969	SSH2	chr17:27952965-28257018:-	-0.16	-4.27	2.33E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs4579242	chr5:156939498	ADAM19	chr5:156822542-157002768:-	0.14	4.41	1.26E-5	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.41	4.7	3.38E-6	Crohn's disease	
LUAD	cis	1	rs4580915	chr6:111760764	KIAA1919	chr6:111580482-111590259:+	0.45	4.02	6.68E-5	Psoriasis	
LUAD	cis	1	rs4581755	chr17:28427898	EFCAB5	chr17:28256874-28435469:+	0.33	5.99	4.1E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4581755	chr17:28427898	SSH2	chr17:27952965-28257018:-	0.15	4.01	6.93E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs458196	chr22:29978026	NIPSNAP1	chr22:29950800-29977144:-	0.28	4.4	1.34E-5	Lipid traits	
LUAD	cis	1	rs458291	chr7:65520479	CCT6P1	chr7:65216092-65228661:+	0.24	3.79	0.000166	Diabetic kidney disease	
LUAD	cis	1	rs4585797	chr9:102674147	STX17	chr9:102668915-102736817:+	-0.17	-3.73	0.000217	Alopecia areata	
LUAD	cis	1	rs459048	chr6:111689632	KIAA1919	chr6:111580482-111590259:+	0.48	4.15	3.88E-5	Psoriasis	
LUAD	cis	1	rs4594164	chr14:35509571	KIAA0391	chr14:35591776-35786673:+	0.26	3.84	0.00014	Atopic dermatitis	
LUAD	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.33	5.05	6.12E-7	Atopic dermatitis	
LUAD	cis	1	rs4595427	chr10:65012944	NRBF2	chr10:64893007-64914785:+	-0.21	-4.65	4.33E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4604732	chr1:247623872	LOC148824	chr1:247687982-247694106:-	0.24	3.89	0.000116	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
LUAD	cis	1	rs4604805	chr10:102261409	SEC31B	chr10:102246403-102289636:-	-0.18	-5.89	7.32E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4605213	chr17:49244747	NME1-NME2	chr17:49230920-49249104:+	0.29	5.96	4.88E-9	Height	
LUAD	cis	1	rs462853	chr7:65558167	CCT6P1	chr7:65216092-65228661:+	0.25	3.93	9.83E-5	Diabetic kidney disease	
LUAD	cis	1	rs4631830	chr10:51543344	MSMB	chr10:51549553-51562590:+	0.27	5.89	7.33E-9	Prostate-specific antigen levels	
LUAD	cis	1	rs463543	chr6:111667552	KIAA1919	chr6:111580482-111590259:+	0.48	4.15	3.88E-5	Psoriasis	
LUAD	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.54	5.01E-8	Body mass index	
LUAD	cis	1	rs4643294	chr15:85250253	LOC388152	chr15:84867600-84898920:-	-0.32	-5.99	4.09E-9	Schizophrenia	
LUAD	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.46	8.33	7.92E-16	Multiple sclerosis	
LUAD	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.22	-4.48	9.49E-6	Multiple sclerosis	
LUAD	cis	1	rs464895	chr7:65527106	CCT6P1	chr7:65216092-65228661:+	0.23	3.67	0.000269	Diabetic kidney disease	
LUAD	cis	1	rs465359	chr7:65558164	CCT6P1	chr7:65216092-65228661:+	0.25	3.93	9.83E-5	Diabetic kidney disease	
LUAD	cis	1	rs4655524	chr1:67629469	C1orf141	chr1:67557859-67600653:-	-0.19	-6.05	2.88E-9	Psoriasis	
LUAD	cis	1	rs4655682	chr1:67610967	C1orf141	chr1:67557859-67600653:-	-0.18	-5.79	1.27E-8	Psoriasis	
LUAD	cis	1	rs4655683	chr1:67611613	C1orf141	chr1:67557859-67600653:-	-0.19	-5.85	9.02E-9	Psoriasis	
LUAD	cis	1	rs4655684	chr1:67611772	C1orf141	chr1:67557859-67600653:-	0.18	5.54	4.92E-8	Psoriasis	
LUAD	cis	1	rs4656958	chr1:160856964	ITLN1	chr1:160846332-160854960:-	0.26	4.68	3.74E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs465742	chr22:29959335	NIPSNAP1	chr22:29950800-29977144:-	-0.27	-3.93	9.88E-5	Lipid traits	
LUAD	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.88	17.79	5.87E-55	Homocysteine levels	
LUAD	cis	1	rs4660306	chr1:45978675	MUTYH	chr1:45794915-45806142:-	-0.21	-4.45	1.06E-5	Homocysteine levels	
LUAD	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.01E-12	Body mass index	
LUAD	cis	1	rs4660317	chr1:46326226	MUTYH	chr1:45794915-45806142:-	0.18	4.31	1.99E-5	Body mass index	
LUAD	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.01E-12	Body mass index	
LUAD	cis	1	rs4660319	chr1:46341623	MUTYH	chr1:45794915-45806142:-	0.18	4.31	1.99E-5	Body mass index	
LUAD	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.71E-12	Body mass index	
LUAD	cis	1	rs4660321	chr1:46366760	MUTYH	chr1:45794915-45806142:-	0.18	4.22	2.9E-5	Body mass index	
LUAD	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.78	-15.62	6.32E-45	Homocysteine levels	
LUAD	cis	1	rs4660870	chr1:45995231	MUTYH	chr1:45794915-45806142:-	0.18	3.83	0.000147	Homocysteine levels	
LUAD	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.19	2.43E-12	Body mass index	
LUAD	cis	1	rs4660898	chr1:46402171	MUTYH	chr1:45794915-45806142:-	0.17	4.07	5.49E-5	Body mass index	
LUAD	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.34	9.1E-13	Body mass index	
LUAD	cis	1	rs4660910	chr1:46548402	MUTYH	chr1:45794915-45806142:-	0.17	3.87	0.000122	Body mass index	
LUAD	cis	1	rs4664308	chr2:160917497	LY75	chr2:160625141-160761262:-	0.2	4.57	6.29E-6	Idiopathic membranous nephropathy	
LUAD	cis	1	rs4665147	chr2:160917062	LY75	chr2:160625141-160761262:-	0.2	4.56	6.54E-6	Idiopathic membranous nephropathy	
LUAD	cis	1	rs4665238	chr2:23942446	C2orf84	chr2:24397531-24414566:+	-0.23	-4.04	6.33E-5	Obesity-related traits	
LUAD	cis	1	rs4665238	chr2:23942446	LOC375190	chr2:24299728-24397519:+	0.22	4.16	3.83E-5	Obesity-related traits	
LUAD	cis	1	rs4665768	chr2:25372229	POMC	chr2:25383722-25391559:-	0.24	4.16	3.78E-5	Body mass index	
LUAD	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.42	9.16E-8	Body mass index	
LUAD	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.41	9.84E-8	Body mass index	
LUAD	cis	1	rs466983	chr7:65520496	CCT6P1	chr7:65216092-65228661:+	0.24	3.79	0.000166	Diabetic kidney disease	
LUAD	cis	1	rs4671400	chr2:61472632	AHSA2	chr2:61404553-61414058:+	-0.17	-3.88	0.000118	3-hydroxypropylmercapturic acid levels in smokers	
LUAD	cis	1	rs4674284	chr2:219161241	DIRC3	chr2:218148748-218621316:-	-0.19	-4.08	5.22E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs4675310	chr2:203880834	ALS2CR8	chr2:203776978-203851060:+	0.22	4.41	1.25E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs4675860	chr2:241840417	C2orf54	chr2:241825466-241835573:-	0.33	5.83	1.0E-8	Urinary metabolites	
LUAD	cis	1	rs4675863	chr2:241830763	C2orf54	chr2:241825466-241835573:-	0.33	5.96	4.73E-9	Urinary metabolites	
LUAD	cis	1	rs4675868	chr2:241828542	C2orf54	chr2:241825466-241835573:-	0.32	5.88	7.45E-9	Urinary metabolites	
LUAD	cis	1	rs4675874	chr2:241819796	C2orf54	chr2:241825466-241835573:-	-0.31	-5.45	7.91E-8	Urinary metabolites	
LUAD	cis	1	rs4681734	chr3:56715009	CCDC66	chr3:56591184-56655846:+	0.2	5.55	4.69E-8	Height	
LUAD	cis	1	rs4682000	chr3:56720591	CCDC66	chr3:56591184-56655846:+	0.19	5.51	5.94E-8	Height	
LUAD	cis	1	rs4683341	chr3:42877394	CCDC13	chr3:42749875-42814745:-	-0.15	-3.88	0.000117	Obesity-related traits	
LUAD	cis	1	rs4684847	chr3:12386337	MKRN2	chr3:12598594-12625208:+	0.36	4.4	1.33E-5	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs4684847	chr3:12386337	RAF1	chr3:12625102-12705700:-	0.33	3.85	0.000132	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs4687205	chr3:190983967	UTS2D	chr3:190984945-191048325:-	-0.26	-5.49	6.36E-8	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs4687552	chr3:52838402	ITIH4	chr3:52847007-52866554:-	0.23	5.04	6.5E-7	Bipolar disorder	
LUAD	cis	1	rs4687697	chr3:53090490	ITIH4	chr3:52847007-52866554:-	0.17	3.71	0.000234	Ulcerative colitis	
LUAD	cis	1	rs4687697	chr3:53090490	MUSTN1	chr3:52863876-52876976:-	0.14	3.72	0.000219	Ulcerative colitis	
LUAD	cis	1	rs4687701	chr3:53121276	RFT1	chr3:53122503-53164470:-	0.19	3.8	0.000165	Height	
LUAD	cis	1	rs468795	chr22:29955450	NIPSNAP1	chr22:29950800-29977144:-	-0.28	-4.45	1.05E-5	Lipid traits	
LUAD	cis	1	rs468852	chr22:29956156	NIPSNAP1	chr22:29950800-29977144:-	-0.29	-4.48	9.23E-6	Lipid traits	
LUAD	cis	1	rs4689088	chr4:7222253	SORCS2	chr4:7194374-7744563:+	-0.22	-4.49	8.83E-6	Insulin-like growth factors	
LUAD	cis	1	rs4689653	chr4:7223319	SORCS2	chr4:7194374-7744563:+	-0.21	-4.28	2.25E-5	Insulin-like growth factors	
LUAD	cis	1	rs4690071	chr4:3086753	C4orf44	chr4:3250767-3265839:+	-0.21	-4.62	4.8E-6	Parental longevity (mother's age at death)	
LUAD	cis	1	rs4691139	chr4:165908721	C4orf39	chr4:165878100-165880273:+	0.3	5.77	1.42E-8	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.45	-11.13	8.22E-26	Ankylosing spondylitis	
LUAD	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.45	8.61	9.98E-17	Ankylosing spondylitis	
LUAD	cis	1	rs4698433	chr4:15964863	BST1	chr4:15704573-15739933:+	-0.17	-3.7	0.000237	QT interval	
LUAD	cis	1	rs4698648	chr4:17692715	MED28	chr4:17616273-17629791:+	0.16	3.68	0.000256	Parasitemia in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs4698649	chr4:17692782	MED28	chr4:17616273-17629791:+	0.16	3.68	0.000256	Parasitemia in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs4698651	chr4:17694223	MED28	chr4:17616273-17629791:+	0.16	3.67	0.000272	Parasitemia in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs4699052	chr4:104137790	BDH2	chr4:103998783-104021024:-	0.27	5.47	7.02E-8	Testicular germ cell tumor	
LUAD	cis	1	rs4699052	chr4:104137790	MANBA	chr4:103552644-103682151:-	0.28	5.5	6.05E-8	Testicular germ cell tumor	
LUAD	cis	1	rs4699055	chr4:104154500	BDH2	chr4:103998783-104021024:-	0.26	5.41	9.82E-8	Testicular germ cell tumor	
LUAD	cis	1	rs4699055	chr4:104154500	MANBA	chr4:103552644-103682151:-	0.29	5.53	5.09E-8	Testicular germ cell tumor	
LUAD	cis	1	rs470119	chr22:50966914	TYMP	chr22:50964184-50968514:-	-0.22	-5.33	1.52E-7	Mean corpuscular hemoglobin	
LUAD	cis	1	rs4704729	chr5:156424516	TIMD4	chr5:156346293-156390266:-	-0.22	-3.98	7.83E-5	Hypertriglyceridemia	
LUAD	cis	1	rs4704825	chr5:156382308	TIMD4	chr5:156346293-156390266:-	-0.2	-3.83	0.000144	Triglycerides;Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.63	-11.81	1.68E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.64	-12.01	2.68E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs4713	chr9:131910805	CRAT	chr9:131857075-131873070:-	-0.35	-6.72	5.14E-11	Blood metabolite ratios	
LUAD	cis	1	rs4713	chr9:131910805	PPP2R4	chr9:131873244-131911223:+	-0.22	-4.41	1.29E-5	Blood metabolite ratios	
LUAD	cis	1	rs4715129	chr6:49415043	CENPQ	chr6:49431096-49460820:+	-0.28	-7.08	4.96E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.33	6.73	4.81E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs4715130	chr6:49416825	CENPQ	chr6:49431096-49460820:+	-0.27	-6.63	8.74E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.33	6.73	4.89E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs4715134	chr6:49488287	CENPQ	chr6:49431096-49460820:+	0.17	4.3	2.08E-5	Brain structure	
LUAD	cis	1	rs4717907	chr7:74086493	STAG3L2	chr7:74298846-74306731:-	-0.21	-3.7	0.00024	Menarche (age at onset)	
LUAD	cis	1	rs4718269	chr7:65200778	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.98	7.85E-5	Diabetic kidney disease	
LUAD	cis	1	rs4718270	chr7:65202407	CCT6P1	chr7:65216092-65228661:+	0.25	3.88	0.00012	Diabetic kidney disease	
LUAD	cis	1	rs4718315	chr7:65648541	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.92	0.000102	Diabetic kidney disease	
LUAD	cis	1	rs4718316	chr7:65648731	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.92	0.000102	Diabetic kidney disease	
LUAD	cis	1	rs4718317	chr7:65648901	CRCP	chr7:65579805-65619551:+	0.32	3.83	0.000146	Diabetic kidney disease	
LUAD	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.34	-6.36	4.58E-10	Obesity-related traits	
LUAD	cis	1	rs4726669	chr7:143758191	OR2A7	chr7:143955790-143974852:-	0.21	3.75	0.000198	Obesity-related traits	
LUAD	cis	1	rs4726669	chr7:143758191	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-5.01	7.5E-7	Obesity-related traits	
LUAD	cis	1	rs4727443	chr7:99593346	TRIM4	chr7:99488037-99517154:-	-0.24	-4.48	9.27E-6	Interstitial lung disease	
LUAD	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.25	6.52	1.77E-10	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.33	7.25	1.67E-12	Response to temozolomide	
LUAD	cis	1	rs4732038	chr7:134250322	AKR1B15	chr7:134233849-134264300:+	0.18	3.76	0.00019	Longevity	
LUAD	cis	1	rs4733384	chr8:29985381	MBOAT4	chr8:29989188-30002200:-	0.36	5.21	2.73E-7	Migraine	
LUAD	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.35	7.46	4.04E-13	Response to temozolomide	
LUAD	cis	1	rs4742777	chr9:102679173	STX17	chr9:102668915-102736817:+	-0.17	-3.73	0.000217	Alopecia areata	
LUAD	cis	1	rs4742778	chr9:102701967	STX17	chr9:102668915-102736817:+	-0.18	-3.92	9.96E-5	Alopecia areata	
LUAD	cis	1	rs4745740	chr10:75942469	ADK	chr10:75910965-76469059:+	0.24	4.03	6.42E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.35	-7.7	7.72E-14	Response to temozolomide	
LUAD	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.21	-3.93	9.64E-5	Subjective well-being	
LUAD	cis	1	rs4752797	chr11:47874364	MYBPC3	chr11:47352958-47374253:-	-0.19	-4.18	3.47E-5	Subjective well-being	
LUAD	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.23	-4.39	1.39E-5	Subjective well-being	
LUAD	cis	1	rs4752856	chr11:47648042	MYBPC3	chr11:47352958-47374253:-	-0.24	-5.23	2.5E-7	Subjective well-being	
LUAD	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.11	4.56E-5	Subjective well-being	
LUAD	cis	1	rs4752857	chr11:47655752	MYBPC3	chr11:47352958-47374253:-	-0.22	-4.85	1.68E-6	Subjective well-being	
LUAD	cis	1	rs4752873	chr11:47857520	C1QTNF4	chr11:47611216-47615961:-	-0.21	-4.03	6.37E-5	Subjective well-being	
LUAD	cis	1	rs4752873	chr11:47857520	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.52	7.82E-6	Subjective well-being	
LUAD	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.5	-10.14	4.82E-22	Forced vital capacity	
LUAD	cis	1	rs4757400	chr11:16469929	C11orf58	chr11:16760148-16779901:+	0.25	3.69	0.000247	Obesity and osteoporosis	
LUAD	cis	1	rs4757676	chr11:18640477	SPTY2D1	chr11:18627949-18656020:-	-0.23	-5	7.92E-7	Cholesterol, total	
LUAD	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.62	-14.89	1.33E-41	Cognitive function	
LUAD	cis	1	rs4759523	chr12:131315412	STX2	chr12:131274149-131323811:-	0.19	4.18	3.45E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs4759524	chr12:131315610	STX2	chr12:131274149-131323811:-	0.19	4.19	3.32E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs4759787	chr12:131290180	STX2	chr12:131274149-131323811:-	0.19	4.15	3.89E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs4759793	chr12:131297238	STX2	chr12:131274149-131323811:-	0.19	4.17	3.64E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.17	-4.77	2.42E-6	Type 1 diabetes	
LUAD	cis	1	rs4766646	chr12:110398145	C12orf24	chr12:110906229-110928191:+	-0.17	-4.08	5.33E-5	Metabolite levels (MHPG)	
LUAD	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.32	7.03	6.76E-12	Response to temozolomide	
LUAD	cis	1	rs4780401	chr16:11839326	TXNDC11	chr16:11772943-11836648:-	-0.19	-4.12	4.53E-5	Rheumatoid arthritis	
LUAD	cis	1	rs4783570	chr16:68806539	NFATC3	chr16:68118654-68260837:+	-0.16	-3.68	0.000264	Colorectal cancer	
LUAD	cis	1	rs4783681	chr16:68806508	NFATC3	chr16:68118654-68260837:+	-0.16	-3.68	0.000264	Colorectal cancer	
LUAD	cis	1	rs4785450	chr16:50792268	CYLD	chr16:50775961-50835846:+	-0.15	-4.06	5.83E-5	Leprosy	
LUAD	cis	1	rs4787480	chr16:29857316	LOC440356	chr16:29875004-29879374:+	-0.27	-3.84	0.000139	Multiple sclerosis	
LUAD	cis	1	rs4788188	chr16:29860863	LOC440356	chr16:29875004-29879374:+	-0.27	-4.01	7.02E-5	Multiple sclerosis	
LUAD	cis	1	rs4788196	chr16:29967434	LOC440356	chr16:29875004-29879374:+	-0.18	-3.79	0.000168	Pubertal anthropometrics	
LUAD	cis	1	rs4789693	chr17:80421870	HEXDC	chr17:80376252-80400515:+	0.17	3.98	7.82E-5	Glucocorticoid-induced osteonecrosis	
LUAD	cis	1	rs4791212	chr17:65975385	LOC440461	chr17:66194801-66196436:+	0.27	4.46	1.02E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs4791299	chr17:65930937	LOC440461	chr17:66194801-66196436:+	0.22	3.69	0.00025	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs479343	chr6:111690904	KIAA1919	chr6:111580482-111590259:+	0.48	4.15	3.88E-5	Psoriasis	
LUAD	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.32	-6.62	9.57E-11	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.31	6.13	1.82E-9	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.32	-5.77	1.42E-8	Alzheimer's disease (cognitive decline)	
LUAD	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.33	7.25	1.67E-12	Response to temozolomide	
LUAD	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.64	-12.67	5.06E-32	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.63	-12.47	3.57E-31	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.64	-12.53	1.95E-31	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.63	-12.44	4.72E-31	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.63	-12.44	4.72E-31	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.64	-12.67	5.06E-32	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs4795525	chr17:28388487	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.9	6.75E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs4795525	chr17:28388487	SSH2	chr17:27952965-28257018:-	-0.16	-4.28	2.25E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs4802307	chr19:46849806	CCDC9	chr19:47759731-47775208:+	-0.24	-5.43	8.73E-8	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.59	12.26	2.63E-30	Schizophrenia	
LUAD	cis	1	rs480643	chr10:131400308	MGMT	chr10:131265454-131565783:+	0.34	7.25	1.62E-12	Response to temozolomide	
LUAD	cis	1	rs4815404	chr20:25301845	FAM182A	chr20:26035250-26067552:+	0.18	3.75	0.0002	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4815405	chr20:25317492	FAM182A	chr20:26035250-26067552:+	0.18	3.68	0.000263	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4815411	chr20:25350223	NINL	chr20:25433338-25566153:-	0.16	3.93	9.83E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4815412	chr20:25350325	NINL	chr20:25433338-25566153:-	-0.15	-3.73	0.000213	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs4819388	chr21:45647421	ICOSLG	chr21:45646724-45660834:-	-0.24	-4.52	7.85E-6	Celiac disease	
LUAD	cis	1	rs4820294	chr22:38071043	LGALS2	chr22:37966254-37976024:-	0.17	3.94	9.22E-5	Fat distribution (HIV)	
LUAD	cis	1	rs4838890	chr1:110616679	ALX3	chr1:110602998-110613322:-	-0.21	-4.04	6.11E-5	Blood metabolite levels	
LUAD	cis	1	rs4839103	chr1:110620701	ALX3	chr1:110602998-110613322:-	-0.2	-3.94	9.18E-5	Blood metabolite levels	
LUAD	cis	1	rs4840351	chr8:8573148	CLDN23	chr8:8559666-8561616:+	-0.33	-5.53	5.15E-8	Obesity-related traits	
LUAD	cis	1	rs4840352	chr8:8573508	CLDN23	chr8:8559666-8561616:+	-0.32	-5.38	1.13E-7	Obesity-related traits	
LUAD	cis	1	rs4841016	chr8:8572561	CLDN23	chr8:8559666-8561616:+	-0.32	-5.29	1.82E-7	Obesity-related traits	
LUAD	cis	1	rs4841017	chr8:8577093	CLDN23	chr8:8559666-8561616:+	-0.3	-5.17	3.4E-7	Obesity-related traits	
LUAD	cis	1	rs4846085	chr1:12050634	MFN2	chr1:12040238-12073571:+	-0.19	-3.85	0.000136	Platelet count	
LUAD	cis	1	rs4847181	chr1:93028792	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs4848300	chr2:113527906	IL1A	chr2:113531493-113542971:-	0.23	4.23	2.76E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.32	7.03	6.76E-12	Response to temozolomide	
LUAD	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.23	5.45	7.88E-8	Longevity	
LUAD	cis	1	rs4858817	chr3:48416756	ATRIP	chr3:48488141-48507708:+	-0.21	-3.85	0.000132	Longevity	
LUAD	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.25	5.99	4.18E-9	Longevity	
LUAD	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.36	7.21	2.12E-12	Longevity	
LUAD	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.37	-7.42	5.3E-13	Longevity	
LUAD	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.37	-7.42	5.33E-13	Longevity	
LUAD	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.42	11.49	3.13E-27	Kawasaki disease	
LUAD	cis	1	rs4865463	chr4:1742400	FAM53A	chr4:1641609-1685854:-	-0.32	-5.59	3.69E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs4865467	chr4:1745500	FAM53A	chr4:1641609-1685854:-	0.32	5.65	2.73E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs4869313	chr5:96223880	ERAP1	chr5:96096515-96149837:-	0.19	4.33	1.84E-5	Pediatric autoimmune diseases	
LUAD	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-0.99	-28.99	2.99E-108	Pediatric autoimmune diseases	
LUAD	cis	1	rs4870040	chr6:151872090	C6orf97	chr6:151815175-151942327:+	0.16	3.93	9.71E-5	Bone mineral density (spine)	
LUAD	cis	1	rs4870041	chr6:151872324	C6orf97	chr6:151815175-151942327:+	0.16	3.93	9.71E-5	Bone mineral density (spine)	
LUAD	cis	1	rs4886018	chr13:52990717	CKAP2	chr13:53029495-53050763:+	-0.16	-5.06	5.9E-7	Lewy body disease	
LUAD	cis	1	rs4886238	chr13:61113739	TDRD3	chr13:60970591-61148012:+	0.37	7.33	9.83E-13	Menopause (age at onset)	
LUAD	cis	1	rs4886818	chr15:76880939	SCAPER	chr15:76640529-77197744:-	-0.21	-4.94	1.07E-6	Blood metabolite levels	
LUAD	cis	1	rs4887783	chr16:74700743	RFWD3	chr16:74655298-74700779:-	-0.29	-6.62	9.57E-11	Testicular germ cell tumor	
LUAD	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.28	-6.45	2.71E-10	Testicular germ cell tumor	
LUAD	cis	1	rs4888264	chr16:74681632	RFWD3	chr16:74655298-74700779:-	-0.27	-6.35	4.85E-10	Testicular germ cell tumor	
LUAD	cis	1	rs4888265	chr16:74683737	RFWD3	chr16:74655298-74700779:-	-0.28	-6.53	1.67E-10	Testicular germ cell tumor	
LUAD	cis	1	rs4898805	chr14:53938972	GPR137C	chr14:53019866-53104430:+	0.17	3.69	0.00025	Optic cup area	
LUAD	cis	1	rs4899544	chr14:75546556	MLH3	chr14:75480467-75518235:-	0.24	4.64	4.58E-6	Height	
LUAD	cis	1	rs4899546	chr14:75594946	EIF2B2	chr14:75469612-75476292:+	0.22	4.12	4.41E-5	Height	
LUAD	cis	1	rs4899546	chr14:75594946	MLH3	chr14:75480467-75518235:-	0.28	5.47	7.29E-8	Height	
LUAD	cis	1	rs4901426	chr14:53939120	GPR137C	chr14:53019866-53104430:+	0.17	3.69	0.00025	Optic cup area	
LUAD	cis	1	rs4903201	chr14:74659690	C14orf45	chr14:74486059-74549566:+	-0.19	-4.23	2.85E-5	Common traits (Other)	
LUAD	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.46	-10.3	1.25E-22	Common traits (Other)	
LUAD	cis	1	rs4903201	chr14:74659690	ZNF410	chr14:74318674-74398803:+	-0.19	-3.83	0.000147	Common traits (Other)	
LUAD	cis	1	rs4903202	chr14:74660302	C14orf45	chr14:74486059-74549566:+	-0.19	-4.23	2.85E-5	Common traits (Other)	
LUAD	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.46	-10.3	1.25E-22	Common traits (Other)	
LUAD	cis	1	rs4903202	chr14:74660302	ZNF410	chr14:74318674-74398803:+	-0.19	-3.83	0.000147	Common traits (Other)	
LUAD	cis	1	rs4903203	chr14:74660508	C14orf45	chr14:74486059-74549566:+	-0.19	-4.23	2.85E-5	Common traits (Other)	
LUAD	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.46	-10.3	1.25E-22	Common traits (Other)	
LUAD	cis	1	rs4903203	chr14:74660508	ZNF410	chr14:74318674-74398803:+	-0.19	-3.83	0.000147	Common traits (Other)	
LUAD	cis	1	rs4903275	chr14:75512509	MLH3	chr14:75480467-75518235:-	0.23	4.4	1.36E-5	Height	
LUAD	cis	1	rs4903279	chr14:75546583	MLH3	chr14:75480467-75518235:-	0.24	4.64	4.58E-6	Height	
LUAD	cis	1	rs4903281	chr14:75554361	MLH3	chr14:75480467-75518235:-	0.23	4.35	1.64E-5	Height	
LUAD	cis	1	rs4903284	chr14:75592483	EIF2B2	chr14:75469612-75476292:+	0.22	4.19	3.33E-5	Height	
LUAD	cis	1	rs4903284	chr14:75592483	MLH3	chr14:75480467-75518235:-	0.28	5.39	1.12E-7	Height	
LUAD	cis	1	rs4903289	chr14:75623988	MLH3	chr14:75480467-75518235:-	-0.24	-4.71	3.29E-6	Height	
LUAD	cis	1	rs4907130	chr1:85536879	WDR63	chr1:85527993-85598820:+	0.17	3.74	0.000206	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs4907131	chr1:85537502	WDR63	chr1:85527993-85598820:+	-0.17	-3.73	0.000214	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs4907132	chr1:85537522	WDR63	chr1:85527993-85598820:+	0.17	3.83	0.000146	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs4911178	chr20:33952620	UQCC	chr20:33890383-33999833:-	0.31	5.78	1.36E-8	Height	
LUAD	cis	1	rs4911180	chr20:33972948	UQCC	chr20:33890383-33999833:-	0.3	5.44	8.65E-8	Height	
LUAD	cis	1	rs4911491	chr20:33947285	UQCC	chr20:33890383-33999833:-	0.3	5.64	2.88E-8	Height	
LUAD	cis	1	rs4911492	chr20:33951799	UQCC	chr20:33890383-33999833:-	0.3	5.64	2.88E-8	Height	
LUAD	cis	1	rs4911494	chr20:33971914	UQCC	chr20:33890383-33999833:-	0.31	5.81	1.13E-8	Height	
LUAD	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.29	-5.5	6.03E-8	Height	
LUAD	cis	1	rs4917385	chr10:105003721	C10orf32	chr10:104613967-104624718:+	-0.22	-5.12	4.38E-7	Systemic lupus erythematosus	
LUAD	cis	1	rs4917901	chr10:102201773	SEC31B	chr10:102246403-102289636:-	-0.22	-7.04	6.55E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4919464	chr10:102221195	SEC31B	chr10:102246403-102289636:-	-0.22	-7.03	7.21E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4919465	chr10:102221703	SEC31B	chr10:102246403-102289636:-	-0.22	-7.03	7.21E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4919466	chr10:102241213	SEC31B	chr10:102246403-102289636:-	-0.19	-6.03	3.17E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4919468	chr10:102288343	SEC31B	chr10:102246403-102289636:-	-0.23	-7.16	3.06E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4919469	chr10:102298855	SEC31B	chr10:102246403-102289636:-	-0.2	-6.4	3.56E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4919470	chr10:102298920	SEC31B	chr10:102246403-102289636:-	-0.24	-7.4	6.0E-13	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4919471	chr10:102299239	SEC31B	chr10:102246403-102289636:-	-0.2	-6.34	5.33E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4919472	chr10:102315864	SEC31B	chr10:102246403-102289636:-	-0.2	-6.45	2.75E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.41	9.01	4.76E-18	Arsenic metabolism	
LUAD	cis	1	rs4925166	chr17:18210810	FAM106A	chr17:18427880-18430160:-	-0.27	-4.81	1.99E-6	Multiple sclerosis	
LUAD	cis	1	rs4925166	chr17:18210810	LOC220594	chr17:18414577-18445234:-	-0.37	-6.41	3.39E-10	Multiple sclerosis	
LUAD	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.66	-12.95	3.57E-33	Type 2 diabetes	
LUAD	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.67	-14.25	9.08E-39	Type 2 diabetes	
LUAD	cis	1	rs4939312	chr11:59900106	CCDC86	chr11:60609429-60618561:+	0.17	3.83	0.000146	Alzheimer's disease (late onset)	
LUAD	cis	1	rs4939314	chr11:59900575	CCDC86	chr11:60609429-60618561:+	-0.17	-3.77	0.000183	Alzheimer's disease (late onset)	
LUAD	cis	1	rs494003	chr11:65542298	SNX32	chr11:65601410-65621170:+	0.3	4.14	4.03E-5	Systemic lupus erythematosus	
LUAD	cis	1	rs494221	chr11:30492581	MPPED2	chr11:30406040-30607930:-	0.23	4.54	7.02E-6	Dental caries	
LUAD	cis	1	rs4949222	chr1:32220915	COL16A1	chr1:32117848-32169768:-	-0.2	-3.93	9.75E-5	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs4950848	chr1:202356174	PPP1R12B	chr1:202317836-202557697:+	0.22	4.87	1.54E-6	Sex ratio	
LUAD	cis	1	rs4950849	chr1:202408518	PPP1R12B	chr1:202317836-202557697:+	0.22	4.9	1.33E-6	Sex ratio	
LUAD	cis	1	rs4951261	chr1:205717823	PM20D1	chr1:205797154-205819245:-	0.39	7.88	2.19E-14	Menarche (age at onset)	
LUAD	cis	1	rs4953925	chr2:135471290	TMEM163	chr2:135213331-135525334:-	-0.22	-4.14	4.1E-5	Gut microbiome composition (winter)	
LUAD	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.51	9.88	4.28E-21	Height	
LUAD	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.52	10.08	7.71E-22	Height	
LUAD	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.44	4.87	1.48E-6	Crohn's disease	
LUAD	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.39	4.6	5.41E-6	Crohn's disease	
LUAD	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.33	-4.92	1.19E-6	Tumor biomarkers	
LUAD	cis	1	rs496584	chr15:43831923	CATSPER2	chr15:43922774-43959900:-	-0.27	-4.48	9.2E-6	Tumor biomarkers	
LUAD	cis	1	rs4970696	chr1:92968853	EVI5	chr1:92974255-93257961:-	-0.27	-4.29	2.11E-5	Cholesterol, total	
LUAD	cis	1	rs4970698	chr1:92972933	EVI5	chr1:92974255-93257961:-	-0.27	-4.35	1.66E-5	Cholesterol, total	
LUAD	cis	1	rs4970705	chr1:92971828	EVI5	chr1:92974255-93257961:-	0.27	4.34	1.75E-5	Cholesterol, total	
LUAD	cis	1	rs4970708	chr1:92986514	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs4970709	chr1:92988592	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs4970710	chr1:92988717	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs4970712	chr1:92993547	EVI5	chr1:92974255-93257961:-	0.24	4.1	4.76E-5	Cholesterol, total	
LUAD	cis	1	rs4970948	chr1:151291243	LASS2	chr1:150937650-150947440:-	0.18	3.78	0.000178	Gut microbiota (functional units)	
LUAD	cis	1	rs4973380	chr2:228725402	WDR69	chr2:228736327-228789026:+	0.28	5.99	4.01E-9	Blood pressure	
LUAD	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.51	10.01	1.37E-21	Height	
LUAD	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.51	10.04	1.04E-21	Height	
LUAD	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.52	10.23	2.17E-22	Height	
LUAD	cis	1	rs4974559	chr4:1380848	CRIPAK	chr4:1385340-1389782:+	-0.22	-4.95	1.02E-6	Systolic blood pressure	
LUAD	cis	1	rs4980171	chr10:124743200	C10orf88	chr10:124690419-124713919:-	-0.2	-4.17	3.68E-5	Migraine without aura	
LUAD	cis	1	rs4980239	chr10:124741184	C10orf88	chr10:124690419-124713919:-	-0.2	-4.16	3.83E-5	Migraine without aura	
LUAD	cis	1	rs4988359	chr11:112025915	IL18	chr11:112013976-112034840:-	-0.28	-6.67	7.1E-11	Interleukin-18 levels	
LUAD	cis	1	rs499293	chr11:30504660	MPPED2	chr11:30406040-30607930:-	0.21	4.06	5.8E-5	Dental caries	
LUAD	cis	1	rs501220	chr6:25873025	BTN3A2	chr6:26365398-26378546:+	-0.28	-4.51	8.08E-6	Homocysteine levels	
LUAD	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.34	7.36	8.1E-13	Response to temozolomide	
LUAD	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.34	7.46	3.95E-13	Response to temozolomide	
LUAD	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.35	-7.5	3.12E-13	Response to temozolomide	
LUAD	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.33	7.34	8.79E-13	Response to temozolomide	
LUAD	cis	1	rs514591	chr1:196640320	CFHR3	chr1:196743930-196762872:+	0.24	3.77	0.000181	Circulating myeloperoxidase levels (serum)	
LUAD	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.35	7.62	1.36E-13	Response to temozolomide	
LUAD	cis	1	rs518471	chr18:618124	CLUL1	chr18:596998-650291:+	0.18	3.82	0.000148	Electroencephalogram traits	
LUAD	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.33	-7.18	2.68E-12	Response to temozolomide	
LUAD	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.33	7.24	1.78E-12	Response to temozolomide	
LUAD	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.32	-7	8.72E-12	Response to temozolomide	
LUAD	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.34	7.43	4.82E-13	Response to temozolomide	
LUAD	cis	1	rs540885	chr9:15294596	TTC39B	chr9:15171561-15307244:-	-0.28	-3.69	0.000251	Coenzyme Q10 levels;Metabolite levels (lipoprotein measures)	
LUAD	cis	1	rs545610	chr11:30508108	MPPED2	chr11:30406040-30607930:-	0.2	3.88	0.000119	Dental caries	
LUAD	cis	1	rs546131	chr11:34851760	APIP	chr11:34896714-34937939:-	0.25	4.75	2.74E-6	Lung disease severity in cystic fibrosis	
LUAD	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.34	7.49	3.22E-13	Response to temozolomide	
LUAD	cis	1	rs551397	chr1:196642072	CFHR1	chr1:196748292-196801316:+	0.23	3.91	0.000107	Circulating myeloperoxidase levels (serum)	
LUAD	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.34	7.39	6.27E-13	Response to temozolomide	
LUAD	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.35	7.61	1.43E-13	Response to temozolomide	
LUAD	cis	1	rs556292	chr10:105961957	C10orf79	chr10:105889647-105992120:-	0.11	3.7	0.000245	Attention deficit hyperactivity disorder	
LUAD	cis	1	rs55670848	chr1:171697497	VAMP4	chr1:171669298-171711214:-	0.25	3.97	8.11E-5	Hippocampal atrophy	
LUAD	cis	1	rs55674647	chr17:61794195	FTSJ3	chr17:61896795-61905031:-	0.21	4.16	3.73E-5	Body mass index	
LUAD	cis	1	rs55737216	chr9:100695901	C9orf156	chr9:100666772-100684852:-	-0.19	-3.86	0.00013	Quantitative traits	
LUAD	cis	1	rs55749333	chr17:7371932	CHRNB1	chr17:7348406-7360931:+	-0.21	-4.01	6.94E-5	Height	
LUAD	cis	1	rs55752096	chr18:48368918	MRO	chr18:48321491-48351754:-	0.36	5.91	6.41E-9	Entorhinal cortical thickness	
LUAD	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.62	-13.95	1.78E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs55767108	chr2:137313594	THSD7B	chr2:137523115-138435287:+	0.25	3.73	0.000212	Cognitive test performance	
LUAD	cis	1	rs55786720	chr6:56783647	BEND6	chr6:56819773-56892138:+	-0.26	-5.4	1.04E-7	Menarche (age at onset)	
LUAD	cis	1	rs55835850	chr2:28949296	PPP1CB	chr2:28974612-29025805:+	-0.18	-3.71	0.000227	Body mass index	
LUAD	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.26	5.2	2.87E-7	Body mass index	
LUAD	cis	1	rs55856327	chr17:33279125	LIG3	chr17:33307538-33332088:+	0.32	3.81	0.000156	Night sleep phenotypes	
LUAD	cis	1	rs55857306	chr1:11895795	CLCN6	chr1:11866207-11907674:+	0.2	3.86	0.000129	QRS complex (12-leadsum)	
LUAD	cis	1	rs55868506	chr17:61851686	FTSJ3	chr17:61896795-61905031:-	0.23	4.78	2.29E-6	Body mass index	
LUAD	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.3	-6.57	1.33E-10	Response to temozolomide	
LUAD	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.49	-11.04	1.9E-25	Inflammatory skin disease	
LUAD	cis	1	rs55879323	chr1:152168740	HRNR	chr1:152184558-152196669:-	0.25	4.59	5.6E-6	Inflammatory skin disease	
LUAD	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.52	10.08	7.71E-22	Height	
LUAD	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.62	6.8	2.98E-11	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.63	-13.85	4.83E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs55938093	chr3:56620172	CCDC66	chr3:56591184-56655846:+	-0.18	-5.3	1.76E-7	Height	
LUAD	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.64	-14	1.12E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs55957623	chr1:152223196	FLG	chr1:152274651-152297679:-	0.26	3.96	8.48E-5	Atopic dermatitis	
LUAD	cis	1	rs55962025	chr4:3112109	C4orf44	chr4:3250767-3265839:+	-0.21	-4.56	6.36E-6	Parental longevity (mother's age at death)	
LUAD	cis	1	rs55971458	chr17:28427016	EFCAB5	chr17:28256874-28435469:+	0.34	6.09	2.29E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs55971458	chr17:28427016	SSH2	chr17:27952965-28257018:-	0.16	4.07	5.59E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs56030203	chr6:56783857	BEND6	chr6:56819773-56892138:+	-0.26	-5.4	1.04E-7	Menarche (age at onset)	
LUAD	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.26	4.93	1.13E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
LUAD	cis	1	rs56040780	chr16:28861881	TUFM	chr16:28853732-28857729:-	0.18	3.91	0.000104	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
LUAD	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.48	-8.68	6.07E-17	Esophageal cancer (squamous cell)	
LUAD	cis	1	rs56057198	chr17:61733332	FTSJ3	chr17:61896795-61905031:-	0.2	4.08	5.21E-5	Body mass index	
LUAD	cis	1	rs56060232	chr14:104386165	TDRD9	chr14:104394817-104519002:+	0.25	3.82	0.000148	Bipolar disorder	
LUAD	cis	1	rs56097052	chr5:132194430	UQCRQ	chr5:132202319-132204536:+	-0.16	-3.91	0.000103	Apolipoprotein A-IV levels	
LUAD	cis	1	rs56100812	chr1:202365422	PPP1R12B	chr1:202317836-202557697:+	0.21	4.54	7.06E-6	Sex ratio	
LUAD	cis	1	rs56104203	chr2:86336256	LOC90784	chr2:86247339-86250991:-	-0.48	-4.55	6.85E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.7	12.02	2.55E-29	Diastolic blood pressure	
LUAD	cis	1	rs56142310	chr15:58574958	HSP90AB4P	chr15:58983302-58985324:-	-0.32	-3.77	0.000185	Metabolite levels (lipoprotein measures)	
LUAD	cis	1	rs56145559	chr2:73623439	ALMS1	chr2:73612886-73837046:+	0.16	3.72	0.00022	Schizophrenia	
LUAD	cis	1	rs56145559	chr2:73623439	ALMS1P	chr2:73872046-73912692:+	0.36	6.74	4.54E-11	Schizophrenia	
LUAD	cis	1	rs56153133	chr1:11885647	CLCN6	chr1:11866207-11907674:+	0.21	3.96	8.76E-5	QRS complex (12-leadsum)	
LUAD	cis	1	rs56154726	chr2:73721767	ALMS1	chr2:73612886-73837046:+	0.18	4.35	1.68E-5	Metabolite levels	
LUAD	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.39	7.31	1.1E-12	Metabolite levels	
LUAD	cis	1	rs56154726	chr2:73721767	FBXO41	chr2:73481800-73498043:-	0.19	3.68	0.000263	Metabolite levels	
LUAD	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.7	12.02	2.55E-29	Diastolic blood pressure	
LUAD	cis	1	rs56159542	chr19:19682971	YJEFN3	chr19:19639720-19648393:+	0.18	3.89	0.000115	Attention deficit hyperactivity disorder symptom score	
LUAD	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.64	-14.14	2.58E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs56190030	chr1:11887382	CLCN6	chr1:11866207-11907674:+	0.19	3.87	0.000122	QRS complex (12-leadsum)	
LUAD	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.66	10.17	3.52E-22	Diastolic blood pressure	
LUAD	cis	1	rs56223710	chr2:70049715	SNRNP27	chr2:70121090-70132348:+	0.21	3.91	0.000105	Colorectal or endometrial cancer	
LUAD	cis	1	rs56280226	chr17:28429575	EFCAB5	chr17:28256874-28435469:+	0.33	5.99	4.1E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs56280226	chr17:28429575	SSH2	chr17:27952965-28257018:-	0.15	4.01	6.93E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs56297666	chr2:160902023	LY75	chr2:160625141-160761262:-	0.2	4.45	1.05E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs56306402	chr20:33937704	UQCC	chr20:33890383-33999833:-	0.29	5.45	8.16E-8	Height	
LUAD	cis	1	rs563092	chr11:30501151	MPPED2	chr11:30406040-30607930:-	0.22	4.35	1.63E-5	Dental caries	
LUAD	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.37	7.35	8.35E-13	Cognitive performance	
LUAD	cis	1	rs56317427	chr10:81861934	PLAC9	chr10:81892258-81904784:+	-0.21	-3.72	0.000226	Chronic obstructive pulmonary disease-related biomarkers	
LUAD	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.63	-14.03	8.24E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs56322409	chr10:97395962	ENTPD1	chr10:97471536-97637022:+	0.2	5.5	6.1E-8	Blood metabolite levels	
LUAD	cis	1	rs56383601	chr17:61929968	FTSJ3	chr17:61896795-61905031:-	0.21	4.38	1.47E-5	Body mass index	
LUAD	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.35	7.55	2.15E-13	Response to temozolomide	
LUAD	cis	1	rs56672945	chr2:73622663	ALMS1	chr2:73612886-73837046:+	0.18	4.25	2.59E-5	Metabolite levels	
LUAD	cis	1	rs56672945	chr2:73622663	ALMS1P	chr2:73872046-73912692:+	0.38	7.26	1.51E-12	Metabolite levels	
LUAD	cis	1	rs56672945	chr2:73622663	FBXO41	chr2:73481800-73498043:-	0.19	3.69	0.000251	Metabolite levels	
LUAD	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.35	7.6	1.5E-13	Response to temozolomide	
LUAD	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.67	12.07	1.54E-29	Diastolic blood pressure	
LUAD	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.72	-14.8	3.24E-41	Crohn's disease	
LUAD	cis	1	rs568617	chr11:65653242	FIBP	chr11:65651212-65656010:-	0.27	4.94	1.05E-6	Crohn's disease	
LUAD	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.39	5.83	1.02E-8	Crohn's disease	
LUAD	cis	1	rs56864281	chr15:85357649	LOC388152	chr15:84867600-84898920:-	-0.29	-5.51	5.91E-8	Schizophrenia	
LUAD	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.63	-12.44	4.72E-31	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.34	7.45	4.3E-13	Response to temozolomide	
LUAD	cis	1	rs57025426	chr10:102205868	SEC31B	chr10:102246403-102289636:-	-0.22	-6.94	1.22E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.26	3.86	0.000128	Atopic dermatitis	
LUAD	cis	1	rs57080353	chr2:203376547	NOP58	chr2:203130515-203168382:+	0.27	4.21	3.06E-5	Urate levels	
LUAD	cis	1	rs57307201	chr17:40572793	NAGLU	chr17:40687951-40696464:+	-0.2	-3.71	0.000235	Crohn's disease	
LUAD	cis	1	rs57411618	chr17:28273052	EFCAB5	chr17:28256874-28435469:+	0.33	5.91	6.58E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs57411618	chr17:28273052	SSH2	chr17:27952965-28257018:-	0.17	4.34	1.7E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs57415683	chr13:36684221	C13orf38	chr13:36801182-36871992:-	0.24	3.82	0.000152	Optic cup area	
LUAD	cis	1	rs5744249	chr11:112025306	IL18	chr11:112013976-112034840:-	-0.28	-6.5	2.03E-10	Interleukin-18 levels	
LUAD	cis	1	rs5744256	chr11:112022848	IL18	chr11:112013976-112034840:-	-0.29	-6.79	3.23E-11	Interleukin-18 levels	
LUAD	cis	1	rs5744258	chr11:112021767	IL18	chr11:112013976-112034840:-	-0.29	-6.76	3.85E-11	Interleukin-18 levels	
LUAD	cis	1	rs574653	chr11:30506207	MPPED2	chr11:30406040-30607930:-	0.22	4.36	1.61E-5	Dental caries	
LUAD	cis	1	rs5750673	chr22:39110124	JOSD1	chr22:39081549-39096459:-	-0.22	-3.75	0.000195	Resting heart rate	
LUAD	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.32	-6.26	8.6E-10	Cognitive function	
LUAD	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.61	-13.38	5.28E-35	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs5756813	chr22:38175477	TRIOBP	chr22:38082344-38172562:+	-0.22	-4.94	1.1E-6	Optic cup area;Vertical cup-disc ratio	
LUAD	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.32	-6.3	6.5E-10	Cognitive function	
LUAD	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.32	-6.3	6.65E-10	Cognitive function	
LUAD	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.32	-6.3	6.5E-10	Cognitive function	
LUAD	cis	1	rs5759113	chr22:43443952	ARFGAP3	chr22:43192532-43253408:-	0.23	4.11	4.7E-5	Schizophrenia	
LUAD	cis	1	rs5763305	chr22:29930195	NIPSNAP1	chr22:29950800-29977144:-	-0.24	-3.83	0.000145	Lipid traits	
LUAD	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.35	7.5	2.98E-13	Response to temozolomide	
LUAD	cis	1	rs578056	chr11:65514874	SNX32	chr11:65601410-65621170:+	0.3	4.17	3.56E-5	Systemic lupus erythematosus	
LUAD	cis	1	rs57832572	chr12:8668281	CLEC4D	chr12:8666136-8674958:+	0.22	4.01	7.08E-5	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
LUAD	cis	1	rs58038553	chr15:58574324	HSP90AB4P	chr15:58983302-58985324:-	-0.34	-3.96	8.73E-5	Metabolite levels (lipoprotein measures)	
LUAD	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.34	7.39	6.42E-13	Response to temozolomide	
LUAD	cis	1	rs581686	chr10:105983356	C10orf79	chr10:105889647-105992120:-	0.11	3.68	0.000257	Attention deficit hyperactivity disorder	
LUAD	cis	1	rs58189451	chr6:149921388	NUP43	chr6:150045453-150067688:-	-0.25	-4.77	2.42E-6	Lung cancer	
LUAD	cis	1	rs58204112	chr14:74359417	LIN52	chr14:74551656-74667117:+	0.26	3.83	0.000146	Morning vs. evening chronotype	
LUAD	cis	1	rs58288071	chr2:203214739	NOP58	chr2:203130515-203168382:+	0.3	4.59	5.63E-6	Urate levels	
LUAD	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.27	4.71	3.28E-6	Schizophrenia (negative symptoms)	
LUAD	cis	1	rs58416181	chr15:85264461	LOC388152	chr15:84867600-84898920:-	-0.33	-6.12	1.92E-9	Schizophrenia	
LUAD	cis	1	rs58455759	chr1:171674987	VAMP4	chr1:171669298-171711214:-	0.24	3.84	0.000141	Hippocampal atrophy	
LUAD	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.64	-14.2	1.43E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs585101	chr5:139058454	DNAJC18	chr5:138747381-138775139:-	0.24	5.61	3.44E-8	Schizophrenia	
LUAD	cis	1	rs58551145	chr17:65837235	LOC440461	chr17:66194801-66196436:+	0.23	3.73	0.000211	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs58660500	chr3:53086573	TMEM110	chr3:52867139-52931547:-	0.47	5.04	6.7E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.4	4.77	2.46E-6	Crohn's disease	
LUAD	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.39	-5.4	1.02E-7	Abdominal aortic aneurysm	
LUAD	cis	1	rs58865519	chr10:46010891	OR13A1	chr10:45798102-45811056:-	-0.26	-3.77	0.000184	HDL cholesterol;Cholesterol, total	
LUAD	cis	1	rs589153	chr5:139057548	DNAJC18	chr5:138747381-138775139:-	0.24	5.33	1.51E-7	Schizophrenia	
LUAD	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.28	5.39	1.08E-7	Pancreatic cancer	
LUAD	cis	1	rs59227481	chr12:110007993	MYO1H	chr12:109826524-109886176:+	0.34	5.95	5.05E-9	Age-related nuclear cataracts	
LUAD	cis	1	rs59244547	chr3:156582997	LEKR1	chr3:156544076-156763918:+	-0.27	-3.99	7.73E-5	Bone mineral density	
LUAD	cis	1	rs59274738	chr17:28437635	EFCAB5	chr17:28256874-28435469:+	0.33	5.97	4.68E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs59274738	chr17:28437635	SSH2	chr17:27952965-28257018:-	0.15	4	7.32E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs59343240	chr16:67850529	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-4.17	3.63E-5	Crohn's disease	
LUAD	cis	1	rs59363432	chr14:74397545	LIN52	chr14:74551656-74667117:+	0.26	3.89	0.000114	Morning vs. evening chronotype	
LUAD	cis	1	rs594074	chr6:6552994	LY86	chr6:6588934-6655216:+	0.12	3.7	0.000236	Diabetic kidney disease	
LUAD	cis	1	rs59468948	chr1:156288058	CCT3	chr1:156278752-156308195:-	-0.16	-4.01	7.13E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.36	4.23	2.82E-5	Crohn's disease	
LUAD	cis	1	rs59583591	chr3:53119581	TMEM110	chr3:52867139-52931547:-	0.35	4.38	1.43E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs59674541	chr2:113553824	IL1A	chr2:113531493-113542971:-	0.22	4.03	6.37E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs59715748	chr5:150189287	LOC134466	chr5:150310000-150326146:-	0.46	5.04	6.61E-7	Crohn's disease	
LUAD	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.63	-12.33	1.31E-30	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.63	-14.06	5.77E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs599573	chr3:54707446	SELK	chr3:53919227-53925989:-	0.24	3.84	0.000139	Fractional exhaled nitric oxide (childhood)	
LUAD	cis	1	rs599946	chr5:139057461	DNAJC18	chr5:138747381-138775139:-	0.24	5.36	1.25E-7	Schizophrenia	
LUAD	cis	1	rs60078907	chr11:73085834	RELT	chr11:73087405-73108518:+	0.22	3.76	0.00019	Pulmonary function (interaction)	
LUAD	cis	1	rs600848	chr5:139057270	DNAJC18	chr5:138747381-138775139:-	0.24	5.42	9.19E-8	Schizophrenia	
LUAD	cis	1	rs601324	chr5:139057179	DNAJC18	chr5:138747381-138775139:-	0.24	5.42	9.29E-8	Schizophrenia	
LUAD	cis	1	rs601336	chr5:139057167	DNAJC18	chr5:138747381-138775139:-	0.24	5.33	1.53E-7	Schizophrenia	
LUAD	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.64	-14	1.03E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs60159753	chr11:64479112	NRXN2	chr11:64373648-64490660:-	0.25	3.81	0.000158	Urate levels	
LUAD	cis	1	rs601728	chr5:139057076	DNAJC18	chr5:138747381-138775139:-	0.24	5.42	9.29E-8	Schizophrenia	
LUAD	cis	1	rs60184524	chr19:44294215	ZNF155	chr19:44488355-44502477:+	-0.24	-4.3	2.05E-5	Breast cancer	
LUAD	cis	1	rs6036630	chr20:24046233	NAPB	chr20:23355157-23402156:-	0.31	3.98	7.78E-5	Erectile dysfunction and prostate cancer treatment	
LUAD	cis	1	rs6037086	chr20:25306338	FAM182A	chr20:26035250-26067552:+	0.19	3.87	0.000126	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6037526	chr20:3251248	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	5.99E-5	IFN-related cytopenia	
LUAD	cis	1	rs6037532	chr20:3267911	ITPA	chr20:3190056-3204504:+	-0.25	-4.51	8.06E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037533	chr20:3268817	ITPA	chr20:3190056-3204504:+	-0.25	-4.51	8.06E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037535	chr20:3270621	ITPA	chr20:3190056-3204504:+	-0.25	-4.53	7.31E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037538	chr20:3282978	ITPA	chr20:3190056-3204504:+	-0.27	-4.8	2.15E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037547	chr20:3299228	ITPA	chr20:3190056-3204504:+	-0.25	-4.47	9.52E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037551	chr20:3306690	ITPA	chr20:3190056-3204504:+	-0.25	-4.53	7.32E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037553	chr20:3313884	ITPA	chr20:3190056-3204504:+	-0.25	-4.36	1.62E-5	IFN-related cytopenia	
LUAD	cis	1	rs6037554	chr20:3315613	ITPA	chr20:3190056-3204504:+	-0.25	-4.54	6.99E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037556	chr20:3317890	ITPA	chr20:3190056-3204504:+	-0.25	-4.54	6.99E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037560	chr20:3323055	ITPA	chr20:3190056-3204504:+	-0.25	-4.36	1.58E-5	IFN-related cytopenia	
LUAD	cis	1	rs6037562	chr20:3326141	ITPA	chr20:3190056-3204504:+	-0.25	-4.55	6.92E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037567	chr20:3332160	ITPA	chr20:3190056-3204504:+	-0.25	-4.53	7.38E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037579	chr20:3347980	ITPA	chr20:3190056-3204504:+	-0.27	-4.82	1.92E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037583	chr20:3360632	ITPA	chr20:3190056-3204504:+	-0.27	-4.87	1.54E-6	IFN-related cytopenia	
LUAD	cis	1	rs6037590	chr20:3374085	ITPA	chr20:3190056-3204504:+	-0.26	-4.75	2.64E-6	IFN-related cytopenia	
LUAD	cis	1	rs6038722	chr20:766336	SIRPG	chr20:1609798-1638425:-	0.2	4.36	1.61E-5	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	
LUAD	cis	1	rs60425110	chr15:75333000	C15orf39	chr15:75491233-75504508:+	0.22	3.83	0.000145	Blood trace element (Zn levels)	
LUAD	cis	1	rs60425110	chr15:75333000	PPCDC	chr15:75315927-75343066:+	0.19	3.77	0.000184	Blood trace element (Zn levels)	
LUAD	cis	1	rs60425110	chr15:75333000	SCAMP5	chr15:75287901-75313836:+	0.35	6.02	3.44E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.64	-14.11	3.44E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs6050542	chr20:25318879	FAM182A	chr20:26035250-26067552:+	0.18	3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6050544	chr20:25320228	FAM182A	chr20:26035250-26067552:+	0.18	3.75	0.000195	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6051080	chr20:25975674	FAM182B	chr20:25744102-25848786:-	0.45	8.9	1.13E-17	Colorectal or endometrial cancer	
LUAD	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.29	-7.26	1.56E-12	Longevity	
LUAD	cis	1	rs6051672	chr20:3224819	ITPA	chr20:3190056-3204504:+	-0.23	-3.99	7.55E-5	IFN-related cytopenia	
LUAD	cis	1	rs6051702	chr20:3251924	ITPA	chr20:3190056-3204504:+	-0.23	-4.05	5.99E-5	IFN-related cytopenia	
LUAD	cis	1	rs6051703	chr20:3252347	ITPA	chr20:3190056-3204504:+	-0.22	-4.06	5.61E-5	IFN-related cytopenia	
LUAD	cis	1	rs6051705	chr20:3253143	ITPA	chr20:3190056-3204504:+	-0.22	-4.06	5.61E-5	IFN-related cytopenia	
LUAD	cis	1	rs6051708	chr20:3262493	ITPA	chr20:3190056-3204504:+	-0.28	-5.17	3.37E-7	IFN-related cytopenia	
LUAD	cis	1	rs6051709	chr20:3263685	ITPA	chr20:3190056-3204504:+	-0.25	-4.5	8.34E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051712	chr20:3265029	ITPA	chr20:3190056-3204504:+	-0.25	-4.51	8.06E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051713	chr20:3265779	ITPA	chr20:3190056-3204504:+	0.26	4.73	2.98E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051715	chr20:3266548	ITPA	chr20:3190056-3204504:+	-0.25	-4.51	8.06E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051716	chr20:3267736	ITPA	chr20:3190056-3204504:+	-0.26	-4.63	4.77E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051718	chr20:3270370	ITPA	chr20:3190056-3204504:+	-0.25	-4.53	7.57E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051722	chr20:3274435	ITPA	chr20:3190056-3204504:+	-0.25	-4.46	1.03E-5	IFN-related cytopenia	
LUAD	cis	1	rs6051723	chr20:3278512	ITPA	chr20:3190056-3204504:+	-0.25	-4.53	7.57E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051724	chr20:3279338	ITPA	chr20:3190056-3204504:+	-0.25	-4.54	7.18E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051732	chr20:3294182	ITPA	chr20:3190056-3204504:+	-0.25	-4.47	9.52E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051736	chr20:3296898	ITPA	chr20:3190056-3204504:+	-0.25	-4.47	9.52E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051737	chr20:3296992	ITPA	chr20:3190056-3204504:+	-0.25	-4.5	8.51E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051745	chr20:3307243	ITPA	chr20:3190056-3204504:+	-0.25	-4.53	7.32E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051747	chr20:3307945	ITPA	chr20:3190056-3204504:+	-0.25	-4.56	6.55E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051751	chr20:3310049	ITPA	chr20:3190056-3204504:+	-0.25	-4.53	7.32E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051753	chr20:3315513	ITPA	chr20:3190056-3204504:+	-0.25	-4.46	1.01E-5	IFN-related cytopenia	
LUAD	cis	1	rs6051762	chr20:3321590	ITPA	chr20:3190056-3204504:+	-0.25	-4.44	1.1E-5	IFN-related cytopenia	
LUAD	cis	1	rs6051763	chr20:3321616	ITPA	chr20:3190056-3204504:+	-0.25	-4.47	9.55E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.23	4.12	4.42E-5	IFN-related cytopenia	
LUAD	cis	1	rs6051779	chr20:3333449	ITPA	chr20:3190056-3204504:+	-0.25	-4.6	5.39E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051790	chr20:3342994	ITPA	chr20:3190056-3204504:+	-0.25	-4.61	5.14E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051792	chr20:3343519	ITPA	chr20:3190056-3204504:+	-0.25	-4.63	4.8E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051806	chr20:3350319	ITPA	chr20:3190056-3204504:+	-0.27	-4.85	1.63E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051807	chr20:3350485	ITPA	chr20:3190056-3204504:+	-0.26	-4.57	6.29E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051808	chr20:3350697	ITPA	chr20:3190056-3204504:+	-0.27	-4.91	1.26E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051809	chr20:3352551	ITPA	chr20:3190056-3204504:+	-0.27	-4.91	1.26E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051810	chr20:3355384	ITPA	chr20:3190056-3204504:+	-0.27	-4.85	1.65E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051827	chr20:3372007	ITPA	chr20:3190056-3204504:+	-0.26	-4.8	2.07E-6	IFN-related cytopenia	
LUAD	cis	1	rs6051831	chr20:3373712	ITPA	chr20:3190056-3204504:+	0.28	5.25	2.26E-7	IFN-related cytopenia	
LUAD	cis	1	rs6051838	chr20:3389012	ITPA	chr20:3190056-3204504:+	-0.24	-4.37	1.53E-5	IFN-related cytopenia	
LUAD	cis	1	rs6053815	chr20:5970438	MCM8	chr20:5931298-5975829:+	-0.2	-4.75	2.67E-6	HIV-1 viral setpoint	
LUAD	cis	1	rs6053816	chr20:5970750	MCM8	chr20:5931298-5975829:+	-0.21	-4.92	1.16E-6	HIV-1 viral setpoint	
LUAD	cis	1	rs60571765	chr4:76549046	CXCL9	chr4:76922623-76928641:-	0.15	3.76	0.00019	Magnesium levels	
LUAD	cis	1	rs6058352	chr20:30269179	FRG1B	chr20:29611879-29653908:+	0.22	3.9	0.000111	Subcortical brain region volumes	
LUAD	cis	1	rs6058465	chr20:30397691	FRG1B	chr20:29611879-29653908:+	0.21	3.7	0.000244	Subcortical brain region volumes	
LUAD	cis	1	rs60591831	chr1:32240968	COL16A1	chr1:32117848-32169768:-	-0.2	-3.98	7.85E-5	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs6060244	chr20:33699435	PROCR	chr20:33758727-33765164:+	0.27	3.88	0.000119	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
LUAD	cis	1	rs6060246	chr20:33701107	PROCR	chr20:33758727-33765164:+	-0.28	-3.82	0.000148	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
LUAD	cis	1	rs6060401	chr20:34005214	UQCC	chr20:33890383-33999833:-	0.3	5.42	9.49E-8	Height	
LUAD	cis	1	rs6060402	chr20:34005240	UQCC	chr20:33890383-33999833:-	0.3	5.49	6.5E-8	Height	
LUAD	cis	1	rs6060599	chr20:30257754	FRG1B	chr20:29611879-29653908:+	0.22	3.84	0.000138	Subcortical brain region volumes	
LUAD	cis	1	rs6060621	chr20:30261562	FRG1B	chr20:29611879-29653908:+	0.22	3.87	0.000123	Subcortical brain region volumes	
LUAD	cis	1	rs6060716	chr20:30274847	FRG1B	chr20:29611879-29653908:+	0.23	4.06	5.74E-5	Subcortical brain region volumes	
LUAD	cis	1	rs6060857	chr20:30300222	FRG1B	chr20:29611879-29653908:+	0.22	3.84	0.00014	Subcortical brain region volumes	
LUAD	cis	1	rs6060915	chr20:30330306	FRG1B	chr20:29611879-29653908:+	0.21	3.67	0.000266	Subcortical brain region volumes	
LUAD	cis	1	rs6060919	chr20:30331922	FRG1B	chr20:29611879-29653908:+	0.22	3.82	0.000153	Subcortical brain region volumes	
LUAD	cis	1	rs6060922	chr20:30333909	FRG1B	chr20:29611879-29653908:+	0.22	3.82	0.000153	Subcortical brain region volumes	
LUAD	cis	1	rs6060932	chr20:30350545	FRG1B	chr20:29611879-29653908:+	0.22	3.75	0.000201	Subcortical brain region volumes	
LUAD	cis	1	rs6060933	chr20:30351903	FRG1B	chr20:29611879-29653908:+	0.22	3.75	0.000201	Subcortical brain region volumes	
LUAD	cis	1	rs6060944	chr20:30372114	FRG1B	chr20:29611879-29653908:+	0.22	3.75	0.000201	Subcortical brain region volumes	
LUAD	cis	1	rs6060950	chr20:30378031	FRG1B	chr20:29611879-29653908:+	0.22	3.81	0.000157	Subcortical brain region volumes	
LUAD	cis	1	rs6060962	chr20:30397847	FRG1B	chr20:29611879-29653908:+	0.21	3.7	0.000244	Subcortical brain region volumes	
LUAD	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.29	4.43	1.19E-5	Atopic dermatitis	
LUAD	cis	1	rs6076336	chr20:25319212	FAM182A	chr20:26035250-26067552:+	0.18	3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6076733	chr20:4743033	PRND	chr20:4702556-4709105:+	0.22	3.89	0.000114	Systemic lupus erythematosus	
LUAD	cis	1	rs6083804	chr20:25317060	FAM182A	chr20:26035250-26067552:+	0.18	3.68	0.000259	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6083805	chr20:25317356	FAM182A	chr20:26035250-26067552:+	0.18	3.75	0.0002	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6083856	chr20:25407585	FAM182A	chr20:26035250-26067552:+	0.19	3.91	0.000106	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs60844734	chr2:73623205	ALMS1	chr2:73612886-73837046:+	0.18	4.25	2.59E-5	Metabolite levels	
LUAD	cis	1	rs60844734	chr2:73623205	ALMS1P	chr2:73872046-73912692:+	0.38	7.26	1.51E-12	Metabolite levels	
LUAD	cis	1	rs60844734	chr2:73623205	FBXO41	chr2:73481800-73498043:-	0.19	3.69	0.000251	Metabolite levels	
LUAD	cis	1	rs6084874	chr20:4742527	PRND	chr20:4702556-4709105:+	0.22	3.91	0.000105	Systemic lupus erythematosus	
LUAD	cis	1	rs6084875	chr20:4742705	PRND	chr20:4702556-4709105:+	-0.23	-4.27	2.39E-5	Systemic lupus erythematosus	
LUAD	cis	1	rs6084876	chr20:4742937	PRND	chr20:4702556-4709105:+	-0.2	-3.73	0.000215	Systemic lupus erythematosus	
LUAD	cis	1	rs6087698	chr20:33948919	UQCC	chr20:33890383-33999833:-	0.3	5.64	2.88E-8	Height	
LUAD	cis	1	rs6087702	chr20:33995945	UQCC	chr20:33890383-33999833:-	0.32	5.9	6.98E-9	Height	
LUAD	cis	1	rs6087703	chr20:33996433	UQCC	chr20:33890383-33999833:-	0.3	5.59	3.85E-8	Height	
LUAD	cis	1	rs6087704	chr20:34001058	UQCC	chr20:33890383-33999833:-	0.3	5.55	4.79E-8	Height	
LUAD	cis	1	rs6087705	chr20:34001250	UQCC	chr20:33890383-33999833:-	0.32	5.96	4.75E-9	Height	
LUAD	cis	1	rs6087771	chr20:30306724	FRG1B	chr20:29611879-29653908:+	0.22	3.75	0.000199	Subcortical brain region volumes	
LUAD	cis	1	rs6087779	chr20:30370566	FRG1B	chr20:29611879-29653908:+	0.22	3.75	0.000201	Subcortical brain region volumes	
LUAD	cis	1	rs6087782	chr20:30391580	FRG1B	chr20:29611879-29653908:+	0.22	3.81	0.000157	Subcortical brain region volumes	
LUAD	cis	1	rs6088799	chr20:33934301	UQCC	chr20:33890383-33999833:-	0.3	5.64	2.94E-8	Height	
LUAD	cis	1	rs6088812	chr20:33974163	UQCC	chr20:33890383-33999833:-	0.31	5.81	1.13E-8	Height	
LUAD	cis	1	rs6088813	chr20:33975181	UQCC	chr20:33890383-33999833:-	0.31	5.81	1.13E-8	Height	
LUAD	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.32	5.92	6.03E-9	Height	
LUAD	cis	1	rs6088816	chr20:33982435	UQCC	chr20:33890383-33999833:-	0.32	5.96	4.77E-9	Height	
LUAD	cis	1	rs6088820	chr20:33987298	UQCC	chr20:33890383-33999833:-	0.32	5.9	6.98E-9	Height	
LUAD	cis	1	rs6088821	chr20:33987576	UQCC	chr20:33890383-33999833:-	0.3	5.59	3.85E-8	Height	
LUAD	cis	1	rs6088823	chr20:33994265	UQCC	chr20:33890383-33999833:-	0.3	5.59	3.85E-8	Height	
LUAD	cis	1	rs6088825	chr20:33995972	UQCC	chr20:33890383-33999833:-	0.31	5.78	1.3E-8	Height	
LUAD	cis	1	rs6091236	chr20:49516995	KCNG1	chr20:49620194-49639675:-	-0.39	-4	7.18E-5	Prostate cancer	
LUAD	cis	1	rs60942590	chr3:53016421	TMEM110	chr3:52867139-52931547:-	0.4	4.35	1.68E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs60957376	chr15:85280792	LOC388152	chr15:84867600-84898920:-	-0.32	-6.06	2.77E-9	Schizophrenia	
LUAD	cis	1	rs60967688	chr17:28437052	EFCAB5	chr17:28256874-28435469:+	0.32	5.79	1.25E-8	Coffee consumption (cups per day)	
LUAD	cis	1	rs60967688	chr17:28437052	SSH2	chr17:27952965-28257018:-	0.15	3.85	0.000134	Coffee consumption (cups per day)	
LUAD	cis	1	rs60981340	chr2:86177046	LOC90784	chr2:86247339-86250991:-	-0.43	-4.41	1.25E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs60982898	chr6:49385806	CENPQ	chr6:49431096-49460820:+	-0.26	-6.62	9.68E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.34	6.99	9.16E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.51	-9.89	3.66E-21	Forced vital capacity	
LUAD	cis	1	rs6107045	chr20:25441936	FAM182A	chr20:26035250-26067552:+	-0.19	-3.93	9.59E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6107046	chr20:25442049	FAM182A	chr20:26035250-26067552:+	-0.19	-3.93	9.59E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6107047	chr20:25442097	FAM182A	chr20:26035250-26067552:+	-0.19	-3.93	9.59E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.18	2.56E-12	Body mass index	
LUAD	cis	1	rs61102033	chr1:46382441	MUTYH	chr1:45794915-45806142:-	0.17	4.08	5.34E-5	Body mass index	
LUAD	cis	1	rs6115140	chr20:25285507	FAM182A	chr20:26035250-26067552:+	-0.19	-3.91	0.000106	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6115191	chr20:25440478	FAM182A	chr20:26035250-26067552:+	-0.19	-3.93	9.59E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs61172708	chr3:52996052	TMEM110	chr3:52867139-52931547:-	0.45	4.88	1.46E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs6119650	chr20:30258480	FRG1B	chr20:29611879-29653908:+	0.23	4	7.35E-5	Subcortical brain region volumes	
LUAD	cis	1	rs6119652	chr20:30259445	FRG1B	chr20:29611879-29653908:+	0.22	3.87	0.000123	Subcortical brain region volumes	
LUAD	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.6	-8.19	2.26E-15	Triglycerides	
LUAD	cis	1	rs6121172	chr20:30296095	FRG1B	chr20:29611879-29653908:+	0.22	3.89	0.000114	Subcortical brain region volumes	
LUAD	cis	1	rs613089	chr1:147081187	ACP6	chr1:147119168-147142634:-	-0.28	-4.78	2.33E-6	Schizophrenia (negative symptoms)	
LUAD	cis	1	rs6132835	chr20:25434667	FAM182A	chr20:26035250-26067552:+	-0.19	-3.8	0.000165	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6133036	chr20:3349682	ITPA	chr20:3190056-3204504:+	-0.27	-4.91	1.26E-6	IFN-related cytopenia	
LUAD	cis	1	rs61360320	chr17:61800392	FTSJ3	chr17:61896795-61905031:-	0.23	4.8	2.12E-6	Body mass index	
LUAD	cis	1	rs61366424	chr10:60004851	IPMK	chr10:59955618-60027694:-	0.17	4.07	5.41E-5	Inflammatory bowel disease	
LUAD	cis	1	rs61378129	chr13:36684353	C13orf38	chr13:36801182-36871992:-	0.24	3.82	0.000152	Optic cup area	
LUAD	cis	1	rs6138150	chr20:23847009	CST5	chr20:23856572-23860380:-	0.21	3.76	0.000193	Response to TNF antagonist treatment	
LUAD	cis	1	rs6138572	chr20:25435934	FAM182A	chr20:26035250-26067552:+	-0.2	-3.99	7.47E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6138575	chr20:25438952	FAM182A	chr20:26035250-26067552:+	-0.2	-3.99	7.47E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs6139064	chr20:3277050	ITPA	chr20:3190056-3204504:+	-0.25	-4.54	7.24E-6	IFN-related cytopenia	
LUAD	cis	1	rs6139068	chr20:3284393	ITPA	chr20:3190056-3204504:+	-0.25	-4.61	5.25E-6	IFN-related cytopenia	
LUAD	cis	1	rs6139088	chr20:3329063	ITPA	chr20:3190056-3204504:+	-0.25	-4.55	6.92E-6	IFN-related cytopenia	
LUAD	cis	1	rs6139103	chr20:3361140	ITPA	chr20:3190056-3204504:+	-0.27	-4.81	2.03E-6	IFN-related cytopenia	
LUAD	cis	1	rs6139117	chr20:3387785	ITPA	chr20:3190056-3204504:+	-0.27	-4.76	2.52E-6	IFN-related cytopenia	
LUAD	cis	1	rs6141546	chr20:33949282	UQCC	chr20:33890383-33999833:-	0.3	5.64	2.88E-8	Height	
LUAD	cis	1	rs6141548	chr20:33971085	UQCC	chr20:33890383-33999833:-	0.3	5.67	2.39E-8	Height	
LUAD	cis	1	rs6141549	chr20:33974051	UQCC	chr20:33890383-33999833:-	0.31	5.81	1.13E-8	Height	
LUAD	cis	1	rs6142358	chr20:33960308	UQCC	chr20:33890383-33999833:-	-0.28	-5.26	2.12E-7	Height	
LUAD	cis	1	rs6142359	chr20:33960450	UQCC	chr20:33890383-33999833:-	0.3	5.64	2.88E-8	Height	
LUAD	cis	1	rs6142360	chr20:33960486	UQCC	chr20:33890383-33999833:-	0.29	5.37	1.21E-7	Height	
LUAD	cis	1	rs6142369	chr20:33973315	UQCC	chr20:33890383-33999833:-	0.3	5.61	3.31E-8	Height	
LUAD	cis	1	rs6142370	chr20:33973378	UQCC	chr20:33890383-33999833:-	0.31	5.81	1.13E-8	Height	
LUAD	cis	1	rs6142373	chr20:33983314	UQCC	chr20:33890383-33999833:-	0.33	6.07	2.56E-9	Height	
LUAD	cis	1	rs6142374	chr20:33985568	UQCC	chr20:33890383-33999833:-	0.3	5.59	3.85E-8	Height	
LUAD	cis	1	rs6142376	chr20:33992761	UQCC	chr20:33890383-33999833:-	0.31	5.78	1.3E-8	Height	
LUAD	cis	1	rs6142379	chr20:33999267	UQCC	chr20:33890383-33999833:-	0.3	5.59	3.85E-8	Height	
LUAD	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-0.87	-11.63	8.76E-28	Blood metabolite levels	
LUAD	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.31	5.58	3.95E-8	Metabolite levels (small molecules and protein measures)	
LUAD	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.4	4.88	1.45E-6	Crohn's disease	
LUAD	cis	1	rs61776516	chr1:12047028	MFN2	chr1:12040238-12073571:+	-0.19	-3.85	0.000136	Platelet count	
LUAD	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.74E-12	Body mass index	
LUAD	cis	1	rs61783200	chr1:46297403	MUTYH	chr1:45794915-45806142:-	0.18	4.21	3.1E-5	Body mass index	
LUAD	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.01E-12	Body mass index	
LUAD	cis	1	rs61783220	chr1:46335312	MUTYH	chr1:45794915-45806142:-	0.18	4.31	1.99E-5	Body mass index	
LUAD	cis	1	rs61792114	chr4:289139	ZNF718	chr4:53272-156488:+	0.26	3.83	0.000143	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs61794996	chr4:209328	ZNF718	chr4:53272-156488:+	0.29	4.2	3.13E-5	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs61794997	chr4:222103	ZNF718	chr4:53272-156488:+	0.28	4.15	3.96E-5	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs61795001	chr4:242057	ZNF718	chr4:53272-156488:+	0.27	3.88	0.000117	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs61795002	chr4:242797	ZNF718	chr4:53272-156488:+	0.27	3.88	0.000117	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs61795006	chr4:253601	ZNF718	chr4:53272-156488:+	0.25	3.68	0.000262	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs61795007	chr4:255264	ZNF718	chr4:53272-156488:+	0.25	3.68	0.000262	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs61803655	chr1:153769332	CREB3L4	chr1:153940379-153946832:+	-0.22	-4.71	3.22E-6	Lentiform nucleus volume	
LUAD	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.52	8.18	2.5E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs61820166	chr1:150556036	HORMAD1	chr1:150670542-150693352:-	-0.34	-3.7	0.000243	Congenital left-sided heart lesions	
LUAD	cis	1	rs61871790	chr10:97391223	ENTPD1	chr10:97471536-97637022:+	0.19	5.19	3.01E-7	Blood metabolite levels	
LUAD	cis	1	rs61871792	chr10:97397586	ENTPD1	chr10:97471536-97637022:+	0.2	5.5	6.1E-8	Blood metabolite levels	
LUAD	cis	1	rs61871793	chr10:97407738	ENTPD1	chr10:97471536-97637022:+	0.21	5.74	1.66E-8	Blood metabolite levels	
LUAD	cis	1	rs61872688	chr10:101273546	NKX2-3	chr10:101292690-101296278:+	-0.25	-4.81	1.99E-6	Dental caries	
LUAD	cis	1	rs61873277	chr10:126619331	UROS	chr10:127477148-127511837:-	0.29	3.85	0.000134	Height	
LUAD	cis	1	rs61876335	chr11:488878	LRRC56	chr11:537522-554915:+	0.23	3.74	0.000207	Body mass index	
LUAD	cis	1	rs61889187	chr11:32369603	WIT1	chr11:32457285-32468261:+	0.27	4.1	4.82E-5	Tuberculosis	
LUAD	cis	1	rs62019464	chr15:85294469	LOC388152	chr15:84867600-84898920:-	-0.31	-5.86	8.51E-9	Schizophrenia	
LUAD	cis	1	rs62019469	chr15:85321220	LOC388152	chr15:84867600-84898920:-	-0.3	-5.87	8.26E-9	Schizophrenia	
LUAD	cis	1	rs62021219	chr15:85256159	LOC388152	chr15:84867600-84898920:-	-0.32	-5.99	4.09E-9	Schizophrenia	
LUAD	cis	1	rs62026530	chr15:84775840	GOLGA6L5	chr15:85047738-85060078:-	-0.17	-3.72	0.00022	Schizophrenia	
LUAD	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.38	-7	8.75E-12	Schizophrenia	
LUAD	cis	1	rs62056375	chr16:29857901	LOC440356	chr16:29875004-29879374:+	-0.28	-3.71	0.00023	Multiple sclerosis	
LUAD	cis	1	rs62064224	chr17:30635115	EVI2A	chr17:29644676-29648717:-	-0.07	-3.73	0.000211	Schizophrenia	
LUAD	cis	1	rs62064823	chr17:33288103	LIG3	chr17:33307538-33332088:+	0.32	3.81	0.000158	Night sleep phenotypes	
LUAD	cis	1	rs62070270	chr17:28263980	EFCAB5	chr17:28256874-28435469:+	0.31	5.52	5.56E-8	Coffee consumption (cups per day)	
LUAD	cis	1	rs62070270	chr17:28263980	SSH2	chr17:27952965-28257018:-	0.15	3.93	9.83E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs62070312	chr17:28438877	EFCAB5	chr17:28256874-28435469:+	0.33	5.91	6.45E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs62070312	chr17:28438877	SSH2	chr17:27952965-28257018:-	0.15	4.02	6.83E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs62073605	chr17:18066791	MYO15A	chr17:18012020-18083115:+	0.26	4.84	1.75E-6	Obesity-related traits	
LUAD	cis	1	rs62073606	chr17:18069142	MYO15A	chr17:18012020-18083115:+	0.26	4.78	2.31E-6	Obesity-related traits	
LUAD	cis	1	rs62084213	chr17:65842016	LOC440461	chr17:66194801-66196436:+	0.24	3.76	0.000188	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs62084214	chr17:65843325	LOC440461	chr17:66194801-66196436:+	0.24	3.76	0.000188	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs62085992	chr17:65923083	LOC440461	chr17:66194801-66196436:+	0.24	3.83	0.000146	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs62114497	chr2:214837	SH3YL1	chr2:218138-264810:-	-0.64	-13.81	7.45E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.64	-14.05	6.71E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.64	-14.02	9.12E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.64	-14	1.12E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.63	-13.46	2.46E-35	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs62114762	chr19:24233868	LOC100101266	chr19:24344995-24346249:-	0.25	3.83	0.000142	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs62117633	chr19:24219474	LOC100101266	chr19:24344995-24346249:-	0.25	3.75	0.0002	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs62134006	chr2:70050641	SNRNP27	chr2:70121090-70132348:+	0.21	3.92	0.000103	Colorectal or endometrial cancer	
LUAD	cis	1	rs62134009	chr2:70054296	SNRNP27	chr2:70121090-70132348:+	0.21	3.89	0.000115	Colorectal or endometrial cancer	
LUAD	cis	1	rs62136099	chr19:46847901	CCDC9	chr19:47759731-47775208:+	-0.23	-5.06	6.0E-7	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs62136864	chr2:46829124	ATP6V1E2	chr2:46738988-46769696:-	-0.24	-4.6	5.36E-6	Height	
LUAD	cis	1	rs62151652	chr2:73700131	ALMS1	chr2:73612886-73837046:+	0.18	4.38	1.48E-5	Metabolite levels	
LUAD	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.38	7.24	1.77E-12	Metabolite levels	
LUAD	cis	1	rs62151652	chr2:73700131	FBXO41	chr2:73481800-73498043:-	0.19	3.67	0.000267	Metabolite levels	
LUAD	cis	1	rs62175446	chr2:179952013	SESTD1	chr2:179966421-180129350:-	-0.42	-3.73	0.000216	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62175447	chr2:179964348	SESTD1	chr2:179966421-180129350:-	-0.42	-3.73	0.000216	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62175449	chr2:179990211	SESTD1	chr2:179966421-180129350:-	-0.42	-3.73	0.000214	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62175450	chr2:180003056	SESTD1	chr2:179966421-180129350:-	-0.43	-3.82	0.000151	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62175515	chr2:160909524	LY75	chr2:160625141-160761262:-	0.2	4.31	1.96E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs62175517	chr2:160911575	LY75	chr2:160625141-160761262:-	0.19	4.31	1.99E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs62177277	chr2:180004448	SESTD1	chr2:179966421-180129350:-	-0.43	-3.98	8.01E-5	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62177283	chr2:180036117	SESTD1	chr2:179966421-180129350:-	-0.42	-3.69	0.000249	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62177287	chr2:180052023	SESTD1	chr2:179966421-180129350:-	-0.42	-3.69	0.000249	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62177289	chr2:180053737	SESTD1	chr2:179966421-180129350:-	-0.42	-3.69	0.000249	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62177337	chr2:180125071	SESTD1	chr2:179966421-180129350:-	-0.45	-4.04	6.25E-5	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62177338	chr2:180126141	SESTD1	chr2:179966421-180129350:-	-0.45	-4.04	6.25E-5	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62179066	chr2:180131509	SESTD1	chr2:179966421-180129350:-	-0.45	-4.04	6.25E-5	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62179067	chr2:180135183	SESTD1	chr2:179966421-180129350:-	-0.45	-4.19	3.27E-5	Late-onset Alzheimer's disease	
LUAD	cis	1	rs62184315	chr2:190771945	ORMDL1	chr2:190634994-190649097:-	0.26	4.29	2.16E-5	Alcohol dependence (age at onset)	
LUAD	cis	1	rs62211529	chr20:33959315	UQCC	chr20:33890383-33999833:-	0.29	5.45	8.16E-8	Height	
LUAD	cis	1	rs62236665	chr22:38059847	LGALS2	chr22:37966254-37976024:-	0.18	4.14	4.08E-5	Fat distribution (HIV)	
LUAD	cis	1	rs62236667	chr22:38061520	LGALS2	chr22:37966254-37976024:-	0.17	3.96	8.65E-5	Fat distribution (HIV)	
LUAD	cis	1	rs62236668	chr22:38063870	LGALS2	chr22:37966254-37976024:-	0.17	3.96	8.65E-5	Fat distribution (HIV)	
LUAD	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.37	7.32	1.03E-12	Cognitive performance	
LUAD	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.52	10.27	1.57E-22	Height	
LUAD	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.49	-9.53	7.29E-20	Height	
LUAD	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.49	-9.55	6.35E-20	Height	
LUAD	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.51	9.83	6.51E-21	Height	
LUAD	cis	1	rs62321365	chr4:107013723	TBCK	chr4:106967233-107237861:-	0.25	4.59	5.75E-6	Airflow obstruction	
LUAD	cis	1	rs62392442	chr6:3837366	SERPINB1	chr6:2833736-2842081:-	0.16	3.77	0.000186	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	
LUAD	cis	1	rs62402013	chr6:26915000	BTN3A2	chr6:26365398-26378546:+	0.27	6.31	6.3E-10	Schizophrenia	
LUAD	cis	1	rs62406153	chr6:55935232	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs62406155	chr6:55937492	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs62406176	chr5:179164143	TBC1D9B	chr5:179289073-179334856:-	-0.19	-3.84	0.000141	Resting heart rate	
LUAD	cis	1	rs62411455	chr6:55968366	COL21A1	chr6:55921389-56258892:-	-0.23	-3.7	0.000243	Psychosis (atypical)	
LUAD	cis	1	rs62578008	chr9:117999308	PAPPA	chr9:118916071-119164599:+	0.26	3.72	0.000224	Pancreatic cancer	
LUAD	cis	1	rs62578032	chr9:118043057	PAPPA	chr9:118916071-119164599:+	0.25	3.75	0.0002	Pancreatic cancer	
LUAD	cis	1	rs627147	chr6:150704207	IYD	chr6:150690028-150725764:+	-0.18	-3.85	0.000132	Anger	
LUAD	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.72	-14.77	4.4E-41	Crohn's disease	
LUAD	cis	1	rs641018	chr11:65655393	FIBP	chr11:65651212-65656010:-	0.27	4.91	1.26E-6	Crohn's disease	
LUAD	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.39	5.83	1.02E-8	Crohn's disease	
LUAD	cis	1	rs641862	chr13:110790232	ANKRD10	chr13:111530888-111567416:-	0.55	6.1	2.16E-9	Obesity-related traits	
LUAD	cis	1	rs641862	chr13:110790232	ARHGEF7	chr13:111767624-111958080:+	0.68	7.01	8.09E-12	Obesity-related traits	
LUAD	cis	1	rs641862	chr13:110790232	C13orf29	chr13:111516334-111522655:-	0.46	4.23	2.81E-5	Obesity-related traits	
LUAD	cis	1	rs641862	chr13:110790232	CARKD	chr13:111267881-111292340:+	0.66	7.31	1.13E-12	Obesity-related traits	
LUAD	cis	1	rs641862	chr13:110790232	CARS2	chr13:111293757-111365950:-	0.7	6.46	2.47E-10	Obesity-related traits	
LUAD	cis	1	rs641862	chr13:110790232	ING1	chr13:111365083-111373420:+	0.58	5.38	1.14E-7	Obesity-related traits	
LUAD	cis	1	rs6422512	chr1:93024844	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs6427049	chr1:166956593	GPA33	chr1:167022082-167059868:-	-0.23	-4.32	1.9E-5	Refractive astigmatism	
LUAD	cis	1	rs6427553	chr1:160855813	ITLN1	chr1:160846332-160854960:-	0.27	4.94	1.08E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs6427950	chr1:202472066	PPP1R12B	chr1:202317836-202557697:+	0.23	5.04	6.46E-7	Sex ratio	
LUAD	cis	1	rs6427952	chr1:202492418	PPP1R12B	chr1:202317836-202557697:+	0.22	4.94	1.06E-6	Sex ratio	
LUAD	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.29	5.46	7.63E-8	Height	
LUAD	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.91	-18.57	1.19E-58	Homocysteine levels	
LUAD	cis	1	rs6429567	chr1:45956700	MUTYH	chr1:45794915-45806142:-	0.22	4.58	5.81E-6	Homocysteine levels	
LUAD	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.77	-16.02	9.93E-47	Homocysteine levels	
LUAD	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.32	6.05	2.86E-9	Body mass index	
LUAD	cis	1	rs6429582	chr1:46321843	MUTYH	chr1:45794915-45806142:-	-0.19	-4.56	6.49E-6	Body mass index	
LUAD	cis	1	rs6435079	chr2:202200331	ALS2CR12	chr2:202153148-202222101:-	-0.14	-3.7	0.000241	Basal cell carcinoma	
LUAD	cis	1	rs6435079	chr2:202200331	CASP8	chr2:202098166-202152434:+	0.23	5.28	1.92E-7	Basal cell carcinoma	
LUAD	cis	1	rs6435081	chr2:202220623	ALS2CR12	chr2:202153148-202222101:-	-0.14	-3.83	0.000147	Basal cell carcinoma	
LUAD	cis	1	rs6435081	chr2:202220623	CASP8	chr2:202098166-202152434:+	0.24	5.28	1.94E-7	Basal cell carcinoma	
LUAD	cis	1	rs6435169	chr2:203753016	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs6436741	chr2:228714598	WDR69	chr2:228736327-228789026:+	0.28	5.87	8.06E-9	Blood pressure	
LUAD	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.52	10.31	1.1E-22	Height	
LUAD	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.52	10.31	1.1E-22	Height	
LUAD	cis	1	rs6439649	chr3:136371691	PCCB	chr3:135969167-136056737:+	-0.28	-6.1	2.12E-9	Schizophrenia	
LUAD	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.32	-5.16	3.68E-7	Bone mineral density	
LUAD	cis	1	rs6442117	chr3:48419897	ATRIP	chr3:48488141-48507708:+	-0.2	-3.71	0.000233	Longevity	
LUAD	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.26	6.39	3.89E-10	Longevity	
LUAD	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.29	-7.12	3.84E-12	Longevity	
LUAD	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.29	-7.26	1.51E-12	Longevity	
LUAD	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.32	-8.04	6.97E-15	Longevity	
LUAD	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.29	-7.27	1.4E-12	Longevity	
LUAD	cis	1	rs6444530	chr3:190982425	UTS2D	chr3:190984945-191048325:-	-0.28	-5.84	9.74E-9	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs6444531	chr3:190988002	UTS2D	chr3:190984945-191048325:-	-0.29	-6.09	2.34E-9	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs6445557	chr3:53083969	TMEM110	chr3:52867139-52931547:-	-0.37	-4.61	5.21E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs6445814	chr3:56727885	CCDC66	chr3:56591184-56655846:+	0.19	5.25	2.24E-7	Height	
LUAD	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.79	14.18	1.78E-38	Type 2 diabetes	
LUAD	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.75	13.49	1.74E-35	Type 2 diabetes	
LUAD	cis	1	rs6453279	chr5:76417074	LOC728723	chr5:76382623-76444175:+	-0.19	-3.76	0.000189	Autism	
LUAD	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.63	11.95	4.63E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs6456735	chr6:26574149	BTN2A3	chr6:26422317-26431927:+	0.16	3.7	0.000241	Educational attainment	
LUAD	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.38	-10.33	9.43E-23	Homocysteine levels	
LUAD	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.38	-10.46	3.02E-23	Homocysteine levels	
LUAD	cis	1	rs6458690	chr6:49411619	CENPQ	chr6:49431096-49460820:+	-0.27	-6.69	6.11E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.34	6.99	9.32E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.28	-7.04	6.36E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.32	6.59	1.16E-10	Folate pathway vitamin levels	
LUAD	cis	1	rs6459657	chr6:170136454	C6orf208	chr6:170190169-170202969:+	-0.31	-3.7	0.000236	Thiazide-induced adverse metabolic effects in hypertensive patients	
LUAD	cis	1	rs6460260	chr7:65215455	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.94	9.39E-5	Diabetic kidney disease	
LUAD	cis	1	rs6460261	chr7:65215580	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.94	9.39E-5	Diabetic kidney disease	
LUAD	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.36	6.66	7.51E-11	Obesity-related traits	
LUAD	cis	1	rs6464573	chr7:143748098	OR2A7	chr7:143955790-143974852:-	-0.21	-3.76	0.00019	Obesity-related traits	
LUAD	cis	1	rs6464573	chr7:143748098	OR2A9P	chr7:143991573-143997832:+;chr7	0.26	4.83	1.81E-6	Obesity-related traits	
LUAD	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.36	-6.53	1.62E-10	Obesity-related traits	
LUAD	cis	1	rs6464574	chr7:143748257	OR2A7	chr7:143955790-143974852:-	0.23	3.98	8.04E-5	Obesity-related traits	
LUAD	cis	1	rs6464574	chr7:143748257	OR2A9P	chr7:143991573-143997832:+;chr7	-0.26	-4.55	6.67E-6	Obesity-related traits	
LUAD	cis	1	rs6465657	chr7:97816327	BHLHA15	chr7:97840778-97842271:+	-0.18	-4.5	8.46E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
LUAD	cis	1	rs6465658	chr7:97816638	BHLHA15	chr7:97840778-97842271:+	-0.18	-4.42	1.22E-5	Prostate cancer (gene x gene interaction);Prostate cancer	
LUAD	cis	1	rs6468131	chr8:29981020	MBOAT4	chr8:29989188-30002200:-	-0.38	-5.37	1.21E-7	Migraine	
LUAD	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.32	7.54	2.29E-13	Erythrocyte sedimentation rate	
LUAD	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.51	-10.32	9.71E-23	Erythrocyte sedimentation rate	
LUAD	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.34	-6.78	3.49E-11	Rheumatoid arthritis	
LUAD	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.33	-6.6	1.04E-10	Rheumatoid arthritis	
LUAD	cis	1	rs6478867	chr9:131903923	CRAT	chr9:131857075-131873070:-	-0.33	-6.36	4.68E-10	Blood metabolite ratios	
LUAD	cis	1	rs6478867	chr9:131903923	PPP2R4	chr9:131873244-131911223:+	-0.19	-3.75	0.000196	Blood metabolite ratios	
LUAD	cis	1	rs6478987	chr9:102690883	STX17	chr9:102668915-102736817:+	-0.18	-3.9	0.000108	Alopecia areata	
LUAD	cis	1	rs6480723	chr10:75966366	ADK	chr10:75910965-76469059:+	0.24	3.96	8.48E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs6483880	chr11:22852740	SVIP	chr11:22843600-22851382:-	0.22	4.34	1.73E-5	Dialysis-related mortality	
LUAD	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.51	-10.16	3.9E-22	Forced vital capacity	
LUAD	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.54	10.87	8.4E-25	Forced vital capacity	
LUAD	cis	1	rs6487679	chr12:9371332	LOC642846	chr12:9436253-9466684:+	0.19	4.38	1.47E-5	Non-alcoholic fatty liver disease histology (AST)	
LUAD	cis	1	rs6489785	chr12:121363724	CAMKK2	chr12:121675496-121736111:-	0.19	3.75	0.0002	Longevity	
LUAD	cis	1	rs6489785	chr12:121363724	SPPL3	chr12:121201036-121342151:-	0.28	5.04	6.71E-7	Longevity	
LUAD	cis	1	rs6495206	chr15:76870963	SCAPER	chr15:76640529-77197744:-	-0.22	-5.07	5.61E-7	Blood metabolite levels	
LUAD	cis	1	rs649613	chr6:150702093	IYD	chr6:150690028-150725764:+	-0.17	-3.81	0.000155	Anger	
LUAD	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.67	-13.87	3.98E-37	Type 2 diabetes	
LUAD	cis	1	rs6502677	chr17:18803658	FAM18B	chr17:18684582-18710026:+	-0.23	-4.55	6.91E-6	Educational attainment (years of education)	
LUAD	cis	1	rs6502677	chr17:18803658	FBXW10	chr17:18647326-18682661:+	-0.23	-4.8	2.11E-6	Educational attainment (years of education)	
LUAD	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.64	-12.67	5.06E-32	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs6503703	chr17:40592207	NAGLU	chr17:40687951-40696464:+	-0.21	-3.71	0.00023	Crohn's disease	
LUAD	cis	1	rs6503704	chr17:40592253	NAGLU	chr17:40687951-40696464:+	-0.21	-3.77	0.000185	Crohn's disease	
LUAD	cis	1	rs6503877	chr17:56841948	RAD51C	chr17:56769963-56811690:+	0.23	4.67	3.81E-6	Cognitive test performance	
LUAD	cis	1	rs6503882	chr17:56915761	RAD51C	chr17:56769963-56811690:+	0.21	4.32	1.93E-5	Cognitive test performance	
LUAD	cis	1	rs6504168	chr17:61697469	FTSJ3	chr17:61896795-61905031:-	0.25	5.14	4.03E-7	Body mass index	
LUAD	cis	1	rs6504169	chr17:61709145	FTSJ3	chr17:61896795-61905031:-	0.23	4.9	1.32E-6	Body mass index	
LUAD	cis	1	rs6504170	chr17:61709168	FTSJ3	chr17:61896795-61905031:-	0.2	4.25	2.55E-5	Body mass index	
LUAD	cis	1	rs6504182	chr17:61823672	FTSJ3	chr17:61896795-61905031:-	0.21	4.49	8.86E-6	Body mass index	
LUAD	cis	1	rs6504542	chr17:65836642	LOC440461	chr17:66194801-66196436:+	0.22	3.67	0.000269	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs6504543	chr17:65837659	LOC440461	chr17:66194801-66196436:+	0.22	3.69	0.000245	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs6504555	chr17:65940727	LOC440461	chr17:66194801-66196436:+	-0.22	-3.67	0.000272	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs6505152	chr17:28331466	EFCAB5	chr17:28256874-28435469:+	-0.33	-6	3.81E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs6505152	chr17:28331466	SSH2	chr17:27952965-28257018:-	-0.16	-4.32	1.86E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs6505158	chr17:28403348	EFCAB5	chr17:28256874-28435469:+	-0.33	-6.08	2.39E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs6505158	chr17:28403348	SSH2	chr17:27952965-28257018:-	-0.17	-4.45	1.06E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs6510348	chr19:33601946	GPATCH1	chr19:33571786-33621318:+	0.22	4.09	5.08E-5	Bone properties (heel)	
LUAD	cis	1	rs6510348	chr19:33601946	RHPN2	chr19:33469499-33555824:-	-0.2	-4.16	3.77E-5	Bone properties (heel)	
LUAD	cis	1	rs6532022	chr4:88773734	SPP1	chr4:88896802-88904562:+	-0.2	-4.11	4.72E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
LUAD	cis	1	rs6532023	chr4:88773849	SPP1	chr4:88896802-88904562:+	-0.2	-4.11	4.72E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
LUAD	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.37	-7.33	9.87E-13	Longevity	
LUAD	cis	1	rs6533059	chr4:104133376	BDH2	chr4:103998783-104021024:-	0.26	5.2	2.95E-7	Testicular germ cell tumor	
LUAD	cis	1	rs6533059	chr4:104133376	MANBA	chr4:103552644-103682151:-	0.3	5.69	2.19E-8	Testicular germ cell tumor	
LUAD	cis	1	rs6533060	chr4:104139996	BDH2	chr4:103998783-104021024:-	0.26	5.35	1.39E-7	Testicular germ cell tumor	
LUAD	cis	1	rs6533060	chr4:104139996	MANBA	chr4:103552644-103682151:-	0.28	5.47	7.31E-8	Testicular germ cell tumor	
LUAD	cis	1	rs6536882	chr4:165900680	C4orf39	chr4:165878100-165880273:+	0.29	5.56	4.56E-8	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs6536882	chr4:165900680	TRIM61	chr4:165875600-165898818:-	0.2	3.91	0.000106	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs6536883	chr4:165900704	C4orf39	chr4:165878100-165880273:+	0.29	5.56	4.56E-8	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs6536883	chr4:165900704	TRIM61	chr4:165875600-165898818:-	0.2	3.91	0.000106	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs6542090	chr2:113524795	IL1A	chr2:113531493-113542971:-	0.23	4.23	2.76E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs6542091	chr2:113525311	IL1A	chr2:113531493-113542971:-	0.23	4.23	2.76E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs6542092	chr2:113528322	IL1A	chr2:113531493-113542971:-	0.23	4.24	2.67E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs6542093	chr2:113528536	IL1A	chr2:113531493-113542971:-	0.23	4.24	2.67E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs6542094	chr2:113528625	IL1A	chr2:113531493-113542971:-	0.23	4.24	2.67E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs654316	chr18:70247295	CBLN2	chr18:70203915-70211723:-	0.37	3.93	9.56E-5	Airflow obstruction	
LUAD	cis	1	rs6544065	chr2:37497417	CEBPZ	chr2:37428778-37458740:-	-0.18	-3.91	0.000106	Chronic lymphocytic leukemia	
LUAD	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.13	-5.39	1.12E-7	Tuberculosis	
LUAD	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.49	9.5	9.53E-20	Tuberculosis	
LUAD	cis	1	rs6546835	chr2:73664715	ALMS1	chr2:73612886-73837046:+	0.19	4.7	3.38E-6	Metabolite levels	
LUAD	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.36	6.9	1.57E-11	Metabolite levels	
LUAD	cis	1	rs6546836	chr2:73677833	ALMS1	chr2:73612886-73837046:+	0.18	4.55	6.77E-6	Metabolite levels	
LUAD	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.35	6.84	2.44E-11	Metabolite levels	
LUAD	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.44	8.66E-8	Body mass index	
LUAD	cis	1	rs6553475	chr4:170877160	MFAP3L	chr4:170907750-170947429:-	-0.2	-3.85	0.000136	Educational attainment	
LUAD	cis	1	rs6553477	chr4:170877933	MFAP3L	chr4:170907750-170947429:-	-0.2	-3.81	0.000154	Educational attainment	
LUAD	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.72	-14.77	4.4E-41	Crohn's disease	
LUAD	cis	1	rs656980	chr11:65656282	FIBP	chr11:65651212-65656010:-	0.27	4.91	1.26E-6	Crohn's disease	
LUAD	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.39	5.83	1.02E-8	Crohn's disease	
LUAD	cis	1	rs6573320	chr14:61092022	C14orf39	chr14:60902675-60952764:-	0.33	3.91	0.000103	Gut microbiota (bacterial taxa)	
LUAD	cis	1	rs6579234	chr20:33983485	UQCC	chr20:33890383-33999833:-	0.33	6.07	2.56E-9	Height	
LUAD	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.59	-7.97	1.1E-14	Cholesterol, total	
LUAD	cis	1	rs6579803	chr5:150255559	LOC134466	chr5:150310000-150326146:-	0.3	3.77	0.000181	Crohn's disease	
LUAD	cis	1	rs6579804	chr5:150255931	LOC134466	chr5:150310000-150326146:-	0.3	3.77	0.000181	Crohn's disease	
LUAD	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.47	8.4	4.76E-16	Multiple sclerosis	
LUAD	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.23	-4.71	3.24E-6	Multiple sclerosis	
LUAD	cis	1	rs6583203	chr3:197079586	DLG1	chr3:196769432-197026143:-	-0.2	-3.69	0.000253	Allergic rhinitis	
LUAD	cis	1	rs6584278	chr10:101278099	NKX2-3	chr10:101292690-101296278:+	-0.25	-4.81	2.02E-6	Dental caries	
LUAD	cis	1	rs6584379	chr10:102224490	SEC31B	chr10:102246403-102289636:-	-0.22	-7.03	7.21E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs6584383	chr10:102303065	SEC31B	chr10:102246403-102289636:-	-0.19	-6.15	1.57E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs6592284	chr11:86055901	CCDC81	chr11:86085778-86134150:+	-0.23	-4.35	1.68E-5	Cognitive performance	
LUAD	cis	1	rs6592450	chr11:71671166	KRTAP5-9	chr11:71259466-71260653:+	0.28	3.7	0.000241	Severe influenza A (H1N1) infection	
LUAD	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	0.72	13.47	2.15E-35	Diastolic blood pressure	
LUAD	cis	1	rs6599318	chr4:243968	ZNF718	chr4:53272-156488:+	0.26	3.82	0.000153	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs6599639	chr10:124743751	C10orf88	chr10:124690419-124713919:-	-0.2	-4.18	3.52E-5	Migraine without aura	
LUAD	cis	1	rs6603033	chr15:83335875	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.14	4.3	2.09E-5	Schizophrenia	
LUAD	cis	1	rs6603975	chr1:92951239	EVI5	chr1:92974255-93257961:-	-0.26	-4.14	4.07E-5	Cholesterol, total	
LUAD	cis	1	rs6603979	chr1:92979354	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs6603981	chr1:92993807	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs6603982	chr1:92994033	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs6603984	chr1:93011572	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs6603985	chr1:93017159	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs6603987	chr1:93019313	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs6603990	chr1:93030735	EVI5	chr1:92974255-93257961:-	-0.26	-4.14	4.08E-5	Cholesterol, total	
LUAD	cis	1	rs660686	chr9:15297587	TTC39B	chr9:15171561-15307244:-	-0.28	-3.86	0.000128	Coenzyme Q10 levels;Metabolite levels (lipoprotein measures)	
LUAD	cis	1	rs661048	chr9:15297629	TTC39B	chr9:15171561-15307244:-	-0.28	-3.86	0.000128	Coenzyme Q10 levels;Metabolite levels (lipoprotein measures)	
LUAD	cis	1	rs66518523	chr3:113004759	SIDT1	chr3:113251218-113348421:+	0.23	3.82	0.00015	Dental caries	
LUAD	cis	1	rs6656432	chr1:93029453	EVI5	chr1:92974255-93257961:-	-0.26	-4.14	4.08E-5	Cholesterol, total	
LUAD	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.01E-12	Body mass index	
LUAD	cis	1	rs6656992	chr1:46333068	MUTYH	chr1:45794915-45806142:-	0.18	4.31	1.99E-5	Body mass index	
LUAD	cis	1	rs6656999	chr1:166956807	GPA33	chr1:167022082-167059868:-	-0.24	-4.47	9.69E-6	Refractive astigmatism	
LUAD	cis	1	rs6658708	chr1:202322113	PPP1R12B	chr1:202317836-202557697:+	0.22	4.91	1.25E-6	Sex ratio	
LUAD	cis	1	rs6660290	chr1:101483512	CCDC76	chr1:100598706-100616053:+	-0.18	-3.78	0.000177	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs6661134	chr1:93010908	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs6661167	chr1:152312870	FLG	chr1:152274651-152297679:-	0.27	3.93	9.6E-5	Atopic dermatitis	
LUAD	cis	1	rs6661910	chr1:46290632	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.16	2.94E-12	Body mass index	
LUAD	cis	1	rs6661910	chr1:46290632	MUTYH	chr1:45794915-45806142:-	0.18	4.13	4.35E-5	Body mass index	
LUAD	cis	1	rs6661970	chr1:202520925	PPP1R12B	chr1:202317836-202557697:+	0.22	4.91	1.25E-6	Sex ratio	
LUAD	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.23	1.82E-12	Body mass index	
LUAD	cis	1	rs6662641	chr1:46571509	MUTYH	chr1:45794915-45806142:-	0.16	3.84	0.000137	Body mass index	
LUAD	cis	1	rs6665341	chr1:166947018	GPA33	chr1:167022082-167059868:-	-0.24	-4.48	9.26E-6	Refractive astigmatism	
LUAD	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.9	-18.48	3.06E-58	Homocysteine levels	
LUAD	cis	1	rs6667191	chr1:45982844	MUTYH	chr1:45794915-45806142:-	0.22	4.67	3.87E-6	Homocysteine levels	
LUAD	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.31	1.13E-12	Body mass index	
LUAD	cis	1	rs6668284	chr1:46354510	MUTYH	chr1:45794915-45806142:-	0.18	4.16	3.71E-5	Body mass index	
LUAD	cis	1	rs6668386	chr1:12047233	MFN2	chr1:12040238-12073571:+	-0.2	-3.89	0.000112	Platelet count	
LUAD	cis	1	rs6669263	chr1:171692311	VAMP4	chr1:171669298-171711214:-	0.24	3.93	9.88E-5	Hippocampal atrophy	
LUAD	cis	1	rs6669371	chr1:11882142	CLCN6	chr1:11866207-11907674:+	0.21	4.05	6.04E-5	QRS complex (12-leadsum)	
LUAD	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.19	2.43E-12	Body mass index	
LUAD	cis	1	rs6669522	chr1:46397941	MUTYH	chr1:45794915-45806142:-	0.17	4.07	5.49E-5	Body mass index	
LUAD	cis	1	rs6672267	chr1:12054911	MFN2	chr1:12040238-12073571:+	-0.2	-3.89	0.000114	Platelet count	
LUAD	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.23	1.86E-12	Body mass index	
LUAD	cis	1	rs6672898	chr1:46290588	MUTYH	chr1:45794915-45806142:-	0.18	4.17	3.53E-5	Body mass index	
LUAD	cis	1	rs6675353	chr1:101459625	CCDC76	chr1:100598706-100616053:+	0.18	3.69	0.000253	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.34	9.1E-13	Body mass index	
LUAD	cis	1	rs6675726	chr1:46560643	MUTYH	chr1:45794915-45806142:-	0.17	3.87	0.000122	Body mass index	
LUAD	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.71E-12	Body mass index	
LUAD	cis	1	rs6675946	chr1:46371774	MUTYH	chr1:45794915-45806142:-	0.18	4.22	2.9E-5	Body mass index	
LUAD	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.19	2.43E-12	Body mass index	
LUAD	cis	1	rs6677007	chr1:46400590	MUTYH	chr1:45794915-45806142:-	0.17	4.07	5.49E-5	Body mass index	
LUAD	cis	1	rs66775662	chr6:151876216	C6orf97	chr6:151815175-151942327:+	0.17	3.81	0.000156	Bone mineral density (spine)	
LUAD	cis	1	rs6677930	chr1:197135466	CFHR3	chr1:196743930-196762872:+	0.21	3.84	0.000142	End-stage coagulation	
LUAD	cis	1	rs6678890	chr1:171694566	VAMP4	chr1:171669298-171711214:-	0.25	3.97	8.11E-5	Hippocampal atrophy	
LUAD	cis	1	rs6679073	chr1:205756484	PM20D1	chr1:205797154-205819245:-	-0.37	-6.85	2.22E-11	Prostate-specific antigen levels	
LUAD	cis	1	rs6679145	chr1:156256000	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs6679552	chr1:202449586	PPP1R12B	chr1:202317836-202557697:+	0.23	5.24	2.41E-7	Sex ratio	
LUAD	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.49	8.18	2.39E-15	Diastolic blood pressure;Blood pressure	
LUAD	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.74E-12	Body mass index	
LUAD	cis	1	rs6680380	chr1:46300189	MUTYH	chr1:45794915-45806142:-	0.18	4.21	3.1E-5	Body mass index	
LUAD	cis	1	rs6682062	chr1:166949979	GPA33	chr1:167022082-167059868:-	0.25	4.61	5.05E-6	Refractive astigmatism	
LUAD	cis	1	rs6682784	chr1:202313978	PPP1R12B	chr1:202317836-202557697:+	0.23	5.01	7.64E-7	Sex ratio	
LUAD	cis	1	rs6682873	chr1:101470906	CCDC76	chr1:100598706-100616053:+	0.18	3.74	0.000203	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs6684514	chr1:156255456	CCT3	chr1:156278752-156308195:-	-0.17	-4.17	3.55E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs6685373	chr1:202314199	PPP1R12B	chr1:202317836-202557697:+	0.22	4.73	2.96E-6	Sex ratio	
LUAD	cis	1	rs66864889	chr7:128952560	LOC407835	chr7:128766325-128768041:+	0.25	3.97	8.2E-5	White matter hyperintensity burden	
LUAD	cis	1	rs6688613	chr1:166951869	GPA33	chr1:167022082-167059868:-	0.23	4.29	2.15E-5	Refractive astigmatism	
LUAD	cis	1	rs6690764	chr1:92976590	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs6692187	chr1:93035020	EVI5	chr1:92974255-93257961:-	-0.23	-3.77	0.000186	Cholesterol, total	
LUAD	cis	1	rs6692729	chr1:227018919	PSEN2	chr1:227058273-227083804:+	-0.2	-3.82	0.000153	Electrodermal activity	
LUAD	cis	1	rs6695144	chr1:202489218	PPP1R12B	chr1:202317836-202557697:+	0.22	4.97	9.18E-7	Sex ratio	
LUAD	cis	1	rs6695162	chr1:166953455	GPA33	chr1:167022082-167059868:-	-0.23	-4.39	1.37E-5	Refractive astigmatism	
LUAD	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.78E-12	Body mass index	
LUAD	cis	1	rs6695809	chr1:46285461	MUTYH	chr1:45794915-45806142:-	0.18	4.24	2.72E-5	Body mass index	
LUAD	cis	1	rs66965793	chr1:156285814	CCT3	chr1:156278752-156308195:-	-0.16	-3.99	7.66E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs6696611	chr1:202493689	PPP1R12B	chr1:202317836-202557697:+	0.23	5.1	4.85E-7	Sex ratio	
LUAD	cis	1	rs66990486	chr9:100680919	C9orf156	chr9:100666772-100684852:-	-0.2	-3.97	8.26E-5	Quantitative traits	
LUAD	cis	1	rs6699159	chr1:166946072	GPA33	chr1:167022082-167059868:-	-0.24	-4.48	9.26E-6	Refractive astigmatism	
LUAD	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.29	-5.59	3.88E-8	Height	
LUAD	cis	1	rs6699520	chr1:166955405	GPA33	chr1:167022082-167059868:-	-0.23	-4.32	1.9E-5	Refractive astigmatism	
LUAD	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.03E-12	Body mass index	
LUAD	cis	1	rs6700597	chr1:46284246	MUTYH	chr1:45794915-45806142:-	0.18	4.21	3.01E-5	Body mass index	
LUAD	cis	1	rs6700743	chr1:101447384	CCDC76	chr1:100598706-100616053:+	0.18	3.69	0.000245	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.25	1.66E-12	Body mass index	
LUAD	cis	1	rs6701614	chr1:46309420	MUTYH	chr1:45794915-45806142:-	0.18	4.2	3.23E-5	Body mass index	
LUAD	cis	1	rs67016585	chr6:76330351	IMPG1	chr6:76631062-76782335:-	0.3	4.21	3.02E-5	Height	
LUAD	cis	1	rs67034206	chr1:156270260	CCT3	chr1:156278752-156308195:-	-0.16	-3.89	0.000113	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs6703976	chr1:21836934	HSPC157	chr1:22351707-22357713:+	-0.26	-3.72	0.000223	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	
LUAD	cis	1	rs6704770	chr2:232109816	HTR2B	chr2:231972952-231989824:-	0.23	4.21	3.0E-5	Food antigen IgG levels	
LUAD	cis	1	rs6705122	chr2:86176258	LOC90784	chr2:86247339-86250991:-	-0.43	-4.41	1.25E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs6705489	chr2:73648811	ALMS1	chr2:73612886-73837046:+	0.19	4.65	4.29E-6	Metabolite levels	
LUAD	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.39	7.44	4.53E-13	Metabolite levels	
LUAD	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.23	4.42	1.22E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
LUAD	cis	1	rs6707458	chr2:160914540	LY75	chr2:160625141-160761262:-	0.2	4.56	6.48E-6	Idiopathic membranous nephropathy	
LUAD	cis	1	rs6707722	chr2:73654363	ALMS1	chr2:73612886-73837046:+	0.19	4.68	3.75E-6	Metabolite levels	
LUAD	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.35	6.83	2.49E-11	Metabolite levels	
LUAD	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.28	-5.57	4.17E-8	Body mass index	
LUAD	cis	1	rs6708328	chr2:24412413	C2orf84	chr2:24397531-24414566:+	0.37	6.58	1.2E-10	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs6708328	chr2:24412413	LOC375190	chr2:24299728-24397519:+	-0.23	-4.22	2.86E-5	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.64	-13.91	2.73E-37	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs6710438	chr2:73820108	ALMS1	chr2:73612886-73837046:+	-0.2	-4.73	2.92E-6	Metabolite levels	
LUAD	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.41	-7.75	5.31E-14	Metabolite levels	
LUAD	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.54	5.01E-8	Body mass index	
LUAD	cis	1	rs6711033	chr2:73746643	ALMS1	chr2:73612886-73837046:+	0.17	4.19	3.25E-5	Metabolite levels	
LUAD	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.36	6.96	1.13E-11	Metabolite levels	
LUAD	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.52	-6	3.85E-9	Rheumatoid arthritis	
LUAD	cis	1	rs6711312	chr2:232122348	HTR2B	chr2:231972952-231989824:-	0.23	4.12	4.42E-5	Food antigen IgG levels	
LUAD	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.54	-7.2	2.27E-12	Rheumatoid arthritis	
LUAD	cis	1	rs6714736	chr2:202214148	ALS2CR12	chr2:202153148-202222101:-	0.14	3.97	8.19E-5	Basal cell carcinoma	
LUAD	cis	1	rs6714736	chr2:202214148	CASP8	chr2:202098166-202152434:+	-0.23	-5.2	2.94E-7	Basal cell carcinoma	
LUAD	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.5	-7.45	4.25E-13	Rheumatoid arthritis	
LUAD	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.53	-6.18	1.32E-9	Rheumatoid arthritis	
LUAD	cis	1	rs6715819	chr2:73772309	ALMS1	chr2:73612886-73837046:+	0.19	4.53	7.59E-6	Metabolite levels	
LUAD	cis	1	rs6715819	chr2:73772309	ALMS1P	chr2:73872046-73912692:+	0.35	6.59	1.14E-10	Metabolite levels	
LUAD	cis	1	rs6717918	chr2:233155110	ECEL1	chr2:233344537-233352532:-	-0.24	-3.95	9.09E-5	Height	
LUAD	cis	1	rs6718012	chr2:70078258	SNRNP27	chr2:70121090-70132348:+	0.22	4.04	6.21E-5	Colorectal or endometrial cancer	
LUAD	cis	1	rs6718083	chr2:25362194	POMC	chr2:25383722-25391559:-	0.23	3.9	0.000111	Body mass index	
LUAD	cis	1	rs6719686	chr2:160908292	LY75	chr2:160625141-160761262:-	0.2	4.33	1.78E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.74	-8.98	5.88E-18	Plasma clusterin levels	
LUAD	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.73	-8.74	3.69E-17	Plasma clusterin levels	
LUAD	cis	1	rs6722332	chr2:203745327	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs6723704	chr2:203738664	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.77	2.44E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs67239267	chr7:143745116	ARHGEF35	chr7:143883677-143892736:-	-0.37	-6.77	3.8E-11	Obesity-related traits	
LUAD	cis	1	rs67239267	chr7:143745116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.88	1.41E-6	Obesity-related traits	
LUAD	cis	1	rs6724253	chr2:232121998	HTR2B	chr2:231972952-231989824:-	0.23	4.2	3.15E-5	Food antigen IgG levels	
LUAD	cis	1	rs6724662	chr2:241831560	C2orf54	chr2:241825466-241835573:-	0.34	6.23	9.84E-10	Urinary metabolites	
LUAD	cis	1	rs6725887	chr2:203745885	ALS2CR8	chr2:203776978-203851060:+	0.22	4.52	7.72E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs6730503	chr2:37528478	CEBPZ	chr2:37428778-37458740:-	0.19	4.03	6.38E-5	Chronic lymphocytic leukemia	
LUAD	cis	1	rs6731027	chr2:203202166	NOP58	chr2:203130515-203168382:+	0.31	4.73	3.0E-6	Urate levels	
LUAD	cis	1	rs6734238	chr2:113841030	TTL	chr2:113239743-113290218:+	0.16	3.81	0.000157	C-reactive protein levels or total cholesterol levels (pleiotropy);C-reactive protein;White blood cell count;Fibrinogen;C-reactive protein levels;Fibrinogen levels	
LUAD	cis	1	rs673632	chr5:139057237	DNAJC18	chr5:138747381-138775139:-	0.23	5.17	3.4E-7	Schizophrenia	
LUAD	cis	1	rs6736866	chr2:73661986	ALMS1	chr2:73612886-73837046:+	0.19	4.54	7.2E-6	Metabolite levels	
LUAD	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.39	7.32	1.02E-12	Metabolite levels	
LUAD	cis	1	rs6737085	chr2:202221441	ALS2CR12	chr2:202153148-202222101:-	-0.14	-3.83	0.000147	Basal cell carcinoma	
LUAD	cis	1	rs6737085	chr2:202221441	CASP8	chr2:202098166-202152434:+	0.24	5.28	1.94E-7	Basal cell carcinoma	
LUAD	cis	1	rs67385415	chr8:21853733	FGF17	chr8:21900428-21906317:+	-0.16	-3.83	0.000143	Mean corpuscular volume	
LUAD	cis	1	rs67385638	chr11:5290370	HBG1	chr11:5269502-5271087:-	0.22	4.03	6.39E-5	Hemoglobin levels	
LUAD	cis	1	rs6738618	chr2:203749439	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs6738964	chr2:228739135	WDR69	chr2:228736327-228789026:+	0.27	5.78	1.32E-8	Blood pressure	
LUAD	cis	1	rs6739198	chr2:203356996	NOP58	chr2:203130515-203168382:+	0.25	4.26	2.41E-5	Urate levels	
LUAD	cis	1	rs6739772	chr2:241840711	C2orf54	chr2:241825466-241835573:-	0.32	5.64	2.85E-8	Urinary metabolites	
LUAD	cis	1	rs6740223	chr2:73653332	ALMS1	chr2:73612886-73837046:+	0.19	4.68	3.75E-6	Metabolite levels	
LUAD	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.35	6.83	2.49E-11	Metabolite levels	
LUAD	cis	1	rs67411574	chr17:18797337	FAM18B	chr17:18684582-18710026:+	-0.22	-4.45	1.05E-5	Educational attainment (years of education)	
LUAD	cis	1	rs67411574	chr17:18797337	FBXW10	chr17:18647326-18682661:+	-0.23	-4.69	3.47E-6	Educational attainment (years of education)	
LUAD	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.14	-5.66	2.62E-8	Tuberculosis	
LUAD	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.55	10.31	1.07E-22	Tuberculosis	
LUAD	cis	1	rs6744308	chr2:228711816	WDR69	chr2:228736327-228789026:+	0.28	5.78	1.37E-8	Blood pressure	
LUAD	cis	1	rs67445790	chr6:151876730	C6orf97	chr6:151815175-151942327:+	0.17	3.81	0.000156	Bone mineral density (spine)	
LUAD	cis	1	rs6745368	chr2:73809974	ALMS1	chr2:73612886-73837046:+	0.18	4.26	2.41E-5	Metabolite levels	
LUAD	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.38	7.35	8.32E-13	Metabolite levels	
LUAD	cis	1	rs6748734	chr2:241837452	C2orf54	chr2:241825466-241835573:-	0.31	5.69	2.23E-8	Urinary metabolites	
LUAD	cis	1	rs6751693	chr2:241837332	C2orf54	chr2:241825466-241835573:-	0.32	5.63	3.12E-8	Urinary metabolites	
LUAD	cis	1	rs67520056	chr7:128982075	LOC407835	chr7:128766325-128768041:+	0.24	3.91	0.000106	White matter hyperintensity burden	
LUAD	cis	1	rs6753344	chr2:73653138	ALMS1	chr2:73612886-73837046:+	-0.18	-4.2	3.17E-5	Metabolite levels	
LUAD	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.37	-6.95	1.15E-11	Metabolite levels	
LUAD	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.36	6.43	3.13E-10	Blood trace element (Zn levels)	
LUAD	cis	1	rs6755217	chr2:73641285	ALMS1	chr2:73612886-73837046:+	0.2	4.69	3.58E-6	Metabolite levels	
LUAD	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.39	7.38	6.79E-13	Metabolite levels	
LUAD	cis	1	rs6755241	chr2:73641364	ALMS1	chr2:73612886-73837046:+	0.18	4.36	1.57E-5	Metabolite levels	
LUAD	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.39	7.44	4.68E-13	Metabolite levels	
LUAD	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.25	-4.72	3.15E-6	Triptolide cytotoxicity	
LUAD	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.67	-11.79	2.13E-28	Triptolide cytotoxicity	
LUAD	cis	1	rs6759836	chr2:160912802	LY75	chr2:160625141-160761262:-	0.19	4.3	2.1E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs6759924	chr2:160912747	LY75	chr2:160625141-160761262:-	0.2	4.43	1.15E-5	Idiopathic membranous nephropathy	
LUAD	cis	1	rs6761276	chr2:113832312	IL1F5	chr2:113816215-113822316:+	0.22	4.6	5.37E-6	Protein quantitative trait loci	
LUAD	cis	1	rs6761514	chr2:202227549	ALS2CR12	chr2:202153148-202222101:-	-0.14	-3.78	0.000179	Basal cell carcinoma	
LUAD	cis	1	rs6761514	chr2:202227549	CASP8	chr2:202098166-202152434:+	0.23	5.04	6.62E-7	Basal cell carcinoma	
LUAD	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.51	10.11	6.26E-22	Height	
LUAD	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.52	10.2	2.7E-22	Height	
LUAD	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.51	9.81	7.66E-21	Height	
LUAD	cis	1	rs6767784	chr3:16616712	GALNTL2	chr3:15935569-16271252:+	-0.17	-3.77	0.000185	Testicular germ cell tumor	
LUAD	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.67	12.07	1.54E-29	Diastolic blood pressure	
LUAD	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.67	12.06	1.72E-29	Diastolic blood pressure	
LUAD	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.67	12.06	1.72E-29	Diastolic blood pressure	
LUAD	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.52	10.11	6.21E-22	Height	
LUAD	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.26	-6.45	2.76E-10	Longevity	
LUAD	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.51	9.83	6.23E-21	Height	
LUAD	cis	1	rs6773375	chr3:190980432	UTS2D	chr3:190984945-191048325:-	-0.24	-5.13	4.22E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs6773528	chr3:190980379	UTS2D	chr3:190984945-191048325:-	0.24	5.05	6.11E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs67766926	chr2:61163581	C2orf74	chr2:61372243-61391964:+	0.37	5.76	1.49E-8	Inflammatory skin disease	
LUAD	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.32	-8.09	4.87E-15	Longevity	
LUAD	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.27	-4.68	3.73E-6	Schizophrenia (negative symptoms)	
LUAD	cis	1	rs6780538	chr3:190982512	UTS2D	chr3:190984945-191048325:-	-0.26	-5.42	9.42E-8	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs6781811	chr3:10121922	IL17RE	chr3:9944303-9958082:+	0.21	3.82	0.000148	Alzheimer's disease	
LUAD	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.51	-9.81	7.12E-21	Height	
LUAD	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.71	13.18	3.77E-34	Diastolic blood pressure	
LUAD	cis	1	rs6784322	chr3:48422235	ATRIP	chr3:48488141-48507708:+	0.22	4.2	3.22E-5	Longevity	
LUAD	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.27	-6.77	3.6E-11	Longevity	
LUAD	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.22	2.41E-22	Height	
LUAD	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.54	10.57	1.19E-23	Height	
LUAD	cis	1	rs678741	chr10:102997581	CWF19L1	chr10:101992055-102027437:-	0.22	4.72	3.14E-6	Adolescent idiopathic scoliosis	
LUAD	cis	1	rs6787952	chr3:156609375	LEKR1	chr3:156544076-156763918:+	-0.29	-4.47	9.62E-6	Bone mineral density	
LUAD	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.65	10.61	7.94E-24	Diastolic blood pressure	
LUAD	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.51	9.94	2.48E-21	Height	
LUAD	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.71	13.27	1.52E-34	Diastolic blood pressure	
LUAD	cis	1	rs679206	chr10:102997450	CWF19L1	chr10:101992055-102027437:-	0.21	4.64	4.56E-6	Adolescent idiopathic scoliosis	
LUAD	cis	1	rs67927699	chr2:61187415	AHSA2	chr2:61404553-61414058:+	-0.13	-5.26	2.19E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.47	8.73	3.94E-17	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.5	-9.76	1.08E-20	Height	
LUAD	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.29	-7.15	3.17E-12	Longevity	
LUAD	cis	1	rs6795976	chr3:190982545	UTS2D	chr3:190984945-191048325:-	-0.26	-5.42	9.42E-8	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.29	-7.03	6.81E-12	Longevity	
LUAD	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.51	9.84	5.61E-21	Height	
LUAD	cis	1	rs6800	chr1:156262653	CCT3	chr1:156278752-156308195:-	-0.17	-4.28	2.26E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LUAD	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.52	10.16	3.9E-22	Height	
LUAD	cis	1	rs6802498	chr3:56723660	CCDC66	chr3:56591184-56655846:+	0.19	5.53	5.14E-8	Height	
LUAD	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.52	10.27	1.57E-22	Height	
LUAD	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.71	13.21	2.78E-34	Diastolic blood pressure	
LUAD	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.71	13.21	2.78E-34	Diastolic blood pressure	
LUAD	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.52	10.13	5.14E-22	Height	
LUAD	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.29	-7.05	6.3E-12	Longevity	
LUAD	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.67	12.06	1.72E-29	Diastolic blood pressure	
LUAD	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.36	6.87E-23	Height	
LUAD	cis	1	rs6807846	chr3:10134491	IL17RE	chr3:9944303-9958082:+	-0.21	-3.91	0.000104	Alzheimer's disease	
LUAD	cis	1	rs68088462	chr15:63397617	LACTB	chr15:63414032-63434254:+	0.2	3.77	0.00018	HDL cholesterol	
LUAD	cis	1	rs6809499	chr3:56687093	CCDC66	chr3:56591184-56655846:+	0.18	5.21	2.75E-7	Height	
LUAD	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.26	-6.45	2.76E-10	Longevity	
LUAD	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.65	-11.65	7.42E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs6821283	chr4:165901645	C4orf39	chr4:165878100-165880273:+	0.31	5.9	6.86E-9	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs6821283	chr4:165901645	TRIM61	chr4:165875600-165898818:-	0.2	4.02	6.68E-5	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs682164	chr5:139058589	DNAJC18	chr5:138747381-138775139:-	0.23	5.3	1.73E-7	Schizophrenia	
LUAD	cis	1	rs6823347	chr4:106962725	TBCK	chr4:106967233-107237861:-	0.24	4.54	7.05E-6	Airflow obstruction	
LUAD	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.37	-7.32	1.0E-12	Longevity	
LUAD	cis	1	rs6832503	chr4:48028442	NIPAL1	chr4:48018791-48039078:+	-0.33	-6.61	9.89E-11	Renal underexcretion gout;Gout	
LUAD	cis	1	rs683395	chr3:182869818	PARL	chr3:183547174-183602693:-	0.31	3.83	0.000144	Bipolar disorder	
LUAD	cis	1	rs6837335	chr4:48363983	NIPAL1	chr4:48018791-48039078:+	-0.19	-3.89	0.000115	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs6846579	chr4:107011756	TBCK	chr4:106967233-107237861:-	0.25	4.54	7.0E-6	Airflow obstruction	
LUAD	cis	1	rs6852678	chr4:76542749	CXCL9	chr4:76922623-76928641:-	-0.15	-3.87	0.000125	Magnesium levels	
LUAD	cis	1	rs6855591	chr4:165906723	C4orf39	chr4:165878100-165880273:+	0.29	5.72	1.81E-8	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs6855591	chr4:165906723	TRIM61	chr4:165875600-165898818:-	0.19	3.89	0.000116	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs6860540	chr5:156938327	NIPAL4	chr5:156887027-156901729:+	-0.38	-7.92	1.63E-14	Inflammatory skin disease	
LUAD	cis	1	rs6862569	chr5:156466548	TIMD4	chr5:156346293-156390266:-	-0.2	-3.71	0.000235	Hypertriglyceridemia	
LUAD	cis	1	rs6869774	chr5:110467086	WDR36	chr5:110427870-110466201:+	0.21	3.9	0.00011	Eosinophil counts	
LUAD	cis	1	rs6874202	chr5:156391628	TIMD4	chr5:156346293-156390266:-	-0.21	-4.17	3.64E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.72	14.52	5.73E-40	Crohn's disease	
LUAD	cis	1	rs687672	chr11:65649984	FIBP	chr11:65651212-65656010:-	-0.28	-5.04	6.54E-7	Crohn's disease	
LUAD	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.38	-5.67	2.49E-8	Crohn's disease	
LUAD	cis	1	rs6878680	chr5:156387137	TIMD4	chr5:156346293-156390266:-	-0.19	-3.75	0.000195	Triglycerides;Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs6882076	chr5:156390297	TIMD4	chr5:156346293-156390266:-	-0.21	-4.05	5.83E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.81	14.16	2.22E-38	Type 2 diabetes	
LUAD	cis	1	rs6887546	chr5:156009046	SGCD	chr5:155135063-156194796:+	0.15	3.85	0.000136	Airway responsiveness in chronic obstructive pulmonary disease	
LUAD	cis	1	rs6893300	chr5:179135815	TBC1D9B	chr5:179289073-179334856:-	-0.2	-4.07	5.56E-5	Resting heart rate	
LUAD	cis	1	rs6901575	chr6:28250984	ZNF187	chr6:28234788-28245978:+	-0.22	-3.9	0.000111	Depression	
LUAD	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.38	-10.33	9.13E-23	Homocysteine levels	
LUAD	cis	1	rs6904133	chr6:151881805	C6orf97	chr6:151815175-151942327:+	0.17	3.72	0.000218	Bone mineral density (spine)	
LUAD	cis	1	rs6910233	chr6:33534726	BAK1	chr6:33540324-33548070:-	0.21	3.94	9.42E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs6912959	chr6:170126224	C6orf208	chr6:170190169-170202969:+	-0.31	-3.74	0.000207	Thiazide-induced adverse metabolic effects in hypertensive patients	
LUAD	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.65	-12.3	1.77E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.39	-10.72	3.17E-24	Homocysteine levels	
LUAD	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.38	-10.31	1.09E-22	Homocysteine levels	
LUAD	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.38	-10.47	2.84E-23	Homocysteine levels	
LUAD	cis	1	rs6918586	chr6:26097384	BTN3A2	chr6:26365398-26378546:+	-0.18	-4.18	3.48E-5	Schizophrenia	
LUAD	cis	1	rs6923124	chr6:49419864	CENPQ	chr6:49431096-49460820:+	-0.26	-6.7	5.81E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.32	6.67	6.73E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.68	12.65	6.37E-32	Response to antipsychotic treatment	
LUAD	cis	1	rs6927188	chr6:42912589	GNMT	chr6:42928500-42931617:+	0.23	4.26	2.42E-5	Diabetic kidney disease	
LUAD	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.54	-8.39	5.41E-16	Diabetic kidney disease	
LUAD	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.53	10.45	3.41E-23	Response to antipsychotic treatment	
LUAD	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.63	-11.46	4.28E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.72	-14.8	3.24E-41	Crohn's disease	
LUAD	cis	1	rs693824	chr11:65654783	FIBP	chr11:65651212-65656010:-	0.27	4.94	1.05E-6	Crohn's disease	
LUAD	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.39	5.83	1.02E-8	Crohn's disease	
LUAD	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.63	-11.7	4.71E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs694326	chr6:150702110	IYD	chr6:150690028-150725764:+	-0.17	-3.82	0.000151	Anger	
LUAD	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.73	-14.97	5.45E-42	Crohn's disease	
LUAD	cis	1	rs694994	chr11:65653309	FIBP	chr11:65651212-65656010:-	0.27	4.84	1.71E-6	Crohn's disease	
LUAD	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.38	5.72	1.86E-8	Crohn's disease	
LUAD	cis	1	rs695123	chr2:137313644	THSD7B	chr2:137523115-138435287:+	-0.27	-4.01	6.95E-5	Cognitive test performance	
LUAD	cis	1	rs6951245	chr7:1058193	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.3	1.79E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs6958289	chr7:65657111	CCT6P1	chr7:65216092-65228661:+	-0.24	-3.9	0.000111	Diabetic kidney disease	
LUAD	cis	1	rs6959002	chr7:65650496	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.92	0.000102	Diabetic kidney disease	
LUAD	cis	1	rs6965016	chr7:97807882	BHLHA15	chr7:97840778-97842271:+	-0.18	-4.5	8.51E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
LUAD	cis	1	rs6966322	chr7:65646754	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.92	0.000102	Diabetic kidney disease	
LUAD	cis	1	rs6970597	chr7:21583519	DNAH11	chr7:21582833-21941455:+	-0.41	-9.08	2.65E-18	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
LUAD	cis	1	rs6970985	chr7:21583597	DNAH11	chr7:21582833-21941455:+	-0.41	-9.12	1.9E-18	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
LUAD	cis	1	rs6974373	chr7:99590893	TRIM4	chr7:99488037-99517154:-	-0.25	-4.64	4.54E-6	Interstitial lung disease	
LUAD	cis	1	rs697451	chr1:202480085	PPP1R12B	chr1:202317836-202557697:+	0.19	4.22	2.93E-5	Sex ratio	
LUAD	cis	1	rs6974723	chr7:65637939	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.93	9.89E-5	Diabetic kidney disease	
LUAD	cis	1	rs6977321	chr7:97774859	BHLHA15	chr7:97840778-97842271:+	-0.19	-4.71	3.28E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
LUAD	cis	1	rs6980385	chr7:128943615	LOC407835	chr7:128766325-128768041:+	0.24	3.93	9.76E-5	White matter hyperintensity burden	
LUAD	cis	1	rs6984242	chr8:60700469	CHD7	chr8:61591339-61779463:+	-0.17	-3.92	0.000101	Schizophrenia	
LUAD	cis	1	rs698500	chr15:83237769	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.13	-4.24	2.72E-5	Schizophrenia	
LUAD	cis	1	rs698	chr4:100260789	ADH1C	chr4:100257651-100273917:-	-0.19	-3.74	0.000208	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs7004438	chr8:8574379	CLDN23	chr8:8559666-8561616:+	-0.32	-5.34	1.43E-7	Obesity-related traits	
LUAD	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.89	22.14	9.24E-76	Bone mineral density	
LUAD	cis	1	rs7014578	chr8:92077568	LRRC69	chr8:92114847-92231464:+	-0.22	-3.82	0.000153	Migraine - clinic-based	
LUAD	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.89	22.12	1.18E-75	Bone mineral density	
LUAD	cis	1	rs7018	chr20:25278261	FAM182A	chr20:26035250-26067552:+	-0.18	-3.75	0.0002	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs7019	chr20:25278278	FAM182A	chr20:26035250-26067552:+	-0.19	-3.9	0.000111	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs7020689	chr9:22972985	DMRTA1	chr9:22446840-22452472:+	-0.32	-3.76	0.000194	Cannabis use (initiation)	
LUAD	cis	1	rs7020708	chr9:131885131	CRAT	chr9:131857075-131873070:-	0.32	6.09	2.28E-9	Blood metabolite ratios	
LUAD	cis	1	rs7020	chr20:25278600	FAM182A	chr20:26035250-26067552:+	-0.2	-4.06	5.62E-5	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs7021449	chr9:131899312	CRAT	chr9:131857075-131873070:-	0.35	6.75	4.27E-11	Blood metabolite ratios	
LUAD	cis	1	rs7021449	chr9:131899312	PPP2R4	chr9:131873244-131911223:+	0.22	4.33	1.8E-5	Blood metabolite ratios	
LUAD	cis	1	rs7021663	chr9:136676014	BRD3	chr9:136895454-136933655:-	-0.2	-3.98	7.9E-5	IgG glycosylation	
LUAD	cis	1	rs7021946	chr9:136676275	BRD3	chr9:136895454-136933655:-	0.19	3.83	0.000146	IgG glycosylation	
LUAD	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.28	-5.06	5.92E-7	Hematology traits	
LUAD	cis	1	rs7022999	chr9:102694400	STX17	chr9:102668915-102736817:+	-0.18	-3.89	0.000115	Alopecia areata	
LUAD	cis	1	rs7023900	chr9:131891152	CRAT	chr9:131857075-131873070:-	0.35	6.52	1.78E-10	Blood metabolite ratios	
LUAD	cis	1	rs7023900	chr9:131891152	PPP2R4	chr9:131873244-131911223:+	0.21	4.12	4.48E-5	Blood metabolite ratios	
LUAD	cis	1	rs7027619	chr9:102719728	STX17	chr9:102668915-102736817:+	-0.18	-3.92	0.000103	Alopecia areata	
LUAD	cis	1	rs7027813	chr9:102675372	STX17	chr9:102668915-102736817:+	-0.17	-3.73	0.000217	Alopecia areata	
LUAD	cis	1	rs7029536	chr9:130110411	SLC2A8	chr9:130159465-130170161:+	-0.29	-5.01	7.7E-7	Metabolite levels (HVA)	
LUAD	cis	1	rs7030887	chr9:100688511	C9orf156	chr9:100666772-100684852:-	-0.2	-4.07	5.4E-5	Quantitative traits	
LUAD	cis	1	rs7030907	chr9:100688577	C9orf156	chr9:100666772-100684852:-	-0.2	-4.07	5.4E-5	Quantitative traits	
LUAD	cis	1	rs7036114	chr9:131893406	CRAT	chr9:131857075-131873070:-	0.35	6.6	1.1E-10	Blood metabolite ratios	
LUAD	cis	1	rs7036114	chr9:131893406	PPP2R4	chr9:131873244-131911223:+	0.21	4.15	3.86E-5	Blood metabolite ratios	
LUAD	cis	1	rs7036188	chr9:36203313	GLIPR2	chr9:36136742-36163902:+	-0.25	-4.32	1.92E-5	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs7036236	chr9:131899299	CRAT	chr9:131857075-131873070:-	0.32	6.23	1.03E-9	Blood metabolite ratios	
LUAD	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.33	-6.6	1.04E-10	Rheumatoid arthritis	
LUAD	cis	1	rs7037163	chr9:131894340	CRAT	chr9:131857075-131873070:-	0.36	6.62	9.54E-11	Blood metabolite ratios	
LUAD	cis	1	rs7037163	chr9:131894340	PPP2R4	chr9:131873244-131911223:+	0.22	4.18	3.38E-5	Blood metabolite ratios	
LUAD	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.46	-8.39	5.34E-16	Multiple sclerosis	
LUAD	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.22	4.64	4.47E-6	Multiple sclerosis	
LUAD	cis	1	rs7038506	chr9:102710132	STX17	chr9:102668915-102736817:+	-0.18	-3.84	0.000142	Alopecia areata	
LUAD	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.28	-5.06	5.92E-7	Hematology traits	
LUAD	cis	1	rs7039716	chr9:102670215	STX17	chr9:102668915-102736817:+	-0.17	-3.75	0.000199	Alopecia areata	
LUAD	cis	1	rs7041383	chr9:36204912	GLIPR2	chr9:36136742-36163902:+	0.23	4.1	4.91E-5	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs7044157	chr9:36215536	GLIPR2	chr9:36136742-36163902:+	-0.25	-4.45	1.07E-5	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs7045881	chr9:26935996	LRRC19	chr9:26993143-27005691:-	-0.45	-5.89	7.16E-9	Schizophrenia	
LUAD	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.63	14.48	8.86E-40	Cognitive function	
LUAD	cis	1	rs705731	chr1:202298894	PPP1R12B	chr1:202317836-202557697:+	-0.19	-4.21	3.08E-5	Sex ratio	
LUAD	cis	1	rs705735	chr1:202313481	PPP1R12B	chr1:202317836-202557697:+	-0.21	-4.68	3.79E-6	Sex ratio	
LUAD	cis	1	rs705736	chr1:202442082	PPP1R12B	chr1:202317836-202557697:+	0.2	4.38	1.46E-5	Sex ratio	
LUAD	cis	1	rs705742	chr1:202461982	PPP1R12B	chr1:202317836-202557697:+	0.2	4.43	1.16E-5	Sex ratio	
LUAD	cis	1	rs705743	chr1:202474799	PPP1R12B	chr1:202317836-202557697:+	0.19	4.35	1.69E-5	Sex ratio	
LUAD	cis	1	rs705747	chr1:202505283	PPP1R12B	chr1:202317836-202557697:+	-0.2	-4.61	5.08E-6	Sex ratio	
LUAD	cis	1	rs706201	chr7:134251041	AKR1B15	chr7:134233849-134264300:+	-0.19	-3.72	0.000227	Longevity	
LUAD	cis	1	rs706202	chr7:134250704	AKR1B15	chr7:134233849-134264300:+	-0.21	-4.09	5.12E-5	Longevity	
LUAD	cis	1	rs7068921	chr10:124733526	C10orf88	chr10:124690419-124713919:-	-0.2	-4.14	4.13E-5	Migraine without aura	
LUAD	cis	1	rs7069346	chr10:124729876	C10orf88	chr10:124690419-124713919:-	-0.2	-4.06	5.62E-5	Migraine without aura	
LUAD	cis	1	rs7070296	chr10:65070438	NRBF2	chr10:64893007-64914785:+	-0.21	-4.56	6.4E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs7070776	chr10:102264672	SEC31B	chr10:102246403-102289636:-	-0.19	-6.12	1.89E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7071271	chr10:102264824	SEC31B	chr10:102246403-102289636:-	-0.21	-6.68	6.42E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.48	11.85	1.14E-28	Metabolite levels	
LUAD	cis	1	rs7073432	chr10:75953350	ADK	chr10:75910965-76469059:+	0.24	3.69	0.00025	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs7073497	chr10:100153688	PYROXD2	chr10:100143323-100174978:-	0.34	3.74	0.000203	Aspartate aminotransferase	
LUAD	cis	1	rs7073586	chr10:102307671	SEC31B	chr10:102246403-102289636:-	-0.19	-5.89	7.3E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7073746	chr10:64904071	NRBF2	chr10:64893007-64914785:+	-0.22	-4.92	1.19E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs7077936	chr10:126650065	UROS	chr10:127477148-127511837:-	0.27	3.67	0.000267	Height	
LUAD	cis	1	rs7078219	chr10:101274365	NKX2-3	chr10:101292690-101296278:+	0.26	5.06	6.07E-7	Dental caries	
LUAD	cis	1	rs7078799	chr10:102301447	SEC31B	chr10:102246403-102289636:-	-0.2	-6.32	5.74E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7079136	chr10:102292709	SEC31B	chr10:102246403-102289636:-	-0.2	-6.44	2.85E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7079756	chr10:102302105	SEC31B	chr10:102246403-102289636:-	-0.19	-6.1	2.1E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7080356	chr10:102266735	SEC31B	chr10:102246403-102289636:-	-0.18	-5.86	8.61E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7081330	chr10:101274465	NKX2-3	chr10:101292690-101296278:+	-0.27	-5.11	4.56E-7	Dental caries	
LUAD	cis	1	rs7081350	chr10:75990328	ADK	chr10:75910965-76469059:+	0.24	3.97	8.25E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs708152	chr11:2384348	C11orf21	chr11:2317507-2323143:-	-0.2	-4.61	5.13E-6	Bacteremia	
LUAD	cis	1	rs7084810	chr10:102297546	SEC31B	chr10:102246403-102289636:-	-0.2	-6.36	4.76E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7085439	chr10:102210100	SEC31B	chr10:102246403-102289636:-	-0.21	-6.89	1.77E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7088512	chr10:102303498	SEC31B	chr10:102246403-102289636:-	-0.19	-6.2	1.22E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7088827	chr10:102303865	SEC31B	chr10:102246403-102289636:-	-0.2	-6.36	4.72E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7090431	chr10:102261753	SEC31B	chr10:102246403-102289636:-	-0.18	-5.85	8.93E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7091404	chr10:124745458	C10orf88	chr10:124690419-124713919:-	-0.2	-4.17	3.61E-5	Migraine without aura	
LUAD	cis	1	rs7092008	chr10:126638226	UROS	chr10:127477148-127511837:-	0.29	3.93	9.83E-5	Height	
LUAD	cis	1	rs7095889	chr10:124744265	C10orf88	chr10:124690419-124713919:-	-0.21	-4.18	3.41E-5	Migraine without aura	
LUAD	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.62	-12.25	2.75E-30	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs7095944	chr10:126302936	METTL10	chr10:126447406-126480439:-	-0.24	-5.08	5.25E-7	Asthma	
LUAD	cis	1	rs7096553	chr10:75957835	ADK	chr10:75910965-76469059:+	0.24	4.03	6.57E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs7096614	chr10:124746801	C10orf88	chr10:124690419-124713919:-	-0.22	-4.41	1.3E-5	Migraine without aura	
LUAD	cis	1	rs7099913	chr10:102314777	SEC31B	chr10:102246403-102289636:-	-0.2	-6.24	9.56E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7099965	chr10:102301165	SEC31B	chr10:102246403-102289636:-	-0.2	-6.32	5.74E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7099	chr20:43997646	SYS1	chr20:43991701-44004724:+	-0.23	-3.85	0.000135	Psoriasis	
LUAD	cis	1	rs7100386	chr10:102301417	SEC31B	chr10:102246403-102289636:-	-0.2	-6.32	5.74E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7100697	chr10:124745323	C10orf88	chr10:124690419-124713919:-	-0.2	-4.16	3.83E-5	Migraine without aura	
LUAD	cis	1	rs7105282	chr11:47805614	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.07	5.5E-5	Subjective well-being	
LUAD	cis	1	rs7105282	chr11:47805614	MYBPC3	chr11:47352958-47374253:-	-0.2	-4.39	1.37E-5	Subjective well-being	
LUAD	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.68	-13.79	9.23E-37	Type 2 diabetes	
LUAD	cis	1	rs7112513	chr11:117037361	PCSK7	chr11:117075789-117102811:-	-0.26	-3.86	0.000129	Protein quantitative trait loci	
LUAD	cis	1	rs711255	chr2:36680438	PRKD3	chr2:37477648-37544222:-	-0.22	-4.17	3.65E-5	IgE levels in asthmatics	
LUAD	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.51	-9.89	3.66E-21	Forced vital capacity	
LUAD	cis	1	rs712022	chr11:22843155	SVIP	chr11:22843600-22851382:-	-0.22	-4.42	1.2E-5	Dialysis-related mortality	
LUAD	cis	1	rs7120333	chr11:47817441	C1QTNF4	chr11:47611216-47615961:-	-0.21	-4.05	5.93E-5	Subjective well-being	
LUAD	cis	1	rs7120333	chr11:47817441	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.53	7.49E-6	Subjective well-being	
LUAD	cis	1	rs7121554	chr11:112048051	IL18	chr11:112013976-112034840:-	-0.26	-6.16	1.48E-9	Interleukin-18 levels	
LUAD	cis	1	rs712701	chr7:127251188	LRRC4	chr7:127667126-127671002:-	0.21	3.67	0.000265	Type 2 diabetes	
LUAD	cis	1	rs712704	chr7:127258208	LRRC4	chr7:127667126-127671002:-	-0.23	-3.82	0.000149	Type 2 diabetes	
LUAD	cis	1	rs71299622	chr3:52917038	TMEM110	chr3:52867139-52931547:-	0.5	5.23	2.52E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs71301804	chr3:53073314	TMEM110	chr3:52867139-52931547:-	0.45	5.02	7.08E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs71301808	chr3:53085577	TMEM110	chr3:52867139-52931547:-	0.47	5.04	6.7E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs71301809	chr3:53090312	TMEM110	chr3:52867139-52931547:-	0.47	5.03	6.82E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs71301814	chr3:53117663	TMEM110	chr3:52867139-52931547:-	0.47	5.13	4.12E-7	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs7131094	chr11:112044917	IL18	chr11:112013976-112034840:-	-0.26	-6.16	1.48E-9	Interleukin-18 levels	
LUAD	cis	1	rs713219	chr9:131900920	CRAT	chr9:131857075-131873070:-	0.36	6.97	1.05E-11	Blood metabolite ratios	
LUAD	cis	1	rs713219	chr9:131900920	PPP2R4	chr9:131873244-131911223:+	0.22	4.42	1.2E-5	Blood metabolite ratios	
LUAD	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.52	6.37	4.27E-10	Metabolite levels (HVA/5-HIAA ratio)	
LUAD	cis	1	rs7134594	chr12:110000193	MYO1H	chr12:109826524-109886176:+	0.39	7.2	2.28E-12	HDL cholesterol	
LUAD	cis	1	rs713835	chr22:38064650	LGALS2	chr22:37966254-37976024:-	0.17	3.96	8.65E-5	Fat distribution (HIV)	
LUAD	cis	1	rs71391092	chr16:74567075	RFWD3	chr16:74655298-74700779:-	0.25	3.86	0.000127	Schizophrenia	
LUAD	cis	1	rs7139978	chr13:38196963	POSTN	chr13:38136720-38183563:-	-0.11	-3.76	0.000188	Life satisfaction	
LUAD	cis	1	rs71403859	chr16:71640207	HP	chr16:72088508-72094957:+	-0.3	-3.68	0.000256	Post bronchodilator FEV1	
LUAD	cis	1	rs7141087	chr14:101036052	BEGAIN	chr14:101003486-101036131:-	-0.21	-3.73	0.000218	Menarche (age at onset)	
LUAD	cis	1	rs7142235	chr14:75559963	MLH3	chr14:75480467-75518235:-	0.23	4.4	1.31E-5	Height	
LUAD	cis	1	rs7143682	chr14:104413455	TDRD9	chr14:104394817-104519002:+	0.28	4.24	2.7E-5	Bipolar disorder	
LUAD	cis	1	rs7143936	chr14:104459452	TDRD9	chr14:104394817-104519002:+	0.25	3.74	0.000203	Bipolar disorder	
LUAD	cis	1	rs7145159	chr14:75583268	EIF2B2	chr14:75469612-75476292:+	0.21	3.88	0.000117	Height	
LUAD	cis	1	rs7145159	chr14:75583268	MLH3	chr14:75480467-75518235:-	0.25	4.74	2.87E-6	Height	
LUAD	cis	1	rs7147118	chr14:75610170	MLH3	chr14:75480467-75518235:-	0.26	4.98	8.94E-7	Height	
LUAD	cis	1	rs7148538	chr14:74392342	LIN52	chr14:74551656-74667117:+	0.27	3.96	8.54E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs7153160	chr14:74509377	C14orf45	chr14:74486059-74549566:+	0.19	4.19	3.35E-5	Common traits (Other)	
LUAD	cis	1	rs7153160	chr14:74509377	DNAL1	chr14:74111578-74168647:+	0.18	3.77	0.000182	Common traits (Other)	
LUAD	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.49	11.04	1.85E-25	Common traits (Other)	
LUAD	cis	1	rs7153160	chr14:74509377	ZNF410	chr14:74318674-74398803:+	0.22	4.44	1.11E-5	Common traits (Other)	
LUAD	cis	1	rs7153587	chr14:74509660	C14orf45	chr14:74486059-74549566:+	0.19	4.18	3.41E-5	Common traits (Other)	
LUAD	cis	1	rs7153587	chr14:74509660	DNAL1	chr14:74111578-74168647:+	0.17	3.69	0.000253	Common traits (Other)	
LUAD	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.51	11.31	1.73E-26	Common traits (Other)	
LUAD	cis	1	rs7153587	chr14:74509660	ZNF410	chr14:74318674-74398803:+	0.23	4.64	4.56E-6	Common traits (Other)	
LUAD	cis	1	rs7154306	chr14:35540499	KIAA0391	chr14:35591776-35786673:+	0.25	3.7	0.000244	Atopic dermatitis	
LUAD	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.3	4.52	7.79E-6	Atopic dermatitis	
LUAD	cis	1	rs71550519	chr6:56780272	BEND6	chr6:56819773-56892138:+	-0.27	-5.66	2.65E-8	Menarche (age at onset)	
LUAD	cis	1	rs7155275	chr14:65502271	CHURC1	chr14:65381140-65411309:+	0.34	7.3	1.14E-12	Red blood cell traits	
LUAD	cis	1	rs7155454	chr14:65502239	CHURC1	chr14:65381140-65411309:+	0.35	7.57	1.89E-13	Red blood cell traits	
LUAD	cis	1	rs7156105	chr14:75541954	MLH3	chr14:75480467-75518235:-	0.24	4.52	7.78E-6	Height	
LUAD	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.28	4.23	2.74E-5	Atopic dermatitis	
LUAD	cis	1	rs7156328	chr14:75532941	MLH3	chr14:75480467-75518235:-	0.23	4.32	1.91E-5	Height	
LUAD	cis	1	rs71564866	chr6:56771207	BEND6	chr6:56819773-56892138:+	-0.28	-5.8	1.22E-8	Menarche (age at onset)	
LUAD	cis	1	rs71564868	chr6:56798441	BEND6	chr6:56819773-56892138:+	-0.28	-5.78	1.34E-8	Menarche (age at onset)	
LUAD	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.45	-9.85	5.37E-21	Common traits (Other)	
LUAD	cis	1	rs7157940	chr14:94563193	IFI27L1	chr14:94547639-94569059:+	0.33	7.31	1.09E-12	Anthropometric traits	
LUAD	cis	1	rs71617204	chr3:53042951	TMEM110	chr3:52867139-52931547:-	0.47	4.86	1.59E-6	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.35	6.11	2.09E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs71640036	chr4:187161120	F11	chr4:187187118-187210835:+	-0.16	-3.67	0.00027	L-arginine levels	
LUAD	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	0.37	6.4	3.6E-10	Heschl's gyrus morphology	
LUAD	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.38	6.73	4.83E-11	Heschl's gyrus morphology	
LUAD	cis	1	rs7167285	chr15:75368769	SCAMP5	chr15:75287901-75313836:+	0.35	6.11	2.09E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs7168680	chr15:75369212	SCAMP5	chr15:75287901-75313836:+	0.34	6.04	3.08E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	0.37	6.4	3.6E-10	Heschl's gyrus morphology	
LUAD	cis	1	rs7170930	chr15:66580853	DIS3L	chr15:66585633-66626235:+	0.35	4.47	9.9E-6	Response to cytadine analogues (cytosine arabinoside)	
LUAD	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.28	4.91	1.26E-6	Blood trace element (Zn levels)	
LUAD	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.36	-6.23	1.03E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs7181141	chr15:63398552	LACTB	chr15:63414032-63434254:+	0.21	4.03	6.36E-5	HDL cholesterol	
LUAD	cis	1	rs7182618	chr15:63398622	LACTB	chr15:63414032-63434254:+	0.21	4.03	6.36E-5	HDL cholesterol	
LUAD	cis	1	rs7182945	chr15:101784223	LINS1	chr15:101109436-101142404:-	0.2	3.94	9.16E-5	Corneal structure	
LUAD	cis	1	rs718444	chr13:33147052	CG030	chr13:33078645-33083532:-	-0.13	-4.13	4.3E-5	Body mass index	
LUAD	cis	1	rs7186908	chr16:72220373	HP	chr16:72088508-72094957:+	-0.32	-5.1	4.95E-7	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs7189550	chr16:29911260	LOC440356	chr16:29875004-29879374:+	0.26	4.85	1.63E-6	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs7189750	chr16:29911416	LOC440356	chr16:29875004-29879374:+	-0.27	-5.04	6.58E-7	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs7191665	chr16:74688948	RFWD3	chr16:74655298-74700779:-	-0.27	-6.35	4.85E-10	Testicular germ cell tumor	
LUAD	cis	1	rs7195398	chr16:68175289	ATP6V0D1	chr16:67471917-67515089:-	-0.42	-4.18	3.42E-5	Crohn's disease	
LUAD	cis	1	rs7195398	chr16:68175289	C16orf86	chr16:67700717-67702659:+	-0.36	-3.82	0.000148	Crohn's disease	
LUAD	cis	1	rs7201320	chr16:74694058	RFWD3	chr16:74655298-74700779:-	-0.27	-6.31	6.28E-10	Testicular germ cell tumor	
LUAD	cis	1	rs7201498	chr16:20449449	ACSM1	chr16:20634559-20709066:-	0.24	4.9	1.33E-6	Blood metabolite levels	
LUAD	cis	1	rs7201519	chr16:29859977	LOC440356	chr16:29875004-29879374:+	-0.27	-3.79	0.000169	Multiple sclerosis	
LUAD	cis	1	rs720475	chr7:144074929	OR2A7	chr7:143955790-143974852:-	-0.47	-8.41	4.63E-16	Breast cancer	
LUAD	cis	1	rs7204827	chr16:4467533	LOC342346	chr16:4606491-4650317:+	0.2	3.82	0.000153	Schizophrenia	
LUAD	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.32	6.39	3.96E-10	Height	
LUAD	cis	1	rs7207021	chr17:28400516	EFCAB5	chr17:28256874-28435469:+	-0.34	-6.18	1.39E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs7207021	chr17:28400516	SSH2	chr17:27952965-28257018:-	-0.17	-4.47	9.58E-6	Coffee consumption (cups per day)	
LUAD	cis	1	rs7207276	chr17:18065737	MYO15A	chr17:18012020-18083115:+	0.24	4.47	9.65E-6	Obesity-related traits	
LUAD	cis	1	rs7209131	chr17:7376411	CHRNB1	chr17:7348406-7360931:+	-0.21	-3.98	7.98E-5	Height	
LUAD	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.52	10.73	3.03E-24	Eye color traits	
LUAD	cis	1	rs7209758	chr17:61913621	FTSJ3	chr17:61896795-61905031:-	0.22	4.6	5.28E-6	Body mass index	
LUAD	cis	1	rs7210027	chr17:65977053	LOC440461	chr17:66194801-66196436:+	-0.26	-4.37	1.54E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs7210086	chr17:70641698	SLC39A11	chr17:70642086-71088853:-	-0.27	-4.38	1.43E-5	Ulcerative colitis	
LUAD	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.32	-6.4	3.55E-10	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs7211213	chr17:61769456	FTSJ3	chr17:61896795-61905031:-	0.2	4.15	3.92E-5	Body mass index	
LUAD	cis	1	rs7212497	chr17:28335949	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.98	4.21E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs7212497	chr17:28335949	SSH2	chr17:27952965-28257018:-	-0.16	-4.26	2.43E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.52	10.73	3.03E-24	Eye color traits	
LUAD	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.63	-12.33	1.31E-30	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs7214312	chr17:61870863	FTSJ3	chr17:61896795-61905031:-	0.23	4.81	2.05E-6	Body mass index	
LUAD	cis	1	rs7214921	chr17:40294025	DHX58	chr17:40253422-40264751:-	-0.29	-5.56	4.34E-8	Fibrinogen levels	
LUAD	cis	1	rs7216798	chr17:61740963	FTSJ3	chr17:61896795-61905031:-	0.19	4.03	6.36E-5	Body mass index	
LUAD	cis	1	rs7217982	chr17:61832150	FTSJ3	chr17:61896795-61905031:-	0.23	4.77	2.42E-6	Body mass index	
LUAD	cis	1	rs7218362	chr17:56888299	RAD51C	chr17:56769963-56811690:+	0.22	4.6	5.49E-6	Cognitive test performance	
LUAD	cis	1	rs7218593	chr17:33160435	LIG3	chr17:33307538-33332088:+	0.29	3.79	0.000168	Night sleep phenotypes	
LUAD	cis	1	rs7219220	chr17:40294280	DHX58	chr17:40253422-40264751:-	-0.29	-5.56	4.34E-8	Fibrinogen levels	
LUAD	cis	1	rs7220892	chr17:61908316	FTSJ3	chr17:61896795-61905031:-	0.22	4.63	4.59E-6	Body mass index	
LUAD	cis	1	rs7221109	chr17:38770286	KRT222	chr17:38804829-38821416:-	0.21	3.83	0.000144	Type 1 diabetes	
LUAD	cis	1	rs7221743	chr17:28407876	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.98	4.2E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs7221743	chr17:28407876	SSH2	chr17:27952965-28257018:-	-0.16	-4.26	2.42E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs7222060	chr17:61868279	FTSJ3	chr17:61896795-61905031:-	0.23	4.81	2.05E-6	Body mass index	
LUAD	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.51	10.64	6.12E-24	Eye color traits	
LUAD	cis	1	rs7222308	chr17:28277041	EFCAB5	chr17:28256874-28435469:+	0.33	5.91	6.58E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs7222308	chr17:28277041	SSH2	chr17:27952965-28257018:-	0.17	4.34	1.7E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs7223231	chr17:18811846	FAM18B	chr17:18684582-18710026:+	-0.22	-4.38	1.45E-5	Educational attainment (years of education)	
LUAD	cis	1	rs7223231	chr17:18811846	FBXW10	chr17:18647326-18682661:+	-0.22	-4.65	4.28E-6	Educational attainment (years of education)	
LUAD	cis	1	rs7223231	chr17:18811846	LOC220594	chr17:18414577-18445234:-	-0.22	-3.8	0.000165	Educational attainment (years of education)	
LUAD	cis	1	rs7223412	chr17:61808172	FTSJ3	chr17:61896795-61905031:-	0.23	4.8	2.12E-6	Body mass index	
LUAD	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.52	-10.73	3.03E-24	Eye color traits	
LUAD	cis	1	rs7223672	chr17:61720565	FTSJ3	chr17:61896795-61905031:-	0.21	4.5	8.45E-6	Body mass index	
LUAD	cis	1	rs7223784	chr17:40577580	NAGLU	chr17:40687951-40696464:+	-0.2	-3.71	0.000235	Crohn's disease	
LUAD	cis	1	rs7223786	chr17:28332107	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.99	3.99E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs7223786	chr17:28332107	SSH2	chr17:27952965-28257018:-	-0.16	-4.26	2.45E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs7223813	chr17:65945840	LOC440461	chr17:66194801-66196436:+	0.24	3.78	0.000177	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs7223966	chr17:61893398	FTSJ3	chr17:61896795-61905031:-	0.21	4.4	1.31E-5	Body mass index	
LUAD	cis	1	rs7224737	chr17:40289364	DHX58	chr17:40253422-40264751:-	0.3	5.81	1.12E-8	Fibrinogen levels	
LUAD	cis	1	rs7224923	chr17:65842265	LOC440461	chr17:66194801-66196436:+	0.24	3.76	0.000188	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs7225608	chr17:40298326	DHX58	chr17:40253422-40264751:-	-0.3	-5.83	9.81E-9	Fibrinogen levels	
LUAD	cis	1	rs7238284	chr18:48373876	MRO	chr18:48321491-48351754:-	0.32	5.28	1.99E-7	Entorhinal cortical thickness	
LUAD	cis	1	rs7239867	chr18:47164717	ACAA2	chr18:47309875-47340283:-	-0.27	-3.71	0.000227	HDL cholesterol;Cholesterol, total	
LUAD	cis	1	rs7247513	chr19:12691185	MAN2B1	chr19:12757322-12777591:-	0.21	5.16	3.55E-7	Bipolar disorder	
LUAD	cis	1	rs7247672	chr19:37743928	ZNF585B	chr19:37675724-37701451:-	0.25	3.69	0.000249	Coronary artery calcification	
LUAD	cis	1	rs725309	chr3:48418708	ATRIP	chr3:48488141-48507708:+	-0.19	-3.68	0.000258	Longevity	
LUAD	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.25	6.25	8.98E-10	Longevity	
LUAD	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.26	6.49	2.07E-10	Longevity	
LUAD	cis	1	rs7254349	chr19:24230343	LOC100101266	chr19:24344995-24346249:-	0.26	4	7.2E-5	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs7254758	chr19:33608047	GPATCH1	chr19:33571786-33621318:+	0.23	4.26	2.45E-5	Bone properties (heel)	
LUAD	cis	1	rs7254758	chr19:33608047	RHPN2	chr19:33469499-33555824:-	-0.21	-4.24	2.71E-5	Bone properties (heel)	
LUAD	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.6	12.53	2.01E-31	Schizophrenia	
LUAD	cis	1	rs725908	chr20:33968067	UQCC	chr20:33890383-33999833:-	0.3	5.44	8.53E-8	Height	
LUAD	cis	1	rs7260598	chr19:24222786	LOC100101266	chr19:24344995-24346249:-	-0.25	-3.81	0.000157	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs72627120	chr14:74363480	LIN52	chr14:74551656-74667117:+	0.26	3.89	0.000113	Morning vs. evening chronotype	
LUAD	cis	1	rs72627122	chr14:74368236	LIN52	chr14:74551656-74667117:+	0.27	3.94	9.24E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs72627123	chr14:74368331	LIN52	chr14:74551656-74667117:+	0.27	3.94	9.24E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs72627124	chr14:74369128	LIN52	chr14:74551656-74667117:+	0.27	3.94	9.24E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs72627125	chr14:74369623	LIN52	chr14:74551656-74667117:+	0.27	3.94	9.24E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs72627126	chr14:74370024	LIN52	chr14:74551656-74667117:+	0.27	3.94	9.24E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs72627127	chr14:74370098	LIN52	chr14:74551656-74667117:+	0.27	3.94	9.24E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs72627129	chr14:74374805	LIN52	chr14:74551656-74667117:+	0.27	3.94	9.24E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs72627130	chr14:74374897	LIN52	chr14:74551656-74667117:+	0.27	3.94	9.24E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs72627138	chr14:74401900	LIN52	chr14:74551656-74667117:+	0.26	3.87	0.000123	Morning vs. evening chronotype	
LUAD	cis	1	rs7263203	chr20:33773375	PROCR	chr20:33758727-33765164:+	-0.29	-3.71	0.000235	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
LUAD	cis	1	rs72664932	chr1:32247780	COL16A1	chr1:32117848-32169768:-	-0.21	-4.11	4.58E-5	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs72669974	chr4:106519627	INTS12	chr4:106603787-106629881:-	-0.52	-4.87	1.5E-6	Post bronchodilator FEV1	
LUAD	cis	1	rs72669978	chr4:106520852	INTS12	chr4:106603787-106629881:-	-0.56	-5.26	2.18E-7	Post bronchodilator FEV1	
LUAD	cis	1	rs72669980	chr4:106523563	INTS12	chr4:106603787-106629881:-	-0.56	-5.26	2.21E-7	Post bronchodilator FEV1	
LUAD	cis	1	rs72669982	chr4:106524954	INTS12	chr4:106603787-106629881:-	-0.52	-5.02	7.3E-7	Post bronchodilator FEV1	
LUAD	cis	1	rs72669993	chr4:106583144	INTS12	chr4:106603787-106629881:-	-0.6	-5.74	1.68E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs72669995	chr4:106585256	INTS12	chr4:106603787-106629881:-	-0.6	-5.75	1.59E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs72669997	chr4:106589782	INTS12	chr4:106603787-106629881:-	-0.62	-5.9	6.95E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs72671805	chr4:106603014	INTS12	chr4:106603787-106629881:-	-0.64	-6.58	1.21E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671808	chr4:106605720	INTS12	chr4:106603787-106629881:-	-0.63	-6.46	2.5E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671809	chr4:106611537	INTS12	chr4:106603787-106629881:-	-0.64	-6.59	1.11E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671811	chr4:106615603	INTS12	chr4:106603787-106629881:-	-0.64	-6.62	9.53E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671815	chr4:106618219	INTS12	chr4:106603787-106629881:-	-0.64	-6.59	1.11E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671820	chr4:106620983	INTS12	chr4:106603787-106629881:-	-0.64	-6.32	5.78E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671824	chr4:106623223	INTS12	chr4:106603787-106629881:-	-0.64	-6.59	1.11E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671826	chr4:106624502	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.59E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671828	chr4:106624800	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.68E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671835	chr4:106631356	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.5E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671836	chr4:106633045	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.5E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671837	chr4:106635902	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.35E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671840	chr4:106638697	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.35E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671849	chr4:106643818	INTS12	chr4:106603787-106629881:-	-0.64	-6.64	8.51E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671852	chr4:106646349	INTS12	chr4:106603787-106629881:-	-0.65	-6.47	2.31E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671853	chr4:106646886	INTS12	chr4:106603787-106629881:-	-0.64	-6.64	8.51E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671854	chr4:106647023	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.35E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671856	chr4:106647366	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.35E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671858	chr4:106647679	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.5E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671866	chr4:106657658	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.5E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671869	chr4:106658658	INTS12	chr4:106603787-106629881:-	-0.64	-6.64	8.51E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671870	chr4:106659345	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.5E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671871	chr4:106660324	INTS12	chr4:106603787-106629881:-	-0.64	-6.64	8.51E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671873	chr4:106661194	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.5E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671874	chr4:106661970	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.35E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671878	chr4:106662692	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.35E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671880	chr4:106664424	INTS12	chr4:106603787-106629881:-	-0.63	-6.6	1.08E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72671885	chr4:106668546	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671886	chr4:106670589	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671892	chr4:106680363	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671895	chr4:106685633	INTS12	chr4:106603787-106629881:-	-0.64	-6.68	6.5E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72671896	chr4:106685825	INTS12	chr4:106603787-106629881:-	-0.64	-6.68	6.5E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72673803	chr4:106696756	INTS12	chr4:106603787-106629881:-	-0.64	-6.68	6.5E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72673811	chr4:106707297	INTS12	chr4:106603787-106629881:-	-0.64	-6.68	6.38E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72673812	chr4:106710454	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.43E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72673813	chr4:106710653	INTS12	chr4:106603787-106629881:-	-0.63	-6.36	4.64E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72673817	chr4:106713490	INTS12	chr4:106603787-106629881:-	-0.64	-6.66	7.43E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72673823	chr4:106719973	INTS12	chr4:106603787-106629881:-	-0.63	-6.26	8.56E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72673824	chr4:106724464	INTS12	chr4:106603787-106629881:-	-0.63	-6.56	1.36E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72673828	chr4:106730342	INTS12	chr4:106603787-106629881:-	-0.63	-6.61	9.98E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs72673831	chr4:106733380	INTS12	chr4:106603787-106629881:-	-0.62	-6.61	1.01E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72673832	chr4:106738760	INTS12	chr4:106603787-106629881:-	-0.62	-6.31	6.1E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72673834	chr4:106739374	INTS12	chr4:106603787-106629881:-	-0.62	-6.31	6.1E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs72673853	chr4:106756877	INTS12	chr4:106603787-106629881:-	-0.57	-6.2	1.19E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs72673858	chr4:106758056	INTS12	chr4:106603787-106629881:-	-0.56	-6.08	2.44E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs72673860	chr4:106762900	INTS12	chr4:106603787-106629881:-	-0.56	-5.77	1.41E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs72673866	chr4:106771155	INTS12	chr4:106603787-106629881:-	-0.59	-6.07	2.62E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs72673870	chr4:106779865	INTS12	chr4:106603787-106629881:-	-0.59	-6.07	2.62E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs72673872	chr4:106779925	INTS12	chr4:106603787-106629881:-	-0.59	-6.07	2.62E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs72673873	chr4:106780301	INTS12	chr4:106603787-106629881:-	-0.54	-5.62	3.21E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs72677306	chr4:106997678	TBCK	chr4:106967233-107237861:-	0.25	4.61	5.14E-6	Airflow obstruction	
LUAD	cis	1	rs7267979	chr20:25298087	FAM182A	chr20:26035250-26067552:+	-0.18	-3.77	0.000182	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs72696952	chr1:152172694	FLG	chr1:152274651-152297679:-	0.25	3.86	0.000129	Atopic dermatitis	
LUAD	cis	1	rs72696963	chr1:152181189	FLG	chr1:152274651-152297679:-	0.28	4.19	3.38E-5	Atopic dermatitis	
LUAD	cis	1	rs72696969	chr1:152196339	FLG	chr1:152274651-152297679:-	0.28	4.26	2.45E-5	Atopic dermatitis	
LUAD	cis	1	rs72696989	chr1:152248674	FLG	chr1:152274651-152297679:-	0.28	4.18	3.5E-5	Atopic dermatitis	
LUAD	cis	1	rs72698906	chr1:152307184	FLG	chr1:152274651-152297679:-	0.28	4.29	2.15E-5	Atopic dermatitis	
LUAD	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.4	-5.73	1.74E-8	Abdominal aortic aneurysm	
LUAD	cis	1	rs7274624	chr20:49563100	KCNG1	chr20:49620194-49639675:-	-0.37	-3.67	0.000272	Prostate cancer	
LUAD	cis	1	rs727563	chr22:41867377	PMM1	chr22:41972890-41985871:-	0.18	3.79	0.000172	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs727694	chr8:21849962	FGF17	chr8:21900428-21906317:+	-0.16	-3.76	0.000194	Mean corpuscular volume	
LUAD	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.27	5.54	5.01E-8	Body mass index	
LUAD	cis	1	rs72823619	chr2:102924615	IL1RL1	chr2:102927962-102968497:+	0.34	4.9	1.32E-6	Asthma	
LUAD	cis	1	rs72823621	chr2:102925435	IL1RL1	chr2:102927962-102968497:+	0.33	4.86	1.62E-6	Asthma	
LUAD	cis	1	rs72823632	chr2:102931534	IL1RL1	chr2:102927962-102968497:+	0.34	4.94	1.07E-6	Asthma	
LUAD	cis	1	rs72823635	chr2:102931612	IL1RL1	chr2:102927962-102968497:+	0.34	4.94	1.07E-6	Asthma	
LUAD	cis	1	rs72823646	chr2:102954213	IL1RL1	chr2:102927962-102968497:+	0.34	4.95	1.01E-6	Asthma	
LUAD	cis	1	rs72840063	chr2:85550396	TGOLN2	chr2:85545147-85555374:-	-0.3	-7.3	1.17E-12	Ear protrusion	
LUAD	cis	1	rs72843784	chr6:26498758	BTN3A2	chr6:26365398-26378546:+	-0.71	-8.96	6.68E-18	Schizophrenia	
LUAD	cis	1	rs72845397	chr11:6950903	ZNF215	chr11:6947654-7005861:+	-0.27	-3.76	0.000189	Response to cytadine analogues (cytosine arabinoside)	
LUAD	cis	1	rs72848797	chr17:61934664	FTSJ3	chr17:61896795-61905031:-	0.21	4.37	1.53E-5	Body mass index	
LUAD	cis	1	rs728615	chr10:81848089	PLAC9	chr10:81892258-81904784:+	-0.2	-3.7	0.000244	Chronic obstructive pulmonary disease-related biomarkers	
LUAD	cis	1	rs72871402	chr11:16472994	C11orf58	chr11:16760148-16779901:+	0.28	3.99	7.49E-5	Obesity and osteoporosis	
LUAD	cis	1	rs72873303	chr11:16473612	C11orf58	chr11:16760148-16779901:+	0.28	3.99	7.49E-5	Obesity and osteoporosis	
LUAD	cis	1	rs7291867	chr22:38062112	LGALS2	chr22:37966254-37976024:-	0.16	3.72	0.000226	Fat distribution (HIV)	
LUAD	cis	1	rs72926767	chr2:203796814	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.86	1.57E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926769	chr2:203798318	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926771	chr2:203801226	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926772	chr2:203804289	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926779	chr2:203805929	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926781	chr2:203808835	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926782	chr2:203811628	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926783	chr2:203815740	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926786	chr2:203816494	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926787	chr2:203818299	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926791	chr2:203822891	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926793	chr2:203826396	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926794	chr2:203827432	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926796	chr2:203827480	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72926802	chr2:203830228	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72928605	chr2:203832120	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.65	4.35E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72928608	chr2:203836507	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72928609	chr2:203837573	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72928613	chr2:203839628	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.76	2.58E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72928620	chr2:203840973	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.83	1.79E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72929710	chr18:48372427	MRO	chr18:48321491-48351754:-	0.37	6.08	2.48E-9	Entorhinal cortical thickness	
LUAD	cis	1	rs72929734	chr18:48381990	MRO	chr18:48321491-48351754:-	0.37	5.96	4.86E-9	Entorhinal cortical thickness	
LUAD	cis	1	rs72932553	chr2:203842661	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.73	2.88E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932554	chr2:203845828	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932557	chr2:203846817	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932558	chr2:203847325	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932561	chr2:203848402	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932566	chr2:203855342	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932572	chr2:203859391	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932573	chr2:203861113	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932574	chr2:203866336	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.67	3.94E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932588	chr2:203883193	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.54	7.0E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932590	chr2:203884308	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.5	8.47E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932772	chr2:203682304	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932774	chr2:203685728	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.55	6.66E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932776	chr2:203688300	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.56	6.42E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932777	chr2:203689914	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.61	5.07E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932780	chr2:203695826	ALS2CR8	chr2:203776978-203851060:+	-0.22	-4.42	1.23E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932781	chr2:203697278	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.56	6.49E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932784	chr2:203698470	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.56	6.49E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932786	chr2:203698737	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.54	7.02E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932789	chr2:203699379	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.54	7.02E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932791	chr2:203700870	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.54	7.02E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72932793	chr2:203701004	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.54	7.02E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934505	chr2:203916487	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.6	5.3E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934510	chr2:203925360	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.74	2.82E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934512	chr2:203926271	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.74	2.82E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934513	chr2:203927587	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.74	2.82E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934514	chr2:203933339	ALS2CR8	chr2:203776978-203851060:+	-0.25	-4.84	1.75E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934518	chr2:203937908	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.74	2.82E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934519	chr2:203939640	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.69	3.6E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934537	chr2:203969504	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.69	3.6E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934545	chr2:203975958	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.69	3.6E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934554	chr2:203987806	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.73	2.93E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934556	chr2:203990789	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.46	1.02E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934563	chr2:203995405	ALS2CR8	chr2:203776978-203851060:+	-0.22	-4.42	1.23E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934573	chr2:204005072	ALS2CR8	chr2:203776978-203851060:+	-0.22	-4.44	1.1E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934704	chr2:203706433	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.54	7.02E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934706	chr2:203707752	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.57	6.26E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934707	chr2:203707878	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.57	6.26E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934710	chr2:203709776	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.58	6.03E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934711	chr2:203709997	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.58	6.03E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934714	chr2:203711581	ALS2CR8	chr2:203776978-203851060:+	-0.22	-4.41	1.26E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934715	chr2:203713280	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.6	5.51E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934729	chr2:203737770	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.77	2.44E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934732	chr2:203739856	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.77	2.44E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934735	chr2:203740010	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.77	2.44E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934737	chr2:203740798	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.77	2.44E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934738	chr2:203740861	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.77	2.44E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934740	chr2:203741362	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.77	2.44E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934745	chr2:203744454	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.72	3.13E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934749	chr2:203746816	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934751	chr2:203747522	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934753	chr2:203750272	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934763	chr2:203758396	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934764	chr2:203758521	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934765	chr2:203758551	ALS2CR8	chr2:203776978-203851060:+	-0.22	-4.55	6.75E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934767	chr2:203766563	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.53	-6.98	9.89E-12	Rheumatoid arthritis	
LUAD	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.51	-5.91	6.35E-9	Rheumatoid arthritis	
LUAD	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.52	-6.03	3.26E-9	Rheumatoid arthritis	
LUAD	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.5	-5.77	1.4E-8	Rheumatoid arthritis	
LUAD	cis	1	rs72936304	chr2:204036357	ALS2CR8	chr2:203776978-203851060:+	-0.21	-4.26	2.44E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936309	chr2:204040296	ALS2CR8	chr2:203776978-203851060:+	-0.21	-4.26	2.44E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936323	chr2:204050474	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.62	4.97E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936326	chr2:204054141	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.62	4.97E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936332	chr2:204056678	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.62	4.97E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936348	chr2:204064839	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.62	4.97E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936353	chr2:204070956	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.62	4.97E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936830	chr2:203769803	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936834	chr2:203771260	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936838	chr2:203772984	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936842	chr2:203773686	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936846	chr2:203774734	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936847	chr2:203774748	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936852	chr2:203775475	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936856	chr2:203775712	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936862	chr2:203786812	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936869	chr2:203788950	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936870	chr2:203789679	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936872	chr2:203790889	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936873	chr2:203791333	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936881	chr2:203794262	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72936882	chr2:203794439	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.5	-5.77	1.4E-8	Rheumatoid arthritis	
LUAD	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.5	-5.77	1.4E-8	Rheumatoid arthritis	
LUAD	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.5	-5.77	1.4E-8	Rheumatoid arthritis	
LUAD	cis	1	rs7298108	chr12:9376168	LOC642846	chr12:9436253-9466684:+	-0.19	-4.88	1.43E-6	Non-alcoholic fatty liver disease histology (AST)	
LUAD	cis	1	rs7301826	chr12:131291101	STX2	chr12:131274149-131323811:-	0.19	4.2	3.15E-5	Plasma plasminogen activator levels	
LUAD	cis	1	rs7303	chr14:75520065	MLH3	chr14:75480467-75518235:-	0.22	4.1	4.91E-5	Height	
LUAD	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.67	11.58	1.47E-27	Diastolic blood pressure	
LUAD	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.68	12.84	1.02E-32	Diastolic blood pressure	
LUAD	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.29	-7.03	6.81E-12	Longevity	
LUAD	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.7	11.96	4.14E-29	Diastolic blood pressure	
LUAD	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.67	12.04	1.97E-29	Diastolic blood pressure	
LUAD	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.7	12.14	8.3E-30	Diastolic blood pressure	
LUAD	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.7	12.14	8.3E-30	Diastolic blood pressure	
LUAD	cis	1	rs73081854	chr3:56628226	CCDC66	chr3:56591184-56655846:+	-0.18	-5.3	1.76E-7	Height	
LUAD	cis	1	rs731152	chr17:40279680	DHX58	chr17:40253422-40264751:-	-0.28	-5.28	1.94E-7	Fibrinogen levels	
LUAD	cis	1	rs73116394	chr2:242367915	SEPT2	chr2:242254723-242293439:+	0.57	6.65	7.88E-11	Chronic lymphocytic leukemia	
LUAD	cis	1	rs73116396	chr2:242368693	SEPT2	chr2:242254723-242293439:+	0.57	6.65	7.88E-11	Chronic lymphocytic leukemia	
LUAD	cis	1	rs73128528	chr20:44582187	WFDC3	chr20:44402847-44420547:-	-0.36	-4.5	8.42E-6	Abdominal aortic aneurysm	
LUAD	cis	1	rs73140069	chr7:75986790	UPK3B	chr7:76139745-76157197:+	-0.21	-3.91	0.000105	Multiple sclerosis	
LUAD	cis	1	rs73142121	chr7:65311206	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.00022	Diabetic kidney disease	
LUAD	cis	1	rs73197056	chr12:91473658	KERA	chr12:91444273-91452131:-	0.21	3.75	0.000198	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs73197065	chr12:91477437	KERA	chr12:91444273-91452131:-	0.23	3.83	0.000144	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs73197078	chr12:91481558	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs7322160	chr13:61061456	TDRD3	chr13:60970591-61148012:+	0.36	7.3	1.19E-12	Menopause (age at onset)	
LUAD	cis	1	rs7324557	chr13:24296862	PCOTH	chr13:24463028-24466241:+	0.31	5.54	4.88E-8	Visceral adipose tissue adjusted for BMI	
LUAD	cis	1	rs732528	chr18:48378234	MRO	chr18:48321491-48351754:-	0.37	6.01	3.53E-9	Entorhinal cortical thickness	
LUAD	cis	1	rs73282209	chr5:150174959	LOC134466	chr5:150310000-150326146:-	0.33	3.95	9.15E-5	Crohn's disease	
LUAD	cis	1	rs73282234	chr5:150195924	LOC134466	chr5:150310000-150326146:-	0.41	4.65	4.27E-6	Crohn's disease	
LUAD	cis	1	rs73282255	chr5:150223647	LOC134466	chr5:150310000-150326146:-	0.29	3.77	0.000186	Crohn's disease	
LUAD	cis	1	rs732856	chr22:38060691	LGALS2	chr22:37966254-37976024:-	-0.17	-4.04	6.27E-5	Fat distribution (HIV)	
LUAD	cis	1	rs73301712	chr14:59898245	C14orf149	chr14:59939406-59951126:-	-0.38	-3.83	0.000145	Schizophrenia	
LUAD	cis	1	rs73301725	chr14:59902159	C14orf149	chr14:59939406-59951126:-	-0.39	-3.89	0.000113	Schizophrenia	
LUAD	cis	1	rs7332115	chr13:33147548	CG030	chr13:33078645-33083532:-	-0.13	-4.13	4.3E-5	Body mass index	
LUAD	cis	1	rs7332763	chr13:33147888	CG030	chr13:33078645-33083532:-	-0.13	-4.13	4.3E-5	Body mass index	
LUAD	cis	1	rs73337598	chr17:61732576	FTSJ3	chr17:61896795-61905031:-	0.2	4.15	3.86E-5	Body mass index	
LUAD	cis	1	rs73348070	chr5:127893533	FBN2	chr5:127593602-127873916:-	0.59	7.86	2.46E-14	Multiple system atrophy	
LUAD	cis	1	rs7340989	chr4:107148720	TBCK	chr4:106967233-107237861:-	0.27	5.02	7.12E-7	Airflow obstruction	
LUAD	cis	1	rs734999	chr1:2513216	MMEL1	chr1:2522081-2564481:-	-0.29	-5.79	1.23E-8	Ulcerative colitis	
LUAD	cis	1	rs735531	chr20:33947730	UQCC	chr20:33890383-33999833:-	0.29	5.45	8.16E-8	Height	
LUAD	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.53	10.39	5.69E-23	Height	
LUAD	cis	1	rs735737	chr2:86177101	LOC90784	chr2:86247339-86250991:-	-0.43	-4.41	1.25E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs73591936	chr16:67761825	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-4.02	6.82E-5	Crohn's disease	
LUAD	cis	1	rs73591936	chr16:67761825	HSD11B2	chr16:67465036-67471452:+	-0.4	-3.86	0.000127	Crohn's disease	
LUAD	cis	1	rs736197	chr1:67607135	C1orf141	chr1:67557859-67600653:-	-0.18	-5.61	3.34E-8	Psoriasis	
LUAD	cis	1	rs736344	chr12:110001195	MYO1H	chr12:109826524-109886176:+	0.39	7.2	2.26E-12	HDL cholesterol	
LUAD	cis	1	rs736408	chr3:52835354	ITIH4	chr3:52847007-52866554:-	0.21	4.66	4.05E-6	Bipolar disorder	
LUAD	cis	1	rs7366341	chr1:202333695	PPP1R12B	chr1:202317836-202557697:+	0.21	4.54	6.98E-6	Sex ratio	
LUAD	cis	1	rs736699	chr2:26913930	SLC5A6	chr2:27422459-27435071:-	-0.19	-3.82	0.000151	Mean arterial pressure	
LUAD	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.54	10.63	7.08E-24	Height	
LUAD	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.52	10.25	1.86E-22	Height	
LUAD	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.53	10.33	9.63E-23	Height	
LUAD	cis	1	rs73889754	chr3:189334675	IL1RAP	chr3:190231891-190375843:+	0.37	4.04	6.22E-5	Brain imaging	
LUAD	cis	1	rs73909829	chr20:49526297	KCNG1	chr20:49620194-49639675:-	-0.38	-3.7	0.000244	Prostate cancer	
LUAD	cis	1	rs73909831	chr20:49526485	KCNG1	chr20:49620194-49639675:-	-0.39	-3.86	0.00013	Prostate cancer	
LUAD	cis	1	rs73909841	chr20:49548807	KCNG1	chr20:49620194-49639675:-	-0.39	-3.83	0.000142	Prostate cancer	
LUAD	cis	1	rs73909842	chr20:49550814	KCNG1	chr20:49620194-49639675:-	-0.39	-3.83	0.000145	Prostate cancer	
LUAD	cis	1	rs73909848	chr20:49570403	KCNG1	chr20:49620194-49639675:-	-0.4	-3.92	0.000101	Prostate cancer	
LUAD	cis	1	rs739139	chr22:38067011	LGALS2	chr22:37966254-37976024:-	0.17	3.96	8.72E-5	Fat distribution (HIV)	
LUAD	cis	1	rs7394190	chr10:75421648	NUDT13	chr10:74870210-74891580:+	-0.22	-4.34	1.74E-5	Atrial fibrillation	
LUAD	cis	1	rs739637	chr17:40280944	DHX58	chr17:40253422-40264751:-	-0.28	-5.28	1.94E-7	Fibrinogen levels	
LUAD	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.5	10.19	3.01E-22	Eye color traits	
LUAD	cis	1	rs7411035	chr1:160856076	ITLN1	chr1:160846332-160854960:-	0.27	4.97	9.19E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs74210981	chr10:102287520	SEC31B	chr10:102246403-102289636:-	-0.23	-7.21	2.2E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.87	-10.79	1.65E-24	Plasma clusterin levels	
LUAD	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.24	1.93E-22	Height	
LUAD	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.37	7.47	3.79E-13	Cognitive performance	
LUAD	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.53	10.39	5.69E-23	Height	
LUAD	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.52	10.31	1.1E-22	Height	
LUAD	cis	1	rs7428	chr2:85545490	TGOLN2	chr2:85545147-85555374:-	0.3	7.31	1.1E-12	Ear protrusion	
LUAD	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.51	-10.01	1.36E-21	Height	
LUAD	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.53	10.39	5.69E-23	Height	
LUAD	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.52	10.08	7.5E-22	Height	
LUAD	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.51	9.83	6.51E-21	Height	
LUAD	cis	1	rs74347384	chr7:1072440	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.87	8.02E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.36	-7.19	2.42E-12	Longevity	
LUAD	cis	1	rs7436403	chr4:17692685	MED28	chr4:17616273-17629791:+	-0.18	-3.99	7.73E-5	Parasitemia in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs74366004	chr7:1088630	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.9	6.84E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs74369356	chr7:1071711	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.87	8.02E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7438704	chr4:48363245	NIPAL1	chr4:48018791-48039078:+	0.19	3.99	7.75E-5	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs74398423	chr4:106720966	INTS12	chr4:106603787-106629881:-	-0.63	-6.56	1.36E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs74421437	chr2:203831252	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs74497593	chr4:106616214	INTS12	chr4:106603787-106629881:-	-0.64	-6.59	1.11E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs7450492	chr6:55935891	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs74508472	chr2:203382013	NOP58	chr2:203130515-203168382:+	0.27	4.34	1.73E-5	Urate levels	
LUAD	cis	1	rs74552817	chr2:179990932	SESTD1	chr2:179966421-180129350:-	-0.42	-3.69	0.000249	Late-onset Alzheimer's disease	
LUAD	cis	1	rs7456042	chr7:65299778	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.00022	Diabetic kidney disease	
LUAD	cis	1	rs74568699	chr4:106665995	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.5E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs74589786	chr20:61860939	BIRC7	chr20:61867276-61871853:+	0.36	4.22	2.94E-5	Response to cytadine analogues (cytosine arabinoside)	
LUAD	cis	1	rs74607112	chr2:86305534	LOC90784	chr2:86247339-86250991:-	-0.41	-3.78	0.000174	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs746489	chr9:131910093	CRAT	chr9:131857075-131873070:-	0.33	6.28	7.28E-10	Blood metabolite ratios	
LUAD	cis	1	rs74650218	chr10:102293830	SEC31B	chr10:102246403-102289636:-	-0.2	-6.29	7.08E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs74652290	chr7:1090109	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.31	1.7E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.33	-7.21	2.09E-12	Response to temozolomide	
LUAD	cis	1	rs74766638	chr2:203309891	NOP58	chr2:203130515-203168382:+	0.26	4.07	5.42E-5	Urate levels	
LUAD	cis	1	rs7477246	chr10:102261538	SEC31B	chr10:102246403-102289636:-	-0.21	-6.7	5.9E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7477	chr17:16246016	ZSWIM7	chr17:15879877-15903006:-	-0.15	-3.78	0.000176	Amyotrophic lateral sclerosis	
LUAD	cis	1	rs74785791	chr7:1088494	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.9	6.84E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs74817508	chr16:68138349	ATP6V0D1	chr16:67471917-67515089:-	-0.38	-3.72	0.000227	Crohn's disease	
LUAD	cis	1	rs74817508	chr16:68138349	C16orf86	chr16:67700717-67702659:+	-0.37	-3.78	0.000173	Crohn's disease	
LUAD	cis	1	rs748404	chr15:43559231	STRC	chr15:43891762-43924561:-	0.2	3.86	0.000129	Lung cancer	
LUAD	cis	1	rs74851284	chr16:68172568	ATP6V0D1	chr16:67471917-67515089:-	-0.42	-4.2	3.12E-5	Crohn's disease	
LUAD	cis	1	rs74851284	chr16:68172568	C16orf86	chr16:67700717-67702659:+	-0.36	-3.84	0.00014	Crohn's disease	
LUAD	cis	1	rs7488394	chr12:91480002	KERA	chr12:91444273-91452131:-	0.23	3.96	8.55E-5	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs74887741	chr7:1110658	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.82	1.08E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs749050	chr10:97376115	ENTPD1	chr10:97471536-97637022:+	0.2	5.44	8.22E-8	Blood metabolite levels	
LUAD	cis	1	rs74917833	chr4:106643161	INTS12	chr4:106603787-106629881:-	-0.64	-6.64	8.51E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs74960631	chr2:180049503	SESTD1	chr2:179966421-180129350:-	-0.42	-3.74	0.000208	Late-onset Alzheimer's disease	
LUAD	cis	1	rs7496954	chr15:83345536	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.15	4.77	2.43E-6	Schizophrenia	
LUAD	cis	1	rs75016635	chr7:1094121	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.78	1.34E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.52	10.73	3.03E-24	Eye color traits	
LUAD	cis	1	rs75040639	chr2:203351696	NOP58	chr2:203130515-203168382:+	0.28	4.4	1.34E-5	Urate levels	
LUAD	cis	1	rs750474	chr3:53085280	TMEM110	chr3:52867139-52931547:-	0.35	4.23	2.77E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs75063298	chr10:102213600	SEC31B	chr10:102246403-102289636:-	-0.22	-6.98	9.94E-12	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs75092650	chr4:106523436	INTS12	chr4:106603787-106629881:-	-0.56	-5.26	2.21E-7	Post bronchodilator FEV1	
LUAD	cis	1	rs7512552	chr1:150265704	C1orf54	chr1:150244773-150253325:+	0.13	4.19	3.3E-5	Atopic dermatitis	
LUAD	cis	1	rs75141346	chr2:203685119	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.55	6.66E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.36	8.0E-13	Body mass index	
LUAD	cis	1	rs7515491	chr1:46355079	MUTYH	chr1:45794915-45806142:-	0.18	4.17	3.59E-5	Body mass index	
LUAD	cis	1	rs7515577	chr1:93009438	EVI5	chr1:92974255-93257961:-	-0.26	-4.21	3.0E-5	Cholesterol, total	
LUAD	cis	1	rs75156726	chr4:106677999	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.92E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs75166090	chr2:203692760	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.46	1.01E-5	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7517	chr1:150596411	HORMAD1	chr1:150670542-150693352:-	0.38	4.04	6.1E-5	Congenital left-sided heart lesions	
LUAD	cis	1	rs7518155	chr1:166954896	GPA33	chr1:167022082-167059868:-	0.22	4.25	2.6E-5	Refractive astigmatism	
LUAD	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.86	-10.52	1.8E-23	Plasma clusterin levels	
LUAD	cis	1	rs7518935	chr1:202503549	PPP1R12B	chr1:202317836-202557697:+	0.22	4.86	1.61E-6	Sex ratio	
LUAD	cis	1	rs752092	chr15:101781934	LINS1	chr15:101109436-101142404:-	-0.19	-3.76	0.00019	Corneal structure	
LUAD	cis	1	rs7521424	chr1:101475901	CCDC76	chr1:100598706-100616053:+	0.18	3.74	0.000203	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs75217232	chr3:53132373	TMEM110	chr3:52867139-52931547:-	0.33	3.88	0.000118	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.79E-12	Body mass index	
LUAD	cis	1	rs7522601	chr1:46419021	MUTYH	chr1:45794915-45806142:-	0.17	4.01	6.9E-5	Body mass index	
LUAD	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.78	15.56	1.17E-44	Homocysteine levels	
LUAD	cis	1	rs7522991	chr1:202492151	PPP1R12B	chr1:202317836-202557697:+	0.2	4.56	6.6E-6	Sex ratio	
LUAD	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.17	2.7E-12	Body mass index	
LUAD	cis	1	rs7524495	chr1:46266932	MUTYH	chr1:45794915-45806142:-	0.18	4.23	2.75E-5	Body mass index	
LUAD	cis	1	rs752621	chr17:61901880	FTSJ3	chr17:61896795-61905031:-	0.21	4.38	1.45E-5	Body mass index	
LUAD	cis	1	rs7527292	chr1:85537890	WDR63	chr1:85527993-85598820:+	-0.17	-3.98	7.88E-5	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	0.37	6.38	4.12E-10	Heschl's gyrus morphology	
LUAD	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.29	8.77	3.0E-17	Type 1 diabetes autoantibodies	
LUAD	cis	1	rs7528849	chr1:166954870	GPA33	chr1:167022082-167059868:-	-0.24	-4.5	8.6E-6	Refractive astigmatism	
LUAD	cis	1	rs75292879	chr3:189333590	IL1RAP	chr3:190231891-190375843:+	0.41	4.05	5.86E-5	Brain imaging	
LUAD	cis	1	rs75294883	chr5:150196503	LOC134466	chr5:150310000-150326146:-	0.49	5.27	2.06E-7	Crohn's disease	
LUAD	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.85	-10.34	8.61E-23	Plasma clusterin levels	
LUAD	cis	1	rs7531202	chr1:110616474	ALX3	chr1:110602998-110613322:-	-0.22	-4.28	2.22E-5	Blood metabolite levels	
LUAD	cis	1	rs75324925	chr2:203698300	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.56	6.49E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7532835	chr1:202518291	PPP1R12B	chr1:202317836-202557697:+	0.22	4.9	1.3E-6	Sex ratio	
LUAD	cis	1	rs7533623	chr1:110616475	ALX3	chr1:110602998-110613322:-	-0.22	-4.21	3.06E-5	Blood metabolite levels	
LUAD	cis	1	rs7533688	chr1:166944123	GPA33	chr1:167022082-167059868:-	-0.24	-4.43	1.14E-5	Refractive astigmatism	
LUAD	cis	1	rs7534086	chr1:202453155	PPP1R12B	chr1:202317836-202557697:+	0.22	4.75	2.62E-6	Sex ratio	
LUAD	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.89	-18.18	8.21E-57	Homocysteine levels	
LUAD	cis	1	rs7534467	chr1:45988691	MUTYH	chr1:45794915-45806142:-	0.21	4.44	1.13E-5	Homocysteine levels	
LUAD	cis	1	rs7534485	chr1:168720621	DPT	chr1:168664707-168698428:-	0.19	4.47	9.78E-6	Diisocyanate-induced asthma	
LUAD	cis	1	rs7535068	chr1:101490329	CCDC76	chr1:100598706-100616053:+	0.18	3.72	0.000224	Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.79	-16.18	1.86E-47	Homocysteine levels	
LUAD	cis	1	rs7536557	chr1:45992114	MUTYH	chr1:45794915-45806142:-	0.17	3.72	0.000219	Homocysteine levels	
LUAD	cis	1	rs7537765	chr1:11887303	CLCN6	chr1:11866207-11907674:+	-0.2	-4.09	4.97E-5	QRS complex (12-leadsum)	
LUAD	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.24	1.71E-12	Body mass index	
LUAD	cis	1	rs7539932	chr1:46292354	MUTYH	chr1:45794915-45806142:-	0.18	4.22	2.93E-5	Body mass index	
LUAD	cis	1	rs75399471	chr1:76339092	MSH4	chr1:76262630-76378923:+	-0.39	-3.92	0.000101	Attention function in attention deficit hyperactive disorder	
LUAD	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.22	2.01E-12	Body mass index	
LUAD	cis	1	rs7540325	chr1:46338217	MUTYH	chr1:45794915-45806142:-	0.18	4.31	1.99E-5	Body mass index	
LUAD	cis	1	rs75412200	chr2:180046477	SESTD1	chr2:179966421-180129350:-	-0.42	-3.75	0.000199	Late-onset Alzheimer's disease	
LUAD	cis	1	rs754388	chr14:93115410	MOAP1	chr14:93648543-93651249:-	0.22	4.23	2.75E-5	Post bronchodilator FEV1/FVC ratio	
LUAD	cis	1	rs7545911	chr1:166947681	GPA33	chr1:167022082-167059868:-	-0.24	-4.38	1.42E-5	Refractive astigmatism	
LUAD	cis	1	rs7547997	chr1:158341273	CD1E	chr1:158323254-158327341:+	0.23	4.94	1.08E-6	QRS duration	
LUAD	cis	1	rs75488469	chr7:1102122	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.84	9.5E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7550698	chr1:166951081	GPA33	chr1:167022082-167059868:-	-0.24	-4.44	1.13E-5	Refractive astigmatism	
LUAD	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.37	7.53E-13	Body mass index	
LUAD	cis	1	rs7550746	chr1:46351719	MUTYH	chr1:45794915-45806142:-	0.18	4.12	4.38E-5	Body mass index	
LUAD	cis	1	rs755109	chr9:100696203	C9orf156	chr9:100666772-100684852:-	0.19	4.01	6.97E-5	Quantitative traits	
LUAD	cis	1	rs7551222	chr1:204599295	GOLT1A	chr1:204167288-204183220:-	-0.24	-4.13	4.28E-5	Schizophrenia	
LUAD	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.27	4.91	1.23E-6	Height	
LUAD	cis	1	rs7551874	chr1:12048130	MFN2	chr1:12040238-12073571:+	-0.19	-3.85	0.000136	Platelet count	
LUAD	cis	1	rs7554962	chr1:166956297	GPA33	chr1:167022082-167059868:-	-0.23	-4.32	1.9E-5	Refractive astigmatism	
LUAD	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.39	7.22	2.04E-12	Body mass index	
LUAD	cis	1	rs7556436	chr1:46363880	MUTYH	chr1:45794915-45806142:-	-0.17	-4.14	4.03E-5	Body mass index	
LUAD	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.17	2.79E-12	Body mass index	
LUAD	cis	1	rs7556615	chr1:46461369	MUTYH	chr1:45794915-45806142:-	0.17	3.96	8.57E-5	Body mass index	
LUAD	cis	1	rs7556629	chr1:202483678	PPP1R12B	chr1:202317836-202557697:+	0.23	5.04	6.48E-7	Sex ratio	
LUAD	cis	1	rs7557709	chr2:219167529	DIRC3	chr2:218148748-218621316:-	0.18	3.85	0.000133	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs7558944	chr2:73810909	ALMS1	chr2:73612886-73837046:+	0.18	4.4	1.36E-5	Metabolite levels	
LUAD	cis	1	rs7558944	chr2:73810909	ALMS1P	chr2:73872046-73912692:+	0.39	7.48	3.47E-13	Metabolite levels	
LUAD	cis	1	rs7558944	chr2:73810909	FBXO41	chr2:73481800-73498043:-	0.19	3.67	0.000267	Metabolite levels	
LUAD	cis	1	rs75599828	chr22:22333062	YPEL1	chr22:22051828-22090071:-	0.22	3.68	0.000262	Attention deficit hyperactivity disorder	
LUAD	cis	1	rs7560328	chr2:202164837	ALS2CR12	chr2:202153148-202222101:-	-0.19	-5.02	7.12E-7	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs7560328	chr2:202164837	CASP8	chr2:202098166-202152434:+	0.21	4.59	5.63E-6	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs7560547	chr2:203757916	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7562170	chr2:28943516	PPP1CB	chr2:28974612-29025805:+	-0.18	-3.69	0.000247	Body mass index	
LUAD	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.26	5.12	4.41E-7	Body mass index	
LUAD	cis	1	rs7564890	chr2:73641853	ALMS1	chr2:73612886-73837046:+	0.2	4.74	2.78E-6	Metabolite levels	
LUAD	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.39	7.51	2.76E-13	Metabolite levels	
LUAD	cis	1	rs7565875	chr2:203381135	NOP58	chr2:203130515-203168382:+	0.24	4.07	5.43E-5	Urate levels	
LUAD	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.64	-14.26	7.77E-39	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs7567025	chr2:70185108	ASPRV1	chr2:70187226-70314147:-	0.28	4.04	6.11E-5	Obesity-related traits	
LUAD	cis	1	rs7567389	chr2:127982645	ERCC3	chr2:128014866-128051752:-	0.21	3.77	0.000182	Self-rated health	
LUAD	cis	1	rs756777	chr9:136679080	BRD3	chr9:136895454-136933655:-	0.21	4.12	4.47E-5	IgG glycosylation	
LUAD	cis	1	rs75687134	chr18:65472043	CCDC102B	chr18:66382491-66722426:+	0.41	4.37	1.52E-5	Bipolar disorder (body mass index interaction)	
LUAD	cis	1	rs756920	chr11:2310870	C11orf21	chr11:2317507-2323143:-	0.25	5	8.12E-7	Obesity-related traits	
LUAD	cis	1	rs7570215	chr2:113527660	IL1A	chr2:113531493-113542971:-	0.23	4.23	2.76E-5	Response to antipsychotic treatment in schizophrenia (working memory)	
LUAD	cis	1	rs7572722	chr2:73724675	ALMS1	chr2:73612886-73837046:+	0.18	4.27	2.34E-5	Metabolite levels	
LUAD	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.39	7.35	8.47E-13	Metabolite levels	
LUAD	cis	1	rs75733050	chr16:68101941	ATP6V0D1	chr16:67471917-67515089:-	-0.38	-3.72	0.000224	Crohn's disease	
LUAD	cis	1	rs75733050	chr16:68101941	C16orf86	chr16:67700717-67702659:+	-0.37	-3.77	0.000184	Crohn's disease	
LUAD	cis	1	rs75739761	chr16:68122914	ATP6V0D1	chr16:67471917-67515089:-	-0.38	-3.72	0.000227	Crohn's disease	
LUAD	cis	1	rs75739761	chr16:68122914	C16orf86	chr16:67700717-67702659:+	-0.37	-3.78	0.000173	Crohn's disease	
LUAD	cis	1	rs7574255	chr2:228699884	WDR69	chr2:228736327-228789026:+	-0.28	-5.94	5.5E-9	Blood pressure	
LUAD	cis	1	rs7576245	chr2:73829678	ALMS1	chr2:73612886-73837046:+	0.19	4.62	4.8E-6	Metabolite levels	
LUAD	cis	1	rs7576245	chr2:73829678	ALMS1P	chr2:73872046-73912692:+	0.33	6.48	2.18E-10	Metabolite levels	
LUAD	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.31	3.75	0.000197	Crohn's disease	
LUAD	cis	1	rs7577762	chr2:70184590	ASPRV1	chr2:70187226-70314147:-	-0.3	-4.19	3.26E-5	Obesity-related traits	
LUAD	cis	1	rs7578199	chr2:242192848	SEPT2	chr2:242254723-242293439:+	0.21	3.69	0.000245	Chronic lymphocytic leukemia	
LUAD	cis	1	rs7578456	chr2:202235348	CASP8	chr2:202098166-202152434:+	0.24	5.17	3.49E-7	Basal cell carcinoma	
LUAD	cis	1	rs75788262	chr16:68172490	ATP6V0D1	chr16:67471917-67515089:-	-0.42	-4.18	3.42E-5	Crohn's disease	
LUAD	cis	1	rs75788262	chr16:68172490	C16orf86	chr16:67700717-67702659:+	-0.36	-3.82	0.000148	Crohn's disease	
LUAD	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.45	8.07E-8	Body mass index	
LUAD	cis	1	rs757978	chr2:242371101	SEPT2	chr2:242254723-242293439:+	0.51	6.24	9.64E-10	Chronic lymphocytic leukemia	
LUAD	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.24	4.51	7.95E-6	Breast cancer (estrogen-receptor negative);Breast cancer	
LUAD	cis	1	rs7580825	chr2:73635148	ALMS1	chr2:73612886-73837046:+	0.19	4.56	6.61E-6	Metabolite levels	
LUAD	cis	1	rs7580825	chr2:73635148	ALMS1P	chr2:73872046-73912692:+	0.4	7.49	3.32E-13	Metabolite levels	
LUAD	cis	1	rs7580825	chr2:73635148	FBXO41	chr2:73481800-73498043:-	0.2	3.73	0.00021	Metabolite levels	
LUAD	cis	1	rs7581224	chr2:84709215	DNAH6	chr2:84743579-85046711:+	0.21	5.95	5.19E-9	Coronary artery calcification	
LUAD	cis	1	rs75817507	chr4:106767623	INTS12	chr4:106603787-106629881:-	-0.59	-6.08	2.41E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs75824542	chr14:74523047	C14orf45	chr14:74486059-74549566:+	0.19	4.13	4.21E-5	Common traits (Other)	
LUAD	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.5	11.23	3.48E-26	Common traits (Other)	
LUAD	cis	1	rs75824542	chr14:74523047	ZNF410	chr14:74318674-74398803:+	0.22	4.56	6.47E-6	Common traits (Other)	
LUAD	cis	1	rs75824619	chr20:61856471	BIRC7	chr20:61867276-61871853:+	0.36	4.23	2.76E-5	Response to cytadine analogues (cytosine arabinoside)	
LUAD	cis	1	rs7582606	chr2:73813945	ALMS1	chr2:73612886-73837046:+	0.19	4.47	9.84E-6	Metabolite levels	
LUAD	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.4	7.67	9.42E-14	Metabolite levels	
LUAD	cis	1	rs7582720	chr2:203753072	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.66	4.15E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7583236	chr2:70182805	ASPRV1	chr2:70187226-70314147:-	-0.27	-3.8	0.000162	Obesity-related traits	
LUAD	cis	1	rs7583255	chr2:73797996	ALMS1	chr2:73612886-73837046:+	0.17	4.22	2.96E-5	Metabolite levels	
LUAD	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.39	7.43	4.94E-13	Metabolite levels	
LUAD	cis	1	rs7584535	chr2:232106857	HTR2B	chr2:231972952-231989824:-	0.25	4.53	7.5E-6	Food antigen IgG levels	
LUAD	cis	1	rs7584575	chr2:73666402	ALMS1	chr2:73612886-73837046:+	0.2	4.84	1.7E-6	Metabolite levels	
LUAD	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.36	7.02	7.4E-12	Metabolite levels	
LUAD	cis	1	rs7585004	chr2:73666645	ALMS1	chr2:73612886-73837046:+	0.17	4.03	6.43E-5	Metabolite levels	
LUAD	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.35	6.65	7.62E-11	Metabolite levels	
LUAD	cis	1	rs758598	chr17:59492714	TBX2	chr17:59477257-59486825:+	0.13	3.79	0.00017	Sitting height ratio	
LUAD	cis	1	rs758599	chr17:59492268	TBX2	chr17:59477257-59486825:+	0.13	3.75	0.000197	Sitting height ratio	
LUAD	cis	1	rs7586463	chr2:73798476	ALMS1	chr2:73612886-73837046:+	0.18	4.29	2.12E-5	Metabolite levels	
LUAD	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.39	7.53	2.4E-13	Metabolite levels	
LUAD	cis	1	rs75869289	chr2:203806724	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7587220	chr2:219160864	DIRC3	chr2:218148748-218621316:-	-0.19	-4.08	5.22E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs7587234	chr2:203216422	NOP58	chr2:203130515-203168382:+	0.29	4.52	7.72E-6	Urate levels	
LUAD	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.28	4.28	2.22E-5	Atopic dermatitis	
LUAD	cis	1	rs758944	chr7:75953297	UPK3B	chr7:76139745-76157197:+	-0.2	-3.86	0.000128	Multiple sclerosis	
LUAD	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.83	-10.04	1.09E-21	Plasma clusterin levels	
LUAD	cis	1	rs75904349	chr4:106526694	INTS12	chr4:106603787-106629881:-	-0.56	-5.32	1.57E-7	Post bronchodilator FEV1	
LUAD	cis	1	rs7591163	chr2:228715375	WDR69	chr2:228736327-228789026:+	0.29	5.97	4.46E-9	Blood pressure	
LUAD	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	0.65	7.62	1.29E-13	Chronic obstructive pulmonary disease-related biomarkers	
LUAD	cis	1	rs7591472	chr2:201889751	CFLAR	chr2:201980816-202029001:+	-0.23	-4.46	1.02E-5	Triptolide cytotoxicity	
LUAD	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.75	-13.77	1.06E-36	Triptolide cytotoxicity	
LUAD	cis	1	rs7592764	chr2:240448167	PP14571	chr2:241388732-241396117:-	-0.38	-3.94	9.46E-5	Blood pressure (smoking interaction)	
LUAD	cis	1	rs7594511	chr2:73681639	ALMS1	chr2:73612886-73837046:+	0.18	4.43	1.14E-5	Metabolite levels	
LUAD	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.39	7.37	7.44E-13	Metabolite levels	
LUAD	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.64	-14.19	1.58E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs7596362	chr2:61204688	AHSA2	chr2:61404553-61414058:+	-0.13	-5.63	3.11E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.46	8.45	3.36E-16	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs7597156	chr2:203194062	NOP58	chr2:203130515-203168382:+	0.27	4.43	1.18E-5	Urate levels	
LUAD	cis	1	rs7597469	chr2:203194270	NOP58	chr2:203130515-203168382:+	0.3	4.62	4.96E-6	Urate levels	
LUAD	cis	1	rs7598396	chr2:73652628	ALMS1	chr2:73612886-73837046:+	0.2	4.93	1.11E-6	Metabolite levels	
LUAD	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.4	7.72	6.51E-14	Metabolite levels	
LUAD	cis	1	rs7598419	chr2:73798223	ALMS1	chr2:73612886-73837046:+	0.18	4.41	1.27E-5	Metabolite levels	
LUAD	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.39	7.49	3.25E-13	Metabolite levels	
LUAD	cis	1	rs75987339	chr9:36200885	GLIPR2	chr9:36136742-36163902:+	-0.24	-4.02	6.83E-5	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.27	-5.57	4.26E-8	Body mass index	
LUAD	cis	1	rs7601738	chr2:242375813	SEPT2	chr2:242254723-242293439:+	-0.57	-6.65	7.81E-11	Chronic lymphocytic leukemia	
LUAD	cis	1	rs76021735	chr2:203376199	NOP58	chr2:203130515-203168382:+	0.27	4.19	3.31E-5	Urate levels	
LUAD	cis	1	rs76024966	chr7:75995021	UPK3B	chr7:76139745-76157197:+	-0.21	-3.93	9.62E-5	Multiple sclerosis	
LUAD	cis	1	rs76029149	chr18:70263292	CBLN2	chr18:70203915-70211723:-	0.52	4.63	4.6E-6	Airflow obstruction	
LUAD	cis	1	rs7604393	chr2:241825034	C2orf54	chr2:241825466-241835573:-	0.32	5.88	7.45E-9	Urinary metabolites	
LUAD	cis	1	rs7604682	chr2:73788026	ALMS1	chr2:73612886-73837046:+	0.18	4.57	6.2E-6	Metabolite levels	
LUAD	cis	1	rs7604682	chr2:73788026	ALMS1P	chr2:73872046-73912692:+	0.35	6.89	1.7E-11	Metabolite levels	
LUAD	cis	1	rs7605484	chr2:203724495	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.47	9.85E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.63	14.03	8.42E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs7607014	chr2:73730174	ALMS1	chr2:73612886-73837046:+	-0.17	-4.34	1.75E-5	Metabolite levels	
LUAD	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.36	-7.03	7.19E-12	Metabolite levels	
LUAD	cis	1	rs7608623	chr2:23948953	C2orf84	chr2:24397531-24414566:+	-0.21	-3.81	0.000157	Obesity-related traits	
LUAD	cis	1	rs7608623	chr2:23948953	LOC375190	chr2:24299728-24397519:+	0.24	4.71	3.19E-6	Obesity-related traits	
LUAD	cis	1	rs7608697	chr2:61204641	AHSA2	chr2:61404553-61414058:+	-0.13	-5.48	6.65E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.42	7.74	5.63E-14	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs7608910	chr2:61204856	AHSA2	chr2:61404553-61414058:+	0.12	5.09	5.15E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.44	-8.14	3.26E-15	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LUAD	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.32	-5.32	1.55E-7	Bone mineral density	
LUAD	cis	1	rs7610055	chr3:12388409	MKRN2	chr3:12598594-12625208:+	0.32	4.06	5.64E-5	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs7610821	chr3:10136150	IL17RE	chr3:9944303-9958082:+	-0.2	-3.71	0.000228	Alzheimer's disease	
LUAD	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.51	9.83	6.51E-21	Height	
LUAD	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.52	10.31	1.1E-22	Height	
LUAD	cis	1	rs76129108	chr7:1089159	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.82	1.05E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.34	-5.37	1.22E-7	Blood pressure (smoking interaction)	
LUAD	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.35	5.46	7.58E-8	Blood pressure (smoking interaction)	
LUAD	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.71	13.28	1.38E-34	Diastolic blood pressure	
LUAD	cis	1	rs7617331	chr3:56624159	CCDC66	chr3:56591184-56655846:+	-0.18	-5.3	1.76E-7	Height	
LUAD	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.72	-13.08	1.02E-33	Diastolic blood pressure	
LUAD	cis	1	rs7617912	chr3:156576412	LEKR1	chr3:156544076-156763918:+	-0.27	-4.16	3.76E-5	Bone mineral density	
LUAD	cis	1	rs7618007	chr3:56728899	CCDC66	chr3:56591184-56655846:+	0.19	5.26	2.12E-7	Height	
LUAD	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.41	7.32	1.04E-12	Height	
LUAD	cis	1	rs7620259	chr3:56666025	CCDC66	chr3:56591184-56655846:+	0.18	5.21	2.76E-7	Height	
LUAD	cis	1	rs7620458	chr3:156576850	LEKR1	chr3:156544076-156763918:+	-0.29	-4.56	6.38E-6	Bone mineral density	
LUAD	cis	1	rs76214082	chr7:1102097	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.82	1.09E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.72	13.32	9.3E-35	Diastolic blood pressure	
LUAD	cis	1	rs7622420	chr3:53111069	TMEM110	chr3:52867139-52931547:-	0.32	4.04	6.14E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.72	13.35	7.29E-35	Diastolic blood pressure	
LUAD	cis	1	rs7624377	chr3:190988079	UTS2D	chr3:190984945-191048325:-	-0.29	-6.09	2.34E-9	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs7625448	chr3:53120766	TMEM110	chr3:52867139-52931547:-	0.35	4.28	2.26E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs76284304	chr2:203291839	NOP58	chr2:203130515-203168382:+	0.26	4.09	5.13E-5	Urate levels	
LUAD	cis	1	rs76298043	chr2:203814694	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.32	6.35	5.03E-10	Height	
LUAD	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.27	-6.66	7.47E-11	Longevity	
LUAD	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.52	-10.02	1.27E-21	Height	
LUAD	cis	1	rs7631026	chr3:190979823	UTS2D	chr3:190984945-191048325:-	-0.24	-5.13	4.17E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.74	13.36	6.5E-35	Diastolic blood pressure	
LUAD	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.27	-6.54	1.57E-10	Longevity	
LUAD	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.27	-6.38	4.06E-10	Longevity	
LUAD	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.29	-7.23	1.92E-12	Longevity	
LUAD	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.25	-5.91	6.35E-9	Longevity	
LUAD	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.52	10.29	1.26E-22	Height	
LUAD	cis	1	rs7637404	chr3:190981868	UTS2D	chr3:190984945-191048325:-	-0.26	-5.42	9.44E-8	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs7637449	chr3:56628031	CCDC66	chr3:56591184-56655846:+	-0.19	-5.35	1.38E-7	Height	
LUAD	cis	1	rs76388414	chr7:1100694	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.82	1.09E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7638903	chr3:12383714	MKRN2	chr3:12598594-12625208:+	0.32	4.05	6.04E-5	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs763919	chr20:44016052	SYS1	chr20:43991701-44004724:+	-0.24	-4.04	6.33E-5	Psoriasis	
LUAD	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.29	-4.71	3.19E-6	Bone mineral density	
LUAD	cis	1	rs76419734	chr4:106624285	INTS12	chr4:106603787-106629881:-	-0.64	-6.36	4.59E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.42	5.01	7.59E-7	Crohn's disease	
LUAD	cis	1	rs76435840	chr11:58285981	CNTF	chr11:58390146-58393203:+	0.33	4.48	9.29E-6	Lymphoma	
LUAD	cis	1	rs7644510	chr3:190980797	UTS2D	chr3:190984945-191048325:-	-0.24	-5.2	3.01E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.51	9.83	6.52E-21	Height	
LUAD	cis	1	rs76454304	chr20:49513290	KCNG1	chr20:49620194-49639675:-	-0.37	-3.67	0.000269	Prostate cancer	
LUAD	cis	1	rs7645611	chr3:53125297	TMEM110	chr3:52867139-52931547:-	0.33	4.03	6.37E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.74	13.36	6.5E-35	Diastolic blood pressure	
LUAD	cis	1	rs76461893	chr2:203865515	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.67	3.94E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7647481	chr3:12391813	MKRN2	chr3:12598594-12625208:+	0.31	3.89	0.000113	Type 2 diabetes;Fasting insulin-related traits (interaction with BMI)	
LUAD	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.72	13.43	3.05E-35	Diastolic blood pressure	
LUAD	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.52	10.31	1.1E-22	Height	
LUAD	cis	1	rs76506978	chr18:51790340	POLI	chr18:51795849-51824602:+	0.22	4.14	4.09E-5	Psoriasis	
LUAD	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.31	-7.8	3.81E-14	Longevity	
LUAD	cis	1	rs76528043	chr2:203330839	NOP58	chr2:203130515-203168382:+	0.27	4.3	2.07E-5	Urate levels	
LUAD	cis	1	rs7653691	chr3:48419689	ATRIP	chr3:48488141-48507708:+	-0.2	-3.69	0.000248	Longevity	
LUAD	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.26	6.31	6.24E-10	Longevity	
LUAD	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.31	-4.54	7.16E-6	Tumor biomarkers	
LUAD	cis	1	rs76542740	chr15:43891512	CATSPER2	chr15:43922774-43959900:-	-0.26	-4.22	2.92E-5	Tumor biomarkers	
LUAD	cis	1	rs7654345	chr4:17691796	MED28	chr4:17616273-17629791:+	0.16	3.68	0.000256	Parasitemia in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs76548544	chr5:150223515	LOC134466	chr5:150310000-150326146:-	0.29	3.75	0.000198	Crohn's disease	
LUAD	cis	1	rs765516	chr6:117728118	DCBLD1	chr6:117803820-117891018:+	0.17	3.76	0.000193	Lung cancer	
LUAD	cis	1	rs76553384	chr14:74383679	LIN52	chr14:74551656-74667117:+	0.27	4.03	6.53E-5	Morning vs. evening chronotype	
LUAD	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.46	-8.39	5.29E-16	Plasma amyloid beta peptide concentrations (ABx-40)	
LUAD	cis	1	rs7657962	chr4:106966715	TBCK	chr4:106967233-107237861:-	0.24	4.46	1.01E-5	Airflow obstruction	
LUAD	cis	1	rs7658118	chr4:99994608	ADH5	chr4:99992132-100009931:-	0.29	3.69	0.000249	Smoking initiation	
LUAD	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.47	-8.54	1.73E-16	Plasma amyloid beta peptide concentrations (ABx-40)	
LUAD	cis	1	rs7661702	chr4:104140129	BDH2	chr4:103998783-104021024:-	0.26	5.38	1.13E-7	Testicular germ cell tumor	
LUAD	cis	1	rs7661702	chr4:104140129	MANBA	chr4:103552644-103682151:-	0.28	5.42	9.13E-8	Testicular germ cell tumor	
LUAD	cis	1	rs7662987	chr4:99991642	ADH5	chr4:99992132-100009931:-	0.3	3.76	0.000187	Smoking initiation	
LUAD	cis	1	rs76635824	chr16:20606442	ACSM1	chr16:20634559-20709066:-	0.52	5.84	9.66E-9	Schizophrenia	
LUAD	cis	1	rs7665727	chr4:277057	ZNF718	chr4:53272-156488:+	0.27	3.92	9.94E-5	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs76683169	chr10:102358397	SEC31B	chr10:102246403-102289636:-	-0.16	-4.83	1.81E-6	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs76685994	chr20:49564211	KCNG1	chr20:49620194-49639675:-	-0.39	-3.84	0.000138	Prostate cancer	
LUAD	cis	1	rs76693798	chr3:184711113	C3orf70	chr3:184795840-184870802:-	-0.31	-3.96	8.53E-5	Heschl's gyrus morphology	
LUAD	cis	1	rs76694233	chr4:106681036	INTS12	chr4:106603787-106629881:-	-0.64	-6.37	4.26E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs76733757	chr18:70256669	CBLN2	chr18:70203915-70211723:-	0.5	4.5	8.52E-6	Airflow obstruction	
LUAD	cis	1	rs7674560	chr4:263319	ZNF718	chr4:53272-156488:+	0.26	3.86	0.000128	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs7676975	chr4:106763811	INTS12	chr4:106603787-106629881:-	-0.48	-5.62	3.13E-8	Post bronchodilator FEV1	
LUAD	cis	1	rs7677248	chr4:106960497	TBCK	chr4:106967233-107237861:-	-0.26	-4.96	9.71E-7	Airflow obstruction	
LUAD	cis	1	rs76773990	chr18:70251042	CBLN2	chr18:70203915-70211723:-	0.5	4.4	1.33E-5	Airflow obstruction	
LUAD	cis	1	rs7678847	chr4:106987426	TBCK	chr4:106967233-107237861:-	0.26	4.87	1.5E-6	Airflow obstruction	
LUAD	cis	1	rs76804143	chr7:1082021	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.89	7.39E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.62	6.78	3.48E-11	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs7682206	chr4:68428980	STAP1	chr4:68424446-68473053:+	-0.18	-3.79	0.000172	Parkinson's disease	
LUAD	cis	1	rs7682402	chr4:1743343	FAM53A	chr4:1641609-1685854:-	-0.3	-5.21	2.86E-7	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs76833820	chr7:1070278	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.87	8.02E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7683802	chr4:99995138	ADH5	chr4:99992132-100009931:-	0.3	3.76	0.000192	Smoking initiation	
LUAD	cis	1	rs76841360	chr1:40060025	PABPC4	chr1:40026485-40042521:-	-0.26	-3.85	0.000136	C-reactive protein levels or triglyceride levels (pleiotropy)	
LUAD	cis	1	rs7684318	chr4:90655003	MMRN1	chr4:90816003-90875778:+	0.26	3.81	0.000154	Parkinson's disease	
LUAD	cis	1	rs7686546	chr4:240614	ZNF718	chr4:53272-156488:+	0.27	3.99	7.76E-5	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.44	-8.42	4.33E-16	Plasma amyloid beta peptide concentrations (ABx-40)	
LUAD	cis	1	rs76878669	chr11:66092567	CTSF	chr11:66330936-66336047:-	0.24	3.84	0.000137	Educational attainment (years of education)	
LUAD	cis	1	rs7688014	chr4:103975060	BDH2	chr4:103998783-104021024:-	0.21	4.19	3.33E-5	Schizophrenia	
LUAD	cis	1	rs7688014	chr4:103975060	MANBA	chr4:103552644-103682151:-	0.3	5.59	3.69E-8	Schizophrenia	
LUAD	cis	1	rs76890136	chr2:203850011	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.75	2.67E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7690734	chr4:76537889	CXCL9	chr4:76922623-76928641:-	0.15	3.83	0.000144	Magnesium levels	
LUAD	cis	1	rs7692069	chr4:106959289	TBCK	chr4:106967233-107237861:-	0.24	4.45	1.06E-5	Airflow obstruction	
LUAD	cis	1	rs76924975	chr18:70253060	CBLN2	chr18:70203915-70211723:-	0.49	4.42	1.22E-5	Airflow obstruction	
LUAD	cis	1	rs7692919	chr4:165902781	C4orf39	chr4:165878100-165880273:+	0.29	5.72	1.87E-8	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs7692919	chr4:165902781	TRIM61	chr4:165875600-165898818:-	0.2	4.03	6.55E-5	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs7693977	chr4:165903050	C4orf39	chr4:165878100-165880273:+	0.31	6.14	1.74E-9	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs7693977	chr4:165903050	TRIM61	chr4:165875600-165898818:-	0.19	3.94	9.35E-5	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs7694190	chr4:104168017	BDH2	chr4:103998783-104021024:-	0.27	5.43	8.68E-8	Testicular germ cell tumor	
LUAD	cis	1	rs7694190	chr4:104168017	MANBA	chr4:103552644-103682151:-	0.28	5.4	1.06E-7	Testicular germ cell tumor	
LUAD	cis	1	rs7694379	chr4:88186509	HSD17B13	chr4:88224941-88244056:-	-0.27	-5.8	1.16E-8	Platelet count	
LUAD	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	0.36	5.97	4.61E-9	Heschl's gyrus morphology	
LUAD	cis	1	rs7705093	chr5:96290647	ERAP1	chr5:96096515-96149837:-	-0.18	-4.12	4.4E-5	Birdshot chorioretinopathy	
LUAD	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.05	33.94	1.24E-130	Birdshot chorioretinopathy	
LUAD	cis	1	rs77055954	chr16:68246428	ATP6V0D1	chr16:67471917-67515089:-	-0.39	-3.77	0.000182	Crohn's disease	
LUAD	cis	1	rs77055954	chr16:68246428	C16orf86	chr16:67700717-67702659:+	-0.37	-3.69	0.000247	Crohn's disease	
LUAD	cis	1	rs77078697	chr4:252048	ZNF718	chr4:53272-156488:+	0.25	3.68	0.000262	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs77083167	chr7:1071823	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.87	8.02E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.77	7.71	6.92E-14	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs7719994	chr5:156430076	TIMD4	chr5:156346293-156390266:-	-0.24	-4.23	2.82E-5	Hypertriglyceridemia	
LUAD	cis	1	rs77230711	chr2:203805552	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7726556	chr5:156478780	TIMD4	chr5:156346293-156390266:-	-0.28	-5.11	4.63E-7	Hypertriglyceridemia	
LUAD	cis	1	rs77268589	chr2:203751981	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.34E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7729274	chr5:156935908	ADAM19	chr5:156822542-157002768:-	0.14	4.36	1.57E-5	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs77305932	chr7:1100861	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.82	1.09E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs77337809	chr2:179979147	SESTD1	chr2:179966421-180129350:-	-0.42	-3.73	0.000216	Late-onset Alzheimer's disease	
LUAD	cis	1	rs77346188	chr7:1114023	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.65	2.77E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7734928	chr5:150256613	LOC134466	chr5:150310000-150326146:-	0.3	3.77	0.000181	Crohn's disease	
LUAD	cis	1	rs7740682	chr6:49488745	CENPQ	chr6:49431096-49460820:+	0.17	4.23	2.82E-5	Brain structure	
LUAD	cis	1	rs77435512	chr2:203198888	NOP58	chr2:203130515-203168382:+	0.22	3.86	0.000128	Urate levels	
LUAD	cis	1	rs7746877	chr6:3828676	SERPINB1	chr6:2833736-2842081:-	-0.17	-3.89	0.000113	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	
LUAD	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.25	3.81	0.000155	Atopic dermatitis	
LUAD	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.64	-12.14	7.72E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs7750803	chr6:111800113	KIAA1919	chr6:111580482-111590259:+	-0.48	-4.17	3.67E-5	Psoriasis	
LUAD	cis	1	rs7750918	chr6:49430082	CENPQ	chr6:49431096-49460820:+	-0.27	-6.77	3.73E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.33	6.73	4.75E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	0.35	6.21	1.11E-9	Heschl's gyrus morphology	
LUAD	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.62	-11.49	3.16E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs77562891	chr18:51791235	POLI	chr18:51795849-51824602:+	0.22	4.14	4.15E-5	Psoriasis	
LUAD	cis	1	rs7756805	chr6:97991743	GPR63	chr6:97245889-97285353:-	0.3	3.9	0.00011	Multiple sclerosis (OCB status)	
LUAD	cis	1	rs7757014	chr6:49491690	CENPQ	chr6:49431096-49460820:+	-0.18	-4.25	2.58E-5	Brain structure	
LUAD	cis	1	rs7758454	chr6:97415116	GPR63	chr6:97245889-97285353:-	-0.25	-3.72	0.000221	Body mass index	
LUAD	cis	1	rs7758623	chr6:97415238	GPR63	chr6:97245889-97285353:-	-0.27	-4.17	3.66E-5	Body mass index	
LUAD	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.38	-10.47	2.76E-23	Homocysteine levels	
LUAD	cis	1	rs7759572	chr6:97415135	GPR63	chr6:97245889-97285353:-	0.27	4.33	1.84E-5	Body mass index	
LUAD	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.63	-11.62	9.93E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.64	-12.01	2.68E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs77702926	chr7:1088838	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.9	6.84E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7770535	chr6:97425095	GPR63	chr6:97245889-97285353:-	-0.26	-3.95	9.09E-5	Body mass index	
LUAD	cis	1	rs7770923	chr6:117726980	DCBLD1	chr6:117803820-117891018:+	0.17	3.77	0.00018	Lung cancer	
LUAD	cis	1	rs7771211	chr6:117727025	DCBLD1	chr6:117803820-117891018:+	0.18	3.93	9.54E-5	Lung cancer	
LUAD	cis	1	rs7771271	chr6:117727236	DCBLD1	chr6:117803820-117891018:+	0.18	3.93	9.54E-5	Lung cancer	
LUAD	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.62	-11.49	3.16E-27	Response to antipsychotic treatment	
LUAD	cis	1	rs7771437	chr6:117727313	DCBLD1	chr6:117803820-117891018:+	0.18	3.93	9.54E-5	Lung cancer	
LUAD	cis	1	rs7771637	chr6:117727491	DCBLD1	chr6:117803820-117891018:+	0.17	3.85	0.000134	Lung cancer	
LUAD	cis	1	rs7772046	chr6:117727485	DCBLD1	chr6:117803820-117891018:+	0.17	3.85	0.000134	Lung cancer	
LUAD	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.38	-10.33	9.13E-23	Homocysteine levels	
LUAD	cis	1	rs77760339	chr7:1083927	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.93	5.58E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7776244	chr6:117727949	DCBLD1	chr6:117803820-117891018:+	0.18	3.94	9.22E-5	Lung cancer	
LUAD	cis	1	rs77763497	chr20:3250007	ITPA	chr20:3190056-3204504:+	-0.23	-4.13	4.33E-5	IFN-related cytopenia	
LUAD	cis	1	rs7777389	chr7:143744802	ARHGEF35	chr7:143883677-143892736:-	-0.37	-6.78	3.52E-11	Obesity-related traits	
LUAD	cis	1	rs7777389	chr7:143744802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.27	-4.84	1.73E-6	Obesity-related traits	
LUAD	cis	1	rs7778277	chr7:128978805	LOC407835	chr7:128766325-128768041:+	0.23	3.67	0.000267	White matter hyperintensity burden	
LUAD	cis	1	rs77868187	chr7:1093968	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.78	1.34E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.15	-5.92	6.01E-9	Tuberculosis	
LUAD	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.57	10.46	3.07E-23	Tuberculosis	
LUAD	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.14	-5.9	6.71E-9	Tuberculosis	
LUAD	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.56	10.38	6.15E-23	Tuberculosis	
LUAD	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.15	-5.91	6.46E-9	Tuberculosis	
LUAD	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.56	10.41	4.51E-23	Tuberculosis	
LUAD	cis	1	rs7787818	chr7:134251597	AKR1B15	chr7:134233849-134264300:+	0.19	3.84	0.00014	Longevity	
LUAD	cis	1	rs77931721	chr2:203763076	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7798197	chr7:19037661	TWIST1	chr7:19155093-19157295:-	0.19	3.94	9.42E-5	Intracranial aneurysm	
LUAD	cis	1	rs78032828	chr2:86309032	LOC90784	chr2:86247339-86250991:-	-0.54	-4.82	1.96E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LUAD	cis	1	rs7804223	chr7:65664559	CCT6P1	chr7:65216092-65228661:+	-0.24	-3.84	0.000137	Diabetic kidney disease	
LUAD	cis	1	rs7806994	chr7:56139505	ZNF713	chr7:55955162-56008433:+	-0.29	-4.69	3.48E-6	PR interval in Tripanosoma cruzi seropositivity	
LUAD	cis	1	rs78075821	chr1:171724645	VAMP4	chr1:171669298-171711214:-	0.24	3.81	0.000159	Hippocampal atrophy	
LUAD	cis	1	rs7810543	chr7:110894778	IMMP2L	chr7:110303110-111202538:-	-0.2	-3.85	0.000135	Schizophrenia	
LUAD	cis	1	rs781149	chr7:65481284	CRCP	chr7:65579805-65619551:+	-0.32	-3.69	0.000254	Diabetic kidney disease	
LUAD	cis	1	rs781150	chr7:65480973	CCT6P1	chr7:65216092-65228661:+	0.23	3.68	0.000264	Diabetic kidney disease	
LUAD	cis	1	rs781156	chr7:65479141	CRCP	chr7:65579805-65619551:+	-0.32	-3.69	0.000254	Diabetic kidney disease	
LUAD	cis	1	rs781157	chr7:65478311	CRCP	chr7:65579805-65619551:+	-0.32	-3.69	0.000249	Diabetic kidney disease	
LUAD	cis	1	rs78133532	chr18:51794210	POLI	chr18:51795849-51824602:+	0.22	4.16	3.69E-5	Psoriasis	
LUAD	cis	1	rs78143408	chr7:1096846	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.73	1.73E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	0.35	6.21	1.11E-9	Heschl's gyrus morphology	
LUAD	cis	1	rs78158942	chr7:1090440	ZFAND2A	chr7:1192544-1199855:-	-0.37	-5.71	2.0E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs78172786	chr17:61847114	FTSJ3	chr17:61896795-61905031:-	0.22	4.45	1.05E-5	Body mass index	
LUAD	cis	1	rs78185558	chr7:1090183	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.4	1.02E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs78185801	chr7:1096367	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.75	1.61E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7820159	chr8:8576215	CLDN23	chr8:8559666-8561616:+	-0.31	-5.16	3.55E-7	Obesity-related traits	
LUAD	cis	1	rs78207779	chr14:35506387	KIAA0391	chr14:35591776-35786673:+	0.26	3.84	0.00014	Atopic dermatitis	
LUAD	cis	1	rs78207779	chr14:35506387	PPP2R3C	chr14:35554679-35591679:-	0.33	5.05	6.12E-7	Atopic dermatitis	
LUAD	cis	1	rs78213404	chr1:171685491	VAMP4	chr1:171669298-171711214:-	0.24	3.89	0.000114	Hippocampal atrophy	
LUAD	cis	1	rs7824557	chr8:11104111	TDH	chr8:11197146-11225961:+	0.21	4.08	5.27E-5	Retinal vascular caliber	
LUAD	cis	1	rs782590	chr2:55843413	PNPT1	chr2:55861198-55921011:-	-0.22	-5.38	1.18E-7	Metabolic syndrome	
LUAD	cis	1	rs782594	chr2:55844445	PNPT1	chr2:55861198-55921011:-	-0.22	-5.36	1.28E-7	Metabolic syndrome	
LUAD	cis	1	rs782876	chr7:134240770	AKR1B15	chr7:134233849-134264300:+	0.21	4.05	5.98E-5	Longevity	
LUAD	cis	1	rs78300366	chr11:71205514	NADSYN1	chr11:71164217-71212579:+	0.21	3.79	0.000171	Vitamin D levels	
LUAD	cis	1	rs78308415	chr7:1072634	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.87	7.85E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs78343340	chr4:267437	ZNF718	chr4:53272-156488:+	0.26	3.73	0.00021	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs783531	chr15:83249119	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.13	-4.01	6.92E-5	Schizophrenia	
LUAD	cis	1	rs783540	chr15:83254708	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.13	4.27	2.32E-5	Schizophrenia	
LUAD	cis	1	rs7841489	chr8:119758427	MAL2	chr8:120220610-120257911:+	-0.31	-3.7	0.000241	Pancreatitis	
LUAD	cis	1	rs78417837	chr18:70253402	CBLN2	chr18:70203915-70211723:-	0.49	4.42	1.22E-5	Airflow obstruction	
LUAD	cis	1	rs7843488	chr8:8576217	CLDN23	chr8:8559666-8561616:+	-0.31	-5.16	3.55E-7	Obesity-related traits	
LUAD	cis	1	rs7849160	chr9:131874552	CRAT	chr9:131857075-131873070:-	0.33	6.37	4.28E-10	Blood metabolite ratios	
LUAD	cis	1	rs7849160	chr9:131874552	PPP2R4	chr9:131873244-131911223:+	0.19	3.71	0.00023	Blood metabolite ratios	
LUAD	cis	1	rs7849270	chr9:131874641	CRAT	chr9:131857075-131873070:-	0.35	6.7	5.73E-11	Blood metabolite ratios	
LUAD	cis	1	rs7849270	chr9:131874641	PPP2R4	chr9:131873244-131911223:+	0.2	3.84	0.00014	Blood metabolite ratios	
LUAD	cis	1	rs78523927	chr7:1089458	ZFAND2A	chr7:1192544-1199855:-	-0.36	-5.4	1.03E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.51	2.85E-13	Body mass index	
LUAD	cis	1	rs785464	chr1:46523089	MUTYH	chr1:45794915-45806142:-	0.17	3.88	0.00012	Body mass index	
LUAD	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.41	-7.53	2.51E-13	Body mass index	
LUAD	cis	1	rs785471	chr1:46518677	MUTYH	chr1:45794915-45806142:-	0.17	3.89	0.000115	Body mass index	
LUAD	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.23	1.83E-12	Body mass index	
LUAD	cis	1	rs785479	chr1:46492144	MUTYH	chr1:45794915-45806142:-	0.17	3.9	0.000111	Body mass index	
LUAD	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.34	9.1E-13	Body mass index	
LUAD	cis	1	rs785481	chr1:46554518	MUTYH	chr1:45794915-45806142:-	0.17	3.87	0.000122	Body mass index	
LUAD	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.35	8.36E-13	Body mass index	
LUAD	cis	1	rs785485	chr1:46574424	MUTYH	chr1:45794915-45806142:-	0.16	3.78	0.000173	Body mass index	
LUAD	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.32	1.03E-12	Body mass index	
LUAD	cis	1	rs785488	chr1:46576095	MUTYH	chr1:45794915-45806142:-	0.17	3.88	0.000119	Body mass index	
LUAD	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.32	1.03E-12	Body mass index	
LUAD	cis	1	rs785489	chr1:46576390	MUTYH	chr1:45794915-45806142:-	0.17	3.88	0.000119	Body mass index	
LUAD	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.25	1.67E-12	Body mass index	
LUAD	cis	1	rs785491	chr1:46583418	MUTYH	chr1:45794915-45806142:-	0.16	3.83	0.000144	Body mass index	
LUAD	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.15	3.19E-12	Body mass index	
LUAD	cis	1	rs785492	chr1:46583607	MUTYH	chr1:45794915-45806142:-	0.16	3.81	0.000156	Body mass index	
LUAD	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.2	2.3E-12	Body mass index	
LUAD	cis	1	rs785494	chr1:46586626	MUTYH	chr1:45794915-45806142:-	0.17	3.87	0.000126	Body mass index	
LUAD	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.09	4.81E-12	Body mass index	
LUAD	cis	1	rs785495	chr1:46587887	MUTYH	chr1:45794915-45806142:-	0.17	3.99	7.61E-5	Body mass index	
LUAD	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.25	1.67E-12	Body mass index	
LUAD	cis	1	rs785503	chr1:46595868	MUTYH	chr1:45794915-45806142:-	0.16	3.83	0.000144	Body mass index	
LUAD	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.33	9.49E-13	Body mass index	
LUAD	cis	1	rs785520	chr1:46568836	MUTYH	chr1:45794915-45806142:-	0.17	3.87	0.000126	Body mass index	
LUAD	cis	1	rs7855278	chr9:131921365	CRAT	chr9:131857075-131873070:-	-0.37	-7.07	5.28E-12	Blood metabolite ratios	
LUAD	cis	1	rs7855278	chr9:131921365	PPP2R4	chr9:131873244-131911223:+	-0.28	-5.63	3.11E-8	Blood metabolite ratios	
LUAD	cis	1	rs7856353	chr9:20096454	KIAA1797	chr9:20658309-20995954:+	0.33	4.16	3.76E-5	Asthma (toluene diisocyanate-induced)	
LUAD	cis	1	rs78587942	chr16:68216739	ATP6V0D1	chr16:67471917-67515089:-	-0.42	-4.18	3.48E-5	Crohn's disease	
LUAD	cis	1	rs78587942	chr16:68216739	C16orf86	chr16:67700717-67702659:+	-0.36	-3.81	0.000159	Crohn's disease	
LUAD	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	0.36	6.36	4.75E-10	Heschl's gyrus morphology	
LUAD	cis	1	rs7861658	chr9:100679954	C9orf156	chr9:100666772-100684852:-	-0.2	-3.97	8.26E-5	Quantitative traits	
LUAD	cis	1	rs78628466	chr7:1068453	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.77	1.41E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs786425	chr12:124085502	ATP6V0A2	chr12:124196865-124246299:+	-0.29	-5.78	1.37E-8	Pubertal anthropometrics	
LUAD	cis	1	rs78679088	chr21:33910827	TCP10L	chr21:33947152-33957845:-	-0.25	-3.68	0.000257	Gastritis	
LUAD	cis	1	rs7868408	chr9:131917864	CRAT	chr9:131857075-131873070:-	0.33	6.33	5.58E-10	Blood metabolite ratios	
LUAD	cis	1	rs7868408	chr9:131917864	PPP2R4	chr9:131873244-131911223:+	0.19	3.69	0.000251	Blood metabolite ratios	
LUAD	cis	1	rs7869804	chr9:131913144	CRAT	chr9:131857075-131873070:-	0.33	6.28	7.28E-10	Blood metabolite ratios	
LUAD	cis	1	rs78861357	chr7:1095418	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.71	1.95E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs78896566	chr7:1080182	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.89	7.39E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs78907692	chr2:203932176	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.74	2.82E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7893480	chr10:124734829	C10orf88	chr10:124690419-124713919:-	-0.2	-4.14	4.13E-5	Migraine without aura	
LUAD	cis	1	rs78945802	chr6:111728346	KIAA1919	chr6:111580482-111590259:+	0.47	4.1	4.74E-5	Psoriasis	
LUAD	cis	1	rs78953187	chr1:93000574	EVI5	chr1:92974255-93257961:-	-0.26	-4.27	2.3E-5	Cholesterol, total	
LUAD	cis	1	rs7896033	chr10:124731507	C10orf88	chr10:124690419-124713919:-	-0.2	-4.07	5.42E-5	Migraine without aura	
LUAD	cis	1	rs78961715	chr16:68131407	ATP6V0D1	chr16:67471917-67515089:-	-0.38	-3.72	0.000227	Crohn's disease	
LUAD	cis	1	rs78961715	chr16:68131407	C16orf86	chr16:67700717-67702659:+	-0.37	-3.78	0.000173	Crohn's disease	
LUAD	cis	1	rs78967641	chr20:33783053	PROCR	chr20:33758727-33765164:+	-0.32	-3.96	8.72E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
LUAD	cis	1	rs78974622	chr22:38059925	LGALS2	chr22:37966254-37976024:-	0.18	4.14	4.08E-5	Fat distribution (HIV)	
LUAD	cis	1	rs7897778	chr10:75916105	ADK	chr10:75910965-76469059:+	0.26	4.05	6.08E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs78996483	chr6:55934556	COL21A1	chr6:55921389-56258892:-	-0.22	-3.67	0.000267	Psychosis (atypical)	
LUAD	cis	1	rs789970	chr10:105977721	C10orf79	chr10:105889647-105992120:-	0.11	3.67	0.00027	Attention deficit hyperactivity disorder	
LUAD	cis	1	rs7900134	chr10:124744123	C10orf88	chr10:124690419-124713919:-	-0.2	-4.16	3.83E-5	Migraine without aura	
LUAD	cis	1	rs7902253	chr10:124739748	C10orf88	chr10:124690419-124713919:-	-0.2	-4.18	3.39E-5	Migraine without aura	
LUAD	cis	1	rs7902273	chr10:124734824	C10orf88	chr10:124690419-124713919:-	-0.2	-4.14	4.13E-5	Migraine without aura	
LUAD	cis	1	rs7903456	chr10:88919319	FAM35A	chr10:88854953-88951220:+	-0.32	-6.43	3.0E-10	Renal underexcretion gout;Gout	
LUAD	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	0.37	6.38	4.12E-10	Heschl's gyrus morphology	
LUAD	cis	1	rs7905536	chr10:75997209	ADK	chr10:75910965-76469059:+	0.23	3.84	0.000139	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs7905961	chr10:102297391	SEC31B	chr10:102246403-102289636:-	-0.2	-6.37	4.34E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs7907801	chr10:75976638	ADK	chr10:75910965-76469059:+	0.24	3.79	0.000171	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs7909664	chr10:75869754	ADK	chr10:75910965-76469059:+	0.24	3.99	7.59E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs7909915	chr10:75960942	ADK	chr10:75910965-76469059:+	0.23	3.67	0.000269	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs79101914	chr12:56729739	STAT2	chr12:56735384-56753909:-	0.32	3.69	0.000247	Psoriasis vulgaris	
LUAD	cis	1	rs7910927	chr10:65138910	NRBF2	chr10:64893007-64914785:+	-0.22	-4.95	1.0E-6	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs7911712	chr10:45319654	ZNF22	chr10:45496273-45500776:+	0.25	3.76	0.00019	Emphysema-related traits	
LUAD	cis	1	rs7914110	chr10:126599886	UROS	chr10:127477148-127511837:-	0.3	4	7.3E-5	Height	
LUAD	cis	1	rs7917792	chr10:97365627	ENTPD1	chr10:97471536-97637022:+	0.19	5.03	7.07E-7	Blood metabolite levels	
LUAD	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.64	12.3	1.77E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.26	3.86	0.000128	Atopic dermatitis	
LUAD	cis	1	rs7921096	chr10:124731468	C10orf88	chr10:124690419-124713919:-	-0.2	-4.07	5.42E-5	Migraine without aura	
LUAD	cis	1	rs7923609	chr10:65133822	NRBF2	chr10:64893007-64914785:+	-0.23	-4.98	8.91E-7	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs7927771	chr11:47781306	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	5.1E-5	Subjective well-being	
LUAD	cis	1	rs7927771	chr11:47781306	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.46	1.03E-5	Subjective well-being	
LUAD	cis	1	rs7930454	chr11:73085034	RELT	chr11:73087405-73108518:+	0.21	3.72	0.00022	Pulmonary function (interaction)	
LUAD	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.37	-6.73	4.62E-11	Schizophrenia	
LUAD	cis	1	rs79327308	chr7:1108141	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.8	1.19E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs79327462	chr16:67958058	ATP6V0D1	chr16:67471917-67515089:-	-0.42	-4.17	3.65E-5	Crohn's disease	
LUAD	cis	1	rs79327462	chr16:67958058	C16orf86	chr16:67700717-67702659:+	-0.36	-3.73	0.000217	Crohn's disease	
LUAD	cis	1	rs79366248	chr4:266659	ZNF718	chr4:53272-156488:+	0.26	3.73	0.00021	Immune response to smallpox vaccine (IL-6)	
LUAD	cis	1	rs7940310	chr11:117024481	PCSK7	chr11:117075789-117102811:-	-0.26	-3.84	0.000137	Protein quantitative trait loci	
LUAD	cis	1	rs79412014	chr4:106755444	INTS12	chr4:106603787-106629881:-	-0.57	-5.9	6.95E-9	Post bronchodilator FEV1	
LUAD	cis	1	rs79422648	chr7:1080241	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.89	7.39E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7943121	chr11:18656062	SPTY2D1	chr11:18627949-18656020:-	-0.22	-4.89	1.34E-6	Cholesterol, total	
LUAD	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.26	3.86	0.000128	Atopic dermatitis	
LUAD	cis	1	rs7944004	chr11:2311152	C11orf21	chr11:2317507-2323143:-	0.2	5.79	1.23E-8	Chronic lymphocytic leukemia	
LUAD	cis	1	rs7944004	chr11:2311152	TSPAN32	chr11:2323243-2339430:+	0.14	4.2	3.21E-5	Chronic lymphocytic leukemia	
LUAD	cis	1	rs79443843	chr7:1075245	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.87	8.09E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.26	4.82	1.94E-6	Pancreatic cancer	
LUAD	cis	1	rs79475579	chr11:58295900	CNTF	chr11:58390146-58393203:+	0.33	4.5	8.39E-6	Lymphoma	
LUAD	cis	1	rs7947730	chr11:47786184	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	5.1E-5	Subjective well-being	
LUAD	cis	1	rs7947730	chr11:47786184	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.46	1.03E-5	Subjective well-being	
LUAD	cis	1	rs7953014	chr12:109998097	MYO1H	chr12:109826524-109886176:+	0.4	7.35	8.43E-13	HDL cholesterol	
LUAD	cis	1	rs79539678	chr2:203740938	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.77	2.44E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs7954144	chr12:110015893	MYO1H	chr12:109826524-109886176:+	0.39	7.19	2.39E-12	HDL cholesterol	
LUAD	cis	1	rs7954638	chr12:96314795	AMDHD1	chr12:96337071-96362369:+	0.34	6.43	3.02E-10	Metabolite levels (small molecules and protein measures)	
LUAD	cis	1	rs79571438	chr4:106616198	INTS12	chr4:106603787-106629881:-	-0.64	-6.32	5.78E-10	Post bronchodilator FEV1	
LUAD	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.76	7.74	5.93E-14	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs79617366	chr7:1111958	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.82	1.08E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs79633844	chr2:203683990	ALS2CR8	chr2:203776978-203851060:+	-0.24	-4.63	4.59E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.81	8.17	2.59E-15	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs79634040	chr11:71230169	NADSYN1	chr11:71164217-71212579:+	0.2	3.69	0.000254	Vitamin D levels	
LUAD	cis	1	rs7964021	chr12:109997645	MYO1H	chr12:109826524-109886176:+	0.4	7.35	8.43E-13	HDL cholesterol	
LUAD	cis	1	rs79642273	chr2:203830851	ALS2CR8	chr2:203776978-203851060:+	-0.23	-4.7	3.37E-6	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
LUAD	cis	1	rs79683221	chr7:1096139	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.75	1.61E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7969148	chr12:124614538	ATP6V0A2	chr12:124196865-124246299:+	0.22	3.8	0.000161	Clubfoot	
LUAD	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.29	4.46	1.02E-5	Atopic dermatitis	
LUAD	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.64	-14.13	2.84E-38	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs7973719	chr12:7334813	PEX5	chr12:7341759-7371167:+	0.26	4.84	1.75E-6	IgG glycosylation	
LUAD	cis	1	rs79765398	chr7:1073764	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.9	6.62E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs7978454	chr12:124316876	ATP6V0A2	chr12:124196865-124246299:+	0.19	3.83	0.000146	IgG glycosylation	
LUAD	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.36	-5.8	1.2E-8	Educational attainment;Height;Head circumference (infant)	
LUAD	cis	1	rs79824801	chr12:56728137	STAT2	chr12:56735384-56753909:-	0.32	3.69	0.000247	Psoriasis vulgaris	
LUAD	cis	1	rs79831012	chr10:102237059	SEC31B	chr10:102246403-102289636:-	-0.21	-6.9	1.58E-11	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs798719	chr4:1698183	FAM53A	chr4:1641609-1685854:-	-0.33	-5.74	1.63E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs798724	chr4:1704643	FAM53A	chr4:1641609-1685854:-	-0.34	-6.08	2.46E-9	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs798741	chr4:1712413	FAM53A	chr4:1641609-1685854:-	-0.34	-6.04	3.03E-9	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs798744	chr4:1714684	FAM53A	chr4:1641609-1685854:-	-0.32	-5.51	5.73E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs798754	chr4:1720757	FAM53A	chr4:1641609-1685854:-	-0.3	-5.39	1.08E-7	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs798755	chr4:1720824	FAM53A	chr4:1641609-1685854:-	-0.3	-5.48	6.86E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs798756	chr4:1707447	FAM53A	chr4:1641609-1685854:-	-0.32	-5.56	4.47E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs798762	chr4:1731150	FAM53A	chr4:1641609-1685854:-	-0.32	-5.62	3.16E-8	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs798766	chr4:1734239	FAM53A	chr4:1641609-1685854:-	0.3	5.17	3.38E-7	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs798767	chr4:1734281	FAM53A	chr4:1641609-1685854:-	-0.31	-5.38	1.16E-7	Urinary bladder cancer;Bladder cancer	
LUAD	cis	1	rs79888893	chr14:35510676	KIAA0391	chr14:35591776-35786673:+	0.26	3.8	0.00016	Atopic dermatitis	
LUAD	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.33	5.09	5.02E-7	Atopic dermatitis	
LUAD	cis	1	rs79919139	chr2:203247509	NOP58	chr2:203130515-203168382:+	0.26	4.09	5.09E-5	Urate levels	
LUAD	cis	1	rs7992980	chr13:33181142	CG030	chr13:33078645-33083532:-	-0.13	-4.24	2.68E-5	Body mass index	
LUAD	cis	1	rs79972507	chr16:68282777	ATP6V0D1	chr16:67471917-67515089:-	-0.39	-3.72	0.000224	Crohn's disease	
LUAD	cis	1	rs7997302	chr13:94035652	GPC6	chr13:93879078-95060267:+	-0.24	-3.88	0.00012	Neuroticism	
LUAD	cis	1	rs7999125	chr13:33145995	CG030	chr13:33078645-33083532:-	-0.12	-3.78	0.000174	Body mass index	
LUAD	cis	1	rs800142	chr11:2385071	C11orf21	chr11:2317507-2323143:-	-0.2	-4.59	5.69E-6	Bacteremia	
LUAD	cis	1	rs800153	chr11:2373515	C11orf21	chr11:2317507-2323143:-	-0.2	-4.51	8.07E-6	Bacteremia	
LUAD	cis	1	rs800156	chr11:2376436	C11orf21	chr11:2317507-2323143:-	-0.2	-4.44	1.09E-5	Bacteremia	
LUAD	cis	1	rs800157	chr11:2376602	C11orf21	chr11:2317507-2323143:-	-0.2	-4.52	7.67E-6	Bacteremia	
LUAD	cis	1	rs800158	chr11:2378447	C11orf21	chr11:2317507-2323143:-	0.21	4.59	5.58E-6	Bacteremia	
LUAD	cis	1	rs800160	chr11:2380134	C11orf21	chr11:2317507-2323143:-	0.18	4.22	2.89E-5	Bacteremia	
LUAD	cis	1	rs8002861	chr13:44474517	CCDC122	chr13:44410491-44453826:-	-0.28	-5.03	6.98E-7	Leprosy	
LUAD	cis	1	rs800292	chr1:196642233	CFHR1	chr1:196748292-196801316:+	0.22	3.84	0.000142	Circulating myeloperoxidase levels (serum)	
LUAD	cis	1	rs80031817	chr7:1096793	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.73	1.73E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs8003506	chr14:75586288	EIF2B2	chr14:75469612-75476292:+	-0.22	-4.06	5.8E-5	Height	
LUAD	cis	1	rs8003506	chr14:75586288	MLH3	chr14:75480467-75518235:-	-0.29	-5.53	5.11E-8	Height	
LUAD	cis	1	rs8006419	chr14:65500735	CHURC1	chr14:65381140-65411309:+	-0.34	-7.34	8.93E-13	Red blood cell traits	
LUAD	cis	1	rs80076579	chr4:106991115	TBCK	chr4:106967233-107237861:-	0.26	4.87	1.5E-6	Airflow obstruction	
LUAD	cis	1	rs80085676	chr2:242347907	SEPT2	chr2:242254723-242293439:+	0.59	6.79	3.17E-11	Chronic lymphocytic leukemia	
LUAD	cis	1	rs80094748	chr7:1103958	ZFAND2A	chr7:1192544-1199855:-	-0.39	-5.82	1.09E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.43	-10.11	6.09E-22	IgG glycosylation	
LUAD	cis	1	rs80123796	chr3:184739700	C3orf70	chr3:184795840-184870802:-	-0.31	-3.96	8.53E-5	Heschl's gyrus morphology	
LUAD	cis	1	rs8013540	chr14:35513760	KIAA0391	chr14:35591776-35786673:+	0.25	3.75	0.000198	Atopic dermatitis	
LUAD	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.32	4.89	1.39E-6	Atopic dermatitis	
LUAD	cis	1	rs8017642	chr14:75590822	EIF2B2	chr14:75469612-75476292:+	0.22	4.11	4.66E-5	Height	
LUAD	cis	1	rs8017642	chr14:75590822	MLH3	chr14:75480467-75518235:-	0.27	5.15	3.84E-7	Height	
LUAD	cis	1	rs8018967	chr14:73976934	HEATR4	chr14:73945193-74025651:-	-0.37	-6.44	2.79E-10	Blood metabolite ratios	
LUAD	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.77	7.95	1.32E-14	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs80212261	chr7:1114012	ZFAND2A	chr7:1192544-1199855:-	-0.38	-5.63	3.02E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs8021692	chr14:104428576	TDRD9	chr14:104394817-104519002:+	0.3	4.46	1.01E-5	Bipolar disorder	
LUAD	cis	1	rs80245547	chr4:106628955	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.68E-11	Post bronchodilator FEV1	
LUAD	cis	1	rs8028182	chr15:75718669	SNUPN	chr15:75890426-75918719:-	0.28	5.22	2.6E-7	Sudden cardiac arrest	
LUAD	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.77	7.75	5.34E-14	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
LUAD	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.67	-13.62	4.68E-36	Type 2 diabetes	
LUAD	cis	1	rs80317430	chr12:56727705	STAT2	chr12:56735384-56753909:-	0.32	3.69	0.000247	Psoriasis vulgaris	
LUAD	cis	1	rs8031915	chr15:91519291	UNC45A	chr15:91473410-91497322:+	0.19	3.78	0.000177	Type 2 diabetes	
LUAD	cis	1	rs8032104	chr15:63400584	LACTB	chr15:63414032-63434254:+	0.22	4.15	3.84E-5	HDL cholesterol	
LUAD	cis	1	rs8033360	chr15:101778710	LINS1	chr15:101109436-101142404:-	0.19	3.7	0.000239	Corneal structure	
LUAD	cis	1	rs8033837	chr15:75353975	SCAMP5	chr15:75287901-75313836:+	0.37	6.49	2.09E-10	Blood trace element (Zn levels)	
LUAD	cis	1	rs8033938	chr15:40703114	C15orf23	chr15:40674922-40686488:+	0.39	6.7	5.74E-11	Heschl's gyrus morphology	
LUAD	cis	1	rs8034191	chr15:78806023	AGPHD1	chr15:78799906-78829714:+	-0.18	-3.73	0.000213	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
LUAD	cis	1	rs8036197	chr15:75370232	SCAMP5	chr15:75287901-75313836:+	0.34	6.04	3.08E-9	Blood trace element (Zn levels)	
LUAD	cis	1	rs803688	chr15:83216793	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.13	-4	7.21E-5	Schizophrenia	
LUAD	cis	1	rs8037254	chr15:91520099	UNC45A	chr15:91473410-91497322:+	0.2	3.88	0.00012	Type 2 diabetes	
LUAD	cis	1	rs8045022	chr16:68807087	NFATC3	chr16:68118654-68260837:+	-0.16	-3.68	0.000264	Colorectal cancer	
LUAD	cis	1	rs8047014	chr16:69135049	TMED6	chr16:69377160-69385689:-	-0.17	-3.99	7.7E-5	Attention deficit hyperactivity disorder	
LUAD	cis	1	rs8049439	chr16:28837515	EIF3CL	chr16:28699879-28747052:+;chr16	0.24	4.5	8.32E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
LUAD	cis	1	rs8049439	chr16:28837515	TUFM	chr16:28853732-28857729:-	0.19	4.25	2.55E-5	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
LUAD	cis	1	rs8049622	chr16:67800927	ATP6V0D1	chr16:67471917-67515089:-	-0.36	-4.24	2.71E-5	Crohn's disease	
LUAD	cis	1	rs8051653	chr16:67848515	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-4.17	3.63E-5	Crohn's disease	
LUAD	cis	1	rs8054034	chr16:67773652	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-4.06	5.79E-5	Crohn's disease	
LUAD	cis	1	rs8054034	chr16:67773652	HSD11B2	chr16:67465036-67471452:+	-0.41	-3.93	9.67E-5	Crohn's disease	
LUAD	cis	1	rs8056538	chr16:68802282	NFATC3	chr16:68118654-68260837:+	-0.16	-3.68	0.000263	Colorectal cancer	
LUAD	cis	1	rs8058835	chr16:67814865	ATP6V0D1	chr16:67471917-67515089:-	-0.37	-4.34	1.73E-5	Crohn's disease	
LUAD	cis	1	rs8061384	chr16:67911874	ATP6V0D1	chr16:67471917-67515089:-	-0.38	-4.44	1.09E-5	Crohn's disease	
LUAD	cis	1	rs806216	chr7:127237862	LRRC4	chr7:127667126-127671002:-	-0.25	-4.05	5.96E-5	Type 2 diabetes	
LUAD	cis	1	rs8062783	chr16:74691264	RFWD3	chr16:74655298-74700779:-	0.26	6.13	1.77E-9	Testicular germ cell tumor	
LUAD	cis	1	rs8064261	chr17:61705212	FTSJ3	chr17:61896795-61905031:-	0.24	4.95	1.03E-6	Body mass index	
LUAD	cis	1	rs8065059	chr17:28417376	EFCAB5	chr17:28256874-28435469:+	-0.34	-6.05	2.88E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs8065059	chr17:28417376	SSH2	chr17:27952965-28257018:-	-0.16	-4.07	5.44E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs8065261	chr17:28418041	EFCAB5	chr17:28256874-28435469:+	-0.34	-6.06	2.66E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs8065261	chr17:28418041	SSH2	chr17:27952965-28257018:-	-0.16	-4.07	5.41E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.33	6.78	3.45E-11	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs8065669	chr17:45724996	C17orf57	chr17:45401142-45518675:+	0.33	6.62	9.49E-11	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs8066385	chr17:18761133	FBXW10	chr17:18647326-18682661:+	-0.22	-4.47	9.92E-6	Educational attainment (years of education)	
LUAD	cis	1	rs8066719	chr17:61825764	FTSJ3	chr17:61896795-61905031:-	0.22	4.66	4.16E-6	Body mass index	
LUAD	cis	1	rs8067064	chr17:61825984	FTSJ3	chr17:61896795-61905031:-	0.22	4.67	3.93E-6	Body mass index	
LUAD	cis	1	rs8067431	chr17:61817048	FTSJ3	chr17:61896795-61905031:-	0.23	4.66	4.01E-6	Body mass index	
LUAD	cis	1	rs8067892	chr17:65837983	LOC440461	chr17:66194801-66196436:+	0.22	3.7	0.000243	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs8068603	chr17:61755211	FTSJ3	chr17:61896795-61905031:-	0.19	3.96	8.49E-5	Body mass index	
LUAD	cis	1	rs8069687	chr17:61883023	FTSJ3	chr17:61896795-61905031:-	-0.22	-4.53	7.3E-6	Body mass index	
LUAD	cis	1	rs8070446	chr17:40285879	DHX58	chr17:40253422-40264751:-	-0.28	-5.28	1.94E-7	Fibrinogen levels	
LUAD	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.63	-12.5	2.68E-31	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs8070650	chr17:61744040	FTSJ3	chr17:61896795-61905031:-	0.22	4.53	7.39E-6	Body mass index	
LUAD	cis	1	rs8071463	chr17:65938655	LOC440461	chr17:66194801-66196436:+	-0.23	-3.72	0.000224	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs8071789	chr17:38006333	GSDMA	chr17:38119226-38134019:+	0.25	4.43	1.17E-5	Selective IgA deficiency	
LUAD	cis	1	rs8071789	chr17:38006333	GSDMB	chr17:38060850-38074903:-	-0.22	-5.36	1.29E-7	Selective IgA deficiency	
LUAD	cis	1	rs8071789	chr17:38006333	PGAP3	chr17:37827376-37844310:-	-0.16	-3.78	0.000179	Selective IgA deficiency	
LUAD	cis	1	rs8071789	chr17:38006333	ZPBP2	chr17:38024455-38034144:+	0.21	4.17	3.63E-5	Selective IgA deficiency	
LUAD	cis	1	rs8072100	chr17:45674687	C17orf57	chr17:45401142-45518675:+	-0.31	-6.34	5.35E-10	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LUAD	cis	1	rs8074708	chr17:40286354	DHX58	chr17:40253422-40264751:-	0.3	5.57	4.22E-8	Fibrinogen levels	
LUAD	cis	1	rs8074771	chr17:61735865	FTSJ3	chr17:61896795-61905031:-	0.22	4.53	7.39E-6	Body mass index	
LUAD	cis	1	rs8075061	chr17:61804723	FTSJ3	chr17:61896795-61905031:-	0.23	4.8	2.12E-6	Body mass index	
LUAD	cis	1	rs8075257	chr17:61728750	FTSJ3	chr17:61896795-61905031:-	0.2	4.26	2.4E-5	Body mass index	
LUAD	cis	1	rs8075422	chr17:61804686	FTSJ3	chr17:61896795-61905031:-	0.21	4.46	1.01E-5	Body mass index	
LUAD	cis	1	rs8075521	chr17:61804954	FTSJ3	chr17:61896795-61905031:-	0.23	4.8	2.12E-6	Body mass index	
LUAD	cis	1	rs807624	chr2:15782471	DDX1	chr2:15731770-15771224:+	0.23	4.63	4.76E-6	Wilms tumor	
LUAD	cis	1	rs8076336	chr17:18212614	EVPLL	chr17:18281079-18292958:+	0.16	3.78	0.000179	Parental longevity (combined parental age at death)	
LUAD	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.38	-7.37	7.43E-13	Metabolite levels	
LUAD	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.31	-6.31	6.42E-10	Metabolite levels	
LUAD	cis	1	rs8076717	chr17:61850301	FTSJ3	chr17:61896795-61905031:-	-0.21	-4.33	1.84E-5	Body mass index	
LUAD	cis	1	rs8077577	chr17:18064730	MYO15A	chr17:18012020-18083115:+	0.26	4.84	1.71E-6	Obesity-related traits	
LUAD	cis	1	rs8077577	chr17:18064730	TOP3A	chr17:18177235-18218321:-	0.21	3.74	0.000207	Obesity-related traits	
LUAD	cis	1	rs8078462	chr17:61857937	FTSJ3	chr17:61896795-61905031:-	0.23	4.78	2.37E-6	Body mass index	
LUAD	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.63	-12.53	2.03E-31	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LUAD	cis	1	rs8078862	chr17:61854068	FTSJ3	chr17:61896795-61905031:-	0.23	4.8	2.15E-6	Body mass index	
LUAD	cis	1	rs8080211	chr17:61729882	FTSJ3	chr17:61896795-61905031:-	0.22	4.41	1.29E-5	Body mass index	
LUAD	cis	1	rs8081541	chr17:61812483	FTSJ3	chr17:61896795-61905031:-	0.22	4.75	2.68E-6	Body mass index	
LUAD	cis	1	rs8081612	chr17:61724695	FTSJ3	chr17:61896795-61905031:-	-0.18	-3.95	8.94E-5	Body mass index	
LUAD	cis	1	rs8082512	chr17:65837059	LOC440461	chr17:66194801-66196436:+	0.25	4.04	6.11E-5	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma	
LUAD	cis	1	rs8093534	chr18:48368020	MRO	chr18:48321491-48351754:-	0.36	5.85	9.01E-9	Entorhinal cortical thickness	
LUAD	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.33	9.73E-13	Body mass index	
LUAD	cis	1	rs809775	chr1:46538040	MUTYH	chr1:45794915-45806142:-	0.17	3.88	0.000117	Body mass index	
LUAD	cis	1	rs8098064	chr18:8209269	ANKRD12	chr18:9136758-9285206:+	0.35	4.05	6.04E-5	Dialysis-related mortality	
LUAD	cis	1	rs8100392	chr19:33605933	GPATCH1	chr19:33571786-33621318:+	0.23	4.35	1.69E-5	Bone properties (heel)	
LUAD	cis	1	rs8100392	chr19:33605933	RHPN2	chr19:33469499-33555824:-	-0.2	-4.12	4.4E-5	Bone properties (heel)	
LUAD	cis	1	rs8101881	chr19:33364628	SLC7A9	chr19:33321421-33360683:-	-0.19	-4.05	5.87E-5	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
LUAD	cis	1	rs8110011	chr19:37745813	ZNF585B	chr19:37675724-37701451:-	0.25	3.69	0.000249	Coronary artery calcification	
LUAD	cis	1	rs8110181	chr19:33605939	GPATCH1	chr19:33571786-33621318:+	0.23	4.35	1.69E-5	Bone properties (heel)	
LUAD	cis	1	rs8110181	chr19:33605939	RHPN2	chr19:33469499-33555824:-	-0.2	-4.12	4.4E-5	Bone properties (heel)	
LUAD	cis	1	rs8110727	chr19:24230916	LOC100101266	chr19:24344995-24346249:-	0.26	3.88	0.000118	Response to taxane treatment (placlitaxel)	
LUAD	cis	1	rs8114671	chr20:33789142	PROCR	chr20:33758727-33765164:+	0.21	4.36	1.55E-5	Height	
LUAD	cis	1	rs8123289	chr20:3253831	ITPA	chr20:3190056-3204504:+	-0.24	-4.19	3.24E-5	IFN-related cytopenia	
LUAD	cis	1	rs8125868	chr20:25324410	FAM182A	chr20:26035250-26067552:+	0.18	3.75	0.000195	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs8135828	chr22:29929239	NIPSNAP1	chr22:29950800-29977144:-	-0.27	-4.28	2.27E-5	Lipid traits	
LUAD	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.45	7.93	1.47E-14	Multiple sclerosis	
LUAD	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.25	-5.08	5.48E-7	Multiple sclerosis	
LUAD	cis	1	rs823144	chr1:205744546	PM20D1	chr1:205797154-205819245:-	-0.29	-5.19	3.1E-7	Parkinson's disease	
LUAD	cis	1	rs823156	chr1:205764640	PM20D1	chr1:205797154-205819245:-	-0.32	-5.16	3.53E-7	Parkinson's disease	
LUAD	cis	1	rs823302	chr3:195104741	C3orf21	chr3:194789015-194991895:-	-0.16	-3.96	8.76E-5	Body mass index	
LUAD	cis	1	rs8255	chr10:75879750	ADK	chr10:75910965-76469059:+	0.25	4.06	5.8E-5	Soluble interleukin-2 receptor subunit alpha	
LUAD	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.8	14.27	7.11E-39	Type 2 diabetes	
LUAD	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.81	14.39	2.12E-39	Type 2 diabetes	
LUAD	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.8	14.6	2.41E-40	Type 2 diabetes	
LUAD	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.8	14.1	4.18E-38	Type 2 diabetes	
LUAD	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.8	14.1	4.18E-38	Type 2 diabetes	
LUAD	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.8	14.1	4.18E-38	Type 2 diabetes	
LUAD	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.79	13.99	1.24E-37	Type 2 diabetes	
LUAD	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.79	13.8	7.72E-37	Type 2 diabetes	
LUAD	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.8	14.27	7.11E-39	Type 2 diabetes	
LUAD	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.81	-14.52	5.88E-40	Type 2 diabetes	
LUAD	cis	1	rs842361	chr2:135340840	TMEM163	chr2:135213331-135525334:-	-0.2	-4.86	1.58E-6	Neuroticism	
LUAD	cis	1	rs848512	chr2:36675530	PRKD3	chr2:37477648-37544222:-	-0.21	-4.07	5.37E-5	IgE levels in asthmatics	
LUAD	cis	1	rs848513	chr2:36674996	PRKD3	chr2:37477648-37544222:-	-0.23	-4.47	9.85E-6	IgE levels in asthmatics	
LUAD	cis	1	rs848514	chr2:36674827	PRKD3	chr2:37477648-37544222:-	-0.21	-4.22	2.91E-5	IgE levels in asthmatics	
LUAD	cis	1	rs854572	chr7:94954696	PON1	chr7:94927671-95025687:-	0.2	3.68	0.00026	Paraoxonase activity	
LUAD	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.38	-10.47	2.84E-23	Homocysteine levels	
LUAD	cis	1	rs859767	chr2:135341200	TMEM163	chr2:135213331-135525334:-	-0.19	-4.71	3.18E-6	Neuroticism	
LUAD	cis	1	rs859767	chr2:135341200	ZRANB3	chr2:135957576-136288806:-	-0.18	-3.85	0.000133	Neuroticism	
LUAD	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.81	-14.8	3.28E-41	Type 2 diabetes	
LUAD	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.8	14.27	7.11E-39	Type 2 diabetes	
LUAD	cis	1	rs863352	chr1:158539006	MNDA	chr1:158801168-158819270:+	0.09	3.67	0.000271	Pneumococcal bacteremia	
LUAD	cis	1	rs863353	chr1:158541270	MNDA	chr1:158801168-158819270:+	0.09	3.72	0.000218	Pneumococcal bacteremia	
LUAD	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.79	14.01	1.02E-37	Type 2 diabetes	
LUAD	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.8	14.27	7.11E-39	Type 2 diabetes	
LUAD	cis	1	rs868213	chr16:67220457	DPEP2	chr16:68021295-68034489:-	0.19	4.08	5.22E-5	HDL cholesterol	
LUAD	cis	1	rs868213	chr16:67220457	LRRC29	chr16:67241043-67260901:-	-0.24	-3.96	8.61E-5	HDL cholesterol	
LUAD	cis	1	rs868530	chr5:156430916	TIMD4	chr5:156346293-156390266:-	-0.24	-4.34	1.72E-5	Hypertriglyceridemia	
LUAD	cis	1	rs870355	chr17:76166196	SYNGR2	chr17:76164671-76169009:+	0.17	4.03	6.39E-5	Adenocarcinoma;Lung cancer	
LUAD	cis	1	rs873063	chr8:8572447	CLDN23	chr8:8559666-8561616:+	-0.33	-5.52	5.53E-8	Obesity-related traits	
LUAD	cis	1	rs873064	chr8:8572380	CLDN23	chr8:8559666-8561616:+	-0.33	-5.52	5.53E-8	Obesity-related traits	
LUAD	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.38	10.52	1.88E-23	Kawasaki disease	
LUAD	cis	1	rs8758	chr10:97366107	ENTPD1	chr10:97471536-97637022:+	0.19	5.06	5.81E-7	Blood metabolite levels	
LUAD	cis	1	rs876402	chr14:75601862	EIF2B2	chr14:75469612-75476292:+	-0.22	-4.21	3.05E-5	Height	
LUAD	cis	1	rs876402	chr14:75601862	MLH3	chr14:75480467-75518235:-	-0.3	-5.79	1.26E-8	Height	
LUAD	cis	1	rs876403	chr14:75602834	EIF2B2	chr14:75469612-75476292:+	0.2	3.84	0.000137	Height	
LUAD	cis	1	rs876403	chr14:75602834	MLH3	chr14:75480467-75518235:-	0.28	5.34	1.45E-7	Height	
LUAD	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.64	-15.61	7.29E-45	Cognitive function	
LUAD	cis	1	rs877674	chr1:32242206	COL16A1	chr1:32117848-32169768:-	-0.21	-4.09	5.12E-5	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs877710	chr12:109993976	MYO1H	chr12:109826524-109886176:+	0.38	7	8.48E-12	HDL cholesterol	
LUAD	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.33	-6.68	6.38E-11	Rheumatoid arthritis	
LUAD	cis	1	rs881827	chr21:48019868	C21orf56	chr21:47581063-47604373:-	-0.28	-5.15	3.7E-7	Lymphocyte counts	
LUAD	cis	1	rs882367	chr17:59494574	TBX2	chr17:59477257-59486825:+	0.13	3.7	0.000244	Sitting height ratio	
LUAD	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.79	-16.21	1.37E-47	Homocysteine levels	
LUAD	cis	1	rs882803	chr1:45976147	MUTYH	chr1:45794915-45806142:-	0.18	3.91	0.000105	Homocysteine levels	
LUAD	cis	1	rs883394	chr19:39205613	LGALS7	chr19:39261608-39264157:-	-0.2	-3.78	0.000173	Heart rate	
LUAD	cis	1	rs883433	chr19:39206288	LGALS7	chr19:39261608-39264157:-	0.19	3.8	0.00016	Heart rate	
LUAD	cis	1	rs883565	chr3:39055317	TTC21A	chr3:39149152-39180394:+	0.18	4.63	4.62E-6	Handedness	
LUAD	cis	1	rs883648	chr8:8569521	CLDN23	chr8:8559666-8561616:+	-0.34	-5.78	1.31E-8	Obesity-related traits	
LUAD	cis	1	rs884613	chr20:25288505	FAM182A	chr20:26035250-26067552:+	0.19	3.87	0.000126	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.64	-11.97	3.87E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs884977	chr7:1066410	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.49	6.35E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
LUAD	cis	1	rs885000	chr8:8568875	CLDN23	chr8:8559666-8561616:+	-0.35	-5.83	9.91E-9	Obesity-related traits	
LUAD	cis	1	rs886448	chr7:24240165	C7orf30	chr7:23338940-23349182:+	-0.47	-4.87	1.48E-6	Asthma (childhood onset)	
LUAD	cis	1	rs886448	chr7:24240165	CYCS	chr7:25158277-25164955:-	-0.36	-4.03	6.52E-5	Asthma (childhood onset)	
LUAD	cis	1	rs886448	chr7:24240165	STK31	chr7:23749838-23944365:+	-0.44	-3.88	0.000117	Asthma (childhood onset)	
LUAD	cis	1	rs886448	chr7:24240165	TRA2A	chr7:23544402-23571656:-	-0.42	-4.23	2.79E-5	Asthma (childhood onset)	
LUAD	cis	1	rs888192	chr12:109995097	MYO1H	chr12:109826524-109886176:+	-0.38	-7.07	5.53E-12	HDL cholesterol	
LUAD	cis	1	rs889312	chr5:56031884	C5orf35	chr5:56205103-56213010:+	0.36	6.55	1.44E-10	Breast cancer (early onset);Breast cancer	
LUAD	cis	1	rs889398	chr16:69556715	CLEC18A	chr16:69984626-69997887:+	0.17	3.86	0.00013	Body mass index	
LUAD	cis	1	rs889399	chr16:69556583	CLEC18A	chr16:69984626-69997887:+	0.17	3.78	0.000175	Body mass index	
LUAD	cis	1	rs889877	chr7:134232615	AKR1B15	chr7:134233849-134264300:+	0.21	4.09	5.1E-5	Longevity	
LUAD	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.2	-4	7.31E-5	Height	
LUAD	cis	1	rs892974	chr3:49398514	CCDC36	chr3:49235861-49295537:+	0.21	3.74	0.000208	Menarche (age at onset)	
LUAD	cis	1	rs893363	chr3:53847062	ACTR8	chr3:53901156-53916187:-	-0.2	-3.68	0.000258	Axial length	
LUAD	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.26	6.21	1.13E-9	Longevity	
LUAD	cis	1	rs902774	chr12:53273904	TENC1	chr12:53440810-53458160:+	0.2	4.2	3.22E-5	Prostate cancer	
LUAD	cis	1	rs904095	chr4:100263383	ADH1C	chr4:100257651-100273917:-	-0.19	-3.74	0.000207	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs904096	chr4:100263584	ADH1C	chr4:100257651-100273917:-	-0.19	-3.74	0.000207	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs906134	chr7:65444288	CCT6P1	chr7:65216092-65228661:+	0.24	3.75	0.000196	Diabetic kidney disease	
LUAD	cis	1	rs910316	chr14:75626042	MLH3	chr14:75480467-75518235:-	0.25	4.85	1.67E-6	Height	
LUAD	cis	1	rs910997	chr20:25267301	FAM182A	chr20:26035250-26067552:+	-0.18	-3.7	0.00024	Liver enzyme levels (alkaline phosphatase)	
LUAD	cis	1	rs914187	chr21:42619749	BACE2	chr21:42539728-42648523:+	-0.23	-4.93	1.12E-6	Body mass index	
LUAD	cis	1	rs916134	chr12:54069803	ATP5G2	chr12:54058945-54070512:-	0.28	6.09	2.29E-9	Height	
LUAD	cis	1	rs916926	chr17:39030283	TMEM99	chr17:38975374-38992526:+	0.2	3.86	0.000131	Height	
LUAD	cis	1	rs9174	chr4:25419283	ANAPC4	chr4:25378848-25420119:+	-0.18	-3.71	0.000229	Rheumatoid arthritis	
LUAD	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.17	4.73	2.96E-6	Type 1 diabetes	
LUAD	cis	1	rs917911	chr12:9905851	KLRF1	chr12:9980077-9997601:+	0.25	4.03	6.47E-5	Type 1 diabetes	
LUAD	cis	1	rs918814	chr2:23948466	C2orf84	chr2:24397531-24414566:+	-0.22	-3.94	9.21E-5	Obesity-related traits	
LUAD	cis	1	rs918814	chr2:23948466	LOC375190	chr2:24299728-24397519:+	0.21	4.03	6.57E-5	Obesity-related traits	
LUAD	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.62	-13.51	1.43E-35	Spherical equivalent (joint main effects and education interaction)	
LUAD	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.28	7.02	7.67E-12	Longevity	
LUAD	cis	1	rs923372	chr4:48410454	NIPAL1	chr4:48018791-48039078:+	0.19	3.87	0.000125	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs925410	chr2:160912652	LY75	chr2:160625141-160761262:-	-0.2	-4.52	7.64E-6	Idiopathic membranous nephropathy	
LUAD	cis	1	rs925532	chr1:202533880	PPP1R12B	chr1:202317836-202557697:+	0.21	4.49	8.7E-6	Sex ratio	
LUAD	cis	1	rs925533	chr1:202534108	PPP1R12B	chr1:202317836-202557697:+	0.21	4.56	6.55E-6	Sex ratio	
LUAD	cis	1	rs9282650	chr16:68809640	NFATC3	chr16:68118654-68260837:+	-0.16	-3.68	0.000264	Colorectal cancer	
LUAD	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.79	14.06	5.77E-38	Type 2 diabetes	
LUAD	cis	1	rs9288316	chr2:202163483	ALS2CR12	chr2:202153148-202222101:-	0.18	4.73	2.93E-6	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs9288316	chr2:202163483	CASP8	chr2:202098166-202152434:+	-0.23	-4.86	1.55E-6	Melanoma;Esophageal squamous cell carcinoma	
LUAD	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.36	5.54	4.83E-8	Blood pressure (smoking interaction)	
LUAD	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.51	10	1.54E-21	Height	
LUAD	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.52	10.08	7.5E-22	Height	
LUAD	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.51	9.94	2.51E-21	Height	
LUAD	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.52	10.16	3.9E-22	Height	
LUAD	cis	1	rs929039	chr22:38071511	LGALS2	chr22:37966254-37976024:-	0.17	4.08	5.23E-5	Fat distribution (HIV)	
LUAD	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.35	-8.07	5.56E-15	Plasma homocysteine levels (post-methionine load test)	
LUAD	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.76	16.97	4.0E-51	Plasma homocysteine levels (post-methionine load test)	
LUAD	cis	1	rs9296504	chr6:46629505	CYP39A1	chr6:46517445-46620523:-	0.18	3.68	0.000259	QRS complex (Sokolow-Lyon)	
LUAD	cis	1	rs9296504	chr6:46629505	SLC25A27	chr6:46620679-46645925:+	0.18	5.29	1.85E-7	QRS complex (Sokolow-Lyon)	
LUAD	cis	1	rs9296505	chr6:46629841	SLC25A27	chr6:46620679-46645925:+	0.19	5.47	7.21E-8	QRS complex (Sokolow-Lyon)	
LUAD	cis	1	rs9296616	chr6:49414235	CENPQ	chr6:49431096-49460820:+	-0.27	-6.63	8.74E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.33	6.73	4.89E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.28	-7.08	4.93E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.33	6.89	1.69E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs929843	chr16:70045748	CLEC18A	chr16:69984626-69997887:+	-0.41	-7.63	1.23E-13	Menarche (age at onset)	
LUAD	cis	1	rs929843	chr16:70045748	EXOSC6	chr16:70284134-70285833:-	-0.3	-4.49	8.96E-6	Menarche (age at onset)	
LUAD	cis	1	rs929843	chr16:70045748	PDXDC2	chr16:70010210-70099851:-	-0.18	-5.26	2.11E-7	Menarche (age at onset)	
LUAD	cis	1	rs9299335	chr9:102691446	STX17	chr9:102668915-102736817:+	-0.18	-3.9	0.000108	Alopecia areata	
LUAD	cis	1	rs9303401	chr17:56847945	RAD51C	chr17:56769963-56811690:+	0.22	4.62	4.84E-6	Cognitive test performance	
LUAD	cis	1	rs9304742	chr19:53451291	ZNF321	chr19:53430388-53466114:-	0.17	3.73	0.000211	Psoriasis	
LUAD	cis	1	rs9304742	chr19:53451291	ZNF702P	chr19:53471505-53496784:-	0.21	3.94	9.37E-5	Psoriasis	
LUAD	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.36	-7.19	2.42E-12	Longevity	
LUAD	cis	1	rs930734	chr1:202318316	PPP1R12B	chr1:202317836-202557697:+	-0.2	-4.44	1.14E-5	Sex ratio	
LUAD	cis	1	rs9309331	chr2:61141615	C2orf74	chr2:61372243-61391964:+	0.37	5.86	8.31E-9	Inflammatory skin disease	
LUAD	cis	1	rs9309473	chr2:73743982	ALMS1	chr2:73612886-73837046:+	0.19	4.46	1.01E-5	Metabolite levels	
LUAD	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.39	7.49	3.16E-13	Metabolite levels	
LUAD	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.38	4.13	4.18E-5	Crohn's disease	
LUAD	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.27	-6.54	1.57E-10	Longevity	
LUAD	cis	1	rs9313617	chr5:156933458	ADAM19	chr5:156822542-157002768:-	0.14	4.24	2.65E-5	Pulmonary function;Pulmonary function (interaction)	
LUAD	cis	1	rs9318086	chr13:24432467	PCOTH	chr13:24463028-24466241:+	0.35	7	8.39E-12	Myopia (pathological)	
LUAD	cis	1	rs9320287	chr6:109744690	AKD1	chr6:109814059-110012415:-	-0.2	-3.92	0.000101	Height	
LUAD	cis	1	rs9320287	chr6:109744690	SMPD2	chr6:109761931-109765121:+	0.22	4.28	2.21E-5	Height	
LUAD	cis	1	rs9322193	chr6:149919143	C6orf72	chr6:149887528-149912067:+	-0.18	-4.2	3.16E-5	Lung cancer	
LUAD	cis	1	rs9322193	chr6:149919143	NUP43	chr6:150045453-150067688:-	-0.25	-5.06	6.04E-7	Lung cancer	
LUAD	cis	1	rs9324660	chr5:150257054	LOC134466	chr5:150310000-150326146:-	0.31	4.03	6.57E-5	Crohn's disease	
LUAD	cis	1	rs9326244	chr11:114390106	FAM55D	chr11:114441314-114466484:-	0.29	4.2	3.12E-5	IgG glycosylation	
LUAD	cis	1	rs932833	chr9:131884041	CRAT	chr9:131857075-131873070:-	0.32	6.13	1.85E-9	Blood metabolite ratios	
LUAD	cis	1	rs932835	chr9:131887071	CRAT	chr9:131857075-131873070:-	0.35	6.63	9.12E-11	Blood metabolite ratios	
LUAD	cis	1	rs932835	chr9:131887071	PPP2R4	chr9:131873244-131911223:+	0.22	4.25	2.56E-5	Blood metabolite ratios	
LUAD	cis	1	rs9329165	chr8:8576642	CLDN23	chr8:8559666-8561616:+	0.29	5	8.14E-7	Obesity-related traits	
LUAD	cis	1	rs9329166	chr8:8576655	CLDN23	chr8:8559666-8561616:+	-0.31	-5.39	1.1E-7	Obesity-related traits	
LUAD	cis	1	rs9330316	chr2:110284236	ANKRD57	chr2:110371911-110376563:+	-0.32	-5.39	1.09E-7	Schizophrenia	
LUAD	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.52	10.16	4.01E-22	Height	
LUAD	cis	1	rs9341531	chr6:76382065	IMPG1	chr6:76631062-76782335:-	0.31	4.39	1.37E-5	Height	
LUAD	cis	1	rs934298	chr2:137338721	THSD7B	chr2:137523115-138435287:+	0.28	4.15	3.87E-5	Cognitive test performance	
LUAD	cis	1	rs934299	chr2:137338940	THSD7B	chr2:137523115-138435287:+	0.28	4.13	4.31E-5	Cognitive test performance	
LUAD	cis	1	rs9343320	chr6:76415683	IMPG1	chr6:76631062-76782335:-	0.3	4.1	4.89E-5	Height	
LUAD	cis	1	rs9350596	chr6:76381046	IMPG1	chr6:76631062-76782335:-	0.31	4.26	2.47E-5	Height	
LUAD	cis	1	rs9352217	chr6:76259125	IMPG1	chr6:76631062-76782335:-	0.28	3.89	0.000113	Height	
LUAD	cis	1	rs9357037	chr6:27327349	ZNF391	chr6:27356524-27369227:+	0.22	3.78	0.000176	Glomerular filtration rate (creatinine)	
LUAD	cis	1	rs9357619	chr6:49490094	CENPQ	chr6:49431096-49460820:+	0.18	4.32	1.92E-5	Brain structure	
LUAD	cis	1	rs9359133	chr6:76325675	IMPG1	chr6:76631062-76782335:-	0.3	4.21	3.02E-5	Height	
LUAD	cis	1	rs9360921	chr6:76265642	IMPG1	chr6:76631062-76782335:-	0.28	3.89	0.000113	Height	
LUAD	cis	1	rs9360926	chr6:76299994	IMPG1	chr6:76631062-76782335:-	0.29	4.05	5.91E-5	Height	
LUAD	cis	1	rs9360930	chr6:76380677	IMPG1	chr6:76631062-76782335:-	0.31	4.39	1.37E-5	Height	
LUAD	cis	1	rs9360932	chr6:76387937	IMPG1	chr6:76631062-76782335:-	0.31	4.39	1.37E-5	Height	
LUAD	cis	1	rs9362395	chr6:87854341	C6orf163	chr6:88057220-88075180:+	-0.52	-5.55	4.72E-8	Schizophrenia	
LUAD	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.38	-10.33	9.48E-23	Homocysteine levels	
LUAD	cis	1	rs9371537	chr6:151872500	C6orf97	chr6:151815175-151942327:+	-0.16	-3.93	9.75E-5	Bone mineral density (spine)	
LUAD	cis	1	rs9372149	chr6:107473218	PDSS2	chr6:107473761-107780779:-	-0.25	-3.98	8.02E-5	Childhood and early adolescence aggressive behavior	
LUAD	cis	1	rs9377228	chr6:149921998	C6orf72	chr6:149887528-149912067:+	-0.2	-4.52	7.65E-6	Lung cancer	
LUAD	cis	1	rs9377228	chr6:149921998	NUP43	chr6:150045453-150067688:-	-0.27	-5.48	6.97E-8	Lung cancer	
LUAD	cis	1	rs9377229	chr6:149928791	C6orf72	chr6:149887528-149912067:+	-0.18	-4.11	4.71E-5	Lung cancer	
LUAD	cis	1	rs9377229	chr6:149928791	NUP43	chr6:150045453-150067688:-	-0.26	-5.05	6.15E-7	Lung cancer	
LUAD	cis	1	rs9381040	chr6:41154650	LOC221442	chr6:41068773-41108567:+	0.25	5.72	1.87E-8	Alzheimer's disease (late onset)	
LUAD	cis	1	rs9381469	chr6:46630068	SLC25A27	chr6:46620679-46645925:+	-0.18	-5.21	2.77E-7	QRS complex (Sokolow-Lyon)	
LUAD	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.37	9.52	7.78E-20	Homocysteine levels	
LUAD	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.42	-6.92	1.41E-11	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
LUAD	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.39	-10.74	2.61E-24	Homocysteine levels	
LUAD	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.72	-13.08	1.02E-33	Diastolic blood pressure	
LUAD	cis	1	rs9397240	chr6:155648579	TFB1M	chr6:155578791-155635626:-	0.31	4.49	8.91E-6	Life satisfaction	
LUAD	cis	1	rs9397425	chr6:151873024	C6orf97	chr6:151815175-151942327:+	0.17	3.79	0.000168	Bone mineral density (spine)	
LUAD	cis	1	rs9397427	chr6:151875034	C6orf97	chr6:151815175-151942327:+	0.16	3.74	0.000203	Bone mineral density (spine)	
LUAD	cis	1	rs9397428	chr6:151875080	C6orf97	chr6:151815175-151942327:+	0.17	3.81	0.000156	Bone mineral density (spine)	
LUAD	cis	1	rs9397429	chr6:151877569	C6orf97	chr6:151815175-151942327:+	0.18	3.88	0.000117	Bone mineral density (spine)	
LUAD	cis	1	rs9397431	chr6:151883930	C6orf97	chr6:151815175-151942327:+	0.17	3.71	0.000235	Bone mineral density (spine)	
LUAD	cis	1	rs9398235	chr6:110732116	DDO	chr6:110713384-110736753:-	-0.24	-4.71	3.25E-6	Systemic lupus erythematosus	
LUAD	cis	1	rs9399693	chr6:149933854	C6orf72	chr6:149887528-149912067:+	-0.19	-4.26	2.5E-5	Lung cancer	
LUAD	cis	1	rs9399693	chr6:149933854	NUP43	chr6:150045453-150067688:-	-0.26	-5.1	4.91E-7	Lung cancer	
LUAD	cis	1	rs9400478	chr6:111799644	KIAA1919	chr6:111580482-111590259:+	-0.48	-4.19	3.36E-5	Psoriasis	
LUAD	cis	1	rs940174	chr3:136309710	PCCB	chr3:135969167-136056737:+	0.28	6.17	1.4E-9	Schizophrenia	
LUAD	cis	1	rs940341	chr2:228724726	WDR69	chr2:228736327-228789026:+	0.28	5.82	1.09E-8	Blood pressure	
LUAD	cis	1	rs941653	chr14:35592538	PPP2R3C	chr14:35554679-35591679:-	0.25	3.73	0.000214	Atopic dermatitis	
LUAD	cis	1	rs9416684	chr10:59994722	IPMK	chr10:59955618-60027694:-	0.17	4.24	2.73E-5	Inflammatory bowel disease	
LUAD	cis	1	rs9419897	chr10:102246125	SEC31B	chr10:102246403-102289636:-	-0.2	-6.2	1.18E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs9420782	chr10:102235015	SEC31B	chr10:102246403-102289636:-	-0.19	-6.03	3.17E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs9420785	chr10:102240451	SEC31B	chr10:102246403-102289636:-	-0.19	-6.03	3.17E-9	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs9420797	chr10:102331147	SEC31B	chr10:102246403-102289636:-	-0.19	-6.33	5.48E-10	Palmitoleic acid (16:1n-7) plasma levels	
LUAD	cis	1	rs9423239	chr10:124740727	C10orf88	chr10:124690419-124713919:-	0.19	4.01	7.01E-5	Migraine without aura	
LUAD	cis	1	rs9423295	chr10:124733664	C10orf88	chr10:124690419-124713919:-	-0.19	-3.93	9.89E-5	Migraine without aura	
LUAD	cis	1	rs9426935	chr1:153769400	CREB3L4	chr1:153940379-153946832:+	-0.22	-4.71	3.22E-6	Lentiform nucleus volume	
LUAD	cis	1	rs942812	chr10:100153664	PYROXD2	chr10:100143323-100174978:-	0.34	3.74	0.000203	Aspartate aminotransferase	
LUAD	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.4	-7.39	6.39E-13	Body mass index	
LUAD	cis	1	rs9429183	chr1:46524582	MUTYH	chr1:45794915-45806142:-	0.17	3.85	0.000133	Body mass index	
LUAD	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.3	8.91	1.01E-17	Type 1 diabetes autoantibodies	
LUAD	cis	1	rs9463473	chr6:49380121	CENPQ	chr6:49431096-49460820:+	-0.26	-6.62	9.43E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.34	6.86	2.05E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9463474	chr6:49380199	CENPQ	chr6:49431096-49460820:+	-0.26	-6.62	9.43E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.34	6.86	2.05E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.26	6.46	2.6E-10	Folate pathway vitamin levels	
LUAD	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.34	-6.85	2.22E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9463477	chr6:49386446	CENPQ	chr6:49431096-49460820:+	-0.26	-6.62	9.68E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.34	6.99	9.16E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.38	-10.31	1.09E-22	Homocysteine levels	
LUAD	cis	1	rs9463479	chr6:49393275	CENPQ	chr6:49431096-49460820:+	-0.27	-6.68	6.65E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.34	6.93	1.33E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9463480	chr6:49400795	CENPQ	chr6:49431096-49460820:+	-0.27	-6.78	3.48E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.34	6.92	1.39E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.39	-7.17	2.84E-12	Body mass index	
LUAD	cis	1	rs946529	chr1:46485548	MUTYH	chr1:45794915-45806142:-	0.16	3.8	0.000164	Body mass index	
LUAD	cis	1	rs947211	chr1:205752665	PM20D1	chr1:205797154-205819245:-	-0.3	-5.42	9.15E-8	Parkinson's disease	
LUAD	cis	1	rs9473549	chr6:49380020	CENPQ	chr6:49431096-49460820:+	-0.26	-6.36	4.65E-10	Folate pathway vitamin levels	
LUAD	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.33	6.65	8.0E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.37	-10.08	7.92E-22	Homocysteine levels	
LUAD	cis	1	rs9473552	chr6:49387154	CENPQ	chr6:49431096-49460820:+	-0.27	-6.68	6.65E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.34	6.93	1.33E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9473553	chr6:49395977	CENPQ	chr6:49431096-49460820:+	-0.27	-6.71	5.33E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.34	6.99	8.81E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs9473555	chr6:49409487	CENPQ	chr6:49431096-49460820:+	-0.27	-6.74	4.51E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.34	6.95	1.19E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.28	-7.08	4.93E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.33	6.89	1.69E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.28	-7.03	6.77E-12	Folate pathway vitamin levels	
LUAD	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.33	6.91	1.5E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.27	-6.65	8.0E-11	Folate pathway vitamin levels	
LUAD	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.32	6.48	2.22E-10	Folate pathway vitamin levels	
LUAD	cis	1	rs9473582	chr6:49488908	CENPQ	chr6:49431096-49460820:+	0.17	4.23	2.82E-5	Brain structure	
LUAD	cis	1	rs9475752	chr6:56780741	BEND6	chr6:56819773-56892138:+	-0.25	-5.48	6.77E-8	Menarche (age at onset)	
LUAD	cis	1	rs9480933	chr6:109671391	AKD1	chr6:109814059-110012415:-	-0.19	-3.71	0.000229	Height	
LUAD	cis	1	rs9480933	chr6:109671391	SMPD2	chr6:109761931-109765121:+	0.23	4.57	6.28E-6	Height	
LUAD	cis	1	rs9480953	chr6:109739144	AKD1	chr6:109814059-110012415:-	-0.22	-4.22	2.9E-5	Height	
LUAD	cis	1	rs9480953	chr6:109739144	SMPD2	chr6:109761931-109765121:+	0.23	4.62	4.97E-6	Height	
LUAD	cis	1	rs9480955	chr6:109744533	AKD1	chr6:109814059-110012415:-	-0.2	-3.92	0.000101	Height	
LUAD	cis	1	rs9480955	chr6:109744533	SMPD2	chr6:109761931-109765121:+	0.22	4.28	2.21E-5	Height	
LUAD	cis	1	rs948562	chr11:58347765	CNTF	chr11:58390146-58393203:+	0.27	3.73	0.000214	Lymphoma	
LUAD	cis	1	rs9487094	chr6:109742015	AKD1	chr6:109814059-110012415:-	-0.21	-4.11	4.58E-5	Height	
LUAD	cis	1	rs9487094	chr6:109742015	SMPD2	chr6:109761931-109765121:+	0.23	4.53	7.51E-6	Height	
LUAD	cis	1	rs9487605	chr6:111582885	KIAA1919	chr6:111580482-111590259:+	-0.37	-6.67	6.94E-11	Inflammatory skin disease	
LUAD	cis	1	rs9491140	chr6:124691237	NKAIN2	chr6:124125069-125146784:+	0.2	3.9	0.00011	Neuroticism	
LUAD	cis	1	rs9491142	chr6:124693017	NKAIN2	chr6:124125069-125146784:+	0.2	3.73	0.000215	Neuroticism	
LUAD	cis	1	rs9494145	chr6:135432552	ALDH8A1	chr6:135238529-135271244:-	-0.27	-4.36	1.59E-5	Fetal hemoglobin levels in sickle cell anemia;Platelet count;Mean platelet volume;Red blood cell traits	
LUAD	cis	1	rs9500256	chr6:58308955	GUSBL2	chr6:58246159-58287724:-	-0.24	-4.79	2.16E-6	Eosinophilic esophagitis (pediatric)	
LUAD	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.38	-7.06	5.76E-12	Schizophrenia	
LUAD	cis	1	rs9503750	chr6:3824776	SERPINB1	chr6:2833736-2842081:-	-0.16	-3.7	0.000238	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	
LUAD	cis	1	rs950880	chr2:102932562	IL1RL1	chr2:102927962-102968497:+	-0.23	-4.38	1.45E-5	Serum protein levels (sST2)	
LUAD	cis	1	rs951366	chr1:205685352	PM20D1	chr1:205797154-205819245:-	-0.35	-7.14	3.39E-12	Menarche (age at onset)	
LUAD	cis	1	rs9524038	chr13:94038182	GPC6	chr13:93879078-95060267:+	-0.23	-3.75	0.000198	Neuroticism	
LUAD	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.41	-9.05	3.34E-18	Arsenic metabolism	
LUAD	cis	1	rs9528136	chr13:61013615	TDRD3	chr13:60970591-61148012:+	0.34	6.96	1.09E-11	Menopause (age at onset)	
LUAD	cis	1	rs9531455	chr13:36685304	C13orf38	chr13:36801182-36871992:-	0.24	3.78	0.000178	Optic cup area	
LUAD	cis	1	rs9538719	chr13:61052747	TDRD3	chr13:60970591-61148012:+	0.34	7.01	7.97E-12	Menopause (age at onset)	
LUAD	cis	1	rs9546421	chr13:36690750	C13orf38	chr13:36801182-36871992:-	0.24	3.71	0.000231	Optic cup area	
LUAD	cis	1	rs9546430	chr13:36692673	C13orf38	chr13:36801182-36871992:-	0.24	3.68	0.000261	Optic cup area	
LUAD	cis	1	rs9546434	chr13:36694391	C13orf38	chr13:36801182-36871992:-	0.24	3.69	0.000253	Optic cup area	
LUAD	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.65	12	2.97E-29	Response to antipsychotic treatment	
LUAD	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.65	-11.72	3.81E-28	Response to antipsychotic treatment	
LUAD	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.68	-12.27	2.43E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs9581943	chr13:28493997	PDX1	chr13:28494168-28500451:+	-0.17	-4.07	5.39E-5	Pancreatic cancer	
LUAD	cis	1	rs958755	chr3:56716922	CCDC66	chr3:56591184-56655846:+	0.19	5.5	6.04E-8	Height	
LUAD	cis	1	rs9591134	chr13:33148216	CG030	chr13:33078645-33083532:-	-0.13	-4.13	4.3E-5	Body mass index	
LUAD	cis	1	rs9591143	chr13:33159438	CG030	chr13:33078645-33083532:-	-0.13	-4.28	2.25E-5	Body mass index	
LUAD	cis	1	rs9591145	chr13:33161459	CG030	chr13:33078645-33083532:-	-0.13	-4.31	1.94E-5	Body mass index	
LUAD	cis	1	rs9591165	chr13:33185153	CG030	chr13:33078645-33083532:-	-0.12	-3.95	8.95E-5	Body mass index	
LUAD	cis	1	rs9593	chr12:109994870	MYO1H	chr12:109826524-109886176:+	0.39	7.24	1.76E-12	HDL cholesterol	
LUAD	cis	1	rs9595905	chr13:33183403	CG030	chr13:33078645-33083532:-	-0.12	-3.95	9.07E-5	Body mass index	
LUAD	cis	1	rs9595908	chr13:33184288	CG030	chr13:33078645-33083532:-	-0.13	-4.09	5.1E-5	Body mass index	
LUAD	cis	1	rs962221	chr1:92970770	EVI5	chr1:92974255-93257961:-	-0.27	-4.35	1.66E-5	Cholesterol, total	
LUAD	cis	1	rs962222	chr1:92970953	EVI5	chr1:92974255-93257961:-	-0.27	-4.35	1.66E-5	Cholesterol, total	
LUAD	cis	1	rs9624447	chr22:24681555	POM121L9P	chr22:24647589-24661490:+	-0.27	-5.93	5.87E-9	Gut microbiome composition (summer)	
LUAD	cis	1	rs963427	chr1:67609347	C1orf141	chr1:67557859-67600653:-	-0.19	-6.02	3.47E-9	Psoriasis	
LUAD	cis	1	rs9635324	chr15:40703211	DISP2	chr15:40650434-40663256:+	0.34	5.73	1.8E-8	Blood metabolite levels;Blood metabolite ratios	
LUAD	cis	1	rs9638180	chr7:72998952	MLXIPL	chr7:73007524-73038870:-	0.27	4.11	4.67E-5	Triglycerides	
LUAD	cis	1	rs9638182	chr7:72999105	MLXIPL	chr7:73007524-73038870:-	0.28	4.14	4.14E-5	Triglycerides	
LUAD	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.64	-12.14	7.8E-30	Response to antipsychotic treatment	
LUAD	cis	1	rs9653557	chr2:73795962	ALMS1	chr2:73612886-73837046:+	0.17	4.19	3.28E-5	Metabolite levels	
LUAD	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.39	7.53	2.41E-13	Metabolite levels	
LUAD	cis	1	rs965469	chr20:3381549	ITPA	chr20:3190056-3204504:+	-0.24	-4.32	1.9E-5	IFN-related cytopenia	
LUAD	cis	1	rs9655613	chr7:151713518	GALNT11	chr7:151722778-151819427:+	-0.17	-3.91	0.000104	Kidney function decline traits	
LUAD	cis	1	rs9661504	chr1:205915667	PM20D1	chr1:205797154-205819245:-	0.19	3.74	0.000209	Cystic fibrosis-related diabetes	
LUAD	cis	1	rs9662221	chr1:205915745	PM20D1	chr1:205797154-205819245:-	0.22	4.16	3.78E-5	Cystic fibrosis-related diabetes	
LUAD	cis	1	rs9665626	chr10:104300638	SFXN2	chr10:104474298-104498946:+	0.36	3.85	0.000135	Schizophrenia	
LUAD	cis	1	rs9672027	chr14:53976012	GPR137C	chr14:53019866-53104430:+	0.17	3.68	0.000258	Optic cup area	
LUAD	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.52	10.73	2.97E-24	Eye color traits	
LUAD	cis	1	rs9677476	chr2:232126290	HTR2B	chr2:231972952-231989824:-	-0.24	-4.37	1.53E-5	Food antigen IgG levels	
LUAD	cis	1	rs968433	chr20:4742080	PRND	chr20:4702556-4709105:+	-0.22	-3.95	9.03E-5	Systemic lupus erythematosus	
LUAD	cis	1	rs968434	chr20:4741960	PRND	chr20:4702556-4709105:+	0.23	4.07	5.55E-5	Systemic lupus erythematosus	
LUAD	cis	1	rs968567	chr11:61595564	FADS2	chr11:61583728-61634825:+	0.34	4.89	1.37E-6	Blood metabolite levels;Rheumatoid arthritis;Glycerophospholipid levels	
LUAD	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.33	7.79	3.98E-14	Erythrocyte sedimentation rate	
LUAD	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.51	-10.7	3.61E-24	Erythrocyte sedimentation rate	
LUAD	cis	1	rs9697030	chr9:131920181	CRAT	chr9:131857075-131873070:-	0.36	6.79	3.36E-11	Blood metabolite ratios	
LUAD	cis	1	rs9697030	chr9:131920181	PPP2R4	chr9:131873244-131911223:+	0.23	4.58	5.87E-6	Blood metabolite ratios	
LUAD	cis	1	rs9715911	chr5:156394441	TIMD4	chr5:156346293-156390266:-	-0.19	-3.76	0.000194	Triglycerides;Cholesterol, total;LDL cholesterol	
LUAD	cis	1	rs9729046	chr1:67607082	C1orf141	chr1:67557859-67600653:-	-0.18	-5.67	2.43E-8	Psoriasis	
LUAD	cis	1	rs974016	chr4:48409315	NIPAL1	chr4:48018791-48039078:+	0.19	3.84	0.000137	Crohn's disease;Inflammatory bowel disease	
LUAD	cis	1	rs974417	chr6:97419598	GPR63	chr6:97245889-97285353:-	-0.27	-4.02	6.88E-5	Body mass index	
LUAD	cis	1	rs9747164	chr17:61864787	FTSJ3	chr17:61896795-61905031:-	0.22	4.47	9.78E-6	Body mass index	
LUAD	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.52	10.73	3.03E-24	Eye color traits	
LUAD	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.52	10.74	2.56E-24	Eye color traits	
LUAD	cis	1	rs975459	chr6:151876909	C6orf97	chr6:151815175-151942327:+	0.17	3.81	0.000156	Bone mineral density (spine)	
LUAD	cis	1	rs9767077	chr6:150109615	C6orf72	chr6:149887528-149912067:+	-0.21	-4.77	2.45E-6	Lung cancer	
LUAD	cis	1	rs9767077	chr6:150109615	NUP43	chr6:150045453-150067688:-	-0.28	-5.58	4.03E-8	Lung cancer	
LUAD	cis	1	rs9769882	chr7:65642925	CCT6P1	chr7:65216092-65228661:+	-0.25	-3.92	0.000102	Diabetic kidney disease	
LUAD	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.5	9.99	1.7E-21	Forced vital capacity	
LUAD	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.27	5.08	5.44E-7	Pancreatic cancer	
LUAD	cis	1	rs9783386	chr11:18386625	GTF2H1	chr11:18343816-18388590:+	0.24	4.42	1.21E-5	Pancreatic cancer	
LUAD	cis	1	rs9793138	chr1:202339956	PPP1R12B	chr1:202317836-202557697:+	0.22	4.72	3.08E-6	Sex ratio	
LUAD	cis	1	rs9805979	chr14:75566209	MLH3	chr14:75480467-75518235:-	0.24	4.57	6.13E-6	Height	
LUAD	cis	1	rs9809263	chr3:190989466	UTS2D	chr3:190984945-191048325:-	-0.29	-6.02	3.33E-9	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.52	10.09	6.92E-22	Height	
LUAD	cis	1	rs980972	chr4:100279247	ADH1C	chr4:100257651-100273917:-	-0.19	-3.7	0.000239	Oral cavity and pharyngeal cancer	
LUAD	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.29	-7.03	6.81E-12	Longevity	
LUAD	cis	1	rs9810077	chr3:195005422	TFRC	chr3:195776156-195809032:-	-0.15	-3.69	0.000248	Body mass index	
LUAD	cis	1	rs9810089	chr3:135807609	PCCB	chr3:135969167-136056737:+	-0.23	-5.01	7.71E-7	Gestational age at birth (child effect)	
LUAD	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.28	7	8.23E-12	Longevity	
LUAD	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.52	10.13	5.14E-22	Height	
LUAD	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.51	-9.98	1.79E-21	Height	
LUAD	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.27	-6.53	1.68E-10	Longevity	
LUAD	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.7	12.14	8.3E-30	Diastolic blood pressure	
LUAD	cis	1	rs9817062	chr3:190978642	UTS2D	chr3:190984945-191048325:-	-0.24	-4.98	8.99E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.28	-7.15	3.22E-12	Longevity	
LUAD	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.68	12.13	8.65E-30	Diastolic blood pressure	
LUAD	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.52	10.08	7.71E-22	Height	
LUAD	cis	1	rs9821494	chr3:190979316	UTS2D	chr3:190984945-191048325:-	-0.25	-5.16	3.65E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs982256	chr7:110904226	IMMP2L	chr7:110303110-111202538:-	0.2	3.83	0.000144	Schizophrenia	
LUAD	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.7	12.09	1.33E-29	Diastolic blood pressure	
LUAD	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.7	12.09	1.33E-29	Diastolic blood pressure	
LUAD	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.29	-7.03	6.81E-12	Longevity	
LUAD	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.52	10.01	1.39E-21	Height	
LUAD	cis	1	rs9827082	chr3:112501840	CCDC80	chr3:112323411-112359977:-	0.12	3.81	0.000157	Prostate cancer (gene x gene interaction)	
LUAD	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.53	10.33	9.63E-23	Height	
LUAD	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.52	10.31	1.1E-22	Height	
LUAD	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.51	10.05	1.03E-21	Height	
LUAD	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.72	13.27	1.51E-34	Diastolic blood pressure	
LUAD	cis	1	rs9830468	chr3:23191098	RPL15	chr3:23958639-23965185:+	-0.2	-3.69	0.000245	Type 2 diabetes	
LUAD	cis	1	rs9832488	chr3:190981512	UTS2D	chr3:190984945-191048325:-	-0.26	-5.42	9.44E-8	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9832495	chr3:190981523	UTS2D	chr3:190984945-191048325:-	-0.26	-5.42	9.44E-8	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.52	10.2	2.7E-22	Height	
LUAD	cis	1	rs9832873	chr3:190981552	UTS2D	chr3:190984945-191048325:-	-0.26	-5.42	9.44E-8	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9833926	chr3:56650178	CCDC66	chr3:56591184-56655846:+	0.19	5.35	1.32E-7	Height	
LUAD	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.51	9.97	1.93E-21	Height	
LUAD	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.52	10.31	1.1E-22	Height	
LUAD	cis	1	rs9835332	chr3:56667682	CCDC66	chr3:56591184-56655846:+	0.18	5.21	2.75E-7	Height	
LUAD	cis	1	rs9835434	chr3:190986962	UTS2D	chr3:190984945-191048325:-	-0.29	-6.21	1.16E-9	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9835883	chr3:190987251	UTS2D	chr3:190984945-191048325:-	-0.3	-6.26	8.19E-10	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9836053	chr3:150885877	P2RY12	chr3:151055238-151102544:-	0.16	3.73	0.000216	Heschl's gyrus morphology	
LUAD	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.31	-7.9	1.82E-14	Longevity	
LUAD	cis	1	rs9839065	chr3:56716089	CCDC66	chr3:56591184-56655846:+	0.19	5.5	6.04E-8	Height	
LUAD	cis	1	rs9840500	chr3:136621338	PCCB	chr3:135969167-136056737:+	-0.22	-3.94	9.18E-5	Body mass index	
LUAD	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.72	13.32	9.3E-35	Diastolic blood pressure	
LUAD	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.51	9.84	5.93E-21	Height	
LUAD	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.38	-7.37	7.34E-13	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
LUAD	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.65	-11.45	4.7E-27	Diastolic blood pressure	
LUAD	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.7	12.07	1.54E-29	Diastolic blood pressure	
LUAD	cis	1	rs9847242	chr3:190989523	UTS2D	chr3:190984945-191048325:-	-0.29	-6.16	1.5E-9	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.67	11.47	4.06E-27	Diastolic blood pressure	
LUAD	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.63	10.23	2.26E-22	Diastolic blood pressure	
LUAD	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.29	-7.26	1.56E-12	Longevity	
LUAD	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.53	10.33	9.63E-23	Height	
LUAD	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.51	9.86	4.81E-21	Height	
LUAD	cis	1	rs9852327	chr3:190981404	UTS2D	chr3:190984945-191048325:-	-0.26	-5.42	9.44E-8	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9854249	chr3:190978633	UTS2D	chr3:190984945-191048325:-	-0.24	-4.98	8.99E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.51	10.04	1.08E-21	Height	
LUAD	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.66	10.72	3.11E-24	Diastolic blood pressure	
LUAD	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.68	12.13	8.65E-30	Diastolic blood pressure	
LUAD	cis	1	rs9856076	chr3:190987344	UTS2D	chr3:190984945-191048325:-	-0.3	-6.26	8.19E-10	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.68	12.13	8.65E-30	Diastolic blood pressure	
LUAD	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.73	13.37	5.56E-35	Diastolic blood pressure	
LUAD	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.51	9.83	6.51E-21	Height	
LUAD	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.69	12.9	5.45E-33	Diastolic blood pressure	
LUAD	cis	1	rs9857697	chr3:190991384	UTS2D	chr3:190984945-191048325:-	-0.3	-6.25	8.76E-10	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.52	10.1	6.58E-22	Height	
LUAD	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.63	10.46	3.03E-23	Diastolic blood pressure	
LUAD	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.51	9.88	4.25E-21	Height	
LUAD	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.29	-7.31	1.13E-12	Longevity	
LUAD	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.51	9.88	4.28E-21	Height	
LUAD	cis	1	rs9867325	chr3:136618909	PCCB	chr3:135969167-136056737:+	-0.22	-3.94	9.18E-5	Body mass index	
LUAD	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.74	-12.86	8.62E-33	Diastolic blood pressure	
LUAD	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.71	13.28	1.38E-34	Diastolic blood pressure	
LUAD	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.52	10.31	1.1E-22	Height	
LUAD	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.51	10.02	1.31E-21	Height	
LUAD	cis	1	rs9872999	chr3:133457514	TF	chr3:133419211-133497635:+	-0.27	-5.62	3.25E-8	Iron status biomarkers	
LUAD	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.7	12.02	2.55E-29	Diastolic blood pressure	
LUAD	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.7	12.14	8.3E-30	Diastolic blood pressure	
LUAD	cis	1	rs9874517	chr3:53128371	TMEM110	chr3:52867139-52931547:-	0.35	4.3	2.03E-5	Immune reponse to smallpox (secreted IL-2)	
LUAD	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.66	10.72	3.11E-24	Diastolic blood pressure	
LUAD	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.69	12.85	9.14E-33	Diastolic blood pressure	
LUAD	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.5	-10.01	1.37E-21	Height	
LUAD	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.28	-7.09	4.63E-12	Longevity	
LUAD	cis	1	rs9877400	chr3:190991439	UTS2D	chr3:190984945-191048325:-	0.31	6.45	2.68E-10	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9878373	chr3:56666957	CCDC66	chr3:56591184-56655846:+	0.18	5.21	2.75E-7	Height	
LUAD	cis	1	rs9878833	chr3:190988302	UTS2D	chr3:190984945-191048325:-	-0.28	-5.77	1.41E-8	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9879311	chr3:10415343	GHRLOS	chr3:10322637-10335132:+	0.26	5.99	4.03E-9	Schizophrenia	
LUAD	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.32	-8.15	3.16E-15	Longevity	
LUAD	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.52	10.16	3.9E-22	Height	
LUAD	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.32	-8.04	6.97E-15	Longevity	
LUAD	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.28	-7.15	3.22E-12	Longevity	
LUAD	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.53	10.32	1.01E-22	Height	
LUAD	cis	1	rs9889618	chr17:40293467	DHX58	chr17:40253422-40264751:-	-0.29	-5.56	4.34E-8	Fibrinogen levels	
LUAD	cis	1	rs9889640	chr17:40293497	DHX58	chr17:40253422-40264751:-	-0.29	-5.56	4.34E-8	Fibrinogen levels	
LUAD	cis	1	rs9890205	chr17:28382704	EFCAB5	chr17:28256874-28435469:+	-0.32	-5.68	2.26E-8	Coffee consumption (cups per day)	
LUAD	cis	1	rs9890205	chr17:28382704	SSH2	chr17:27952965-28257018:-	-0.16	-4.23	2.8E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs9890886	chr17:28391076	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.9	6.91E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs9890886	chr17:28391076	SSH2	chr17:27952965-28257018:-	-0.16	-4.27	2.31E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs9891018	chr17:61827856	FTSJ3	chr17:61896795-61905031:-	0.22	4.61	5.07E-6	Body mass index	
LUAD	cis	1	rs9891871	chr17:28370191	EFCAB5	chr17:28256874-28435469:+	-0.32	-5.72	1.82E-8	Coffee consumption (cups per day)	
LUAD	cis	1	rs9891871	chr17:28370191	SSH2	chr17:27952965-28257018:-	-0.16	-4.28	2.26E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs9893348	chr17:61676534	FTSJ3	chr17:61896795-61905031:-	0.23	4.76	2.6E-6	Body mass index	
LUAD	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.5	10.19	3.01E-22	Eye color traits	
LUAD	cis	1	rs9895920	chr17:61852719	FTSJ3	chr17:61896795-61905031:-	0.21	4.44	1.11E-5	Body mass index	
LUAD	cis	1	rs9896062	chr17:28357047	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.89	7.37E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs9896062	chr17:28357047	SSH2	chr17:27952965-28257018:-	-0.16	-4.27	2.33E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs9897206	chr17:28406108	EFCAB5	chr17:28256874-28435469:+	-0.34	-6.17	1.42E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs9897206	chr17:28406108	SSH2	chr17:27952965-28257018:-	-0.17	-4.46	1.01E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs9899491	chr17:61934384	FTSJ3	chr17:61896795-61905031:-	0.21	4.38	1.43E-5	Body mass index	
LUAD	cis	1	rs9899788	chr17:61756384	FTSJ3	chr17:61896795-61905031:-	0.19	3.96	8.49E-5	Body mass index	
LUAD	cis	1	rs9901112	chr17:61730617	FTSJ3	chr17:61896795-61905031:-	0.22	4.61	5.18E-6	Body mass index	
LUAD	cis	1	rs9901507	chr17:61765524	FTSJ3	chr17:61896795-61905031:-	0.19	4.15	3.95E-5	Body mass index	
LUAD	cis	1	rs9902453	chr17:28349095	EFCAB5	chr17:28256874-28435469:+	-0.33	-5.9	6.65E-9	Coffee consumption (cups per day)	
LUAD	cis	1	rs9902453	chr17:28349095	SSH2	chr17:27952965-28257018:-	-0.15	-4.03	6.55E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs9903204	chr17:40288062	DHX58	chr17:40253422-40264751:-	-0.28	-5.24	2.42E-7	Fibrinogen levels	
LUAD	cis	1	rs9903903	chr17:61762044	FTSJ3	chr17:61896795-61905031:-	0.19	4.09	4.95E-5	Body mass index	
LUAD	cis	1	rs9904677	chr17:56873025	RAD51C	chr17:56769963-56811690:+	0.22	4.6	5.35E-6	Cognitive test performance	
LUAD	cis	1	rs9906340	chr17:28398977	EFCAB5	chr17:28256874-28435469:+	-0.28	-5.19	3.05E-7	Coffee consumption (cups per day)	
LUAD	cis	1	rs9906340	chr17:28398977	SSH2	chr17:27952965-28257018:-	-0.14	-3.78	0.000176	Coffee consumption (cups per day)	
LUAD	cis	1	rs9908044	chr17:61747032	FTSJ3	chr17:61896795-61905031:-	0.19	3.97	8.24E-5	Body mass index	
LUAD	cis	1	rs9908102	chr17:12896553	ELAC2	chr17:12895703-12921359:-	0.24	4.52	7.62E-6	Schizophrenia	
LUAD	cis	1	rs9908349	chr17:76165368	SYNGR2	chr17:76164671-76169009:+	-0.18	-4.19	3.3E-5	Adenocarcinoma;Lung cancer	
LUAD	cis	1	rs9908552	chr17:1297991	TUSC5	chr17:1182957-1204281:+	-0.22	-4.45	1.08E-5	Schizophrenia	
LUAD	cis	1	rs9909940	chr17:80689036	FN3K	chr17:80693452-80709073:+	-0.2	-4.14	4.11E-5	Glycated hemoglobin levels	
LUAD	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.33	-5.52	5.43E-8	Glycated hemoglobin levels	
LUAD	cis	1	rs9909992	chr17:61731931	FTSJ3	chr17:61896795-61905031:-	0.22	4.58	5.94E-6	Body mass index	
LUAD	cis	1	rs9909	chr11:47799775	C1QTNF4	chr11:47611216-47615961:-	-0.22	-4.09	5.1E-5	Subjective well-being	
LUAD	cis	1	rs9909	chr11:47799775	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.46	1.03E-5	Subjective well-being	
LUAD	cis	1	rs9910816	chr17:66344703	FAM20A	chr17:66531258-66597095:-	-0.18	-3.83	0.000146	Bipolar disorder (inflammation and infection response interaction)	
LUAD	cis	1	rs9912088	chr17:40288278	DHX58	chr17:40253422-40264751:-	-0.28	-5.26	2.11E-7	Fibrinogen levels	
LUAD	cis	1	rs9912201	chr17:61763208	FTSJ3	chr17:61896795-61905031:-	0.23	4.73	2.93E-6	Body mass index	
LUAD	cis	1	rs9912741	chr17:28359511	EFCAB5	chr17:28256874-28435469:+	-0.32	-5.68	2.26E-8	Coffee consumption (cups per day)	
LUAD	cis	1	rs9912741	chr17:28359511	SSH2	chr17:27952965-28257018:-	-0.16	-4.23	2.8E-5	Coffee consumption (cups per day)	
LUAD	cis	1	rs9912904	chr17:61763534	FTSJ3	chr17:61896795-61905031:-	0.22	4.58	6.01E-6	Body mass index	
LUAD	cis	1	rs9914266	chr17:2133250	SRR	chr17:2207248-2228553:+	0.22	3.88	0.00012	Myocardial infarction	
LUAD	cis	1	rs991427	chr12:91474422	KERA	chr12:91444273-91452131:-	0.22	3.86	0.000128	Systolic blood pressure (alcohol consumption interaction)	
LUAD	cis	1	rs9914544	chr17:18787828	FAM18B	chr17:18684582-18710026:+	-0.22	-4.36	1.61E-5	Educational attainment (years of education)	
LUAD	cis	1	rs9914544	chr17:18787828	FBXW10	chr17:18647326-18682661:+	-0.23	-4.82	1.89E-6	Educational attainment (years of education)	
LUAD	cis	1	rs9915255	chr17:40284191	DHX58	chr17:40253422-40264751:-	-0.28	-5.11	4.71E-7	Fibrinogen levels	
LUAD	cis	1	rs9916245	chr17:18766825	FAM18B	chr17:18684582-18710026:+	-0.19	-3.69	0.000246	Educational attainment (years of education)	
LUAD	cis	1	rs9916245	chr17:18766825	FBXW10	chr17:18647326-18682661:+	-0.22	-4.43	1.17E-5	Educational attainment (years of education)	
LUAD	cis	1	rs9917716	chr3:190979147	UTS2D	chr3:190984945-191048325:-	-0.25	-5.17	3.48E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9917717	chr3:190979176	UTS2D	chr3:190984945-191048325:-	-0.25	-5.17	3.43E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9917773	chr3:190979184	UTS2D	chr3:190984945-191048325:-	-0.25	-5.17	3.43E-7	Age-related hearing impairment (interaction)	
LUAD	cis	1	rs9917978	chr4:165885143	C4orf39	chr4:165878100-165880273:+	0.3	5.8	1.22E-8	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs9917978	chr4:165885143	TRIM61	chr4:165875600-165898818:-	0.2	3.92	0.000101	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs9923145	chr16:74686166	RFWD3	chr16:74655298-74700779:-	-0.27	-6.35	4.85E-10	Testicular germ cell tumor	
LUAD	cis	1	rs992416	chr17:61745905	FTSJ3	chr17:61896795-61905031:-	0.21	4.47	9.89E-6	Body mass index	
LUAD	cis	1	rs9928374	chr16:67811930	PARD6A	chr16:67694851-67696680:+	0.37	3.67	0.000271	Crohn's disease	
LUAD	cis	1	rs9928374	chr16:67811930	RANBP10	chr16:67757006-67840555:-	0.33	3.75	0.000199	Crohn's disease	
LUAD	cis	1	rs9928847	chr16:68797893	NFATC3	chr16:68118654-68260837:+	-0.16	-3.76	0.000194	Colorectal cancer	
LUAD	cis	1	rs9929218	chr16:68820946	NFATC3	chr16:68118654-68260837:+	-0.17	-3.77	0.00018	Colorectal cancer	
LUAD	cis	1	rs9929423	chr16:67733113	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-4.1	4.78E-5	Crohn's disease	
LUAD	cis	1	rs9929423	chr16:67733113	HSD11B2	chr16:67465036-67471452:+	-0.39	-3.81	0.000154	Crohn's disease	
LUAD	cis	1	rs9929496	chr16:74668473	RFWD3	chr16:74655298-74700779:-	-0.28	-6.38	4.09E-10	Testicular germ cell tumor	
LUAD	cis	1	rs9931225	chr16:74699293	RFWD3	chr16:74655298-74700779:-	-0.29	-6.73	4.76E-11	Testicular germ cell tumor	
LUAD	cis	1	rs9936621	chr16:68798682	NFATC3	chr16:68118654-68260837:+	-0.16	-3.76	0.000191	Colorectal cancer	
LUAD	cis	1	rs9937664	chr16:68784603	NFATC3	chr16:68118654-68260837:+	-0.17	-3.86	0.000129	Colorectal cancer	
LUAD	cis	1	rs9938862	chr16:67723801	RANBP10	chr16:67757006-67840555:-	-0.32	-3.73	0.000218	Crohn's disease	
LUAD	cis	1	rs9939768	chr16:67219107	DPEP2	chr16:68021295-68034489:-	0.18	3.67	0.000271	HDL cholesterol	
LUAD	cis	1	rs9943661	chr11:32893777	CCDC73	chr11:32623627-32816187:-	0.22	4.2	3.24E-5	Parkinson's disease (age of onset)	
LUAD	cis	1	rs9954139	chr18:70282386	CBLN2	chr18:70203915-70211723:-	0.37	5.05	6.11E-7	Airflow obstruction	
LUAD	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.51	-9.95	2.25E-21	Height	
LUAD	cis	1	rs9981595	chr21:40560678	WRB	chr21:40752213-40769814:+	0.27	3.81	0.000155	Venous thromboembolism (SNP x SNP interaction)	
LUAD	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.5	-9.56	5.74E-20	Height	
LUAD	cis	1	rs9988450	chr1:62924448	DOCK7	chr1:62920398-63153969:-	-0.16	-3.88	0.000119	Triglycerides	
LUAD	cis	1	rs9988866	chr11:18392983	GTF2H1	chr11:18343816-18388590:+	0.27	5.19	3.07E-7	Pancreatic cancer	
LUAD	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.52	10.16	3.9E-22	Height	
LUAD	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.5	-9.8	8.05E-21	Height	
LUAD	cis	1	rs9990702	chr4:88772316	SPP1	chr4:88896802-88904562:+	-0.19	-3.82	0.000152	Bone mineral density;Bone mineral density (paediatric, total body less head)	
LUAD	cis	1	rs9991678	chr4:165885039	C4orf39	chr4:165878100-165880273:+	0.31	5.94	5.41E-9	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs9991678	chr4:165885039	TRIM61	chr4:165875600-165898818:-	0.2	3.92	9.92E-5	Ovarian cancer in BRCA1 mutation carriers	
LUAD	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.37	-7.37	7.24E-13	Longevity	
LUAD	cis	1	rs9998898	chr4:88772189	SPP1	chr4:88896802-88904562:+	-0.19	-3.82	0.000152	Bone mineral density;Bone mineral density (paediatric, total body less head)	
LUAD	cis	1	rs9998975	chr4:88772233	SPP1	chr4:88896802-88904562:+	-0.19	-3.82	0.000152	Bone mineral density;Bone mineral density (paediatric, total body less head)	
LUAD	trans	1	rs1001687	chr6:26573218	ZNF322B	chr9:99957633-99961910:-	0.4	7.99	9.88E-15	Educational attainment	
LUAD	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.47	-9.82	6.87E-21	Migraine without aura	
LUAD	trans	1	rs10179758	chr2:169868814	FLI1	chr11:128556430-128683161:+	0.26	6.02	3.46E-9	Liver enzyme levels (alkaline phosphatase)	
LUAD	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.39	7.85	2.72E-14	Educational attainment	
LUAD	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.38	7.77	4.62E-14	Educational attainment	
LUAD	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.79E-14	Educational attainment	
LUAD	trans	1	rs10742862	chr11:48649316	FOLH1B	chr11:89392465-89431885:+	-0.32	-6.19	1.25E-9	HDL cholesterol	
LUAD	trans	1	rs10769371	chr11:48531184	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.45E-10	HDL cholesterol	
LUAD	trans	1	rs10769390	chr11:48618222	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.65	7.97E-11	HDL cholesterol	
LUAD	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.03E-14	Educational attainment	
LUAD	trans	1	rs10794671	chr1:121168242	NBPF14	chr1:148003643-148346791:-	0.31	6.98	9.78E-12	Hip geometry	
LUAD	trans	1	rs10838912	chr11:48496477	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.67	6.83E-11	HDL cholesterol	
LUAD	trans	1	rs10838917	chr11:48503127	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.66	7.29E-11	HDL cholesterol	
LUAD	trans	1	rs10838931	chr11:48540973	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.49	2.07E-10	HDL cholesterol	
LUAD	trans	1	rs10838943	chr11:48557442	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.48	2.24E-10	HDL cholesterol	
LUAD	trans	1	rs10838944	chr11:48559571	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.63	9.05E-11	HDL cholesterol	
LUAD	trans	1	rs10838954	chr11:48579323	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.69	6.01E-11	HDL cholesterol	
LUAD	trans	1	rs10838966	chr11:48589723	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.68	6.35E-11	HDL cholesterol	
LUAD	trans	1	rs10838971	chr11:48606624	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.54	1.51E-10	HDL cholesterol	
LUAD	trans	1	rs10838975	chr11:48617615	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.45E-10	HDL cholesterol	
LUAD	trans	1	rs10839171	chr11:48923034	FOLH1B	chr11:89392465-89431885:+	0.33	6.56	1.33E-10	HDL cholesterol	
LUAD	trans	1	rs10903159	chr1:121181997	NBPF14	chr1:148003643-148346791:-	0.32	7.12	3.77E-12	Hip geometry	
LUAD	trans	1	rs10903161	chr1:121178741	NBPF14	chr1:148003643-148346791:-	0.32	7.08	5.09E-12	Hip geometry	
LUAD	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.38	7.74	5.67E-14	Educational attainment	
LUAD	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.1E-14	Educational attainment	
LUAD	trans	1	rs11039745	chr11:48463811	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.65	7.95E-11	HDL cholesterol	
LUAD	trans	1	rs11039777	chr11:48517049	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.7	5.84E-11	HDL cholesterol	
LUAD	trans	1	rs11039779	chr11:48517895	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.68	6.5E-11	HDL cholesterol	
LUAD	trans	1	rs11039800	chr11:48542579	FOLH1B	chr11:89392465-89431885:+	0.33	6.6	1.06E-10	HDL cholesterol	
LUAD	trans	1	rs11039817	chr11:48561480	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.58	1.23E-10	HDL cholesterol	
LUAD	trans	1	rs11039819	chr11:48562181	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.66	7.21E-11	HDL cholesterol	
LUAD	trans	1	rs11039820	chr11:48562252	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.66	7.46E-11	HDL cholesterol	
LUAD	trans	1	rs11039821	chr11:48562875	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.58	1.23E-10	HDL cholesterol	
LUAD	trans	1	rs11039851	chr11:48600839	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.68	6.43E-11	HDL cholesterol	
LUAD	trans	1	rs11039854	chr11:48607688	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.64	8.31E-11	HDL cholesterol	
LUAD	trans	1	rs11039857	chr11:48610853	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.59	1.15E-10	HDL cholesterol	
LUAD	trans	1	rs11039859	chr11:48611988	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.45E-10	HDL cholesterol	
LUAD	trans	1	rs11039862	chr11:48618306	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.62	9.27E-11	HDL cholesterol	
LUAD	trans	1	rs11039868	chr11:48622146	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.65	7.97E-11	HDL cholesterol	
LUAD	trans	1	rs11039871	chr11:48626620	FOLH1B	chr11:89392465-89431885:+	0.34	6.71	5.39E-11	HDL cholesterol	
LUAD	trans	1	rs11039890	chr11:48653468	FOLH1B	chr11:89392465-89431885:+	-0.32	-6.3	6.52E-10	HDL cholesterol	
LUAD	trans	1	rs11249350	chr1:121178446	NBPF14	chr1:148003643-148346791:-	0.32	7.12	3.77E-12	Hip geometry	
LUAD	trans	1	rs11249351	chr1:121171942	NBPF14	chr1:148003643-148346791:-	0.33	7.43	5.0E-13	Hip geometry	
LUAD	trans	1	rs115224187	chr11:48757499	FOLH1B	chr11:89392465-89431885:+	0.34	6.6	1.04E-10	HDL cholesterol	
LUAD	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.1E-14	Educational attainment	
LUAD	trans	1	rs11965538	chr6:28239915	BTN3A2	chr6:26365398-26378546:+	-0.35	-6.53	1.63E-10	Depression	
LUAD	trans	1	rs12047116	chr1:121185770	NBPF14	chr1:148003643-148346791:-	0.32	7.12	3.93E-12	Hip geometry	
LUAD	trans	1	rs12145080	chr1:121185531	NBPF14	chr1:148003643-148346791:-	-0.31	-6.8	2.99E-11	Hip geometry	
LUAD	trans	1	rs12361812	chr11:48563104	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.58	1.23E-10	HDL cholesterol	
LUAD	trans	1	rs12365220	chr11:48555957	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.48	2.24E-10	HDL cholesterol	
LUAD	trans	1	rs12366208	chr11:48563128	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.53	1.68E-10	HDL cholesterol	
LUAD	trans	1	rs12419576	chr11:48581644	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.7	5.93E-11	HDL cholesterol	
LUAD	trans	1	rs12420372	chr11:48497603	FOLH1B	chr11:89392465-89431885:+	0.33	6.55	1.46E-10	HDL cholesterol	
LUAD	trans	1	rs12421159	chr11:48624841	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.65	7.97E-11	HDL cholesterol	
LUAD	trans	1	rs12421879	chr11:48689978	FOLH1B	chr11:89392465-89431885:+	-0.32	-6.31	6.35E-10	HDL cholesterol	
LUAD	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.38	7.75	5.38E-14	Educational attainment	
LUAD	trans	1	rs12663883	chr6:26577326	ZNF322B	chr9:99957633-99961910:-	0.41	8.16	2.79E-15	Educational attainment	
LUAD	trans	1	rs12665431	chr6:26577308	ZNF322B	chr9:99957633-99961910:-	0.41	8.09	4.91E-15	Educational attainment	
LUAD	trans	1	rs12806328	chr11:48647971	FOLH1B	chr11:89392465-89431885:+	-0.32	-6.34	5.27E-10	HDL cholesterol	
LUAD	trans	1	rs13195401	chr6:26463574	ZFP57	chr6:29640171-29648887:-	0.61	6.08	2.37E-9	Schizophrenia	
LUAD	trans	1	rs13195402	chr6:26463575	ZFP57	chr6:29640171-29648887:-	0.61	6.08	2.37E-9	Schizophrenia	
LUAD	trans	1	rs13200462	chr6:28218199	BTN3A2	chr6:26365398-26378546:+	-0.36	-6.48	2.2E-10	Depression	
LUAD	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.36	-7.43	4.94E-13	Educational attainment	
LUAD	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.1E-14	Educational attainment	
LUAD	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.38	7.77	4.82E-14	Educational attainment	
LUAD	trans	1	rs1419183	chr6:28242794	BTN3A2	chr6:26365398-26378546:+	-0.35	-6.44	2.83E-10	Depression	
LUAD	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.38	7.8	3.74E-14	Educational attainment	
LUAD	trans	1	rs1570059	chr6:26573325	ZNF322B	chr9:99957633-99961910:-	0.41	8.1	4.56E-15	Educational attainment	
LUAD	trans	1	rs1570060	chr6:26573562	ZNF322B	chr9:99957633-99961910:-	0.4	7.99	9.88E-15	Educational attainment	
LUAD	trans	1	rs1570061	chr6:26575986	ZNF322B	chr9:99957633-99961910:-	0.4	7.99	9.88E-15	Educational attainment	
LUAD	trans	1	rs1591882	chr1:121183313	NBPF14	chr1:148003643-148346791:-	0.31	7	8.65E-12	Hip geometry	
LUAD	trans	1	rs1605364	chr11:48684843	FOLH1B	chr11:89392465-89431885:+	-0.31	-6.16	1.51E-9	HDL cholesterol	
LUAD	trans	1	rs1679709	chr6:28228342	BTN3A2	chr6:26365398-26378546:+	0.35	6.49	2.07E-10	Depression	
LUAD	trans	1	rs1679732	chr6:28221264	BTN3A2	chr6:26365398-26378546:+	0.34	6.41	3.45E-10	Depression	
LUAD	trans	1	rs1778508	chr6:28229881	BTN3A2	chr6:26365398-26378546:+	0.33	6.24	9.28E-10	Depression	
LUAD	trans	1	rs1778511	chr6:28229411	BTN3A2	chr6:26365398-26378546:+	0.36	6.7	5.7E-11	Depression	
LUAD	trans	1	rs1809986	chr11:48987539	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.52	1.76E-10	HDL cholesterol	
LUAD	trans	1	rs1832558	chr1:121177380	NBPF14	chr1:148003643-148346791:-	0.31	6.89	1.73E-11	Hip geometry	
LUAD	trans	1	rs1856572	chr1:121169579	NBPF14	chr1:148003643-148346791:-	0.31	7.05	5.97E-12	Hip geometry	
LUAD	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.38	7.71	7.17E-14	Educational attainment	
LUAD	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.38	7.8	3.74E-14	Educational attainment	
LUAD	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.03E-14	Educational attainment	
LUAD	trans	1	rs1936365	chr6:28268452	BTN3A2	chr6:26365398-26378546:+	0.36	6.59	1.13E-10	Depression	
LUAD	trans	1	rs1977201	chr6:26573674	ZNF322B	chr9:99957633-99961910:-	0.4	7.99	9.88E-15	Educational attainment	
LUAD	trans	1	rs1979	chr6:26377591	ZFP57	chr6:29640171-29648887:-	0.54	6.12	1.93E-9	Schizophrenia	
LUAD	trans	1	rs1986111	chr1:121204788	NBPF14	chr1:148003643-148346791:-	0.32	7.05	6.27E-12	Hip geometry	
LUAD	trans	1	rs2084385	chr3:196553867	LOC646214	chr15:21932514-21940739:-	-0.44	-6.89	1.71E-11	Total ventricular volume (Alzheimer's disease interaction)	
LUAD	trans	1	rs2185281	chr1:121179991	NBPF14	chr1:148003643-148346791:-	0.31	6.86	2.12E-11	Hip geometry	
LUAD	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.79E-14	Educational attainment	
LUAD	trans	1	rs2221559	chr11:48707973	FOLH1B	chr11:89392465-89431885:+	0.33	6.44	2.95E-10	HDL cholesterol	
LUAD	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.38	7.77	4.62E-14	Educational attainment	
LUAD	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.81E-14	Educational attainment	
LUAD	trans	1	rs2292239	chr12:56482180	RPS26P11	chrX:71264259-71264809:+	0.45	8.77	3.06E-17	Cognitive function	
LUAD	trans	1	rs2319969	chr1:121207335	NBPF14	chr1:148003643-148346791:-	0.31	6.9	1.61E-11	Hip geometry	
LUAD	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.38	7.69	8.29E-14	Educational attainment	
LUAD	trans	1	rs2799077	chr6:28234597	BTN3A2	chr6:26365398-26378546:+	-0.35	-6.58	1.22E-10	Depression	
LUAD	trans	1	rs2799079	chr6:28235176	BTN3A2	chr6:26365398-26378546:+	-0.34	-6.48	2.29E-10	Depression	
LUAD	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.18E-14	Educational attainment	
LUAD	trans	1	rs34636547	chr11:48590103	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.68	6.35E-11	HDL cholesterol	
LUAD	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.79E-14	Educational attainment	
LUAD	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.79E-14	Educational attainment	
LUAD	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.38	7.73	6.22E-14	Educational attainment	
LUAD	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.38	7.77	4.82E-14	Educational attainment	
LUAD	trans	1	rs4759229	chr12:56474480	RPS26P11	chrX:71264259-71264809:+	-0.41	-7.57	1.84E-13	Cognitive function	
LUAD	trans	1	rs4844380	chr1:121193620	NBPF14	chr1:148003643-148346791:-	0.3	6.84	2.33E-11	Hip geometry	
LUAD	trans	1	rs4844381	chr1:121184898	NBPF14	chr1:148003643-148346791:-	0.31	7.13	3.59E-12	Hip geometry	
LUAD	trans	1	rs4844607	chr1:121184059	NBPF14	chr1:148003643-148346791:-	-0.29	-6.71	5.25E-11	Hip geometry	
LUAD	trans	1	rs4844616	chr1:121171208	NBPF14	chr1:148003643-148346791:-	0.33	7.55	2.22E-13	Hip geometry	
LUAD	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.38	7.71	7.17E-14	Educational attainment	
LUAD	trans	1	rs4881994	chr11:48498139	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.68	6.46E-11	HDL cholesterol	
LUAD	trans	1	rs4882010	chr11:48559173	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.63	9.05E-11	HDL cholesterol	
LUAD	trans	1	rs4882015	chr11:48565573	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.51	1.89E-10	HDL cholesterol	
LUAD	trans	1	rs4882016	chr11:48570125	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.61	9.9E-11	HDL cholesterol	
LUAD	trans	1	rs4882017	chr11:48570182	FOLH1B	chr11:89392465-89431885:+	0.33	6.66	7.37E-11	HDL cholesterol	
LUAD	trans	1	rs4882019	chr11:48598748	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.42E-10	HDL cholesterol	
LUAD	trans	1	rs4882021	chr11:48615966	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.45E-10	HDL cholesterol	
LUAD	trans	1	rs4882096	chr11:48534102	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.45E-10	HDL cholesterol	
LUAD	trans	1	rs4882111	chr11:48558447	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.63	9.05E-11	HDL cholesterol	
LUAD	trans	1	rs4882117	chr11:48565468	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.51	1.89E-10	HDL cholesterol	
LUAD	trans	1	rs4882120	chr11:48573529	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.58	1.22E-10	HDL cholesterol	
LUAD	trans	1	rs4882123	chr11:48575739	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.58	1.22E-10	HDL cholesterol	
LUAD	trans	1	rs4882129	chr11:48588774	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.68	6.35E-11	HDL cholesterol	
LUAD	trans	1	rs4882130	chr11:48588954	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.68	6.35E-11	HDL cholesterol	
LUAD	trans	1	rs4882132	chr11:48593125	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.6	1.05E-10	HDL cholesterol	
LUAD	trans	1	rs4882134	chr11:48598795	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.42E-10	HDL cholesterol	
LUAD	trans	1	rs4882136	chr11:48615311	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.65	7.97E-11	HDL cholesterol	
LUAD	trans	1	rs4925166	chr17:18210810	LOC162632	chr17:16614993-16707819:+	0.48	9.35	3.21E-19	Multiple sclerosis	
LUAD	trans	1	rs55834832	chr11:48562583	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.58	1.23E-10	HDL cholesterol	
LUAD	trans	1	rs61504845	chr2:169856729	PREX1	chr20:47240793-47444420:-	0.35	6.02	3.46E-9	Liver enzyme levels (alkaline phosphatase)	
LUAD	trans	1	rs641862	chr13:110790232	ABHD13	chr13:108870763-108886602:+	0.57	6.12	1.9E-9	Obesity-related traits	
LUAD	trans	1	rs641862	chr13:110790232	ARGLU1	chr13:107195664-107220514:-	0.4	6.33	5.6E-10	Obesity-related traits	
LUAD	trans	1	rs641862	chr13:110790232	CDC16	chr13:115000362-115038150:+	0.84	7.67	9.11E-14	Obesity-related traits	
LUAD	trans	1	rs641862	chr13:110790232	CUL4A	chr13:113863086-113919391:+	0.75	6.52	1.76E-10	Obesity-related traits	
LUAD	trans	1	rs641862	chr13:110790232	DCUN1D2	chr13:114110134-114145023:-	0.61	6.83	2.56E-11	Obesity-related traits	
LUAD	trans	1	rs641862	chr13:110790232	ERCC5	chr13:103459496-103528345:+	0.56	6.47	2.33E-10	Obesity-related traits	
LUAD	trans	1	rs641862	chr13:110790232	LAMP1	chr13:113951469-113977741:+	0.62	6.06	2.71E-9	Obesity-related traits	
LUAD	trans	1	rs641862	chr13:110790232	LIG4	chr13:108859794-108870716:-	0.7	6.54	1.54E-10	Obesity-related traits	
LUAD	trans	1	rs641862	chr13:110790232	TPP2	chr13:103249286-103331521:+	0.64	6.41	3.52E-10	Obesity-related traits	
LUAD	trans	1	rs641862	chr13:110790232	UPF3A	chr13:115047078-115071281:+	0.64	6.57	1.3E-10	Obesity-related traits	
LUAD	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.39	7.9	1.84E-14	Educational attainment	
LUAD	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.38	7.8	3.74E-14	Educational attainment	
LUAD	trans	1	rs6456735	chr6:26574149	ZNF322B	chr9:99957633-99961910:-	0.41	8.1	4.56E-15	Educational attainment	
LUAD	trans	1	rs6485872	chr11:48579710	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.5	1.95E-10	HDL cholesterol	
LUAD	trans	1	rs6485875	chr11:48581034	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.65	8.02E-11	HDL cholesterol	
LUAD	trans	1	rs6485888	chr11:48605339	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.54	1.51E-10	HDL cholesterol	
LUAD	trans	1	rs6485903	chr11:48639004	FOLH1B	chr11:89392465-89431885:+	-0.31	-6.12	1.92E-9	HDL cholesterol	
LUAD	trans	1	rs6485907	chr11:48651695	FOLH1B	chr11:89392465-89431885:+	-0.32	-6.38	4.21E-10	HDL cholesterol	
LUAD	trans	1	rs6485911	chr11:48654784	FOLH1B	chr11:89392465-89431885:+	-0.31	-6.17	1.47E-9	HDL cholesterol	
LUAD	trans	1	rs6600669	chr1:121213639	NBPF14	chr1:148003643-148346791:-	0.32	7.09	4.61E-12	Hip geometry	
LUAD	trans	1	rs6600671	chr1:121200490	NBPF14	chr1:148003643-148346791:-	-0.31	-6.63	8.69E-11	Hip geometry	
LUAD	trans	1	rs68141011	chr6:28217797	BTN3A2	chr6:26365398-26378546:+	-0.36	-6.48	2.2E-10	Depression	
LUAD	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.48	10.17	3.58E-22	Migraine without aura	
LUAD	trans	1	rs6901575	chr6:28250984	BTN3A2	chr6:26365398-26378546:+	-0.36	-6.58	1.18E-10	Depression	
LUAD	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.75E-14	Educational attainment	
LUAD	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.38	7.73	6.22E-14	Educational attainment	
LUAD	trans	1	rs6913462	chr6:26577530	ZNF322B	chr9:99957633-99961910:-	0.4	7.99	9.88E-15	Educational attainment	
LUAD	trans	1	rs6918360	chr6:26577867	ZNF322B	chr9:99957633-99961910:-	0.41	8.16	2.79E-15	Educational attainment	
LUAD	trans	1	rs6918506	chr6:26577857	ZNF322B	chr9:99957633-99961910:-	0.41	8.16	2.79E-15	Educational attainment	
LUAD	trans	1	rs6918854	chr6:26577924	ZNF322B	chr9:99957633-99961910:-	0.41	8.16	2.79E-15	Educational attainment	
LUAD	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.39	-8.03	7.19E-15	Educational attainment	
LUAD	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.03E-14	Educational attainment	
LUAD	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.38	7.73	6.22E-14	Educational attainment	
LUAD	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.03E-14	Educational attainment	
LUAD	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.75E-14	Educational attainment	
LUAD	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.38	7.77	4.62E-14	Educational attainment	
LUAD	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.03E-14	Educational attainment	
LUAD	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.38	7.77	4.82E-14	Educational attainment	
LUAD	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.38	7.75	5.48E-14	Educational attainment	
LUAD	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.37	7.44	4.44E-13	Educational attainment	
LUAD	trans	1	rs705696	chr12:56480648	RPS26P11	chrX:71264259-71264809:+	0.44	7.94	1.36E-14	Cognitive function	
LUAD	trans	1	rs7107184	chr11:48577069	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.53	1.69E-10	HDL cholesterol	
LUAD	trans	1	rs7121460	chr11:48545232	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.43	3.07E-10	HDL cholesterol	
LUAD	trans	1	rs7121992	chr11:48592582	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.57	1.31E-10	HDL cholesterol	
LUAD	trans	1	rs7129386	chr11:48616694	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.45E-10	HDL cholesterol	
LUAD	trans	1	rs72843784	chr6:26498758	ZFP57	chr6:29640171-29648887:-	0.64	6.08	2.4E-9	Schizophrenia	
LUAD	trans	1	rs735765	chr6:28170297	BTN3A2	chr6:26365398-26378546:+	-0.4	-6.64	8.2E-11	Depression	
LUAD	trans	1	rs7395662	chr11:48518893	FOLH1B	chr11:89392465-89431885:+	0.33	6.51	1.83E-10	HDL cholesterol	
LUAD	trans	1	rs7478900	chr11:48544003	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.49	2.07E-10	HDL cholesterol	
LUAD	trans	1	rs7479134	chr11:48625409	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.63	8.84E-11	HDL cholesterol	
LUAD	trans	1	rs7479498	chr11:48660499	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.46	2.48E-10	HDL cholesterol	
LUAD	trans	1	rs7481308	chr11:48600067	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.61	1.01E-10	HDL cholesterol	
LUAD	trans	1	rs7481880	chr11:48609347	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.64	8.31E-11	HDL cholesterol	
LUAD	trans	1	rs7482176	chr11:48604620	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.59	1.14E-10	HDL cholesterol	
LUAD	trans	1	rs7482528	chr11:48640052	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.41	3.4E-10	HDL cholesterol	
LUAD	trans	1	rs7483920	chr11:48599969	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.42E-10	HDL cholesterol	
LUAD	trans	1	rs7532615	chr1:121172840	NBPF14	chr1:148003643-148346791:-	-0.34	-7.71	7.23E-14	Hip geometry	
LUAD	trans	1	rs76329678	chr5:49830286	LOC647121	chr1:121260910-121313686:+	-0.32	-6.57	1.29E-10	Schizophrenia	
LUAD	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.38	7.77	4.62E-14	Educational attainment	
LUAD	trans	1	rs7738109	chr6:105610727	C12orf11	chr12:27058115-27091254:-	-0.4	-6.14	1.68E-9	Multiple sclerosis	
LUAD	trans	1	rs7740487	chr6:28216486	BTN3A2	chr6:26365398-26378546:+	-0.36	-6.48	2.2E-10	Depression	
LUAD	trans	1	rs7868954	chr9:4889208	FAM118B	chr11:126081619-126132540:+	0.27	6.2	1.2E-9	Dementia and core Alzheimer's disease neuropathologic changes	
LUAD	trans	1	rs7925955	chr11:48647533	FOLH1B	chr11:89392465-89431885:+	-0.32	-6.34	5.27E-10	HDL cholesterol	
LUAD	trans	1	rs7928083	chr11:48613148	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.55	1.45E-10	HDL cholesterol	
LUAD	trans	1	rs7931984	chr11:48580835	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.65	8.1E-11	HDL cholesterol	
LUAD	trans	1	rs7938880	chr11:48642154	FOLH1B	chr11:89392465-89431885:+	-0.32	-6.3	6.56E-10	HDL cholesterol	
LUAD	trans	1	rs7944356	chr11:48610154	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.59	1.15E-10	HDL cholesterol	
LUAD	trans	1	rs7945192	chr11:48580737	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.65	8.1E-11	HDL cholesterol	
LUAD	trans	1	rs7948486	chr11:48912140	FOLH1B	chr11:89392465-89431885:+	0.31	6.23	9.94E-10	HDL cholesterol	
LUAD	trans	1	rs7949348	chr11:48493801	FOLH1B	chr11:89392465-89431885:+	-0.33	-6.67	6.83E-11	HDL cholesterol	
LUAD	trans	1	rs7949554	chr11:48581992	FOLH1B	chr11:89392465-89431885:+	-0.34	-6.68	6.35E-11	HDL cholesterol	
LUAD	trans	1	rs853676	chr6:28299687	BTN3A2	chr6:26365398-26378546:+	-0.37	-6.41	3.41E-10	Depression	
LUAD	trans	1	rs853678	chr6:28297313	BTN3A2	chr6:26365398-26378546:+	-0.38	-6.95	1.2E-11	Depression	
LUAD	trans	1	rs853679	chr6:28296863	BTN3A2	chr6:26365398-26378546:+	-0.38	-6.95	1.2E-11	Depression	
LUAD	trans	1	rs853685	chr6:28288785	BTN3A2	chr6:26365398-26378546:+	-0.39	-7.01	8.04E-12	Depression	
LUAD	trans	1	rs853694	chr6:28279100	BTN3A2	chr6:26365398-26378546:+	-0.36	-6.37	4.28E-10	Depression	
LUAD	trans	1	rs877636	chr12:56480583	RPS26P11	chrX:71264259-71264809:+	-0.46	-8.57	1.41E-16	Cognitive function	
LUAD	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.38	-7.73	6.25E-14	Educational attainment	
LUAD	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.35	7.23	1.86E-12	Educational attainment	
LUAD	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.79E-14	Educational attainment	
LUAD	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.38	7.73	6.1E-14	Educational attainment	
LUAD	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.1E-14	Educational attainment	
LUAD	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.1E-14	Educational attainment	
LUAD	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.79E-14	Educational attainment	
LUAD	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.38	7.67	9.18E-14	Educational attainment	
LUAD	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.75E-14	Educational attainment	
LUAD	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.39	7.8	3.79E-14	Educational attainment	
LUAD	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.1E-14	Educational attainment	
LUAD	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.37	-7.53	2.46E-13	Educational attainment	
LUAD	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.38	7.71	7.17E-14	Educational attainment	
LUAD	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.37	7.59	1.66E-13	Educational attainment	
LUAD	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.38	7.67	9.18E-14	Educational attainment	
LUAD	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.37	-7.48	3.48E-13	Educational attainment	
LUAD	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.03E-14	Educational attainment	
LUAD	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.38	7.79	4.03E-14	Educational attainment	
LUAD	trans	1	rs9467798	chr6:26575697	ZNF322B	chr9:99957633-99961910:-	0.4	7.99	9.88E-15	Educational attainment	
LUAD	trans	1	rs9467799	chr6:26578364	ZNF322B	chr9:99957633-99961910:-	0.42	8.27	1.26E-15	Educational attainment	
LUAD	trans	1	rs9467800	chr6:26578525	ZNF322B	chr9:99957633-99961910:-	0.41	8.16	2.79E-15	Educational attainment	
LUAD	trans	1	rs9467802	chr6:26581168	ZNF322B	chr9:99957633-99961910:-	0.41	8.16	2.79E-15	Educational attainment	
LUAD	trans	1	rs9645642	chr11:48705455	FOLH1B	chr11:89392465-89431885:+	-0.32	-6.3	6.54E-10	HDL cholesterol	
LUAD	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.38	7.61	1.4E-13	Educational attainment	
LUAD	trans	1	rs9986596	chr6:28219661	BTN3A2	chr6:26365398-26378546:+	-0.35	-6.31	6.31E-10	Depression	
